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Abstract	  
Hepatocytes	   are	   the	   main	   functional	   cells	   of	   the	   liver	   and	   are	   used	   extensively	   in	   vitro	   for	  
predicting	   in	   vivo	   drug	   toxicity	  profiles.	  However,	   the	  predictive	  accuracy	  of	   in	   vitro	   hepatocyte	  
models	  depends	  on	  the	  physiological	  relevance	  of	  the	  artificial	  growth	  environment.	  Conventional	  
in	   vitro	   hepatocyte	   models	   have	   employed	   monolayer	   cultures	   on	   two-­‐dimensional	   (2D)	  
substrates,	  forcing	  cells	  into	  a	  flattened	  morphology	  that	  is	  far	  removed	  from	  the	  in	  vivo	  scenario.	  
Unsurprisingly,	   2D	   cultures	   often	   show	   significant	   deviations	   from	   native	   liver	   genotype	   and	  
phenotype	  and	   so	  are	  unable	   to	  accurately	  predict	  drug	   toxicity.	  Accordingly,	   it	   is	  hypothesised	  
that	  approximating	  the	  native	  liver	  three-­‐dimensional	  (3D)	  tissue	  architecture	  in	  vitro	  will	  help	  to	  
preserve	  genotype	  and	  phenotype	  and	  so	  improve	  predictive	  accuracy.	  
	  
In	   this	   study,	   emulsion	   templated	   porous	   polymers	   were	   investigated	   as	   scaffolds	   for	   3D	  
hepatocyte	   culture.	   In	   particular,	   porous	   polystyrene	   scaffolds	  were	   explored	   due	   to	   their	   high	  
porosity,	  reproducibility	  and	  suitable	  mechanical	  strength	  properties.	  Hepatocytes	  were	  cultured	  
on	   polystyrene	   scaffolds	   under	   a	   range	   of	   culture	   conditions	   and	   were	   found	   to	   approximate	  
native	   liver	   density	   and	   architecture.	   The	   morphology	   of	   hepatocytes	   in	   scaffolds	   was	  
representative	  of	   in	  vivo,	  unlike	   the	   flattened	  morphology	  of	  2D	  cultures.	  Crucial	  ultrastructural	  
features	   involved	   in	   drug	   detoxification	   such	   as	   bile	   canaliculi	   were	   also	   present	   in	   scaffold	  
cultures,	   but	   almost	   absent	   from	   2D	   cultures.	   Importantly,	   these	   representative	   structural	  
features	   translated	   into	   functional	   and	   genetic	   improvements	   in	   vitro.	   Hepatocytes	   in	   scaffolds	  
displayed	  increased	  albumin	  synthesis,	  a	  key	  marker	  of	  hepatocyte	  function.	  Hepatic	  cell	  lines	  also	  
showed	  increased	  resistance	  to	  drug	  toxicity	  compared	  to	  2D	  cultures.	  Hepatic	  drug	  metabolising	  
genotype	  was	  also	  increased	  to	  more	  physiologically	  relevant	  levels	   in	  scaffolds	  compared	  to	  2D	  
cultures.	  
	  
In	   addition,	   emulsion	   templated	   polystyrene	   scaffolds	   were	   also	   made	   more	   biochemically	  
relevant	   by	   surface	   functionalising	   with	   galactose,	   a	   ligand	   known	   to	   selectively	   bind	   to	  
hepatocytes	   in	   vivo	   via	   the	   asialoglycoprotein	   receptor	   (ASGP-­‐R).	   Scaffold	   morphology	   was	  
maintained	  with	  the	   incorporation	  of	  galactose,	  allowing	  cells	   to	  approximate	  native	   liver	   tissue	  
architecture.	   Moreover,	   the	   pendent	   galactose	   ligands	   were	   found	   to	   be	   accessible	   to	  
hepatocytes	  adhering	  onto	  the	  scaffold.	  
	  
In	   summary,	   this	   thesis	   has	   shown	   that	   emulsion	   templated	  porous	  polymers	   can	  offer	   a	  more	  
physiologically	  relevant	  growth	  environment	  for	  hepatocytes	  in	  vitro.	  	  This	  could	  have	  a	  profound	  
effect	  on	  improving	  drug	  toxicity	  predictions	  and	  so	  reducing	  the	  dependence	  on	  animal	  testing.	  	  
	   	   iii	  
Acknowledgements	  
	  
I	  would	  like	  to	  acknowledge	  the	  Engineering	  and	  Physical	  Sciences	  Research	  Council	  (EPSRC),	  the	  
Chemistry	   Innovation	  Knowledge	  Transfer	  Network	  (CIKTN)	  and	  Reinnervate	  Ltd	  for	   funding	  this	  
thesis.	  
	  
I	  would	  also	  like	  to	  thank	  the	  following	  people:	  
	  
My	  supervisors	  Professor	  Stefan	  Przyborski	  and	  Professor	  Neil	  Cameron	  for	  all	  their	  kind	  support	  
and	  guidance	  over	  the	  three	  years.	  	  
	  
Dan	   Maltman,	   Frederique	   Tholozan,	   Ross	   Carnachan,	   Bridie	   Murray	   and	   David	   Johnson	   for	   all	  
their	  technical	  advice	  and	  training.	  Christine	  Richardson,	  Helen	  Grindly	  and	  Helen	  Riggs	  for	  their	  
support	  in	  electron	  microscopy.	  Naoko	  Sano	  for	  her	  expertise	  at	  Nexus	  and	  David	  Apperley	  from	  
the	  Durham	  NMR	  service.	  
	  
All	   members,	   past	   and	   present	   of	   the	   two	   research	   groups,	   for	   making	   my	   studentship	   an	  
enjoyable	   and	   memorable	   experience.	   A	   special	   thanks	   to	   Paul	   Thornton,	   Dan	   Tams,	   Matt	  
Didsbury	  and	  Andy	  Henderson	  for	  their	  friendship.	  	  	  
	  
To	  Mum,	  Paul,	  Dad,	  Maurissa,	  Jamie	  and	  Kent	  for	  their	  endless	  love	  and	  support	  throughout	  my	  
life.	  Without	  their	  encouragement	  I	  would	  not	  have	  had	  the	  courage	  to	  leave	  my	  career	  to	  pursue	  
a	  Ph.D.	  	  
	  
Finally,	  to	  Charlene	  who	  has	  stood	  by	  me	  throughout	  and	  put	  up	  with	  the	  frustrations,	  late	  nights	  
and	  even	  writing-­‐up	  on	  holiday.	  I	  am	  so	  grateful	  to	  you.	  
	  




	   	   	   iv	  
Declaration	  
	  
The	  work	  described	  herein	  was	  carried	  out	  in	  the	  School	  of	  Biological	  and	  Biomedical	  Sciences,	  or	  
the	  Department	  of	  Chemistry,	  University	  of	  Durham,	  between	  October	  2010	  and	  February	  2014.	  	  
All	  of	  the	  work	  is	  my	  own,	  except	  where	  specifically	  stated	  otherwise.	  No	  part	  has	  previously	  been	  
submitted	  for	  a	  degree	  at	  this	  or	  any	  other	  university.	  
	  
Statement	  of	  Copyright	  
	  
The	   copyright	   of	   this	   thesis	   rests	   with	   the	   author.	   No	   quotation	   from	   it	   should	   be	   published	  
without	  prior	  written	  consent	  and	  information	  derived	  from	  it	  should	  be	  acknowledged.	  
	  
	   	   	   v	  
Table	  of	  Contents	  
	  
Thesis	  Publications	  and	  Thesis	  Presentations	  (Oral)	   	   	   	   	   	   i	  
Abstract	   	   	   	   	   	   	   	   	   	   	   ii	  
Acknowledgements	   	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  iii	  
Declaration	  and	  Statement	  of	  Copyright	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  iv	  
Table	  of	  Contents	   	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  v-­‐viii	  
List	  of	  Abbreviations	   	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  ix-­‐xi	  
	  
Chapter	  1:	   Literature	  Review	  ................................................................................................	  1	  
1.1	   Hepatocytes	  In	  Vivo	  .......................................................................................................	  2	  
1.1.1	   The	  Liver	  ........................................................................................................................	  2	  
1.1.2	   Hepatocyte	  Cells	  ...........................................................................................................	  3	  
1.1.3	   Role	  of	  Hepatocytes	  in	  Drug	  Metabolism	  .....................................................................	  8	  
1.2	   In	  Vitro	  Hepatocyte	  Culture	  .........................................................................................	  12	  
1.2.1	   General	  Principles	  of	  Animal	  Cell	  Culture:	  2D	  versus	  3D	  ............................................	  12	  
1.2.2	   Conventional	  2D	  Hepatocyte	  Culture	  in	  Drug	  Discovery	  ............................................	  13	  
1.2.3	   The	  Concept	  of	  3D	  Hepatocyte	  Culture	  in	  Drug	  Discovery	  .........................................	  14	  
1.3	   Technology	  Developments	  to	  Enable	  3D	  In	  Vitro	  Hepatocyte	  Culture	  ..........................	  16	  
1.3.1	   Sandwiching	  with	  Extracellular	  Matrix	  Proteins	  .........................................................	  18	  
1.3.2	   Spheroidal	  Aggregate	  Cultures	  ...................................................................................	  19	  
1.3.3	   Hydrogels	  ....................................................................................................................	  20	  
1.3.4	   Electrospun	  Scaffolds.	  .................................................................................................	  22	  
1.3.5	   Rapid	  Prototyping	  .......................................................................................................	  24	  
1.3.6	   Porous	  Polymers	  from	  Fibre	  Bonding	  .........................................................................	  25	  
1.3.7	   Porous	  Polymers	  from	  Solvent	  Casting	  /	  Particle	  Leaching	  ........................................	  26	  
1.3.8	   Porous	  Polymers	  from	  Gas	  Foaming	  ...........................................................................	  27	  
1.3.9	   Porous	  Polymers	  from	  Phase	  Separation	  ....................................................................	  27	  
1.3.10	   Porous	  Polymers	  from	  Emulsion	  Freeze	  Drying	  ........................................................	  28	  
1.4	   Porous	  Polymers	  from	  Emulsion	  Templating	  ...............................................................	  29	  
1.5	   Summary	  .....................................................................................................................	  34	  
1.6	   Project	  Aims	  ................................................................................................................	  35	  
Chapter	  2:	   Materials	  and	  Methods	  .....................................................................................	  36	  
2.1	   Biological	  Procedures	  ..................................................................................................	  37	  
	   	   	   vi	  
2.1.1	   Cell	  Culture	  .................................................................................................................	  37	  
2.1.2	   Coating	  Scaffolds	  with	  Extracellular	  Matrix	  Proteins	  ..................................................	  40	  
2.1.3	   Media	  Perfusion	  Using	  the	  Reinnervate	  Perfusion	  Plate	  ............................................	  40	  
2.1.4	   Histology	  .....................................................................................................................	  45	  
2.1.5	   Imaging	  .......................................................................................................................	  46	  
2.1.6	   Functional	  Assays	  ........................................................................................................	  48	  
2.1.7	   Real	  Time	  Quantitative	  Polymerase	  Chain	  Reaction	  ...................................................	  51	  
2.2	   Procedures	  For	  Materials	  Chemistry	  ............................................................................	  53	  
2.2.1	   Synthesis	  of	  Galactose-­‐Functionalised	  Emulsion	  Templated	  Polystyrene	  Scaffolds	  ...	  53	  
2.2.2	   Scanning	  Electron	  Microscopy	  ....................................................................................	  61	  
2.2.3	   Mercury	  Intrusion	  Porosimetry	  ..................................................................................	  61	  
2.2.4	   Attenuated	  Total	  Reflection	  Fourier	  Transform	  Infra	  Red	  Spectroscopy	  ...................	  61	  
2.2.5	   Solid	  State	  Nuclear	  Magnetic	  Resonance	  Spectroscopy	  .............................................	  61	  
2.2.6	   X-­‐Ray	  Photoelectron	  Spectroscopy	  .............................................................................	  62	  
2.2.7	   Toluidine	  Blue	  O	  Staining	  ............................................................................................	  62	  
2.2.8	   Acid-­‐Base	  Back	  Titration	  .............................................................................................	  62	  
2.2.9	   Scaffold	  Wettability	  By	  Water	  .....................................................................................	  62	  
Chapter	  3:	   Hepatocyte	  Growth	  in	  Emulsion	  Templated	  Polystyrene	  Scaffolds	  Under	  
Different	  Culture	  Conditions	  .....................................................................................................	  63	  
3.1	   Introduction	  ................................................................................................................	  64	  
3.1.1	   Overview	  .....................................................................................................................	  64	  
3.1.2	   Alvetex®Scaffold	  and	  Alvetex®Strata.	  .........................................................................	  64	  
3.1.3	   Anticipated	  Hepatocyte	  Growth	  on	  Alvetex®Scaffold	  and	  Alvetex®Strata	  .................	  65	  
3.1.4	   Scaffold	  Presentation	  and	  Culture	  Conditions	  ............................................................	  67	  
3.1.5	   The	  Use	  of	  Extracellular	  Matrix	  Proteins	  in	  Hepatocyte	  Culture	  ................................	  68	  
3.1.6	   The	  Use	  of	  Media	  Perfusion	  in	  Hepatocyte	  Culture	  ...................................................	  69	  
3.1.7	   Sources	  of	  Hepatocytes	  for	  In	  Vitro	  Use	  .....................................................................	  69	  
3.2	   Aims	  and	  Objectives	  ....................................................................................................	  71	  
3.3	   Results	  ........................................................................................................................	  72	  
3.3.1	   Hepatocyte	  Growth	  in	  2D	  ...........................................................................................	  72	  
3.3.2	   Characterisation	  of	  Alvetex®Scaffold	  and	  Alvetex®Strata	  ..........................................	  76	  
3.3.3	   Hepatocyte	  Growth	  on	  Alvetex®Scaffold	  ....................................................................	  79	  
3.3.4	   Hepatocyte	  Growth	  on	  Alvetex®Strata	  .......................................................................	  92	  
3.3.5	   Optimising	  the	  Scaffold	  Microenvironment	  with	  Protein	  Coatings	  ..........................	  101	  
3.3.6	   Optimising	  the	  Scaffold	  Microenvironment	  with	  Media	  Perfusion	  ..........................	  112	  
	   	   	   vii	  
3.3.7	   Extracting	  Intact	  Hepatocytes	  from	  the	  Scaffold	  Microenvironment	  .......................	  116	  
3.4	   Discussion	  .................................................................................................................	  121	  
3.5	   Conclusions	  ...............................................................................................................	  126	  
Chapter	  4:	   Structure,	  Function	  and	  Gene	  Expression	  of	  Hepatocytes	  Cultured	  in	  Emulsion	  
Templated	  Polystyrene	  Scaffolds	  ............................................................................................	  128	  
4.1	   Introduction	  ..............................................................................................................	  129	  
4.1.1	   Overview	  ...................................................................................................................	  129	  
4.1.2	   Previous	  Reports	  on	  Hepatocyte	  Structure,	  Function	  and	  Gene	  Expression	  in	  
Emulsion	  Templated	  Polystyrene	  Scaffolds	  ...........................................................................	  129	  
4.1.3	   Acetaminophen	  and	  Gemfibrozil	  Metabolism	  ..........................................................	  130	  
4.1.4	   Probing	  Structure,	  Function	  and	  Gene	  Expression	  in	  3D	  ..........................................	  131	  
4.2	   Aims	  and	  Objectives	  ..................................................................................................	  133	  
4.3	   Results	  ......................................................................................................................	  134	  
4.3.1	   Hepatocyte	  Morphology	  ...........................................................................................	  134	  
4.3.2	   Hepatocyte	  Ultrastructure	  ........................................................................................	  140	  
4.3.3	   Hepatocyte	  Function	  (3D	  Static	  versus	  2D	  Static)	  .....................................................	  154	  
4.3.4	   Hepatocyte	  Function	  (3D	  Static	  versus	  3D	  Perfused)	  ...............................................	  159	  
4.3.5	   Hepatocyte	  Gene	  Expression	  ....................................................................................	  161	  
4.4	   Discussion	  .................................................................................................................	  164	  
4.5	   Conclusions	  ...............................................................................................................	  169	  
Chapter	  5:	   Functionalising	  Emulsion	  Templated	  Polystyrene	  Scaffolds	  with	  Galactose	  for	  
Enhanced	  Hepatocyte	  Adhesion	  and	  Function	  ........................................................................	  171	  
5.1	   Introduction	  ..............................................................................................................	  172	  
5.1.1	   Overview	  ...................................................................................................................	  172	  
5.1.2	   Composition	  of	  Emulsion	  Templated	  Polystyrene	  Scaffolds	  .....................................	  173	  
5.1.3	   Synthetic	  Strategy	  .....................................................................................................	  173	  
5.2	   Aims	  and	  Objectives	  ..................................................................................................	  176	  
5.3	   Results	  ......................................................................................................................	  177	  
5.3.1	   Sample	  Naming	  Protocol	  ..........................................................................................	  177	  
5.3.2	   Incorporating	  PFPA	  as	  a	  Functional	  Co-­‐Monomer	  ....................................................	  177	  
5.3.3	   Attaching	  Galactose	  onto	  Poly[26PFPA-­‐SDE(AIBN)]	  .................................................	  184	  
5.3.4	   Assessing	  Hepatocyte	  Function	  on	  GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  ...........................	  188	  
5.3.5	   Incorporating	  Aa	  as	  a	  Functional	  Co-­‐Monomer	  ........................................................	  190	  
5.3.6	   Additional	  Attempts	  at	  Incorporating	  Aa	  using	  KPS	  Initiation	  ..................................	  197	  
	   	   	   viii	  
5.4	   Discussion	  .................................................................................................................	  199	  
5.5	   Conclusions	  ...............................................................................................................	  202	  
Chapter	  6:	   Concluding	  Remarks	  and	  Future	  Work	  ............................................................	  203	  
6.1	   Concluding	  Remarks	  ..................................................................................................	  204	  
6.1.1	   Recap	  of	  Research	  Field	  and	  Project	  Aim	  .................................................................	  204	  
6.1.2	   Summary	  of	  Thesis	  Conclusions	  ................................................................................	  206	  
6.2	   Future	  work	  ..............................................................................................................	  208	  
Chapter	  7:	   References	  ......................................................................................................	  211	  
ix	  
List	  of	  Abbreviations	  
	  
2D	   	   Two-­‐Dimensional	   	  
3D	   	   Three-­‐Dimensional	   	  
Aa	   	   Acrylic	  Acid	   	   	  
ABC	   	   Adenosine	  Triphosphate	  Binding	  Cassette	  (Protein)	  
AIBN	   	   Azobisisobutyronitrile	   	  
APAP	   	   Acetaminophen	  
ASGP-­‐R	   	   Asialoglycoprotein	  Receptor	  
ATR-­‐FTIR	   	   Attenuated	  Total	  Reflection	  Fourier	  Transform	  Infra	  Red	  
BC	   	   Bile	  Canaliculi	   	  
BCRP	   	   Breast	  Cancer	  Resistance	  Protein	  
BD	   	   Interlobular	  Bile	  Duct	   	  
BEC	   	   Biliary	  Epithelial	  Cell	   	  
BPO	   	   Benzoyl	  Peroxide	   	  
BSEP	   	   Bile	  Salt	  Export	  Pump	   	  
CM	   	   Cell	  Membrane	   	  
CoH	   	   Canals	  of	  Herring	   	  
CV	   	   Central	  Vein	   	   	  
CYP	   	   Cytochrome	  P450	   	  
D	   	   Desmosomes	   	  
DMEM	   	   Dulbecco’s	  Modified	  Eagle’s	  Medium	  
DMSO	   	   Dimethyl	  Sulfoxide	   	  
dsDNA	   	   Double	  Stranded	  Deoxyribonucleic	  Acid	  
DVB	   	   Divinylbenzene	   	  
ECM	  	   	   Extracellular	  Matrix	   	  
EHA	   	   2-­‐Ethylhexyl	  Acrylate	   	  
ELISA	   	   Enzyme-­‐linked	  Immunosorbent	  Assay	  
FMO	   	   Flavin-­‐containing	  Monooxygenase	  
GLY	   	   Glycogen	  	   	   	  
GST	   	   Glutathione	  S-­‐transferase	  
HA	   	   Hepatic	  Artery	  
H&E	   	   Haematoxylin	  and	  Eosin	  Staining	  (Histology)	  
HepG2	   	   Human	  Hepatocellular	  Carcinoma	  Cell	  Line	  
HIPE	   	   High	  Internal	  Phase	  Emulsion	  
x	  
HLB	   	   Hydrophilic	  Lipophilic	  Balance	  
HPC	   	   Hepatic	  Progenitor	  Cell	   	  
HPLC	   	   High	  Performance	  Liquid	  Chromatography	  
HSC	   	   Hepatic	  Stellate	  Cell	   	  
KC	   	   Kupffer	  Cell	   	   	  
KPS	   	   Potassium	  Persulfate	   	  
LD	   	   Lipid	  Storing	  Droplets	   	  
LSEC	   	   Liver	  Sinusoidal	  Endothelial	  Cell	  
MDR1	   	   Multi-­‐Drug	  Resistance	  Protein	  1	  
MEM	   	   Minimum	  Essential	  Medium	  
MRP2	   	   Multi-­‐Drug	  Resistance	  Protein	  2	  
MRP3	   	   Multi-­‐Drug	  Resistance	  Protein	  3	  
MRP4	   	   Multi-­‐Drug	  Resistance	  Protein	  4	  
Mt	   	   Mitochondria	   	  
MTT	   	   Thiazolyl	  Blue	  Tetrazolium	  Bromide	  
MV	   	   Microvilli	   	   	  
NAT	   	   N-­‐Acetyltransferase	   	  
NU	   	   Nucleus	   	   	  
O/W	   	   Oil	  in	  Water	  Emulsion	   	  
OAT	   	   Organic	  Anion	  Transporter	  
OATP	   	   Organic	  Anion	  Transport	  Polypeptide	  
OCT	   	   Organic	  Cationic	  Transporter	  
PBS	   	   Phosphate-­‐Buffered	  Saline	  Solution	  
PCL	   	   Polycaprolactone	   	  
PFPA	   	   Pentafluorophenyl	  Acrylate	  
PolyHIPE	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Polymerised	  High	  Internal	  Phase	  Emulsion	  
PV	   	   Portal	  Vein	   	   	  
RER	   	   Rough	  Endoplasmic	  Reticulum	  
RNA	   	   Ribonucleic	  Acid	   	  
RT-­‐PCR	   	   Real-­‐Time	  Quantitative	  Polymerase	  Chain	  Reaction	  
SC	   	   Scaffold	   	   	  
SEM	   	   Scanning	  Electron	  Microscopy	  
SER	   	   Smooth	  Endoplasmic	  Reticulum	  
SoD	   	   Space	  of	  Disse	   	  
ssNMR	   	   Solid	  State	  Nuclear	  Magnetic	  Resonance	  
	   	   	   xi	  
STY	   	   Styrene	   	   	  
SULT	   	   Sulfotransferase	   	  
TBO	   	   Toluidine	  Blue	  O	  	   	  
TEM	   	   Transmission	  Electron	  Microscopy	  
TJ	   	   Tight	  Junction	   	  
UGT	   	   Uridine	  Diphosphate	  Glucuronosyl	  Transferase	  
UV	   	   Ultraviolet	   	   	  
W/O	   	   Water	  in	  Oil	  Emulsion	   	  
XPS	   	   X-­‐ray	  Photoelectron	  Spectroscopy	  
Za	   	   Zonula	  Adherens	   	  
Zo	   	   Zonula	  Occludens	   	  
	   	   	   	   	  
	  













Chapter	  1: Literature	  Review	  
	  
	   2	  
1.1 Hepatocytes	  In	  Vivo	  
In	  order	  to	  re-­‐create	  the	  native	   liver	  environment	   in	  vitro	   it	   is	   first	  necessary	  to	  understand	  the	  
anatomy	  and	  physiology	  experienced	  by	  hepatocytes	   in	  vivo.	   	  This	   first	   section	   therefore	  briefly	  
introduces	   the	   liver	   and	   then	   focuses	   on	   the	   structural	   organisation	   of	   hepatocytes	  within	   the	  
liver.	   A	   description	   of	   hepatocyte	   drug	   metabolism	   physiology	   is	   also	   described	   in	   relation	   to	  
structural	  organisation.	  
	  
1.1.1 The	  Liver	  	  
The	  liver	  is	  the	  largest	  internal	  organ	  and	  gland	  in	  the	  human	  body	  and	  is	  essential	  for	  survival.	  It	  
is	   estimated	   to	   perform	   over	   500	   functions	   and	   plays	   a	   crucial	   role	   in	   digestion,	   metabolism,	  
immunity,	  nutrient	  storage,	  protein	  synthesis	  and	  xenobiotic	  metabolism1.	  	  
	  
1.1.1.1 Gross	  Liver	  Anatomy	  
The	   liver	   is	   a	   soft	   reddish-­‐brown	   organ	   that	   is	   surrounded	   by	   a	   collagenous	   capsule.	   It	   is	  
approximately	  triangular	  in	  shape	  and	  normally	  weighs	  around	  1.5	  kg	  in	  humans2.	  It	  is	  located	  in	  
the	  upper	  right-­‐hand	  side	  of	  the	  abdominal	  cavity,	   just	  below	  the	  diaphragm	  and	  to	  the	  right	  of	  
the	  stomach.	  It	  is	  normally	  divided	  into	  two	  lobes	  when	  viewing	  the	  parietal	  surface;	  a	  large	  right	  
lobe	   and	   a	   smaller	   left	   lobe.	   However	   when	   viewing	   the	   visceral	   surface,	   the	   liver	   is	   typically	  
divided	  into	  four	  lobes;	  right,	  left,	  quadrate	  and	  caudate	  lobes.	  The	  liver	  receives	  its	  blood	  supply	  
from	  two	  major	  blood	  vessels;	  the	  hepatic	  portal	  vein	  and	  the	  hepatic	  artery.	  The	  hepatic	  portal	  
vein	   carries	   venous	   blood	   from	   the	   stomach,	   intestines,	   pancreas	   and	   spleen	   and	   therefore	  
contains	   nutrient-­‐rich/oxygen-­‐poor	   blood	   from	   the	   digestive	   system.	   The	   hepatic	   artery	   stems	  
from	  the	  celiac	  artery	  (a	  descendent	  of	  the	  aorta)	  and	  thus	  supplies	  more	  nutrient-­‐poor/oxygen-­‐
rich	  blood	  into	  the	  liver.	  Blood	  exits	  the	  liver	  via	  the	  hepatic	  veins	  into	  the	  inferior	  vena	  cava	  to	  re-­‐
join	  the	  circulation	  system.	  
	  
1.1.1.2 General	  Liver	  Physiology	  
The	  liver	  has	  many	  functions.	  It	  produces	  bile	  that	  aids	  the	  emulsification	  and	  digestion	  of	  fats.	  It	  
metabolises	   glucose	   into	   the	  macromolecule	   glycogen	   for	   energy	   storage.	   Similarly	   it	   converts	  
glycogen	  back	  into	  glucose	  as	  a	  timely	  energy	  release.	  It	  stores	  essential	  vitamins	  and	  minerals.	  It	  
removes	   various	   bacteria,	   fungi	   and	   parasites	   from	   the	   blood	   stream	   to	   play	   a	   pivotal	   role	   in	  
immunity.	   It	   synthesises	   and	   regulates	   blood	   plasma	  proteins.	   It	   detoxifies	   ammonia	   into	   urea.	  
The	   liver	   is	   also	   the	   principle	   organ	   concerned	   with	   drug/xenobiotic	   metabolism	   and	  
detoxification	  (see	  section	  1.1.3).	  Uniquely,	  the	  liver	  is	  also	  the	  only	  organ	  in	  the	  human	  body	  to	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possess	  a	  regenerative	  capacity,	  and	   is	  able	  to	  reconstruct	   its	  entire	  mass	  from	  just	  25	  %	  of	  the	  
original	  tissue.	  
	  
1.1.2 Hepatocyte	  Cells	  
Hepatocytes	  are	  the	  main	  functional	  cells	  of	  the	  liver	  and	  constitute	  approximately	  80	  %	  of	  total	  
human	  liver	  volume3.	  They	  perform	  most	  functions	  commonly	  associated	  with	  the	  liver,	  including	  
xenobiotic	  metabolism,	  plasma	  protein	  synthesis,	  ammonia	  detoxification,	  glycogen	  storage	  and	  
bile	   secretion4.	   Structurally,	   hepatocytes	   are	   part	   of	   a	   complex	   three-­‐dimensional	   (3D)	  
architecture	  that	  is	  highly	  vascularised	  by	  blood	  sinusoids.	  The	  repeating	  structural	  unit	  of	  this	  3D	  
architecture	  is	  known	  as	  the	  liver	  lobule3	  (see	  Figure	  1.1).	  Thousands	  of	  lobules	  make	  up	  a	  single	  
lobe	  of	  the	  liver.	  When	  viewed	  under	  cross	  section,	  lobules	  are	  hexagonal	  in	  shape.	  At	  the	  centre	  
of	  each	   lobule	   is	   the	  central	  vein,	  which	  serves	  as	   the	  drainage	  point	   for	   the	  vascularised	  blood	  
network.	  At	  the	  corners	  of	  each	  hexagonal	  lobule	  are	  the	  portal	  triads,	  containing	  a	  branch	  of	  the	  
portal	  vein,	  hepatic	  artery	  and	  an	  interlobular	  bile	  duct.	  Approximately	  80	  %	  of	  the	  lobule	  blood	  
supply	  enters	  via	  the	  portal	  vein,	  with	  the	  remainder	  entering	  via	  the	  hepatic	  artery	  to	  provide	  a	  
more	  oxygen-­‐rich	  top-­‐up.	  Hepatocytes	  in	  the	  lobule	  are	  organised	  into	  3D	  plates	  or	  cords	  that	  run	  
parallel	  to	  the	  sinusoids.	  A	  constant	  biochemical	  exchange	  occurs	  between	  hepatocytes	  and	  the	  
blood	  flowing	  through	  the	  sinusoids	  towards	  the	  central	  vein.	  A	  biliary	  network	  running	  counter	  
to	   the	   sinusoidal	   blood	   flow	   towards	   the	   interlobular	   bile	   duct	   further	   complicates	   the	   3D	  
architecture	  of	  the	  liver	  lobule.	  	  
	  
	  
Figure	  1.1	  Illustration	  of	  the	  liver	  lobule.	  (A):	  Each	  lobule	  is	  hexagonal	  in	  shape	  with	  the	  central	  vein	  in	  the	  
middle	  and	  the	  portal	  triads	  at	  the	  corners.	  Hepatocyte	  plates	  radiate	  from	  the	  centre	  out	  to	  the	  edges	  of	  
the	  hexagon.	   (B):	  The	   lobule	  architecture	   is	  3D	  with	  hepatocyte	  plates	  being	  highly	  vascularised	  by	  blood	  
sinusoids	  carrying	  blood	  from	  the	  portal	  vein	  and	  hepatic	  artery	  towards	  the	  central	  vein.	  A	  biliary	  network	  
running	  counter	  to	  the	  sinusoidal	  flow	  towards	  the	  interlobular	  bile	  duct	  is	  also	  present.	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The	  actual	  shape	  of	  hepatocytes	  within	  the	  3D	  plates	  is	  cuboidal	  (see	  Figure	  1.2).	  Each	  hepatocyte	  
is	   multi-­‐polarised	   carrying	   at	   least	   two	   sinusoidal	   (baso-­‐lateral)	   and	   two	   canalicular	   (apical)	  
membrane	   domains5.	   The	   sinusoidal	   domains	   protrude	   surface	   microvilli	   into	   the	   sinusoidal	  
lumen	   for	   endogenous	   and	   exogenous	   uptake	   and	   exchange	   with	   the	   blood	   sinusoids.	   The	  
canaliculi	  domains	  contain	   small	   intercellular	   channels	  between	  adjacent	  hepatocytes	  known	  as	  
the	  bile	  canaliculi.	  These	  channels	  wrap	  around	  the	  hepatocytes	  and	  join	  with	  other	  bile	  canaliculi	  
at	   the	  Canals	  of	  Herring	   to	   form	  an	  extensive	   tubular	  network	  within	   the	  3D	  plate	  architecture.	  
This	  network	  terminates	  at	  the	  interlobular	  bile	  duct	  of	  the	  portal	  triad	  before	  moving	  on	  towards	  
the	  gall	  bladder	  and	  common	  bile	  duct.	  The	  primary	   role	  of	   these	  bile	   canaliculi	   is	   to	  provide	  a	  
transport	   network	   for	   the	  bile	   secreted	  by	  hepatocytes	   to	   eventually	   reach	   the	   gut	   to	   emulsify	  
lipids.	   Indeed,	  various	  transporter	  proteins	  reside	  at	  the	  canalicular	  membrane	  and	  are	   involved	  
in	   pumping	   bile	   acids	   into	   the	   bile	   canaliculi6.	   However,	   bile	   canaliculi	   and	   the	   associated	  
transporter	   proteins	   also	   play	   a	   crucial	   role	   in	   the	   elimination	   of	   many	   xenobiotic	   substances	  
metabolised	  in	  the	  liver	  (see	  section	  1.1.3)7.	  	  
	  
Intercellular	   adhesions	   and	   cell	   junctions	   (cell-­‐cell	   contact)	   within	   the	   3D	   hepatocyte	   plate	   are	  
believed	  to	  be	  crucial	  for	  maintaining	  normal	  hepatocyte	  structure	  and	  function.	  For	  example,	  gap	  
junctions	   between	   hepatocytes	   have	   been	   shown	   to	   be	   important	   in	   controlling	   hepatocyte	  
growth	   mechanisms8,	   9	   and	   inducing	   drug	   metabolising	   enzymes10.	   Moreover,	   bile	   canaliculi	  
formation	   relies	   on	   the	   presence	   of	   effective	   cell-­‐adhesion	   junctions	   involving	   desmosomes,	  
adherens	  and	  occludens11.	  Similar	  adhesion	  complexes	  are	  also	  required	  for	  microvilli	   formation	  
at	   the	   sinusoidal	   domain.	   Hepatocytes	   within	   the	   3D	   plate	   also	   anchor	   and	   interact	   with	   a	  
surrounding	  extracellular	  matrix	  (ECM).	  Within	  the	  liver,	  this	  ECM	  is	  found	  in	  the	  liver	  capsule,	  the	  
portal	  triads	  and	  in	  the	  small	  gap	  between	  hepatocytes	  and	  the	  sinusoids	  known	  as	  the	  Space	  of	  
Disse.	   The	   hepatic	   ECM	   contains	   various	   glycoproteins,	   collagens,	   proteoglycans	   and	  
glycosaminoglycans,	   as	   well	   as	   various	   hormones,	   growth	   factors	   and	   cytokines12.	   Interactions	  
between	  hepatocytes	  and	  the	  ECM	  (integrin	  complexes)	  have	  been	  shown	  to	  regulate	  a	  range	  of	  
hepatocyte	   processes,	   including	   albumin	   synthesis,	   drug	  metabolism	   capacity,	   proliferation	   and	  
differentiation13-­‐17.	   Indeed,	   ECM	   composition	   and	   stiffness	   are	   key	   controllers	   of	   hepatocyte	  
phenotype,	   with	   harder,	   stiff	   ECM	   components	   favouring	   proliferation	   over	   differentiation18.	  
Furthermore,	  ECM	  disruptions	  are	  closely	  associated	  with	  liver	  fibrosis	  and	  cirrhosis,	  emphasising	  
the	  importance	  of	  the	  ECM	  in	  maintaining	  normal	  liver	  function19,	  20.	  
	  
There	   are	   also	   other	   non-­‐parenchymal	   liver	   cells	   that	   have	   influence	   on	   hepatocyte	   physiology	  
with	  the	  3D	  lobule.	  Liver	  sinusoidal	  endothelial	  cells	  (LSECs)	  line	  the	  walls	  of	  the	  sinusoids	  and	  so	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significantly	   influence	   the	   exposure	   of	   hepatocytes	   to	   various	   substances21.	   These	   cells	   also	  
secrete	   various	   cytokines	   into	   the	   ECM	   and	   have	   been	   shown	   to	   possess	   some	   drug	  
biotransformation	  capacity22.	  Hepatic	  stellate	  cells	  (storing	  vitamin	  A)	  are	  present	  in	  the	  Space	  of	  
Disse	  and	  are	  involved	  in	  the	  secretion	  of	  growth	  factors,	  cytokines	  and	  ECM	  components23.	  They	  
also	  have	  been	  linked	  to	  many	  other	  roles	   including	  stem	  cell	  behaviour	   in	   liver	  regeneration	  as	  
well	   as	   immunoregulation24,	  25.	   Kupffer	   cells	   (macrophages)	   are	   present	   in	   the	   sinusoidal	   lumen	  
and	  are	  involved	  in	  scavenging	  various	  pathogens	  and	  particulates	  from	  the	  blood	  stream26.	  These	  
cells	  are	  also	  capable	  of	  regulating	  the	  viability	  and	  function	  of	  hepatocytes	  by	  producing	  various	  
cytokines27.	  All	  of	  these	  non-­‐parenchymal	  cells	  can	  influence	  hepatocyte	  behaviour.	  
	  
	  
Figure	   1.2	   Illustration	   of	   the	   cuboidal	   shape	   of	   hepatocytes	  within	   the	   3D	   plate.	  Hepatocytes	  protrude	  
microvilli	   into	   the	   sinusoidal	  domain	   for	  exchange	  with	   the	   LSECs.	  Cell	   adhesions	  and	  gap	   junctions	   form	  
between	  adjacent	  hepatocytes	  for	  crucial	  communication	  and	  formation	  of	  bile	  canaliculi.	  Hepatocytes	  also	  
anchor	  their	  cytoskeleton	  to	  ECM	  proteins	  via	  integrins.	  Hepatic	  stellate	  cells	  and	  Kupffer	  cells	  are	  nearby	  
providing	  important	  biochemical	  cues	  that	  regulate	  normal	  hepatocyte	  behaviour.	  	  
	  
Significant	  metabolic	   heterogeneity	   exists	   along	   the	   3D	   hepatocyte	   plate,	   forming	   the	   basis	   for	  
the	  liver’s	  functional	  repeating	  unit	  known	  as	  the	  liver	  acinus	  (see	  Figure	  1.3).	  The	  acinus	  spans	  an	  
approximately	   elliptical	   shape	   over	   two	   adjacent	   lobules	   with	   the	   line	   of	   symmetry	   passing	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through	  the	  joining	  portal	  triads.	  As	  blood	  travels	  through	  the	  sinusoids	  towards	  the	  central	  vein,	  
the	  oxygen	  and	  nutrient	  content	  of	  the	  blood	  is	  diminished	  and	  so	  a	  biochemical	  gradient	  is	  set	  up	  
along	  the	  hepatocyte	  plate.	  Hepatocyte	  gene	  expression	  and	  function	  therefore	  differ	  along	  the	  
plate	   depending	   on	   their	   location28,	   29;	   zone	   1	   (periportal);	   zone	   2	   (midlobular);	   zone	   3	  
(pericentral).	   Zone	   1,	   which	   is	   closest	   to	   the	   portal	   triad	   and	   therefore	   has	   the	   richest	   oxygen	  
supply,	   is	   predominantly	   immature	   hepatocytes	   involved	   in	   glycogen	   synthesis,	   oxidation	   and	  
ureogenesis.	   Zone	   3,	   which	   is	   furthest	   from	   the	   portal	   triad	   and	   thus	   has	   the	   poorest	   oxygen	  
content,	  mainly	  contains	  fully	  differentiated	  hepatocytes	  involved	  in	  xenobiotic	  metabolism.	  Zone	  
2	   contains	   a	   mixture	   of	   hepatocytes	   that	   are	   maturing	   parenchyma	   and	   therefore	   displays	   a	  
mixture	  of	  different	   functions.	   	  Hepatic	  progenitor	  cells	   (bi-­‐potential	   stem	  cells)	   supply	   the	   liver	  
with	  these	  maturing	  hepatocytes	  as	  well	  as	  cholangiocytes	  (biliary	  epithelial	  cells,	  BEC)	  and	  reside	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Figure	   1.3	   Illustration	   of	   the	   liver	   acinus.	   (A):	  The	   liver	  acinus	  spans	   two	  adjacent	   lobules	   in	  an	  elliptical	  
shape	   with	   the	   portal	   triad	   providing	   the	   line	   of	   symmetry.	   Hepatocytes	   within	   the	   acinus	   receive	   a	  
different	  quality	  of	  blood	  supply	  depending	  on	  their	   location.	  (B):	  Maturing	  hepatocytes	  along	  the	  acinus.	  
Hepatocytes	  closest	  to	  the	  portal	  triad	  are	  less	  differentiated	  compared	  to	  those	  close	  to	  the	  central	  vein.	  
Hepatic	   progenitor	   cells	   (HPC)	   are	   found	   in	   the	   Canals	   of	   Herring	   (CoH)	   that	   can	   progress	   onto	   either	   a	  
hepatocyte	   or	   biliary	   epithelial	   cell	   (BEC)	   lineage.	   LSEC	   =	   liver	   endothelial	   sinusoidal	   cell.	   SoD	   =	   Space	   of	  
Disse.	  HSC	  =	  	  hepatic	  stellate	  cell.	  KC	  =	  Kupffer	  cell.	  HA	  =	  hepatic	  artery.	  PV	  =	  portal	  vein.	  BD	  =	  interlobular	  
bile	  duct.	  BC	  =	  bile	  canaliculi.	  ECM	  =	  extracellular	  matrix.	  CV	  =	  central	  vein.	  
	  
In	  summary,	  hepatocyte	  anatomy	  and	  physiology	  in	  vivo	  is	  highly	  complex.	  As	  well	  as	  being	  3D	  in	  
shape	  (cuboidal),	  hepatocytes	  belong	  to	  an	  intricate	  3D	  lobule	  architecture	  that	  dictates	  function.	  
They	  are	  multi-­‐polarised	  and	  rely	  on	  crucial	  cell—cell	  and	  cell-­‐ECM	  contact	  for	  regulating	  normal	  
behaviour.	   Other	   non-­‐parenchymal	   liver	   cells	   such	   as	   LSECs,	   HSCs	   and	   Kupffer	   cells	   all	   interact	  
with	  hepatocytes	  to	  influence	  hepatic	  function.	  Moreover,	  a	  biochemical	  gradient	  exists	  along	  the	  
3D	   acinus	   that	   influences	   hepatocyte	   differentiation	   and	   function,	   with	   only	   the	   most	   mature	  
(differentiated)	  hepatocytes	  being	  involved	  in	  drug	  metabolism.	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1.1.3 Role	  of	  Hepatocytes	  in	  Drug	  Metabolism	  
One	   of	   the	   key	   functional	   responsibilities	   of	   differentiated	   hepatocytes	   is	   the	   metabolism	   of	  
xenobiotic	   substances	   such	   as	   drugs,	   making	   them	   crucial	   in	   vitro	   laboratory	   tools	   in	   drug	  
discovery32,	   33.	   Hepatic	   drug	   metabolism	   can	   usually	   be	   separated	   into	   two	   chemical	   reaction	  
phases;	   phase	   I	   and	   phase	   II.	   However	   there	   are	   also	   many	   important	   transporter	   proteins	  
involved	  in	  the	  uptake	  and	  elimination	  process	  (see	  Figure	  1.4)34.	  	  
Drugs	   present	   in	   the	   blood	   stream	   enter	   the	   liver	   lobule	   where	   they	   are	   first	   absorbed	   by	  
hepatocytes.	   Most	   drugs	   require	   transporter	   proteins	   present	   at	   the	   sinusoidal	   interface	   to	  
mediate	  uptake	  into	  hepatocytes.	  The	  organic	  anion	  transport	  polypeptides	  (OATPs)	  and	  organic	  
anion	  transporters	  (OATs)	  are	  involved	  in	  the	  uptake	  of	  most	  hydrophobic	  drugs35,	  36.	  Conversely	  
organic	  cation	  transporters	  (OCTs)	  are	  usually	  involved	  in	  the	  uptake	  of	  small	  hydrophilic	  drugs37.	  	  
Several	  transporter	  proteins	  are	  involved	  in	  the	  elimination	  of	  the	  drug	  and/or	  drug	  metabolites	  
from	  inside	  the	  hepatocyte.	  These	  proteins	  typically	  belong	  to	  the	  adenosine	  triphosphate	  (ATP)	  
binding	  cassette	  (ABC)	  superfamily,	  which	  provide	  a	  pump-­‐efflux	  mechanism	  upon	  ATP	  binding38.	  
For	   example,	   the	   multidrug	   resistance	   proteins	   MDR1	   or	   P-­‐glycoprotein	   (ABCB1)	   and	   MRP2	  
(ABCC2)	  are	  localised	  in	  the	  bile	  canaliculi	  membrane	  alongside	  the	  bile	  salt	  export	  pump	  (BSEP).	  
Similarly	   the	   breast	   cancer	   resistance	   protein	   (BCRP,	   ABCG2)	   is	   also	   located	   at	   this	   canaliculi	  
membrane39.	  These	   transporter	  proteins	  pump	  drugs	  and	  drug	  metabolites	   into	  bile	   to	   then	  re-­‐
enter	  the	  digestive	  system	  to	  be	  secreted	  as	  faeces38.	  Other	  transporter	  proteins	  are	  also	  located	  
at	   the	   sinusoidal	   domain;	   MRP3	   (ABCC3)	   and	   MRP4	   (ABCC4).	   These	   proteins	   control	   the	  
elimination	   of	   drugs	   and	   drug	   metabolites	   back	   into	   the	   sinusoidal	   bloodstream	   to	   enter	   the	  
kidneys	  for	  renal	  excretion40,	  41.	  Whilst	  all	  of	  these	  proteins	  play	  a	  crucial	  role	  in	  drug	  elimination,	  
they	   can	   also	   be	   problematic	   in	   facilitating	   drug	   resistance	   by	   too	   eagerly	   eliminating	   the	   drug	  
from	  the	  body42.	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Figure	   1.4	   Illustration	   of	   the	   different	   hepatocyte	   transporter	   proteins	   involved	   in	   drug	   metabolism.	  
Drugs	   enter	   the	   hepatocyte	   from	   the	   blood	   via	   organic	   anion	   transporter	   polypeptides	   (OATPs),	   organic	  
anion	  transports	  (OATs)	  and	  organic	  cation	  transporters	  (OCTs).	  Drugs	  can	  then	  undergo	  phase	  I	  and	  phase	  
II	  metabolism	  (or	  remain	  in	  the	  parent	  form).	  Drugs	  and/or	  drug	  metabolites	  are	  expelled	  from	  hepatocytes	  
back	   into	   the	   sinusoids	  via	   the	  multidrug	   resistance	  protein	  3	   (MRP3)	  and	  multidrug	   resistance	  protein	  4	  
(MRP4).	   Alternatively	   they	   are	   pumped	   into	   the	   bile	   via	   the	   multidrug	   resistance	   protein	   1	   (MDR1),	  
multidrug	   resistance	   protein	   2	   (MRP2)	   and	   the	   breast	   cancer	   resistance	   protein	   (BCRP).	   These	   proteins	  
reside	  at	  the	  bile	  canaliculi	  domain	  alongside	  the	  bile	  salt	  export	  pump	  (BSEP).	  
	  
Phase	   I	  metabolism	  usually	   involves	   the	  cytochrome	  P450	   (CYP)	  enzyme	  superfamily,	  which	  are	  
predominantly,	   but	   not	   exclusively,	   found	   in	   the	   endoplasmic	   reticulum	  of	   hepatocytes43.	  Most	  
common	  drugs	  are	  metabolised	  by	   the	  CYP1,	  CYP2	  and	  CYP3	   families,	  with	   the	  CYP3A4	   isoform	  
being	   one	   of	   the	   most	   common	   enzymes	   involved	   in	   drug	   metabolism44.	   Some	   typical	   drug	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Table	  1-­‐1	  Typical	  Drugs	  Metabolised	  by	  Hepatocyte	  CYP	  Enzyme	  Isoforms.	  
Table	  adapted	  from	  Rang,	  H.P.	  et	  al.,	  Pharmacology,	  5th	  Edn,	  Churchill	  Livingstone,	  p108	  
	  
CYP	  enzymes	  perform	  a	  range	  of	  chemical	  reactions,	  however	  the	  most	  common	  is	  to	  hydroxlyate	  
the	  drug	  to	  increase	  polarity45.	  They	  are	  heme-­‐thiolate	  proteins	  and	  are	  monooxygenases.	  Flavin-­‐
containing	  monooxygenases	  (FMO)	  are	  another	  family	  of	  phase	  I	  enzymes	  that	  catalyse	  oxidation	  
of	  drugs	  at	  nucleophilic	  nitrogen,	  sulphur	  and	  phosphorus46.	  	  
Phase	  II	  metabolism	  usually	  involves	  a	  conjugation	  reaction	  to	  render	  the	  drug	  more	  polar,	  more	  
acidic	   and	   more	   water-­‐soluble	   to	   then	   allow	   for	   effective	   renal	   elimination	   from	   the	   body.	   A	  
common	  phase	   II	   reaction	   involves	   the	  addition	  of	  glucuronic	  acid	   to	  an	  active	   functional	  group	  
present	  on	  the	  drug.	  The	  enzymes	  responsible	  for	  this	  specific	  type	  of	  conjugation	  are	  the	  uridine	  
diphosphate	  glucuronosyl	  transferases47	  (UGTs),	  which	  are	  a	  family	  of	  enzymes	  also	  located	  in	  the	  
smooth	   endoplasmic	   reticulum	   of	   hepatocytes.	   Other	   conjugation	   mechanisms	   include	   the	  
addition	   of	   sulfate	   groups	   (by	   sulfotransferases,	   SULTs),	   acetyl	   groups	   (by	  N-­‐acetyltransferases,	  
NATs)	   and	   glutathione	   groups	   (by	   glutathione	   S-­‐transferases,	   GSTs).	   Figure	   1.5	   illustrates	   an	  
example	   reaction	   scheme	   for	   a	   drug	   undergoing	   phase	   I	   and	   phase	   II	   metabolism	   inside	   a	  
hepatocyte.	  
CYP	  Isoform	  	   Drug	  
CYP1A1	   Theophylline	  
CYP1A2	   Caffeine,	  paracetamol,	  tacrine,	  theophylline	  
CYP2A6	   Methoxyflurane	  
CYP2C8	   Taxol	  
CYP2C9	   Ibuprofen,	  phenytoin,	  tolbutamide,	  warfarin	  
CYP2C19	   Omeprazole	  
CYP2D6	   Clozapine,	  codeine,	  debrisoquine,	  metoprolol	  
CYP2E1	   Alcohol,	  enflurane,	  halothane	  
CYP3A4/5	   Ciclosporin,	  losartan,	  nifedipine,	  terenadine	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Figure	   1.5	   Illustration	   showing	   example	   phase	   I	   and	   phase	   II	   metabolising	   reactions	   performed	   by	  
hepatocytes.	   Phase	   I	   shows	   the	   CYP	  mediated	   hydroxylation	   of	   a	   drug	   to	   render	   it	  more	   polar.	   Phase	   II	  
shows	  the	  conjugation	  of	  glucuronic	  acid	  to	  the	  substrate	  to	  allow	  for	  effective	  renal	  elimination	  from	  the	  
body.	  
In	  summary,	  hepatocytes	  are	  the	  principal	  cells	  involved	  in	  drug	  metabolism.	  Crucially,	  the	  uptake	  
and	   elimination	   of	   drugs	   by	   various	   hepatic	  membrane	   proteins	   relies	   on	   the	   presence	   of	   key	  
ultrastructural	   features	   such	  as	  bile	   canaliculi	   and	   sinusoidal	  domains.	   Failing	   to	   replicate	   these	  
ultrastructural	  features	   in	  vitro	   is	  expected	  to	  significantly	  alter	  the	  drug	  uptake	  and	  elimination	  
process	  and	  so	  lead	  to	  a	  poor	  predictive	  accuracy	  of	  a	  drug’s	  true	  toxicity	  profile.	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1.2 In	  Vitro	  Hepatocyte	  Culture	  
The	  previous	  section	  described	  the	  in	  vivo	  growth	  environment	  experienced	  by	  hepatocytes	  in	  the	  
liver.	   This	   section	   introduces	   the	   concept	  of	   in	   vitro	   hepatocyte	   culture,	   starting	  with	   a	   general	  
background	  to	  animal	  cell	  culture	  and	  then	  focusing	  on	  in	  vitro	  drug	  toxicity	  models.	  
	  
1.2.1 General	  Principles	  of	  Animal	  Cell	  Culture:	  2D	  versus	  3D	  
Animal	  cell	  or	  tissue	  culture	  refers	  to	  the	  growth	  and	  maintenance	  of	  animal	  cells	   in	  an	  artificial	  
environment.	   The	   technique	   dates	   back	   as	   early	   as	   1885,	  when	   the	  German	   zoologist	  Wilhelm	  
Roux	  first	  cultured	  portions	  of	  the	  medullary	  plate	  of	  an	  embryonic	  chicken	  for	  several	  days	  on	  a	  
flat	   glass	   plate.	   The	   technique	  was	   then	   further	   developed	   by	   scientists	   such	   as	   Ross	   Granville	  
Harrison	  and	  Julius	  Richard	  Petri,	  credited	  with	  the	  Petri	  dish,	  to	  form	  the	  basis	  of	  modern	  day	  cell	  
culture.	   Today	   the	   technique	   typically	   employs	   disposable	   polystyrene	   Petri	   dishes	   and	  welled-­‐
plates	  as	  the	  artificial	  growth	  substrate.	  Cell	  culture	   is	  now	  a	  routine	  and	  often	  high-­‐throughput	  
tool	   for	   progressing	   our	   understanding	   of	   cell	   biology,	   cancer,	   stem	   cell	   research	   and	   drug	  
metabolism.	  	  
Culturing	   animal	   cells	   on	   a	   flat	   two-­‐dimensional	   (2D)	   surface	   such	   as	   a	   Petri	   dish	   has	   proved	  
extremely	   practical.	   Cells	   can	   be	   easily	   monitored	   on	   a	   daily	   basis	   using	   standard	   bright	   field	  
microscopes.	   Most	   cells	   can	   be	   easily	   extracted	   for	   subsequent	   analysis	   and/or	   passaging.	  
Polystyrene	   is	   also	   inexpensive.	   However,	   there	   are	   several	   key	   disadvantages	  with	   2D	   culture	  
that	   has	   severely	   limited	   the	   physiological	   relevance	   and	   predictive	   accuracy	   of	   the	   method.	  
Firstly	   is	   that	  2D	  monolayer	   culture	   forces	   cells	   to	   stretch	  out	  across	   the	  plastic	   into	  a	   severely	  
flattened	  morphology	   that	   lacks	   structural	   organisation.	   This	   is	   far	   removed	   from	   the	   complex	  
three-­‐dimensional	   (3D)	  environment	   found	   in	   vivo.	   Crucially,	   alterations	   in	   cell	  morphology	  and	  
structural	  organisation	  from	  their	  native	  state	  are	  known	  to	  significantly	  impact	  cell	  genotype	  and	  
phenotype48,	  49.	   For	   example,	   cell	   shape	   can	   influence	   stem	   cell	   fate50.	   Cell	   shape	   can	   influence	  
apoptosis51.	  Cell	  geometry	  can	  dictate	  cell	  polarisation	  and	  the	  formation	  of	  specialised	  structural	  
features	   such	   as	   those	   in	   epithelial52.	   Importantly	   these	   specific	   structural	   arrangements	   can	  
influence	  cell	  function,	  as	  demonstrated	  by	  Bissell	  et.	  al.	  for	  breast	  epithelial	  function53.	  Similarly	  
tissue	  morphogenesis	  and	  tumorigenesis	  are	  also	  highly	  influenced	  by	  the	  spatial	  geometry	  of	  the	  
surrounding	   architecture54.	   Unsurprisingly,	   failing	   to	   mimic	   these	   important	   geometric	  
components	  has	  limited	  2D	  cultures	  to	  more	  primitive	  studies	  of	  structure-­‐function	  relationships.	  	  
Another	  disadvantage	  of	  2D	  culture	   is	  that	  most	  of	  the	  cell	  surface	   is	   in	  contact	  with	  the	  plastic	  
substrate,	  restricting	  cell-­‐cell	  contact	  to	  the	  edges	  of	  the	  cells	  (see	  Figure	  1.6).	  Conversely,	  cells	  in	  
vivo	  rely	  on	  frequent	  juxtacrine,	  autocrine	  and	  paracrine	  signalling	  for	  normal	  tissue	  homeostasis	  
and	  function.	   Indeed	  a	  constant	   interplay	  between	  neighbouring	  cells	  and	  the	  surrounding	  ECM	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helps	  cells	  to	  stay	  in	  tune	  with	  their	  surroundings	  and	  adapt	  to	  external	  stimuli	  accordingly.	  The	  
minimal	   cell-­‐cell	   contact	   possible	   in	   2D	   culture	   deprives	   cells	   of	   these	   vital	   communications,	  
making	  them	  more	  vulnerable	  to	  changes	  in	  their	  surroundings.	  	  
A	  third	  disadvantage	  of	  2D	  culture	  is	  that	  the	  absence	  of	  3D	  tissue	  organisation	  fails	  to	  recreate	  
important	  biochemical	  gradients	  found	  in	  vivo.	  Cells	  in	  2D	  are	  uniformly	  exposed	  to	  a	  fluctuating	  
media	  quality,	  unlike	  in	  vivo	  where	  cells	  receive	  a	  steady	  state	  biochemical	  gradient	  dependent	  on	  
their	  location	  in	  the	  vascularised	  tissue.	  Overall	  the	  combination	  of	  distorted	  cell	  geometry,	  poor	  
cell-­‐cell	  contact	  and	  a	  lack	  of	  biochemical	  gradients	  significantly	  contribute	  to	  harsh	  deviations	  in	  
cell	   differentiation,	   gene	   expression	   and	   function	   during	   2D	   culture	   compared	   to	   in	   vivo55.	   For	  
example,	   cell	   lines	   used	   heavily	   in	   2D	   in	   vitro	   models	   are	   often	   over-­‐adherent	   and	   over-­‐
proliferative	  compared	  to	  their	  native	  counterparts56.	  	  
Recognising	   the	   limitations	   of	   2D	   culture	   there	   is	   now	   a	   strong	   demand	   for	  materials	   that	   can	  
offer	  a	  3D	  interface	  for	  cell	  growth57-­‐59.	  By	  adding	  the	  third	  dimension	  to	  the	  growth	  substrate,	  it	  
is	  hypothesised	  that	  cells	  can	  approximate	  their	  native	  3D	  architecture	  and	  organisation	   in	  vitro.	  
This	   in	   turn	   is	   hypothesised	   to	   encourage	   cell-­‐cell	   contact	   and	   so	   preserve	   crucial	   cellular	  
communication.	  The	  formation	  of	  3D	  tissue	  structures	  is	  also	  hypothesised	  to	  replicate	  important	  
biochemical	   gradients	   found	   in	   vivo.	   In	   essence,	   3D	   cultures	   are	   expected	   to	   preserve	   native	  
structure-­‐function	  relationships	  and	  thus	  provide	  more	  accurate	  models	  of	  in	  vivo	  behaviour60.	  
One	   of	   the	   earliest	   reports	   to	   demonstrate	   the	   importance	   of	   re-­‐creating	   the	   3D	  
microenvironment	  for	  predictive	  function	  in	  vitro	  was	  that	  from	  Bissell	  et	  al.,	  where	  they	  showed	  
a	  more	  in	  vivo	  like	  phenotype	  could	  be	  achieved	  for	  breast	  cancer	  cells	  when	  growing	  in	  3D61.	  The	  
same	  group	  also	  produced	  a	  seminal	  paper	  showing	  how	  gene	  expression	  of	  mammary	  epithelial	  
cells	   is	   profoundly	   influenced	   by	   the	   3D	   microenvironment62.	   From	   there	   the	   field	   of	   3D	   cell	  
growth	  exploded;	  3D	  cell	   growth	   is	  now	  being	  used	   to	  direct	   stem	  cell	   fate	  by	  mimicking	  niche	  
architectures	  found	  in	  vivo63,	  64.	  3D	  cell	  growth	  is	  being	  used	  to	  approximate	  the	  complex	  tumour	  
microenvironment	   to	  better	   understand	   the	  mechanisms	  behind	   cancer	   and	   tumorigenesis54,	  65.	  
3D	   cell	   growth	   is	   opening	   up	   exciting	   opportunities	   for	   tissue	   engineering	   and	   regenerative	  
medicine,	  where	  3D	  constructs	  grown	  in	  vitro	  or	  ex	  vivo	  can	  later	  be	  implanted	  into	  the	  body	  for	  
organ	  repair66,	  67.	  However,	  significant	  work	  still	  needs	  to	  be	  done	  in	  transitioning	  these	  learnings	  
into	  successful	  and	  clinically	  relevant	  3D	  products	  for	  commercial	  use68.	  	  
	  
1.2.2 Conventional	  2D	  Hepatocyte	  Culture	  in	  Drug	  Discovery	  
Hepatocyte	  cell	  culture	  forms	  a	  crucial	  part	  of	  in	  vitro	  drug	  toxicity	  screening	  by	  providing	  a	  model	  
of	  native	  liver	  xenobiotic	  metabolism32,	  33.	  Traditionally,	  multi-­‐welled-­‐plates	  have	  been	  used	  as	  the	  
artificial	  growth	  environment	  for	  most	  in	  vitro	  drug	  toxicity	  studies,	  offering	  only	  2D	  interface	  for	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hepatocyte	  attachment	  and	  growth.	  Whilst	  this	  approach	  has	  offered	  a	  high-­‐throughput	  model	  of	  
drug	  toxicity,	  it	  is	  now	  regarded	  as	  highly	  unrealistic	  compared	  to	  the	  complex	  3D	  scenario	  found	  
in	  native	  liver58,	  59.	  The	  2D	  environment	  forces	  hepatocytes	  into	  a	  flattened	  morphology,	  as	  shown	  
in	   Figure	   1.6.	   This	   then	   restricts	   the	   formation	   of	   gap	   junctions	   and	   adhesion	   junctions	   and	  
therefore	   inhibits	   the	   maintenance	   of	   polarised	   membranes	   presenting	   sinusoidal	   and	   bile	  
canaliculi	   domains.	   Moreover,	   important	   biochemical	   gradients	   present	   in	   the	   liver	   acinus	   are	  
almost	   impossible	  to	  replicate	  along	  a	  flat	  2D	  surface.	  Unsurprisingly,	  most	  hepatocytes	  isolated	  
from	   in	   vivo	   rapidly	   lose	   their	   differentiated	   phenotype	   in	   2D	   culture,	   with	   drug	   metabolising	  
capacity	  one	  of	  the	  first	  functions	  to	  be	  lost69.	  The	  result	  is	  a	  poor	  predictive	  capacity	  of	  a	  drug’s	  
biotransformation	  properties	  and	  so	  a	  much	  higher	  risk	  of	  failure	   later	   in	  the	  drug	  development	  
process.	   A	   significant	   dependence	   on	   animal	   testing	   is	   therefore	   required	   due	   to	   the	   poor	  
predictive	  accuracy	  of	  2D	  hepatocyte	  models.	  
	  
	  
Figure	  1.6	   Illustration	  of	  hepatocytes	   cultured	  on	  a	   conventional	  2D	  plastic	   substrate.	   	  Cells	  spread	  out	  
across	  the	  plastic	  creating	  a	  severely	  flattened	  morphology.	  A	  large	  portion	  of	  the	  cell	  is	  in	  contact	  with	  the	  
substrate	  whereas	  only	  a	  small	  portion	  is	  able	  to	  interact	  with	  adjacent	  cells.	  This	  limits	  the	  opportunity	  for	  
cell-­‐cell	  adhesion	  and	  communication	  and	  limits	  polarisation	  towards	  bile	  canaliculi	  and	  sinusoidal	  domains.	  
	  
1.2.3 The	  Concept	  of	  3D	  Hepatocyte	  Culture	  in	  Drug	  Discovery	  
Huge	   emphasis	   is	   now	   placed	   on	   developing	   predictive	   in	   vitro	   hepatocyte	   models	   to	   better	  
screen	   out	   unsuitable	   drug	   candidates	   as	   early	   as	   possible,	   reducing	   the	   risk	   of	   failure	   at	   the	  
animal	  and	  clinical	  stages	  of	  the	  drug	  development	  process70-­‐72.	  However,	  in	  order	  to	  successfully	  
achieve	  this,	   the	  artificial	  growth	  environment	  used	  for	   in	  vitro	  pharmaceutical	   testing	  needs	  to	  
be	  physiologically	  relevant	  to	  that	  of	  the	  native	  liver73,	  74.	  
The	  development	  of	  3D	  hepatocyte	  models	   in	  vitro	   is	  now	  regarded	  a	  key	  part	  of	   improving	  the	  
predictive	  accuracy	  of	  drug	  toxicity	  screening	  and	  are	  therefore	  gaining	  significant	  attention32,	  75.	  
However,	  many	  of	  these	  models	  are	  still	  in	  developmental	  phase	  and	  are	  not	  yet	  commercialised	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or	   even	   suitable	   for	   routine	   application.	   Moreover,	   a	   thorough	   understanding	   of	   hepatocyte	  
behaviour	  in	  these	  3D	  models	  is	  yet	  to	  be	  determined.	  The	  following	  section	  discusses	  in	  turn	  the	  
key	  developments	  in	  3D	  cell	  models	  for	  drug	  discovery	  applications.	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1.3 Technology	  Developments	  to	  Enable	  3D	  In	  Vitro	  Hepatocyte	  Culture	  
There	   are	   now	   a	   variety	   of	   different	   materials	   that	   can	   offer	   a	   3D	   microenvironment	   for	  
hepatocyte	   growth,	   evident	   by	   the	   substantial	   academic	   and	   patent	   literature	   recently	  
published32,	   57,	   75.	   The	   materials	   can	   be	   broadly	   divided	   into	   those	   originating	   from	   natural	  
(biological)	  tissue	  and	  those	  derived	  synthetically.	  Natural	  based	  materials	  such	  as	  protein	  gels	  or	  
polysaccharide	   scaffolds	   offer	   attractive	   biocompatibility	   properties.	   They	   can	   also	   even	  mimic	  
certain	   aspects	   of	   the	   native	   ECM	   that	   influences	   cell	   function.	   However,	   for	   routine	   in	   vitro	  
toxicology	   studies,	   natural	   based	   materials	   have	   several	   limitations.	   Batch	   to	   batch	   variability	  
inherent	   of	   biological	  material	   can	   lead	   poor	   experimental	   reproducibility.	   Biodegradability	   can	  
cause	   issues	   with	   long	   term	   laboratory	   experiments	   and	   storage.	   There	   is	   also	   the	   issue	   of	  
sourcing	   sufficient	   biological	   material	   for	   extensive	   drug	   screening	   studies.	   Consequently	  
synthetic	  materials	  (often	  polymers)	  have	  been	  developed	  to	  provide	  3D	  scaffolds	  for	  a	  range	  of	  
applications,	   including	   tissue	   engineering,	   regenerative	  medicine	   and	   of	   course	   routine	   in	   vitro	  
hepatocyte	   growth	   for	   drug	   toxicity	   studies.	   A	   brief	   summary	   of	   each	   technology	   category	   is	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1.3.1 Sandwiching	  with	  Extracellular	  Matrix	  Proteins	  
1.3.1.1 Overview	  
ECM	  proteins	   such	  as	   collagen,	   laminin	  or	   fibronectin	  have	   long	  been	  used	   to	   coat	  Petri	   dishes	  
and	  welled-­‐plates	   to	   improve	   the	  physiological	   relevance	  of	   the	  2D	   interface	  and	   thus	  promote	  
hepatocyte	  adhesion	  and	  function.	  Taking	  this	  further,	  researchers	  found	  that	  applying	  a	  second	  
layer	  of	  ECM	  protein	  directly	  above	  the	  monolayer,	  to	  create	  a	  sandwich	  of	  protein/cell/protein,	  
was	   beneficial	   for	   hepatocyte	   growth	   (see	   Figure	   1.7)76,	   77.	   In	   this	   configuration,	   cell-­‐matrix	  
adhesion	   from	   above	   and	   below	   reduces	   cytoskeletal	   flattening	   and	  maintains	   cell-­‐cell	   contact	  
between	  adjacent	  hepatocytes.	  Although	  not	  a	  definitive	  3D	  organisation,	  sandwich	  systems	  have	  
been	   shown	   to	   promote	   a	   polygonal	   hepatocyte	   morphology	   for	   extended	   culture	   periods78.	  	  
Results	  have	  shown	  that	  sandwich	  cultures	  with	  matrix	  proteins	  can	  lead	  to	  prolonged	  hepatocyte	  
viability76,	   extended	   cytochrome	   P450	   activity79	   and	   increased	   cell	   polarisation	   towards	   more	  
advanced	  bile	  canaliculi	  networks80.	  Consequently	  this	  approach	  is	  a	  popular	  method	  of	  culturing	  
hepatocyte	  cells,	  particularly	  to	  monitor	  hepatobiliary	  mechanisms	  in	  vitro81.	  	  
1.3.1.2 Advantages	  
ECM	  components	  can	  mimic	  certain	  biochemical	  aspects	  of	  the	  native	  ECM.	  Sandwich	  cultures	  are	  
also	  easy	  to	  set	  up	  and	  are	  useful	  for	  the	  study	  of	  hepatobiliary	  mechanisms.	  
1.3.1.3 Disadvantages	  
Growth	  is	  essentially	  a	  3D	  monolayer	  rather	  than	  an	  extensive	  3D	  organisation.	  Cell-­‐cell	  contact	  is	  
therefore	   still	   limited	  and	  not	   strictly	  3D.	  Biodegradability	  of	   the	  ECM	  proteins	   raises	   issues	   for	  
long	  term	  experiments	  and	  storage.	  Once	  more,	  ECM	  components	  derived	  from	  natural	  sources	  
are	  inherently	  variable	  with	  unknown	  impurities.	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Figure	   1.7	   Illustration	   of	   hepatocytes	   in	   sandwich	   culture.	   An	   ECM	   protein	   coating	   above	   and	   below	  
encourages	   cells	   to	   adopt	   an	   upright	   morphology	   that	   preserves	   cell-­‐cell	   contact.	   This	   allows	   for	   cell	  
adhesions	  that	  retain	  polarisation	  and	  thus	  the	  formation	  of	  bile	  canaliculi.	  
	  
1.3.2 Spheroidal	  Aggregate	  Cultures	  
1.3.2.1 Overview	  
Plating	   cells	   onto	   non-­‐adhesive	   surfaces	   will	   often	   encourage	   the	   formation	   of	   3D	  
spheroid/aggregate	  cultures,	  whereby	  cells	  secrete	  their	  own	  ECM	  to	  keep	  the	  aggregate	  intact82,	  
83.	   Within	   this	   configuration,	   cells	   cluster	   together	   rather	   than	   adhering	   to	   the	   substrate	   to	  
establish	  important	  cell-­‐cell	  contacts	  relevant	  to	  the	  native	  3D	  architecture	  (Figure	  1.8).	  Some	  of	  
the	   first	   reports	   by	   Bissell	   et	   al.	   demonstrating	   the	   influence	   of	   the	   3D	   microenvironment	  
employed	   aggregate	   cultures62.	   Indeed,	   hepatocytes	   in	   spheroid	   culture	   display	   a	   more	  
differentiated	   functional	   behaviour	   and	   gene	   expression	   compared	   to	   2D84-­‐86.	   They	   also	   show	  
prolonged	  (3-­‐4	  weeks)	  viability	  and	  hepatic	  function87,	  88.	  Rainbow	  trout	  hepatocytes	  also	  show	  a	  
much	  closer	  gene	  expression	  profile	  to	  in	  vivo	  when	  cultured	  in	  aggregates	  compared	  to	  2D89.	  
	  
1.3.2.2 Advantages	  
Spheroids/aggregates	   are	   very	   easy	   to	   set	   up	   and	   do	   not	   require	   any	   specialist	   equipment.	  
Moreover,	   the	  formation	  of	  an	  aggregate	  culture	  relies	  on	  the	  secretion	  of	  ECM	  components	  to	  
keep	   the	   aggregate	   intact,	   which	   can	   serve	   to	   mimic	   native	   cell-­‐ECM	   interactions.	   Aggregate	  
cultures	   also	   enable	   the	   formation	   of	   biochemical	   gradients	   to	   be	   set	   up,	   with	   those	   on	   the	  




3D	   cell	   growth	   is	   limited	   to	   individual	   spheroids	   and	   so	   an	   extensive	   3D	   organisation	   cannot	  
usually	  be	  achieved.	  Aggregates	  are	  also	  non-­‐vascularised	  which	  can	  lead	  to	  mass	  transfer	  issues	  
for	  those	  cells	  in	  the	  centre	  of	  the	  aggregate.	  	  	  
Figure	  1.8	  Primary	  human	  hepatocytes	  in	  spheroid	  formation	  after	  2	  weeks	  culture.	  Confocal	  fluorescence	  
microscopy	   was	   used	   to	   obtain	   the	   image;	   Green	   staining	   =	   F-­‐actin;	   Blue	   staining	   =	   DAPI.	   Cells	   are	  
aggregated	  together	  in	  a	  3D	  formation.	  Image	  taken	  from	  Alves	  et	  al.,	  Hepatology	  2012,	  55,	  1227-­‐1236.	  
1.3.3 Hydrogels	  
1.3.3.1 Overview	  
Hydrogels	  derived	  from	  natural	  or	  synthetic	  polymers	  can	  be	  used	  to	  immobilise	  cells	  within	  a	  3D	  
gel	  matrix	  that	  mimics	  certain	  physical,	  mechanical	  and/or	  biochemical	  aspects	  of	  the	  native	  ECM.	  
Their	   soft	   nature	   and	   often	   bio-­‐based	   composition	   makes	   them	   attractive	   materials	   for	   tissue	  
engineering	   and	   regenerative	  medicine	   applications90,	  91.	  Within	   the	   gel,	   cells	   aggregate	   into	  3D	  
structures	   that	   promote	   cell	   contact	   and	   interaction	   across	   multiple	   surfaces	   (see	   Figure	   1.9).	  
Some	  of	  the	  early	  pioneering	  3D	  cell	  culture	  experiments	  involving	  hydrogels	  were	  performed	  by	  
Bissell	   et	   al.,	   demonstrating	   significant	   differences	   in	   breast	   cancer	   growth	   compared	   to	   2D	  
cultures61,	  92.	  Their	  work	  employed	  a	  commercial	  hydrogel	  known	  as	  Matrigel™	   (BD	  Biosciences),	  
based	  on	  a	   cocktail	   of	  different	  ECM	  proteins	  obtained	   from	  a	  mouse	   sarcoma93,	  94.	   Since	   then,	  
Matrigel™	   has	   been	   used	   extensively	   as	   a	   technology	   for	   in	   vitro	   3D	   cell	   growth95.	   For	  
hepatocytes,	  Matrigel™	  has	  been	  shown	  to	  prolong	  aspects	  of	  hepatocyte	  function	  beyond	  those	  
observed	   in	   collagen	   sandwich	   cultures96.	   Hepatocytes	   in	   Matrigel™	   also	   adopt	   a	   more	   native	  
structure	  with	  appropriate	  polarisation97.	  Other	  hydrogel-­‐based	  materials	  have	  also	  been	  applied	  
to	  3D	  cell	  culture.	  For	  example,	  the	  hyaluronate	  based	  	  Extracel™	  (glycosan	  biosystems)	  has	  been	  
shown	  to	  prolong	   in	  vitro	  hepatocyte	  cytochrome	  P450	  activity	  for	  up	  to	  17	  days98.	  PuraMatrix™	  
(3-­‐D	  Matrix)	   is	  another	  commercially	  available	  peptide	  hydrogel	   that	  has	  been	  shown	  to	   induce	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the	  differentiation	  of	  putative	  rat	  liver	  progenitor	  cells	  into	  mature	  hepatocyte-­‐like	  cells	  exhibiting	  
up-­‐regulated	  albumin	  and	  cytochrome	  p450	  activity99.	  	  	  
1.3.3.2 Advantages	  
Hydrogels	  are	  a	  popular	  technology	  choice	  for	  many	  researchers	  as	  they	  can	  replicate	  native	  cell-­‐
cell	   and	   cell-­‐ECM	  biochemical	   and	  physical	   interactions.	   They	   are	  particularly	   attractive	   for	   soft	  
tissue	  growth,	  especially	  as	  the	  surrounding	  matrix	  stiffness	  in	  known	  to	  be	  a	  contributing	  factor	  
to	   cell	   phenotype100.	   Synthetic	   hydrogels	   that	   facilitate	   cell	   invasion	   in	   vivo	   are	   also	   showing	  
extremely	  promising	  results	  for	  tissue	  regeneration	  applications101.	  They	  also	  enable	  extensive	  3D	  
growth	  about	  the	  gel	  and	  are	  commercially	  available.	  	  
1.3.3.3 Disadvantages	  
Mass-­‐transfer	  issues	  have	  long	  been	  a	  concern	  for	  hydrogels,	  in	  that	  the	  diffusion	  of	  nutrients	  and	  
waste	   through	   the	   gel	   may	   be	   too	   slow	   to	   accommodate	   dense	   3D	   structures.	   Natural	   based	  
hydrogels	   such	  as	  Matrigel™	  are	   inherently	   variable	  and	  also	  biodegradable,	   although	   synthetic	  
hydrogels	  help	  to	  address	  this	  issue.	  	  Another	  limitation	  is	  gel	  formation.	  Many	  hydrogels	  require	  
some	   form	   of	   external	   switch	   to	   gel,	   such	   as	   a	   change	   in	   temperature,	   pH	   or	   exposure	   to	   UV	  
radiation.	   Hence	   if	   cells	   are	   dispersed	   into	   the	   material	   prior	   to	   gelation,	   which	   is	   common	  
practice,	   care	   needs	   to	   be	   taken	   to	   ensure	   that	   the	   gelation	   process	   does	   not	   have	   any	  
detrimental	  effect	  on	  cell	  viability.	  Gelation	  also	  adds	  additional	  preparation	  steps	  and	  decreases	  
the	  high	  throughput	  suitability.	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Figure	   1.9	   Illustration	   of	   hepatocytes	   growing	   in	   a	   3D	   hydrogel.	   The	   gel	   encapsulates	   the	   cells	   in	   a	   3D	  
organisation	  encouraging	  cell-­‐cell	  contact	  and	  therefore	  maintenance	  of	  cell	  polarisation	  and	  bile	  canaliculi.	  
ECM	  hydrogels	  such	  as	  Matrigel™	  can	  also	  mimic	  cell-­‐ECM	  interactions	  found	  in	  vivo.	  They	  are	  also	  soft	  and	  
so	  mimic	  certain	  mechanical	  aspects	  of	  the	  native	  ECM.	  	  
1.3.4 Electrospun	  Scaffolds.	  
1.3.4.1 Overview	  
Electrospinning	  is	  a	  technique	  that	  converts	  polymeric	  liquids	  (natural	  or	  synthetic)	  into	  micro-­‐	  or	  
nano-­‐scale	   fibres	   creating	   a	   3D	  mesh	   topography.	   The	   technique	   is	   hugely	   versatile	   enabling	   a	  
range	  of	  different	  fibrous	  compositions	  and	  architectures	  with	  different	  diameters	  and	  porosities	  
to	   be	   formed.	   As	   a	   result	   the	   technique	   has	   attracted	   significant	   attention	   for	   3D	   cell	   growth	  
applications,	  with	  cells	  being	  able	  to	  migrate	  into	  the	  mesh	  structure	  and	  grow	  in	  a	  3D	  manner102.	  
Figure	   1.10	   is	   an	   illustration	   of	   how	   3D	   polymer	   fibres	   provide	   a	   scaffold	   for	   3D	   hepatocyte	  
growth	   and	   Figure	   1.11	   is	   an	   actual	   example	   of	   cells	   growing	   in	   an	   electrospun	   scaffold,	   taken	  
from	  The	  Electrospinning	  Company	  (UK).	  A	  comprehensive	  study	  by	  MacNeil	  et	  al.	  was	  one	  of	  the	  
first	   reports	   to	   demonstrate	   the	   suitability	   of	   electrospun	   scaffolds	   for	   3D	   cell	   culture103.	   They	  
showed	  that	  these	  scaffolds	  encouraged	  3D	  cell	  migration	  and	  3D	  aggregate	  formation	  within	  the	  
material,	   which	   in	   turn	   translated	   into	   a	   more	   physiologically	   accurate	   response	   to	   cytotoxic	  
agents	  compared	  to	  2D	  cell	  culture104.	  	  
Hepatocytes	  cultured	  on	  synthetic	  electrospun	  fibres	  have	  also	  been	  shown	  to	  become	  engulfed	  
by	  the	  fibrous	  structure	  to	  form	  3D	  aggregates	  with	  increased	  cell-­‐cell	  contacts105.	  Such	  scaffolds	  
have	  been	  shown	  to	  enhance	  liver	  specific	  functions	  such	  as	  albumin	  synthesis,	  urea	  synthesis	  and	  
cytochrome	  P450	  activity106.	  Electrospun	  scaffolds	  have	  also	  been	  used	  to	  direct	  stem	  cells	  into	  a	  
differentiated	  hepatocyte	  lineage107.	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1.3.4.2 Advantages	  
Electrospun	  scaffolds	  are	  cheap	  to	  produce	  once	  the	   initial	  electrospinning	  equipment	  has	  been	  
purchased.	   A	   versatile	   range	   of	   polymers	   can	   be	   electrospun,	   offering	   excellent	   choice	   on	  
chemical	  composition.	  Developments	  in	  aligned	  electrospun	  fibres	  are	  also	  showing	  great	  promise	  
for	   neural	   tissue	   engineering108.	   Furthermore,	   electrospun	   materials	   are	   now	   available	   as	  
commercial	  scaffolds	  for	  3D	  cell	  growth	  (Mimetix™,	  The	  Electrospinning	  Company).	  	  
	  
1.3.4.3 Disadvantages	  
Cell	   growth	   is	   generally	   restricted	   to	   the	   nodes	  where	   fibres	   overlap,	   as	   large	   holes	   separating	  
individual	   fibres	   can	   prevent	   extensive	   organisation.	   Consequently	   3D	   growth	   tends	   to	   be	   as	  
individual	  pockets	  dispersed	   throughout	   the	  material,	   and	  very	   rarely	  will	   high	   cell	   densities	  be	  
packed	  into	  the	  structure.	  The	  mechanical	  properties	  of	  electrospun	  scaffolds	  are	  also	  quite	  poor,	  
significantly	  reducing	  their	  suitability	  for	  routine	  in	  vitro	  applications.	  	  
	  
	  
Figure	  1.10	   Illustration	  of	  hepatocytes	  growing	   in	  a	  3D	  electrospun	   scaffold.	  Polymer	  fibres	  create	  a	  3D	  
mesh	  structure	  allowing	  3D	  cell	  growth	  at	  the	  nodes	  of	  overlapping	  fibres.	  These	  pockets	  of	  3D	  cell	  growth	  
enable	  localised	  3D	  cell-­‐cell	  contacts,	  however	  extensive	  3D	  growth	  is	  challenging	  as	  cells	  can	  fall	  through	  
the	  areas	  where	  fibres	  do	  not	  overlap.	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Figure	  1.11	  Micrographs	  of	  3D	  cell	  culture	   in	  electrospun	  scaffolds.	   (A):	  scanning	  electron	  micrograph	  of	  
an	   electrospun	   scaffold.	   (B):	   Confocal	   fluorescence	  microscopy	   of	  MCF7	   breast	   cancer	   cells	   (TO-­‐PRO®-­‐3,	  
blue)	  growing	  in	  the	  Mimetix®	  electrospun	  scaffold	  (Rhodamine	  6G,	  green)	  after	  4	  days.	  Images	  taken	  from	  
E.	  Heister,	  Electrospinning	  Company,	  UK	  (www.electrospinning.co.uk).	  
	  
1.3.5 Rapid	  Prototyping	  
1.3.5.1 Overview	  
The	   development	   of	   3D	   printing,	   selective	   laser	   sintering	   (SLS)	   and	   other	   rapid	   prototyping	  
techniques	   has	   opened	   up	   new	   opportunities	   for	   a	   range	   of	   versatile	   3D	   interfaces	   which	   are	  
suitable	  for	  3D	  cell	  growth109,	  particularly	  for	  hard	  tissues	  such	  as	  bone110.	  Here	  digital	  prototypes	  
are	  used	  to	  construct	  3D	  structures	  of	  a	  material	  one	  layer	  at	  a	  time.	  The	  resulting	  hard	  scaffolds	  
can	   be	   engineered	   to	   mimic	   the	   native	   elasticity	   and	   mechanical	   properties	   of	   bone	   tissue111.	  
Typically	   the	   materials	   offer	   small	   3D	   compartments	   for	   cell	   growth	   as	   printing	   extensive	  
interconnected	   networks	   is	   challenging	   (see	   Figure	   1.12	   and	   Figure	   1.13).	   As	   the	  materials	   are	  




Excellent	   scaffold	   reproducibility	   as	   the	   materials	   as	   digitally	   designed.	   High	   porosities	   are	  
obtainable.	  The	   scaffolds	  also	  offer	  physiologically	   relevant	  mechanical	  properties	   for	  bone	  and	  
cartilage	  tissue	  engineering,	  although	  this	  is	  less	  suitable	  for	  hepatocytes.	  
	  
1.3.5.3 Disadvantages	  
The	  materials	  are	  very	  expensive	  to	  produce	  and	  require	  specialist	  equipment.	  3D	  cell	  growth	  is	  
also	  restricted	  to	   individual	  compartments,	  preventing	  extensive	  3D	  cell	  growth.	  Often	  cells	  can	  
fall	  out	  of	  the	  materials	  if	  the	  voids	  are	  too	  large.	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Figure	  1.12	  Illustration	  of	  hepatocytes	  growing	  on	  a	  3D	  printed	  scaffold.	  Small	  separate	  3D	  compartments	  
encourage	  3D	  growth,	  preventing	  extensive	  3D	  organisation.	  
Figure	  1.13	  Micrograph	  of	  a	  rapid	  prototyped	  scaffold	  used	  in	  3D	  cell	  culture.	  Image	  taken	  from	  Yeong	  et	  
al.,	  Trends	  in	  Biotechnology	  2004,	  22,	  643-­‐652.	  Scale	  bar	  =	  1	  mm.	  
1.3.6 Porous	  Polymers	  from	  Fibre	  Bonding	  
1.3.6.1 Overview	  
With	  a	  versatile	  range	  of	  morphologies	  and	  fabrication	  techniques	  available,	  porous	  polymers	  are	  
attractive	  materials	  as	  substrates	   for	  3D	  cell	  growth112.	  Some	  of	  the	  first	  porous	  polymers	  to	  be	  
used	  as	  3D	  scaffolds	  were	  based	  on	  polylactic	  acid	  (PLA),	  polyglycolic	  acid	  (PGA)	  and	  polylactic-­‐co-­‐
glycolic	  acid	  (PLGA)	  for	  tissue	  engineering	  applications.	  These	  materials	  were	  first	  prepared	  using	  
a	   technique	  known	  as	   fibre	  bonding113,	  114.	  With	  this	  method,	  a	  PLA-­‐solvent	  solution	   is	  cast	  over	  
PGA	   fibres	   to	   create	   a	   composite	   that	   is	   then	   heated	   to	   bond	   the	   fibres	   at	   the	   nodes	   of	  
intersection.	   The	   resulting	  materials	   are	   highly	   porous	   (80	  %)	   and	  display	   void	   diameters	   up	   to	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500	  µm.	  Hepatocytes	   cultured	  on	   these	  materials	   remained	  viable	   for	  1	  week	  and	  also	   showed	  
encouraging	  signs	  of	  3D	  organisation115.	  	  
	  
1.3.6.2 Advantages	  
The	   materials	   display	   high	   porosities	   (typically	   80	   %).	   They	   also	   have	   suitable	   mechanical	  
properties	  for	  routine	  laboratory	  use.	  
	  
1.3.6.3 Disadvantages	  
Residual	   solvents	   from	   fabrication	   can	  be	   toxic	   to	   cells.	   Consequently,	   extensive	  and	  prolonged	  
vacuum	   drying	   steps	   are	   required	   during	   processing.	   Synthetic	   polymers	   often	   display	   an	  
inappropriate	  surface	  chemistry	  for	  optimal	  cell	  growth.	  
	  
1.3.7 Porous	  Polymers	  from	  Solvent	  Casting	  /	  Particle	  Leaching	  
1.3.7.1 Overview	  
An	   alternative	   fabrication	  method	   of	   porous	   polymers	   is	   to	   use	   a	   technique	   known	   as	   solvent	  
casting/particulate	  leaching115,	  116.	  	  Here	  a	  polymer-­‐solvent	  solution	  is	  cast	  over	  a	  mold	  containing	  
porogen	  particles	  such	  as	  crystalline	  salts.	  	  After	  solvent	  evaporation	  the	  polymer-­‐salt	  composite	  
is	   washed	   to	   dissolve	   the	   salt,	   leaving	   a	   porous	   structure	   behind.	   3D	   hepatocytes	   have	   been	  
cultured	   on	   these	   materials	   and	   then	   successfully	   transplanted	   into	   laboratory	   rats117.	  
Hepatocytes	   also	   remained	   viable	   on	   these	   materials	   for	   up	   to	   14	   days,	   although	   a	   gradual	  
reduction	  in	  albumin	  synthesis	  and	  liver-­‐specific	  gene	  expression	  was	  observed118.	  	  
	  
1.3.7.2 Advantages	  
The	   materials	   display	   high	   porosities	   (typically	   80	   %).	   They	   also	   have	   suitable	   mechanical	  
properties	  for	  routine	  laboratory	  use.	  
	  
1.3.7.3 Disadvantages	  
Residual	  salts	  left	  in	  the	  matrix	  can	  affect	  cell	  growth.	  Consequently,	  extensive	  washing	  steps	  are	  
required	   to	   fully	   remove	   the	   salts.	   Salt	   crystal	   size	   cannot	   be	   strictly	   controlled	   and	   so	   void	  
diameter	  can	  be	  variable.	  Synthetic	  polymers	  often	  display	  an	  inappropriate	  surface	  chemistry	  for	  
optimal	  cell	  growth.	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1.3.8 Porous	  Polymers	  from	  Gas	  Foaming	  
1.3.8.1 Overview	  
Gas	   foaming	   is	   another	   fabrication	   method	   of	   porous	   polymers	   used	   for	   3D	   cell	   culture	  
applications119,	  120.	  Here	   solid	   polymer	  discs	   are	   prepared	  using	   compression	  molding.	   The	  discs	  
are	   then	  exposed	   to	  high-­‐pressure	   gas	   (e.g.	   CO2)	   for	   several	   hours/days	   to	   render	  porosities	   of	  
approximately	  90	  %	  and	  void	  sizes	  of	  up	  to	  100	  µm.	  This	  technique	  has	  also	  been	  combined	  with	  
elements	  of	  particle	  leaching,	  employing	  both	  salt	  and	  gas	  as	  porogens.	  Rat	  hepatocytes	  cultured	  
on	  these	  materials	  maintained	  viability	  for	  up	  to	  1	  week121.	  	  
1.3.8.2 Advantages	  
The	   materials	   display	   high	   porosities	   (typically	   90	   %).	   They	   also	   have	   suitable	   mechanical	  
properties	  for	  routine	  laboratory	  use.	  
1.3.8.3 Disadvantages	  
Gas	  bubbles	  can	  coalesce	  and	  so	  void	  diameter	  can	  be	  variable.	  Synthetic	  polymers	  often	  display	  
an	  inappropriate	  surface	  chemistry	  for	  optimal	  cell	  growth.	  
1.3.9 Porous	  Polymers	  from	  Phase	  Separation	  
1.3.9.1 Overview	  
Phase	  separation	  is	  another	  approach	  to	  fabricating	  porous	  polymers122-­‐125.	   	  Here	  the	  polymer	  is	  
dissolved	   in	   a	   solvent	   solution	   that	   then	   cooled	   below	   the	   melting	   point	   of	   the	   solvent.	   The	  
mixture	  is	  then	  vacuum	  dried	  to	  remove	  the	  solvent	  via	  sublimation	  and	  leave	  a	  porous	  polymer.	  
With	  this	  method	  porosities	  of	  up	  to	  90	  %	  and	  void	  diameter	  of	  100	  µm	  have	  been	  reported124.	  
1.3.9.2 Advantages	  
The	   materials	   display	   high	   porosities	   (typically	   90	   %).	   They	   also	   have	   suitable	   mechanical	  
properties	  for	  routine	  laboratory	  use.	  
1.3.9.3 Disadvantages	  
Residual	  organic	  solvents	  can	  be	  toxic	  to	  cells.	  Synthetic	  polymers	  often	  display	  an	  inappropriate	  
surface	  chemistry	  for	  optimal	  cell	  growth.	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1.3.10 Porous	  Polymers	  from	  Emulsion	  Freeze	  Drying	  
1.3.10.1 Overview	  
Emulsion	  freeze	  drying	  is	  another	  common	  approach	  to	  porous	  polymers126.	  Here	  an	  emulsion	  is	  
created	  with	  the	  polymer	  as	  the	  external	  phase	  and	  a	  solvent	  as	  the	  internal	  phase.	  The	  emulsion	  
is	  frozen	  and	  then	  slowly	  dried	  to	  allow	  the	  solvent	  to	  sublime	  and	  thus	  leaving	  a	  porous	  structure	  
behind.	  	  Scaffolds	  with	  high	  porosities	  (90	  %)	  and	  voids	  of	  ca.	  30	  µm	  are	  formed	  which	  have	  been	  
used	  to	  support	  3D	  hepatocyte	  growth	  for	  up	  to	  2	  weeks127.	  	  
A	  similar	  freeze	  drying	  technique	  has	  also	  been	  applied	  to	  alginate	  gels	  to	  create	  porous	  alginate	  
sponges	  with	   voids	   in	   the	   region	   of	   70	   to	   300	  µm128.	   Hepatocytes	   cultured	   on	   these	  materials	  
form	   3D	   spheroid	   structures	   that	   displayed	   enhanced	   albumin	   and	   urea	   function	   over	  
conventional	   2D	   cultures129.	   Moreover,	   new-­‐born	   hepatocytes	   cultured	   on	   alginate	   sponges	  
displayed	   signs	   of	   terminal	   differentiation	   towards	  mature	   hepatocytes	  with	   drug	  metabolising	  
capacity130.	   These	   alginate	   sponges	   are	   now	   commercially	   available	   as	   AlgiMatrix™	   (Life	  
Technologies)	  and	  are	  being	  employed	  for	  routine	  in	  vitro	  cancer	  cell	  studies131.	  	  
	  
1.3.10.2 Advantages	  
The	   materials	   display	   high	   porosities	   (typically	   90	   %).	   They	   also	   have	   suitable	   mechanical	  
properties	  for	  routine	  laboratory	  use.	  
	  
1.3.10.3 Disadvantages	  
Residual	   solvents	   can	  be	   toxic	   to	   cells.	   For	   alginate	   sponges,	   3D	   cell	   growth	   is	   restricted	   to	   the	  
individual	  voids	  rather	  than	  extensively	  throughout	  the	  structure.	  
	  
In	  summary,	  this	  section	  has	  described	  a	  range	  of	  different	  technologies	  that	  can	  be	  used	  to	  re-­‐
create	   aspects	   of	   the	   native	   liver	   microenvironment	   in	   vitro.	   However,	   there	   are	   significant	  
disadvantages	  associated	  with	  many	  of	  these	  technologies.	  Naturally	  derived	  technologies	  (ECM	  
sandwiches	  or	  hydrogels)	  are	  often	  unsuitable	  for	  routine	  in	  vitro	  use	  due	  to	  biodegradability	  and	  
batch	  to	  batch	  variability.	  Similarly	  many	  synthetic	  technologies	  (electrospun	  scaffolds	  or	  porous	  
polymers	   derived	   from	   chemical	   processing)	   are	   either	   poorly	   controlled	   or	   contain	   residual	  
solvents	   that	  may	  be	   toxic	   to	   cells.	   Porous	  polymers	  derived	   from	  emulsion	   templating	  aims	   to	  
address	  some	  of	  these	  issues.	  
	  
	  
	   	   	  
	  
	   29	  
1.4 Porous	  Polymers	  from	  Emulsion	  Templating	  
Emulsion	   templating	   uses	   emulsion	   internal	   phase	   droplets	   to	   template	   voids	   into	   a	   material	  
polymerising	  in	  the	  emulsion	  external	  phase.	  The	  method	  was	  first	  employed	  in	  the	  1960’s	  as	  an	  
emulsion	   based	   polymerisation	   tool132,	   but	   was	   then	   extensively	   developed	   by	   Unilever	   in	   the	  
1980’s	   and	   by	   Sherrington/Cameron	   in	   the	   1990’s	   as	   a	   method	   of	   creating	   highly	   porous	  
polymers133,	   134.	   Typically,	   an	   internal	   droplet	   phase	   is	   slowly	   added	   to	   a	   monomeric	   external	  
(continuous)	   phase	   under	   mixing	   to	   create	   an	   emulsion	   (see	   Figure	   1.14).	   When	   the	   volume	  
fraction	   of	   the	   emulsion	   internal	   phase	   occupies	   greater	   than	   74.05	   %	   of	   the	   total	   emulsion	  
volume	   these	   emulsions	   are	   termed	  high	   internal	   phase	   emulsions	   (HIPEs)	   (74.05	  %	   represents	  
the	   packing	   limit	   of	   uniform	   non-­‐deformable	   spheres).	   The	   external	   phase	   of	   the	   HIPE	   is	   then	  
cured	   around	   the	   internal	   droplets	   to	   produce	   a	   polymer	   (or	   polyHIPE)	   containing	   voids	   in	   the	  
structure	  where	  the	  droplets	  had	  once	  been.	  Once	  more,	  during	  this	  polymerisation	  process,	  the	  
thin	  external	  phase	  film	  separating	  each	  internal	  phase	  droplet	  from	  its	  neighbours	  is	  believed	  to	  
contract	   and	   rupture	   to	   create	   interconnecting	  holes	  within	   the	  material	   voids135.	   The	   resulting	  
polymer	  is	  therefore	  an	  interconnected	  network	  of	  voids	  producing	  a	  highly	  permeable	  material	  
with	  a	  porosity	  of	  around	  90	  %	  	  (see	  Figure	  1.15).	  Usually	  the	  materials	  are	  prepared	  in	  monolithic	  
form,	  however	  a	  variety	  of	  other	  physical	  forms	  have	  been	  reported	  including	  polyHIPE	  beads136	  






Figure	  1.14	   Illustration	   showing	   the	  preparation	  of	   a	  polyHIPE	  using	  emulsion	   templating.	  An	  emulsion	  
internal	  droplet	  phase	  is	  slowly	  added	  to	  an	  emulsion	  external	  phase	  under	  mixing	  to	  create	  a	  HIPE,	  where	  
the	  volume	  fraction	  of	   the	   internal	  phase	   is	  at	   least	  74.05	  %.	  The	   internal	  phase	  droplets	   in	   the	  HIPE	  are	  
then	  used	  to	  template	  voids.	  During	  the	  polymerisation	  process	  the	  thin	  continuous	  phase	  film	  is	  believed	  
to	  rupture	  around	  the	  voids	  creating	  small	  interconnecting	  windows	  between	  each	  void	  in	  the	  polyHIPE.	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Figure	  1.15	  Typical	  polyHIPE	  morphology	  observed	  through	  scanning	  electron	  microscopy	  (SEM).	  Polymer	  
voids	  are	  present	  that	  have	  been	  templated	  from	  the	  internal	  phase.	  These	  voids	  are	  also	  interconnected	  
with	  small	  windows	  to	  render	  a	  highly	  porous	  material.	  The	  image	  was	  obtained	  from	  results	  of	  this	  thesis	  
using	  a	  styrene	  based	  HIPE	  formulation.	  Scale	  bar	  =	  100	  µm.	  
	  
PolyHIPEs	   can	   be	   produced	   using	   either	   water-­‐in-­‐oil	   (w/o)	   or	   oil-­‐in-­‐water	   (o/w)	   emulsions138.	  
Generally	   w/o	   emulsions	   are	   more	   popular	   for	   polyHIPE	   synthesis	   as	   the	   emulsions	   are	   more	  
easily	  stabilised.	  Often	  a	  non-­‐ionic	  surfactant	  with	  a	  low	  hydrophilic-­‐lipophilic	  balance	  (HLB)	  such	  
as	  Span80™	  is	  employed	  for	  w/o	  emulsions.	  Span80™	  is	  insoluble	  in	  the	  water	  droplet	  phase	  and	  
so	   inhibits	   emulsion	   phase	   separation.	   Electrolytes	   such	   as	   calcium	   chloride	   (CaCl2)	   are	   also	  
sometimes	  used	  in	  the	  fabrication	  process	  of	  these	  materials	  to	  promote	  emulsion	  stabilisation	  by	  
improving	   surfactant	   packing	   at	   the	   interface139.	   A	   variety	   of	   different	   polymerisation	   initiators	  
can	  be	  employed,	  including	  potassium	  persulfate	  (KPS),	  azobisisobutyronitrile	  (AIBN)	  and	  benzoyl	  
peroxide	  (BPO).	  The	  potential	  to	  create	  a	  variety	  of	  different	  emulsions	  has	  therefore	  resulted	  in	  a	  
broad	  range	  of	  functional	  polyHIPEs	  derived	  from	  a	  variety	  of	  functional	  monomers140,	  141.	  	  
	  
Importantly,	  the	  structure	  of	  polyHIPEs	  can	  be	  tailored	  by	  manipulating	  the	  initial	  HIPE	  properties	  
prior	   to	   curing142.	   For	   instance,	   methods	   to	   destabilise	   the	   emulsion	   such	   as	   increasing	  
temperature	  or	   reducing	  surfactant	  concentration	  can	  give	   rise	   to	  mechanisms	  such	  as	  Ostwald	  
ripening	  and	  droplet	  coalescence	  that	  serve	  to	  increase	  droplet	  diameter	  and	  ultimately	  increase	  
final	   void	   size.	   As	   a	   result,	   careful	   determination	   and	   selection	   of	   surfactant,	   initiator,	   process	  
conditions,	  phase	  compositions	  and	  the	  use	  of	  additives	  are	  all	  possible	  variables	  to	  help	  control	  
HIPE	  properties	  and	  thus	  tailor	  the	  final	  polyHIPE	  structure.	  This	  morphological	  control	  is	  seen	  as	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a	   key	   advantage	   over	   other	   fabrication	   methods	   of	   porous	   polymers	   as	   it	   allows	   for	   a	  
homogeneous	  and	  reproducible	  scaffold	  structure.	  
Emulsion	  templated	  porous	  polymers	  are	  suitable	  for	  3D	  scaffold	  applications	  for	  several	  reasons.	  
Their	   high	   porosity	   facilitates	   effective	   nutrient	   and	  waste	   transfer	   to	   the	   cells.	   They	   possess	   a	  
controllable,	  uniform	  morphology	   that	  can	  potentially	  allow	   for	  extensive	  homogeneous	  3D	  cell	  
organisation.	   They	   also	   offer	   suitable	   mechanical	   strength	   properties	   when	   fabricated	   with	   a	  
chemical	  cross-­‐linker.	  This	  supports	  the	  weight	  of	  large	  cell	  numbers	  and	  also	  allows	  sectioning	  of	  
the	  polyHIPE	  monolith	  into	  thin	  membranes	  for	  use	  in	  3D	  cell	  culture	  applications.	  Several	  groups	  
have	   therefore	   successfully	   applied	   polyHIPEs	   for	   3D	   scaffold	   applications	   and	   demonstrated	  
more	   appropriate	   cell	   growth	   behaviour	   compared	   to	   conventional	   monolayer	   cultures.	   For	  
example,	  Akay	  et	  al.	  and	  Cosgriff-­‐Hernandez	  et	  al.	  have	  reported	  promising	  results	  in	  developing	  
3D	  bone	  growth	  within	  polyHIPEs143-­‐145.	  Barbetta	  et	  al.	  have	  developed	  biocompatible	  polyHIPEs	  
based	  on	  gelatin	  and	  applied	  these	  to	  3D	  neural	  cell	  growth146,	  147.	  Similarly	  Silverstein	  et	  al.	  have	  
reported	  biocompatible	  and	  biodegradable	  polyHIPEs	  based	  on	  polycaprolactone	  (PCL)	  that	  offer	  
promising	   applications	   in	   tissue	   engineering148,	   149.	   Furthermore,	   Cameron/Przyborski	   et	   al.	  
previously	   reported	   the	   suitability	   of	   polystyrene	   based	   polyHIPEs	   as	   replacements	   for	  
conventional	   2D	   plastic-­‐ware	   with	   a	   range	   of	   cell	   types150-­‐153.	   These	   materials	   are	   particularly	  
attractive	  for	  routine	  in	  vitro	  use	  as	  they	  are	  essentially	  just	  a	  more	  appropriate	  geometric	  version	  
of	   the	   typical	   polystyrene	   plates	   used	   in	   cell	   culture	   for	   decades.	   They	   are	   also	   inert	   and	  
chemically	   stable	   and	   so	   are	   suitable	   for	   routine	   laboratory	   use	   and	   storage.	   Indeed,	   the	  
commercial	   versions	   of	   these	  materials	   (Alvetex®Scaffold	   and	  Alvetex®Strata	   by	  Reinnervate)154	  
are	   already	   being	   adopted	   by	   other	   research	   groups	   as	  more	   appropriate	   tools	   for	   in	   vitro	   cell	  
culture155-­‐158.	  	  
Despite	  the	  encouraging	  results	  of	  emulsion	  templated	  porous	  polymers	  (polyHIPEs)	  as	  scaffolds	  
for	  3D	  cell	  growth,	  very	  few	  reports	  have	  investigated	  the	  materials	  for	  3D	  hepatocyte	  growth	  in	  
the	  context	  of	  drug	  discovery	   tools.	  Przyborski	  et	  al.	   showed	  that	  a	  hepatocyte	  derived	  cell	   line	  
(HepG2)	  displays	  a	  different	   functional	   response	   to	  methotrexate	  compared	   to	  conventional	  2D	  
cultures151.	  They	  also	  showed	  enhanced	  viability	  and	  basal	  albumin	  synthesis	  compared	  to	  2D150.	  
Marshall	   et	   al.	   also	   observed	   a	   different	   functional	   response	   of	   primary	   rat	   hepatocytes	   to	  
acetaminophen	  (APAP)	  compared	  to	  2D,	  with	  hepatocytes	  in	  3D	  being	  more	  sensitive	  to	  the	  toxic	  
intermediate	   produced	   during	   APAP	   metabolism159.	   Barbetta	   et	   al.	   applied	   gelatin	   based	  
polyHIPEs	   for	   3D	   hepatocyte	   growth	   as	   a	   preliminary	   study,	   but	   did	   not	   provide	   a	   functional	  
assessment	  of	  the	  cells	  behaviour146,	  147.	  Whilst	  these	  are	  all	  encouraging	  results,	  a	  more	  in	  depth	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study	   regarding	   the	   suitability	   of	   emulsion	   templated	   porous	   polymers	   as	   scaffolds	   for	   3D	  
hepatocyte	  culture	   is	   required	   if	   the	  materials	  are	  to	  be	  widely	  adopted	   in	  routine	  drug	  toxicity	  
studies.	   For	   example,	   how	   well	   the	   scaffolds	   can	   approximate	   native	   liver	   architecture	   under	  
different	   culture	   conditions	   is	   unknown.	   The	   impact	   of	   the	   scaffold	   microenvironment	   on	  
hepatocyte	  structure,	   function	  and	  gene	  expression	   is	  also	  broadly	  unknown.	  Finally,	  no	  reports	  
have	   addressed	   the	   biochemical	   relevance	   of	   synthetic	   emulsion	   templated	   scaffolds	   for	  
hepatocyte	  culture.	  This	  study	  therefore	  aims	  to	  address	  some	  of	  these	  unknowns.	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1.5 Summary	  
This	  literature	  review	  has	  covered	  the	  following	  key	  concepts	  to	  introduce	  this	  project:	  
• Improving	   the	   predictive	   accuracy	   of	   in	   vitro	   hepatocyte	   models	   requires	   technologies
that	  can	  re-­‐create	  elements	  of	  the	  native	  liver	  environment	  in	  vitro.
• Hepatocytes	  in	  their	  native	  liver	  environment	  are	  part	  of	  a	  complex	  3D	  architecture	  that	  is
crucial	  for	  normal	  cell	  function.	  They	  adopt	  a	  specific	  3D	  shape,	  experience	  extensive	  cell-­‐
cell	   contact,	   are	   multi-­‐polarised	   and	   constantly	   pick	   up	   biochemical	   cues	   from	   their
surroundings	  to	  regulate	  normal	  behaviour.
• Accordingly,	  maintaining	  appropriate	  cell	  shape	  and	  cell-­‐cell	  contact	   in	  vitro	   is	  important
in	   developing	   physiologically	   relevant	   in	   vitro	   hepatocyte	   models.	   Unfortunately,
conventional	   2D	  hepatocyte	  models	   force	   an	  unrealistic	   cell	   shape	  with	   limited	   cell-­‐cell
contacts,	   thus	   promoting	   a	   phenotype	   that	   is	   far	   removed	   from	   the	   in	   vivo	   scenario.
Unsurprisingly,	  2D	  hepatocyte	  models	  are	  not	  very	  predictive	  of	  a	  drug’s	  toxicity	  profile.
• Technologies	  that	  enable	  3D	  hepatocyte	  growth	  in	  vitro	  are	  hypothesised	  to	  improve	  the
physiological	  relevance	  of	  hepatocyte	  culture	  models	  and	  thus	  provide	  more	  predictive	  in
vitro	  drug	  toxicity	  tools.
• A	  range	  of	  different	  technologies	  are	  available	  for	  3D	  hepatocyte	  culture,	  each	  with	  their
own	   advantages	   and	   disadvantages.	   These	   include	   ECM	   sandwich	   cultures,	   spheroid
cultures,	  hydrogels,	  electrospun	  scaffolds,	  rapid	  prototype	  scaffolds	  and	  porous	  polymers
derived	  from	  different	  fabrication	  methods.
• Emulsion	  templated	  porous	  polymers	  are	  an	  attractive	  choice	  for	   in	  vitro	  3D	  hepatocyte
growth	  over	  other	  technologies	  due	  to	  their	  high	  porosity,	  controllable	  morphology	  and
suitable	  mechanical	  strength	  properties.
• A	  comprehensive	  understanding	  of	  3D	  hepatocyte	  growth	  in	  emulsion	  templated	  porous
polymers	   is	   yet	   to	   be	   determined.	   Achieving	   this	   could	   result	   in	   more	   representative
hepatocyte	  culture	  phenotypes	  and	  thus	  more	  predictive	  in	  vitro	  toxicity	  tools.
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1.6 Project	  Aims	  
The	  overall	   aim	  of	   this	  project	   is	   to	  develop	  a	  more	  physiologically	   relevant	   in	   vitro	   hepatocyte	  
model	   using	   emulsion	   templated	   porous	   polystyrene	   scaffolds.	   This	   could	   have	   applications	   for	  
more	  predictive	   in	  vitro	  drug	  toxicity	  tools.	  Importantly	  the	  model	  should	  be	  suitable	  for	  routine	  
application,	   offering	   compatibility	   with	   existing	   laboratory	   plastic	   ware	   (inserts/welled	   plates),	  
excellent	  reproducibility	  and	  suitability	  with	  analytical	  methods.	  	  
The	  overall	  aim	  is	  separated	  into	  three	  sub-­‐aims	  that	  correspond	  to	  the	  three	  results	  chapters.	  	  
	  
• Understand,	  develop	  and	  optimise	  hepatocyte	  growth	  in	  emulsion	  templated	  polystyrene	  
scaffolds.	  This	  will	  include	  exploring	  different	  culture	  conditions	  and	  optimisations	  such	  as	  
protein	   coatings	   and	   3D	  media	   perfusion	   to	   re-­‐create	   native	   liver	   tissue	   architecture	   in	  
vitro.	  
	  
• Compare	  structure,	   function	  and	  gene	  expression	  of	  hepatocytes	   in	  emulsion	  templated	  
polystyrene	  scaffolds	  with	  those	  in	  monolayer	  culture	  and	  in	  vivo.	  	  
	  
• Functionalise	   the	   surface	   chemistry	   of	   emulsion	   templated	   polystyrene	   scaffolds	   to	  
improve	   the	   biochemical	   relevance	   of	   the	   materials	   for	   hepatocytes.	   This	   will	   include	  
developing	   novel	   emulsion	   templated	   scaffolds	   that	   carry	   desirable	   physical	  
characteristics	  whilst	  being	  easily	  functionalisable	  with	  appropriate	  biochemical	  residues	  
that	  mimic	  native	  cell-­‐ECM	  interactions.	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Chapter	  2: Materials	  and	  Methods	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2.1 Biological	  Procedures	  
2.1.1 Cell	  Culture	  
All	  cells	  were	  cultured	   in	  a	  humidified	  atmosphere	  of	  5	  %	  CO2	   in	  air	  at	  37	  oC	   inside	  a	  Sanyo	  CO2	  
incubator.	   Cells	  were	  maintained	   using	   aseptic	   techniques	   in	   a	   class	   II	   biological	   safety	   cabinet	  
(Esco	  Airstream®)	  operating	  under	  class	  I	  procedures.	  	  
	  
2.1.1.1 2D	  HepG2	  Cell	  Culture	  
HepG2	   cells	   (ATCC®,	   HB-­‐8065™)	   with	   passage	   numbers	   between	   4	   and	   30	   were	   used	   for	   all	  
experiments	   throughout	   this	   study.	   Cells	   were	   brought	   up	   from	   frozen	   and	   pre-­‐cultured	   on	  
standard	   T75	   tissue-­‐culture	   flasks	   (Nunc™).	  Minimum	   Essential	  Medium	   Eagle’s	   (MEM)	   (Sigma,	  
500mL)	  supplemented	  with	  50	  mL	   fetal	  bovine	  serum	  (FBS)	   (Gibco),	  5	  mL	  of	  2	  mM	  L-­‐Glutamine	  
(Lonza)	   and	  1.1	  mL	  penicillin/streptomycin	   solution	   (100	  active	  units	   each)	   (Gibco)	  was	  used	  as	  
the	   thawing,	   seeding	   and	   culture	  media	   for	   all	   2D	   and	   3D	  HepG2	   culture.	  Media	  was	   changed	  
every	   2-­‐3	   days.	   Cells	   were	   passaged	   at	   90	   %	   confluence	   into	   fresh	   T75	   flasks	   by	   5	   minutes	  
treatment	  with	  0.25	  %	  Trypsin-­‐EDTA	  solution	  (Sigma).	  	  
Assessments	  of	  HepG2	  structure	  and	  function	  were	  performed	  in	  12-­‐well	  plates	  (Greiner	  Bio-­‐One)	  
with	  or	  without	  circular	  glass	  coverslips	  at	  the	  bottom.	  Wells	  were	  pre-­‐coated	  with	  either	  rat-­‐tail	  
collagen	  I	  (BD	  Biosciences,	  534236),	  or	  bovine	  fibronectin	  (Sigma	  F1141).	  For	  collagen	  I	  coatings,	  
500	  µL	  of	  a	  50	  µg/mL	  collagen	  I	  solution	  in	  0.02M	  acetic	  acid	  was	  added	  to	  the	  each	  well/coverslip	  
for	   1	   hour.	   For	   fibronectin	   coatings,	   500	   µL	   of	   a	   1	   mg/mL	   fibronectin	   solution	   in	   phosphate	  
buffered	  saline	  solution	  (PBS)	  was	  added	  to	  each	  well/coverslip	  for	  1	  hour.	  After	  the	  1	  hour	  period	  
the	   coating	   solutions	  were	   removed	   and	   the	  wells/coverslips	  washed	  extensively	   in	   PBS	  before	  
seeding	  cells.	  	  
Pre-­‐cultured	  HepG2	  cells	  were	  extracted	   from	  T75	   flasks	  and	   counted	  using	  a	  haemocytometer	  
and	   Trypan	   Blue	   staining	   (Gibco).	   A	   cell	   suspension	   of	   0.1	   x	   105	   cells	   in	   500	   µL	   media	   was	  
prepared.	  Each	  well/coverslip	  then	  received	  500	  µL	  of	  this	  cell	  suspension	  (1	  x	  105	  viable	  cells)	  and	  
the	  cells	  were	   left	   to	  adhere	  overnight	   in	   the	   incubator.	  Media	  was	   then	  made	  up	   to	  4	  mL	  and	  
changed	  every	  2-­‐3	  days	  throughout	  the	  2D	  culture	  period.	  
	  
2.1.1.2 3D	  HepG2	  Culture	  
Various	   scaffolds	   were	   used	   for	   3D	   HepG2	   culture	   throughout	   the	   study;	   Alvetex®Scaffold	  
(Reinnervate),	   Alvetex®Strata	   (Reinnervate),	   prototype	   Strata	   materials	   and	   the	   poly[26PFPA-­‐
SDE(AIBN)]	   material	   developed	   in	   Chapter	   5	   (see	   Chapter	   5	   for	   details	   of	   this	   material).	   In	   all	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cases,	  15	  mm	  scaffold	  membranes	  were	  first	  rendered	  hydrophilic	  by	  treatment	  with	  1	  mL	  70	  %	  
ethanol	  followed	  by	  extensive	  PBS	  washing.	  
HepG2	   cells	   were	   always	   seeded	   onto	   scaffolds	   at	   a	   density	   of	   5	   x	   105	   cells	   in	   MEM.	   For	  
Alvetex®Scaffold	   and	   poly[26PFPA-­‐SDE(AIBN)],	   cells	  were	   seeded	   via	   100	  µL	  MEM	  per	   scaffold.	  
For	  Alvetex®Strata	  and	  prototype	  Strata	  materials,	  cells	  were	  seeded	  via	  25	  µL	  MEM	  per	  scaffold.	  
All	   scaffolds	  were	   left	   for	   2	   hours	   in	   the	   incubator	   before	   topping	  up	  with	  media.	   Final	   culture	  
media	  volumes	  for	  each	  scaffold	  presentation/format	  (see	  Chapter	  3	  for	  scaffold	  format	  details)	  
are	  shown	  in	  Table	  2-­‐1.	  As	  with	  2D	  cultures,	  media	  were	  changed	  every	  2-­‐3	  days.	  

















70	  mL	   8	  mL	   4	  mL	   4	  mL	   2	  mL	   1	  mL	  
*Note	  that	  3	  scaffold	  inserts	  are	  housed	  in	  1	  Petri	  dish.
2.1.1.3 2D	  Upcyte®	  Cell	  Culture	  
Cryopreserved	   Upcyte®	   human	   hepatocytes	   (Medicyte,	   422A-­‐03-­‐UH0-­‐C00W-­‐0037)	   were	   kindly	  
donated	  by	  Dr.	  Nicola	  Hewitt	   at	  Medicyte.	   These	   cells	  were	   not	   pre-­‐cultured	   in	   2D	  but	   seeded	  
directly	   onto	   collagen	   I	   coated	   12-­‐well	   plates	   with/without	   glass	   coverslips	   for	   structural	   and	  
functional	  assessments.	  Note	  that	  the	  2D	  collagen	  I	  coatings	  were	  prepared	  as	  described	  above	  in	  
section	  2.1.1.1.	  
Three	   separate	   media	   compositions	   were	   employed	   for	   2D	   and	   3D	   Upcyte®	   culture;	   Upcyte®	  
Thawing	  Media;	   Upcyte®	   Seeding	  Media;	   Upcyte®	   Culture	  Media.	   Upcyte®	   Thawing	  Media	  was	  
kindly	  donated	  by	  Medicyte	  (UH0-­‐MT0-­‐0100).	  Upcyte®	  Seeding	  Media	  consisted	  of	  Upcyte®	  High	  
Performance	   Media	   (UH0-­‐ME0-­‐K500,	   500	   mL)	   supplemented	   with	   10	   %	   FBS,	   5	   mL	   Upcyte®	  
Supplement	   A	   (20130207)	   and	   1.1	   mL	   penicillin/streptomycin	   solution	   (100	   active	   units	   each).	  
Upcyte®	   Culture	  Media	   consisted	   of	   Upcyte®	  High	   Performance	  Media	   (500	  mL)	   supplemented	  
with	   5	  mL	  Upcyte®	   Supplement	  A	   and	  1.1	  mL	  penicillin/streptomycin	   solution	   (100	   active	   units	  
each).	  	  
Upcyte®	  cells	  were	  brought	  up	  from	  frozen	  and	  transferred	  into	  45	  mL	  Upcyte®	  Thawing	  Media.	  
Cells	   were	   then	   re-­‐suspended	   in	   10	   mL	   Upcyte®	   Seeding	   Media	   and	   counted	   using	   a	  
haemocytometer	   and	   Trypan	   Blue	   staining.	   Cells	   were	   then	   again	   re-­‐suspended	   in	   Upcyte®	  
Seeding	  Media	  to	  obtain	  1	  x	  105	  cells	  in	  500	  µL.	  500	  µL	  of	  this	  cell	  suspension	  (1	  x	  105	  viable	  cells)	  
was	   added	   to	   each	   collagen	   I	   coated	   well/glass	   coverslip	   and	   left	   to	   adhere	   overnight	   in	   the	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incubator.	  The	  following	  day	  media	  was	  changed	  to	  4	  mL	  of	  Upcyte®	  Culture	  Media.	  Media	  was	  
changed	  every	  2-­‐3	  days.	  	  
2.1.1.4 3D	  Upcyte®	  Culture	  
Upcyte®	  cells	  were	  brought	  up	  from	  frozen	  and	  seeded	  directly	  onto	  ethanol-­‐wetted	  scaffolds	  (5	  x	  
105	   cells	   in	   100	  µL)	   using	   Upcyte®	   Seeding	  Media.	   Cells	   were	   left	   for	   2	   hours	   in	   the	   incubator	  
before	   replacing	   the	   Upcyte®	   Seeding	   Media	   with	   an	   appropriate	   volume	   of	   Upcyte®	   Culture	  
Media,	   depending	   on	   the	   scaffold	   presentation	   employed	   (see	   Table	   2-­‐1).	  Media	  was	   changed	  
every	   2-­‐3	   days.	   Note	   that	   for	   the	   Upcyte®	   adhesion	   experiments	   involving	   the	   poly[13Aa-­‐
SDE(AIBN)]	  scaffold	  (see	  Chapter	  5)	  only	  a	  small	  48-­‐well	  plate	  scaffold	  presentation	  was	  employed	  
due	  to	  material	  restrictions.	  Here	  Upcyte®	  cells	  were	  seeded	  at	  4	  x	  104	  cells	  in	  500	  µL	  in	  Upcyte®	  
Seeding	   Media	   and	   left	   to	   adhere	   for	   2	   hours	   before	   washing	   with	   PBS	   to	   determine	   cell	  
attachment.	  	  
2.1.1.5 2D	  Primary	  Rat	  Hepatocyte	  Cell	  Culture	  
Male	   Sprague-­‐Dawley	   pooled	   cryopreserved	   primary	   rat	   hepatocytes	   (Grade	   P)	   were	   obtained	  
from	   Biopredic	   International	   (HEP134029).	   These	   cells	  were	   not	   pre-­‐cultured	   in	   2D	   but	   seeded	  
directly	   onto	   collagen	   I	   coated	   12-­‐well	   plates	   with/without	   glass	   coverslips	   for	   structural	   and	  
functional	  assessments.	  Note	  that	  the	  2D	  collagen	  I	  coatings	  were	  prepared	  as	  described	  above	  in	  
section	  2.1.1.1.	  
Similar	   to	   Upcyte®	   culture,	   three	   separate	   media	   were	   employed	   for	   2D	   and	   3D	   primary	   rat	  
culture;	  Rat	  Thawing	  Media;	  Rat	  Seeding	  Media;	  Rat	  Culture	  Media.	  Biopredic	  International	  kindly	  
donated	  Rat	  Thawing	  Media	  (MIL261).	  Rat	  Seeding	  Media	  consisted	  of	  Williams	  E	  Media	  (GIBCO,	  
500	  mL)	  supplemented	  with	  10	  %	  FBS,	  5	  mL	  L-­‐glutamine,	  4	  µg/mL	  bovine	  insulin	  (Sigma)	  and	  1.1	  
mL	   penicillin/streptomycin	   solution	   (100	   active	   units	   each).	   Rat	   Culture	   Media	   consisted	   of	  
Williams	  E	  Media	  (500	  mL)	  supplemented	  with	  5	  mL	  L-­‐glutamine,	  4	  µg/mL	  bovine	  insulin,	  50	  µM	  
hydrocortisone	  (Sigma)	  and	  1.1	  mL	  penicillin/streptomycin	  solution	  (100	  active	  units	  each).	  
Rat	  cells	  were	  brought	  up	  from	  frozen	  and	  transferred	  into	  30	  mL	  Rat	  Thawing	  Media.	  Cells	  were	  
then	  re-­‐suspended	  in	  3	  mL	  Rat	  Seeding	  Media	  and	  counted	  using	  a	  haemocytometer	  and	  Trypan	  
Blue	  staining.	  Cells	  were	  then	  again	  re-­‐suspended	  in	  Rat	  Seeding	  Media	  to	  obtain	  1	  x	  105	  cells	  in	  
500	  µL.	  500	  µL	  of	   this	  cell	  suspension	  (1	  x	  105	  viable	  cells)	  was	  added	  to	  each	  collagen	   I	  coated	  
well/glass	  coverslip	  and	   left	   to	  adhere	  overnight	   in	   the	   incubator.	  The	   following	  day	  media	  was	  
changed	  to	  4	  mL	  of	  Rat	  Culture	  Media.	  Media	  was	  changed	  every	  2-­‐3	  days.	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2.1.1.6 3D	  Primary	  Rat	  Hepatocyte	  Culture	  
Rat	  cells	  were	  brought	  up	  from	  frozen	  and	  seeded	  directly	  onto	  ethanol-­‐wetted	  scaffolds	   in	  Rat	  
Seeding	  Media;	  5	  x	  105	  cells	  in	  100	  µL	  for	  growth	  assessments	  with	  Alvetex®Scaffold	  and	  5	  x	  105	  
cells	   in	   25	   µL	   for	   growth	   assessments	   with	   Alvetex®Strata.	   Cells	   were	   left	   for	   2	   hours	   in	   the	  
incubator	   before	   replacing	   the	   Rat	   Seeding	   Media	   with	   an	   appropriate	   volume	   of	   Rat	   Culture	  
Media,	   depending	   on	   the	   scaffold	   presentation	   employed	   (see	   Table	   2-­‐1).	  Media	  was	   changed	  
every	  2-­‐3	  days.	  Note	  that	  only	  2	  x	  104	  	  cells	  added	  via	  100	  µL	  was	  employed	  for	  the	  rat	  albumin	  
assessments	   using	   the	   GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	   scaffold	   and	   the	   corresponding	   control	  
scaffolds	  described	  in	  Chapter	  5.	  	  
2.1.2 Coating	  Scaffolds	  with	  Extracellular	  Matrix	  Proteins	  
Scaffolds	  were	  first	   rendered	  hydrophilic	  by	  treatment	  with	  70	  %	  ethanol	   followed	  by	  extensive	  
washing	   in	   PBS.	   Collagen	   I	   solutions	  were	   prepared	   in	   0.02M	   acetic	   acid.	   Fibronectin	   solutions	  
were	  prepared	   in	  PBS.	  200	  µL	  of	  the	  appropriate	  protein	  solution	  (see	  Chapter	  3)	  was	  added	  to	  
the	  pre-­‐wetted	  scaffolds	  and	  incubated	  for	  1	  hour	  at	  room	  temperature.	  Extensive	  washing	  in	  PBS	  
was	  then	  performed.	  Protein	  deposition	  onto	  the	  scaffolds	  was	  checked	  by	  a	  1	  hour	  incubation	  in	  
a	  1	  mL	  solution	  of	  Coomassie	  Brilliant	  Blue	  G-­‐245	   (BioRad).	   Scaffolds	  were	   then	  de-­‐stained	   in	  a	  
solution	  of	  15	  %	  methanol	  and	  10	  %	  acetic	  acid	  and	  photographed	  for	  residual	  blue	  dye	  uptake.	  
2.1.3 Media	  Perfusion	  Using	  the	  Reinnervate	  Perfusion	  Plate	  
2.1.3.1 Materials	  
Table	  2-­‐2	  shows	  the	  required	  materials	  for	  media	  perfusion	  with	  the	  Reinnervate	  Perfusion	  Plate.	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Table	  2-­‐2	  Materials	  Required	  for	  the	  Set-­‐Up	  of	  the	  Reinnervate	  Perfusion	  Plate	  
Item	   Supplier	   Details/Product	  Code	  
Reinnervate	  Perfusion	  Plate	   Reinnervate	   N/A	  
Multi-­‐channel	  cassette	  pump	   Watson	  Marlow	   Multichannel	  Cassette	  205S/CA.	  
Product	  code:	  020.3704.00A	  
Silicone	  tubing	   Sigma	  	   T1664-­‐25FT	  (1.6	  mm	  ID)	  
Larger	  silicone	  tubing	   Sigma	   T1914-­‐25FT	  (2.4	  mm	  ID)	  
Luer	  locks	   Value	  Plastics	   MTLL004-­‐6005	  (for	  1.6	  mm	  ID	  
tubing)	  
Larger	  luer	  locks	   Value	  Plastics	   MTLL007-­‐1	  (for	  2.4	  mm	  ID	  tubing)	  
Tube-­‐to-­‐tube	  connectors	   Value	  Plastics	   AA-­‐J1A	  (1.6	  mm)	  
Larger	  tube-­‐to-­‐tube	  connectors	   Value	  Plastics	   DD-­‐1	  (for	  2.4	  mm	  ID	  tubing)	  
0.22	  µm	  sterile	  filter	   Millipore	   SLGP033RS	  
6-­‐well	  plates	  (for	  lids)	   Greiner	  Bio-­‐One	   657160	  
Empty	  1	  mL	  pipette	  tip	  box	   Starlab	   Empty	  (racked)	  1	  mL	  tip	  box	  
	  
The	   Reinnervate	   Perfusion	   Plate	   is	   shown	   in	   Figure	   2.1.	   The	   plate	   is	   based	   on	   a	   modified	  
conventional	   6-­‐well	   plate	   format.	   It	   consists	   of	   an	   in-­‐port,	   out-­‐port,	   two	   levelling/sampling	  
reservoirs	   and	   four	   interconnected	  wells/chambers	   (Figure	   2.1A).	   Each	   plate	   therefore	   has	   the	  
capacity	  to	  house	  up	  to	  four	  scaffold	  inserts,	  one	  in	  each	  chamber.	  Luer	  locks	  and	  silicone	  tubing	  
are	  attached	  to	  the	  ports	  to	  transfer	  media	  in	  and	  out	  of	  the	  plate	  (Figure	  2.1B).	  Media	  is	  pumped	  
from	  a	  bottle	  to	  the	   in-­‐port,	   levels	   in	  the	   levelling	  reservoir	  and	  then	  circulates	  around	  the	  four	  
chambers.	  Media	  is	  then	  pumped	  out	  from	  the	  out-­‐port	  back	  to	  the	  media	  bottle.	  1.6	  mm	  internal	  
diameter	  (ID)	  tubing	  luer	  locks	  and	  silicone	  tubing	  are	  used	  for	  media	  entering	  the	  plate.	  2.4	  mm	  
ID	  tubing	  luer	  locks	  and	  silicone	  tubing	  are	  used	  for	  media	  leaving	  the	  plate.	  The	  larger	  tubing	  on	  
the	  out-­‐port	  helps	  to	  prevent	  media	  build-­‐up	  within	  the	  plate.	  A	  standard	  6-­‐well	  plate	  lid	  is	  used	  
as	  the	  lid	  (Figure	  2.1C).	  Complete	  media	  circulation	  therefore	  requires	  two	  pump	  heads	  per	  plate;	  
one	  pumping	  media	  into	  the	  plate	  and	  the	  other	  pumping	  media	  out	  of	  the	  plate.	  	  
	  
42	  
Figure	  2.1	  Photographs	  of	   the	  Reinnervate	  Perfusion	  Plate.	   (A):	  Plate	  design	  based	  on	  a	  modified	  6-­‐well	  
plate	  format	  but	  with	  an	  in-­‐port,	  out-­‐port	  and	  media	  levelling	  reservoirs.	  (B):	  Luer	  locks	  and	  silicone	  tubing	  
are	  attached	  to	  the	  ports	  to	  transfer	  media.	  1.6	  mm	  internal	  diameter	  (ID)	  tubing	  and	  luer	  locks	  are	  applied	  
for	  media	  entering	  the	  plate	  but	  2.4	  mm	  ID	  tubing	  and	  luer	  locks	  are	  used	  for	  media	  leaving	  the	  plate.	  (C):	  A	  
standard	  6-­‐well	  plate	  lid	  with	  rings	  is	  employed.	  	  
A	  Watson-­‐Marlow	  Multichannel	  Cassette	  Pump	  (205S/CA)	  with	  4	  pump-­‐head	  channels	  was	  used	  
to	   pump	   media	   to	   and	   from	   the	   Reinnervate	   Perfusion	   Plate	   (Figure	   2.2A).	   Four	   pump-­‐head	  
channels	  therefore	  allowed	  for	  two	  media	  circuits	  simultaneously	  (i.e.	  two	  Reinnervate	  Perfusion	  
Plates).	  For	  each	  pump	  channel,	  silicone	  tubing	  connecting	  the	  media	  bottle	  and	  plate	  was	  placed	  
over	   the	  pump	   rollers	   (Figure	  2.2B).	  A	  pump	   channel	   cassette	  was	  used	   to	   clamp	   the	   tubing	   in	  
place.	   The	   rolling	   action	   of	   the	   pump	   over	   the	   silicone	   tubing	   created	   the	   desired	   pumping.	  
IMPORTANT:	   The	  pump	  rolling	  action	   sometimes	  caused	   the	   silicone	   tubing	   to	  be	  pulled	   in	   the	  
direction	  the	  rollers	  were	  moving,	  creating	  unwanted	  tension	  and/or	  tubing	  slippage.	  It	  was	  then	  
important	  to	  place	  a	  tube-­‐to-­‐tube	  straight	  connector	  in	  the	  tubing	  (i.e.	  creating	  a	  joint)	  just	  before	  
the	  tubing	  entered	  the	  pump	  so	  that	  slippage	  was	  prevented.	  	  	  
Media	   flow	  was	  altered	  via	   the	  pump	  rotations-­‐per-­‐minute	   (RPM)	  button	  on	   the	  pump	  keypad.	  
RPM	  was	  set	  to	  2	  and	  the	  media	  direction	  clockwise	  (CW).	  This	  ensured	  a	  media	  flow	  rate	  of	  200	  
µL/min.	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Figure	   2.2	  A	  Watson	  Marlow	   multi-­‐channel	   cassette	   pump	   used	   for	   pumping	   media	   to	   and	   from	   the	  
Reinnervate	  Perfusion	  Plate	  (pump	  model	  205S/CA).	  (A):	  The	  pump	  has	  4	  channels	  and	  therefore	  allowed	  
2	  media	   circuits	   (2	   Reinnervate	   Perfusion	   Plates	   simultaneously).	   (B):	   Tubing	  was	   placed	   over	   the	   pump	  
rollers	  and	  a	  pump	  channel	  cassette	  was	  used	  to	  secure	  it	  in	  place.	  Note	  that	  a	  joint	  in	  the	  tubing	  was	  made	  
with	  a	  tube-­‐to-­‐tube	  straight	  connector	  to	  prevent	  tubing	  slipping	  whilst	  the	  rollers	  were	  moving.	  
The	  media	  reservoir	  was	  housed	  in	  a	  125	  mL	  bottle.	  Three	  small	  holes	  (ca.	  1	  mm	  diameter)	  were	  
drilled	  into	  the	  plastic	  cap	  of	  the	  media	  bottle	  (Figure	  2.3).	  One	  hole	  was	  used	  for	  silicone	  tubing	  
transferring	  media	  to	  the	  plate.	  Another	  hole	  was	  used	  for	  silicone	  tubing	  transferring	  media	  from	  
the	  plate.	  A	  third	  hole	  was	  used	  as	  an	  air	  vent,	  with	  tubing	  connected	  to	  a	  0.22	  µm	  sterile	  filter	  to	  
prevent	  bottle	  deformation	  under	  pressure	  changes.	  	  
Figure	  2.3	  Photograph	  of	  the	  cap	  of	  the	  media	  bottle	  used	  as	  the	  media	  reservoir	  for	  the	  perfusion	  set-­‐up.	  
Three	  holes	  were	  drilled	  into	  the	  cap;	  One	  for	  media	  in;	  One	  for	  Media	  Out;	  One	  for	  an	  air	  vent.	  
Figure	  2.4	  shows	  the	  final	  perfusion	  set-­‐up	  for	  a	  single	  circuit.	  All	  equipment	  was	  assembled	  on	  
top	  of	  an	   incubator	  shelf	  to	  allow	  easy	  access	  to	  and	  from	  the	  incubator.	  Plates	  were	  placed	  on	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top	  of	  an	  upside-­‐down	  empty	  pipette	  tip	  box	  so	  that	  the	  tubing	  height	  remained	  approximately	  
level	  with	  the	  pump-­‐head	  channels.	  IMPORTANT:	  As	  the	  pump	  rollers	  are	  uni-­‐directional	  it	  means	  
that	   each	   pump	   head	   pumps	  media	   in	   the	   same	   direction.	   In	   order	   to	   ensure	   that	  media	  was	  
pumped	  to	  the	  plate	  and	  then	  back	  out	  in	  the	  opposite	  direction,	  the	  media-­‐in	  tubing	  had	  to	  be	  
looped	  around	   the	  pump	   to	  ensure	  media	  always	   travelled	   in	   the	   correct	  direction.	   This	   tubing	  
carrying	  media	  in	  to	  the	  plate	  was	  approximately	  60	  cm	  in	  length.	  The	  tubing	  carrying	  media	  out	  
from	  plate	  was	  approximately	  35	  cm	  in	  length.	  This	  ensured	  that	  media	  in	  tubing	  had	  the	  furthest	  
distance	  to	  travel	  and	  thus	  avoided	  issues	  with	  media	  building	  up	  within	  the	  plate.	  
Figure	  2.4	  Final	  set-­‐up	  for	  3D	  media	  perfusion	  using	  the	  Reinnervate	  Perfusion	  Plate.	  Example	  is	  a	  circuit	  
for	   a	   single	  plate.	  All	  equipment	  was	  assembled	  on	  an	   incubator	   tray.	  The	  plate	  was	  raised	  on	  top	  of	  an	  
upside-­‐down	   empty	   pipette	   tip	   box.	   Tubing	   carrying	   media	   in	   looped	   across	   the	   pump	   (total	   60	   cm	   in	  
length)	  to	  ensure	  a	  correct	  uni-­‐directional	  flow	  of	  media.	  
2.1.3.2 Method	  for	  Perfusion	  with	  the	  Reinnervate	  Perfusion	  Plate	  
Scaffolds	  in	  inserts	  in	  6-­‐well	  plates	  (see	  Chapter	  3)	  were	  ethanol	  wetted	  and	  washed	  extensively	  
in	  PBS.	  Hepatocytes	  were	  seeded	  at	  5	  x	  104	  	   in	  100	  µL	  seeding	  media	  and	  left	  for	  2	  hours	  in	  the	  
incubator.	   Seeding	  media	  was	   then	  made	   to	  8	  mL	  and	   the	   scaffolds	   left	  overnight	   in	   the	  6-­‐well	  
plates	  for	  cultures	  to	  establish	  (static	  media	  conditions).	  Scaffold	  inserts	  were	  then	  placed	  in	  the	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Reinnervate	   Perfusion	   Plate.	   130	  mL	   of	   culture	  media	  was	   added	   to	   the	  media	   bottle	   and	   the	  
media	  perfusion	  was	  applied	  (200	  µL/min).	  Experiments	  were	  performed	  for	  up	  to	  7	  days	  without	  
changing	   the	  media.	   Static	   cultures	   involving	   scaffolds	   in	   inserts	   in	   12-­‐well	   plates	   (4	  mL	  media)	  
were	  used	  as	  controls	  with	  the	  media	  changed	  every	  2	  days.	  	  
2.1.4 Histology	  
2.1.4.1 Haematoxylin	  and	  Eosin	  (H&E)	  Staining	  of	  Scaffolds	  
Haematoxylin	  stains	  cell	  nuclei	  purple	  and	  Eosin	  stains	  the	  cytoplasm	  pink.	  After	  the	  desired	  cell	  
culture	   period,	   scaffolds	   were	   removed	   from	   inserts	   and/or	   plates	   (see	   Chapter	   3)	   and	   gently	  
dipped	  in	  PBS	  before	  transferring	  into	  a	  fresh	  12-­‐well	  plate.	  Cells	  on	  the	  scaffolds	  were	  then	  fixed	  
by	   treatment	   with	   2	  mL	   of	   either	   Bouin’s	   fixative	   or	   4	   %	   paraformaldehyde	   overnight	   at	   4	   oC.	  
Scaffolds	  were	  then	  washed	  3	  x	  5	  minutes	  in	  PBS	  with	  gentle	  agitation.	  Scaffolds	  were	  then	  slowly	  
dehydrated	  through	  a	  series	  of	  ethanol	  gradients	  (15	  minutes	  each);	  30	  %,	  50	  %,	  70	  %,	  80	  %,	  90	  %,	  
95	  %	  and	  100	  %.	  Scaffold	  discs	  were	  then	  cut	  into	  2	  halves	  (to	  produce	  two	  semi-­‐circles)	  and	  then	  
carefully	   placed	   into	   a	   10	   mL	   glass	   vial	   containing	   5	   mL	   Histo-­‐Clear	   (National	   Diagnostics).	  
Scaffolds	  were	  left	  for	  15	  minutes	  in	  Histo-­‐Clear	  before	  an	  additional	  5	  mL	  of	  melted	  paraffin	  wax	  
was	   added	   using	   a	   Leica	   EG1120	   wax	   dispenser	   (to	   create	   a	   50:50	   mixture	   of	   Histo-­‐Clear	   to	  
paraffin	  wax).	  Scaffolds	  were	  incubated	  in	  this	  mixture	  for	  30	  minutes	  in	  a	  60	  oC	  oven.	  Following	  
that	  the	  mixture	  was	  replaced	  with	  10	  mL	  paraffin	  wax.	  Scaffolds	  were	  then	  incubated	  in	  the	  wax	  
for	   1	   hour	   at	   60	   oC.	   After	   this	   time	   the	   scaffold	   semi-­‐circles	   were	   embedded	   vertically	   in	   an	  
embedding	  cassette	   (Simport,	  Histosette	   I)	  and	  plastic	  mould	   (CellPath,	  Dispomould)	  and	   left	   to	  
set	  overnight.	  	  
Sectioning	   of	   wax	   blocks	   into	   a	   hot	   water	   bath	   was	   performed	   using	   a	   Leica	   RM2125RT	  
Microtome.	  	  10	  µm	  sections	  were	  employed	  for	  all	  H&E	  staining	  with	  HepG2	  cells,	  Upcyte®	  cells	  
and	   primary	   rat	   hepatocytes.	   The	   sections	   were	   then	   mounted	   on	   glass	   slides	   and	   left	   to	   dry	  
overnight.	   The	   H&E	   staining	   protocol	   involved	   de-­‐waxing	   the	   slides	   in	   Histoclear	   for	   5	  minutes	  
then	   hydrating	   through	   100	   %	   ethanol	   (2	  minutes),	   95	   %	   ethanol	   (1	  minute),	   70	   %	   ethanol	   (1	  
minute)	  and	  distilled	  H2O	  (1	  minute).	  Nuclei	  were	  stained	  using	  Mayer’s	  Haematoxylin	  (Sigma)	  for	  
5	  minutes	  prior	   to	  being	  washed	   in	  distilled	  H2O	   for	  30	   seconds.	   	  Nuclei	  were	  blued	   in	   alkaline	  
ethanol	  (30	  mL	  ammonia	  in	  970	  mL	  70	  %	  ethanol)	  for	  30	  seconds.	  Slides	  were	  dehydrated	  through	  
70	  %	  and	  95	  %	  ethanol	  for	  30	  seconds	  each	  and	  the	  cytoplasm	  was	  stained	  pink	  using	  Eosin	  Y	  (5	  g	  
in	  1	   L	  of	  70	  %	  ethanol)	   for	  45	   seconds.	   Sections	  were	  quickly	  dipped	   in	  95	  %	  ethanol	  and	   then	  
twice	  in	  100	  %	  ethanol	  before	  clearing	  in	  Histo-­‐Clear.	  Slides	  were	  mounted	  in	  DPX	  mountant	  and	  
cover-­‐slipped.	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2.1.4.2 H&E	  Staining	  of	  Human	  Liver	  Tissue	  
Commercial	   pre-­‐sectioned	   (5	   µm),	   paraffin	   embedded	   histological	   slides	   of	   human	   liver	   tissue	  
were	   obtained	   from	   abcam	   (ab4348).	   These	   were	   H&E	   stained	   following	   the	   H&E	   staining	  
protocol	  described	  above.	  
	  
2.1.4.3 H&E	  Staining	  of	  2D	  Cultures	  
Although	  not	  strictly	  a	  histology	  process,	  cells	  cultured	  on	  collagen	   I	  coated	  12-­‐well	  plates	  were	  
processed	   for	   H&E	   staining	   to	   provide	   a	   direct	   comparison	   with	   scaffold	   and	   in	   vivo	   histology	  
images.	  Samples	  were	  fixed	  in	  4	  %	  paraformaldehyde	  for	  1	  hour	  and	  washed	  excessively	   in	  PBS.	  
Nuclei	  were	  stained	  using	  Mayer’s	  Haematoxylin	  for	  5	  minutes	  prior	  to	  being	  washed	  in	  distilled	  
H2O	   for	   30	   seconds.	   	   Nuclei	   were	   blued	   in	   alkaline	   ethanol	   (30	   mL	   ammonia	   in	   970	   mL	   70	   %	  
ethanol)	   for	  30	  seconds.	  Samples	  were	   then	  dehydrated	  through	  70	  %	  and	  95	  %	  ethanol	   for	  30	  
seconds	  each	  and	  the	  cytoplasm	  was	  stained	  pink	  using	  Eosin	  Y	  (5	  g	  in	  1	  L	  of	  70	  %	  ethanol)	  for	  45	  
seconds.	  Samples	  were	  quickly	  dipped	  in	  95	  %	  ethanol	  and	  then	  twice	  in	  100	  %	  ethanol	  and	  then	  
imaged	  directly.	  	  
	  
2.1.4.4 Toluidine	  Blue	  Staining	  
Resin-­‐embedded	   1	   µm	   sections	   prepared	   from	   transmission	   electron	   microscopy	   (TEM)	  
processing	  (see	  section	  2.1.5.1)	  were	  placed	  on	  a	  glass	  slide	  and	  dried	  on	  a	  hotplate.	  Slides	  were	  
then	  dipped	  in	  a	  Toluidine	  Blue	  O	  (Sigma)	  staining	  solution	  for	  30	  seconds	  and	  rinsed	  extensively	  
in	  distilled	  water.	  	  Slides	  were	  mounted	  in	  DPX	  mountant	  and	  cover-­‐slipped.	  
	  
2.1.5 Imaging	  
2.1.5.1 Transmission	  Electron	  Microscopy	  (TEM)	  
Cell	   culture	   samples	   were	   first	   fixed	   in	   a	   fixative	   solution	   of	   0.1	   M	   sodium	   cacodylate	   buffer	  
containing	   4	  %	   paraformaldehyde	   and	   5	  %	   glutaldehyde	   for	   1	   hour.	  Mouse	   liver	   samples	  were	  
kindly	  donated	  by	  Eleanor	  Knight	  at	  Durham	  University	  and	  were	  obtained	  from	  adult	  male	  nude	  
(nu/nu)	  mice	  in	  accordance	  with	  guidelines	  and	  permission	  granted	  by	  the	  Home	  Office,	  UK.	  Liver	  
tissue	  was	  immediately	  cut	  into	  small	  pieces	  (ca.	  1	  mm3)	  after	  surgical	  extraction	  and	  fixed	  in	  4	  %	  
paraformaldehyde	   overnight	   at	   4	   oC.	   All	   fixed	   samples	   (cell	   culture	   and	   liver	   tissue)	  were	   then	  
washed	  in	  0.1	  M	  sodium	  cacodylate	  buffer	  before	  being	  treated	  with	  1	  %	  osmium	  tetroxide	  for	  1	  
hour.	  Samples	  were	  again	  washed	  in	  0.1	  M	  sodium	  cacodylate	  buffer	  and	  then	  slowly	  dehydrated	  
through	  a	  series	  of	  ethanol	  gradients	  (3	  x	  5	  minutes	  each);	  50	  %,	  70	  %,	  95	  %	  and	  100	  %.	  Samples	  
were	   then	   infiltrated	  with	  mixtures	  of	   ethanol:	   LR	  white	   (Agar	   Scientific,	  Medium	  grade)	   for	  30	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minutes	  each;	  2:1,	  1:1,	  1:2.	  Samples	  were	  then	  left	  in	  resin	  overnight	  before	  being	  embedded	  into	  
polypropylene	  capsules	  (Agar	  Scientific).	  Capsules	  were	  then	  placed	  in	  a	  37	  oC	  oven	  overnight	  to	  
set.	  For	  2D	  cultures,	  the	  glass	  coverslips	  were	  embedded	  horizontally	  on	  top	  of	  the	  capsule.	  Once	  
set,	   the	  coverslip	  was	  removed	   from	  the	  capsule	  by	  exposure	   to	   liquid	  nitrogen	  vapour,	   leaving	  
the	  2D	  cells	  behind	  in	  the	  resin.	  Resins	  were	  removed	  from	  the	  capsules	  and	  then	  sectioned	  using	  
a	   Leica	   Reichert	   Ultracut	   S	  microtome	   using	   a	   glass	   knife	   and	  water	   boat.	   1	  µm	   sections	  were	  
taken	  for	  Toluidine	  Blue	  staining.	  Sections	  of	  ca.	  50	  –	  80	  nm	  were	  placed	  onto	  copper	  grids	  (150	  
mesh)	   and	   stained	   with	   1	   %	   uranyl	   acetate	   followed	   by	   lead	   citrate	   (10	   minutes	   each	   with	  
excessive	  water	  washing	  in	  between).	  Samples	  were	  imaged	  using	  a	  Hitachi	  H-­‐7600	  TEM.	  Images	  
were	  processed	  using	  Adobe	  Photoshop	  CS5.	  
	  
2.1.5.2 Scanning	  Electron	  Microscopy	  (SEM)	  for	  Biological	  Analysis	  
Samples	  were	  first	   fixed	   in	  a	   fixative	  solution	  of	  0.1	  M	  sodium	  cacodylate	  buffer	  containing	  4	  %	  
paraformaldehyde	  and	  5	  %	  glutaldehyde	  for	  1	  hour.	  Samples	  were	  then	  washed	  in	  0.1	  M	  sodium	  
cacodylate	  buffer	  before	  being	  treated	  with	  1	  %	  osmium	  tetroxide	  for	  1	  hour.	  Samples	  were	  again	  
washed	   in	   0.1	   M	   sodium	   cacodylate	   buffer	   and	   then	   slowly	   dehydrated	   through	   a	   series	   of	  
ethanol	  gradients	  (3	  x	  5	  minutes	  each);	  50	  %,	  70	  %,	  95	  %	  and	  100	  %.	  Samples	  were	  then	  passed	  
through	  a	  critical	  point	  dryer	  (Bal-­‐tec	  CPD	  030)	  to	  dry	  the	  samples.	  Two	  SEM	  machines	  were	  used	  
for	  biological	  analysis;	  Hitachi	  S-­‐5200	  and	  Phillips	  XL30	  ESEM.	  For	  the	  Hitachi,	  samples	  were	  first	  
mounted	  on	  silicon	  wafer	  chips	  using	  double	  sided	  sticky	  tape	  and	  then	  platinum	  coated	  using	  a	  
Cressington	  328	  coating	  system	  before	  imaging.	  Images	  were	  taken	  at	  10	  kV.	  For	  the	  Phillips	  XL30	  
ESEM,	   samples	   were	   first	   mounted	   on	   carbon	   fibre	   pads	   pre-­‐adhered	   to	   aluminium	   stubs	   and	  
then	  gold	  coated	  using	  an	  Edwards	  Pirani	  501	  sputter	  coater	  before	  imaging.	  Images	  were	  taken	  
between	  10	  kV	  and	  30	  kV.	  Images	  were	  processed	  using	  Adobe	  Photoshop	  CS5.	  
	  
2.1.5.3 Bright-­‐field	  Light	  Microscopy	  
Histology	  slides	  and	  2D	  cell	  cultures	  were	  imaged	  using	  a	  Leica	  DM500	  light	  microscope.	  Images	  
were	  processed	  using	  Adobe	  Photoshop	  CS5.	  All	   images	  were	  processed	  in	  the	  exactly	  the	  same	  
manner.	   Image	   brightness	   was	   enhanced	   +15	   and	   image	   contrast	   was	   enhanced	   +50.	   Cell	  
diameters	  in	  the	  XY	  plane	  were	  obtained	  from	  light	  microscopy	  images	  using	  ImageJ™	  analysis	  as	  
a	  digital	  measuring	  tool.	  	  
	  
2.1.5.4 Confocal	  Immunofluorescence	  	  
Samples	  were	  first	  fixed	  in	  4	  %	  paraformaldehyde	  overnight	  at	  4	  oC.	  Samples	  were	  then	  washed	  
extensively	   in	  PBS	  and	  then	  permeabilised	  by	  treatment	  with	  0.1	  %	  Triton	  X-­‐100	  solution	  for	  15	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minutes.	  Note	  that	  Ki-­‐67	  immunofluorescence	  (see	  Chapter	  3)	  was	  performed	  on	  wax-­‐embedded	  
samples	   that	   had	   to	   be	   first	   de-­‐paraffinised	   and	   heat-­‐treated	   in	   citrate	   buffer	   before	  
permeabilisation.	  Samples	  were	  then	  exposed	  to	  a	  blocking	  buffer	  of	  1	  %	  normal	  goat	  serum	  and	  
0.1	   %	   Tween	   20	   in	   PBS	   for	   30	   minutes.	   Samples	   were	   then	   exposed	   to	   the	   specific	   primary	  
antibody	  overnight	  at	  4	  oC	  (see	  Table	  2-­‐3).	  A	  control	  (no	  primary	  antibody)	  was	  included	  alongside	  
each	  primary	  antibody.	  
Table	  2-­‐3	  Primary	  and	  Secondary	  Antibodies	  used	  in	  Confocal	  Immunofluorescence	  
Antibody	   Supplier	   Description	   Code	   Dilution	  	  
(in	  blocking	  buffer)	  
ZO1	   Life	  Technologies	   Rabbit	  
Polyclonal	  
402200	   1	  in	  100	  
MDR1	   abcam	   Mouse	  Monoclonal	   ab3366	   1	  in	  100	  
MRP2	   abcam	   Mouse	  Monoclonal	   ab3373	   1	  in	  100	  
Phalloidin	   Cytoskeleton	  Inc.	   Acti-­‐Stain	  
Fluorescent	  488	  
PHDG1	   1	  in	  143*	  
Ki-­‐67	   Leica	   Mouse	  Monoclonal	   NCL-­‐L-­‐Ki67-­‐
MM1	  
1	  in	  100	  
Fibronectin	   Sigma	   Mouse	  Monoclonal	   F7387	   1	  in	  300	  
Collagen	  I	   Sigma	   Mouse	  Monoclonal	   C2456	   1	  in	  2000	  
2o	  Mouse	   Life	  Technologies	   Alexa	  Fluor	  488	  Goat	  
Anti-­‐Mouse	  IgG	  
A-­‐11001	   1	  in	  600	  
2o	  Rabbit	   Life	  Technologies	   Alexa	  Fluor	  488	  Goat	  
Anti-­‐Rabbit	  IgG	  
A-­‐11008	   1	  in	  600	  
*Dilution	  of	  a	  14	  µM	  Phalloidin	  stock	  solution	  in	  blocking	  buffer.
Samples	  were	   then	  washed	  extensively	   in	   blocking	  buffer.	   Samples	  were	   then	   incubated	   in	   the	  
dark	  for	  1	  hour	  with	  secondary	  antibody	  at	  a	  dilution	  of	  1:600	  in	  blocking	  buffer.	  DAPI	  (Hoechst	  
33342)	  was	   also	   included	   at	   1:1000	   as	   a	   nuclei	   counterstain.	  Note	   that	   Phalloidin	  was	   supplied	  
pre-­‐coupled	   to	   a	   green	   fluorescent	   dye	   (proprietary	   to	   Cytoskeleton	   Inc.)	   and	   so	   there	  was	   no	  
need	   for	   incubation	   with	   a	   secondary	   antibody.	   Samples	   were	   then	   washed	   extensively	   in	  
blocking	  buffer	  and	   then	  mounted	   in	  Vectashield	   (VectorLabs).	  Coverslips	  were	   sealed	  with	  nail	  
varnish	  and	  samples	  imaged	  with	  2	  days.	  A	  Zeiss	  Axiovert	  200M	  confocal	  microscope	  was	  used	  for	  
imaging.	  Images	  were	  processed	  using	  Adobe	  Photoshop	  CS5.	  
2.1.6 Functional	  Assays	  
2.1.6.1 MTT	  Metabolic	  Assay	  
The	  MTT	  assay	  exposes	  cells	   to	  Thiazolyl	  Blue	  Tetrazolium	  Bromide	   (MTT,	  Sigma)	   to	  which	   they	  
metabolise	   and	   convert	   into	   an	   insoluble	   blue	   formazan	   product.	   The	   amount	   of	   formazan	  
produced	   is	   therefore	   a	   simple	   indicator	   of	   a	   population’s	   total	   metabolic	   activity.	   An	   MTT	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solution	  of	  1	  mg/mL	  in	  phenol-­‐red	  free	  Dulbecco’s	  Modified	  Eagle’s	  Medium	  (DMEM,	  Sigma)	  was	  
prepared.	  This	  was	  then	  passed	  through	  a	  0.22	  µm	  sterile	   filter	  and	  warmed	  to	  37	  oC.	  Scaffolds	  
were	   removed	   from	   inserts/plates	   and	   transferred	   into	   a	   fresh	   12-­‐well	   plate.	   2D	   cultures	  were	  
analysed	  directly	  in	  the	  welled	  plate.	  A	  short	  PBS	  wash	  of	  the	  cell	  cultures	  was	  applied	  to	  remove	  
residual	  culture	  media.	  1	  mL	  of	  the	  MTT	  solution	  was	  added	  to	  each	  well	  and	  then	  the	  plates	  were	  
incubated	  for	  1	  hour	   in	  the	  dark	   in	  an	   incubator.	  After	  this	  period,	   the	  excess	  MTT	  reagent	  was	  
aspirated	  from	  the	  wells	  and	  1	  mL	  of	  acidified	   isopropyl	  alcohol	  (IPA)	  was	  added	  to	  dissolve	  the	  
blue	   formazan	   product	   (1	   µL	   hydrochloric	   acid	   in	   1	   mL	   IPA).	   200	   µL	   aliquots	   of	   the	   blue	   IPA	  
solutions	  were	   then	   transferred	   into	   a	   96-­‐well	   plate	   and	   the	   absorbance	  measured	   at	   570	   nm	  
using	  a	  BioTek	  ELx800	  plate	  reader.	  
2.1.6.2 Albumin	  Assay	  
Secreted	  albumin	  present	   in	   the	  culture	  media	  was	  assessed	  using	  a	  commercial	  enzyme-­‐linked	  
immunosorbent	  assay	  (ELISA).	  Primary	  rat	  culture	  media	  samples	  were	  assessed	  using	  a	  rat	  ELISA	  
(AssayPro,	  ERA3201-­‐1).	  Human	  HepG2	  culture	  media	  samples	  were	  assessed	  using	  a	  human	  ELISA	  
(AssayPro,	   EA3201-­‐1).	   The	   exact	  manufacturers	   protocol	  was	   followed.	   In	   brief,	   aliquots	   of	   the	  
media	  samples	  were	  taken	  and	  diluted	  in	  the	  assay	  diluent	  as	  per	  the	  protocol	  recommendations.	  
Albumin	  standards	  were	  prepared	  in	  parallel	  using	  known	  rat	  or	  human	  albumin	  concentrations.	  
Samples	   and	   standards	   were	   then	   transferred	   into	   immunosorbent	   plate	   and	   incubated	   in	   the	  
assay	  reagents.	  Plates	  were	  then	  read	  at	  450	  nm	  using	  a	  BioTek	  ELx800	  plate	  reader.	  A	  standard	  
curve	  was	  used	  to	  correlate	  absorbance	  with	  albumin	  quantity	  in	  culture	  samples.	  
2.1.6.3 Urea	  Assay	  
Secreted	   urea	   present	   in	   the	   culture	   media	   was	   assessed	   using	   commercial	   colorimetric	   urea	  
assay	   (BioAssay	   Systems,	   DIUR-­‐500).	   The	   exact	   manufacturers	   protocol	   was	   followed.	   In	   brief,	  
aliquots	   of	   the	  media	   samples	  were	   taken	   and	   diluted	   in	   the	   assay	   diluent	   as	   per	   the	   protocol	  
recommendations.	   Urea	   standards	  were	   prepared	   in	   parallel	   using	   known	   urea	   concentrations.	  
Samples	  and	  standards	  were	  then	  transferred	   into	  a	  96-­‐well	  plate	  and	   incubated	  with	  the	  assay	  
reagent	  for	  40	  minutes.	  Plates	  were	  then	  read	  at	  540	  nm	  using	  a	  BioTek	  ELx800	  plate	  reader.	  A	  
standard	  curve	  was	  used	  to	  correlate	  absorbance	  with	  urea	  quantity	  in	  culture	  samples.	  
2.1.6.4 Quant-­‐iT™	  PicoGreen®	  
A	   commercial	   Quant-­‐iT™	   PicoGreen®	   assay	   (Life	   Technologies,	   P7589)	   was	   used	   to	   quantify	  
double-­‐stranded	  DNA	   (dsDNA)	   in	   the	  hepatocyte	  cultures	  and	   thus	  provide	  an	   indication	  of	   cell	  
number.	   Cultures	  were	   first	   treated	  with	   a	   standard	   lysis	   buffer.	   Lysate	   solutions	   and	   scaffolds	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were	  then	  transferred	  into	  an	  eppendorf	  tube	  and	  homogenised	  with	  a	  20-­‐gauge	  needle.	  Scaffold	  
cultures	  were	  also	  subject	   to	  additional	  vortexing	  and	  centrifugation	  steps	   to	  ensure	  all	   cellular	  
material	  was	  extracted	  from	  the	  scaffold	  into	  the	  lysate.	  Note	  that	  standards	  of	  known	  HepG2	  cell	  
numbers	   (from	   haemocytometer	   counting)	   were	   lysed	   and	   homogenised	   alongside	   the	   culture	  
samples.	  Aliquots	  of	  the	  lysates	  were	  then	  incubated	  with	  the	  Quant-­‐iT™	  PicoGreen®	  reagent	  as	  
per	  the	  assay	  protocol.	  The	  fluorescence	  intensity	  was	  measured	  at	  540	  nm	  was	  measured	  using	  a	  
BioTek	  Synergy	  H4	  plate	   reader	   (excitation	  at	  460	  nm).	  A	   standard	   curve	  was	  used	   to	   correlate	  
fluorescence	  intensity	  with	  cell/DNA	  number	  in	  culture	  samples.	  
2.1.6.5 Flow	  Cytometry	  
The	  commercial	  Guava	  Nexin®	  assay	  (Millipore	  4500-­‐0450)	  was	  used	  for	  flow	  cytometric	  analysis	  
of	   hepatocytes.	   Cells	   on	   scaffolds	   were	   extracted	   by	   15	   minutes	   treatment	   in	   Trypsin-­‐EDTA	  
solution	  followed	  by	  gentle	  scraping	  with	  a	  cell	  scraper.	  The	  cells	  were	  then	  re-­‐suspended	  in	  fresh	  
culture	  media	  and	  then	  treated	  with	  the	  Guava	  Nexin®	  reagent	  as	  per	  the	  assay	  protocol.	  A	  Guava	  
EasyCyte™	  Plus	   flow	  cytometer	  was	  used	   for	   the	  experiment.	  Data	  was	  analysed	  using	  Cytosoft	  
flow	  cytometric	  analysis	  software	  (Millipore).	  Thresholds	  for	  hepatocyte	  apoptosis	  were	  set	  using	  
a	   control	   apoptotic	   population	   pre-­‐treated	   with	   2	   µM	   staurosporine	   (Sigma).	   Thresholds	   for	  
hepatocyte	  necrosis	  were	  set	  using	  a	  control	  necrotic	  population	  pre-­‐exposed	  to	  heat	  treatment	  
(58	  oC	  for	  20	  minutes).	  	  
	  
2.1.6.6 Glucose	  Measurements	  
Media	  glucose	  was	  measured	  directly	  from	  the	  culture	  media	  sample	  using	  the	  GlucCell™	  glucose	  
monitoring	   system	   (CESCO	   BioProducts)160.	   Cultures	   were	   first	   gently	   swirled	   to	   distribute	   the	  
media	  and	  then	  a	  50	  µL	  aliquot	  was	  taken	  and	  vortexed.	  A	  fresh	  glucose	  test	  strip	  was	   inserted	  
into	  the	  GlucCell™	  meter.	  A	  2	  µL	  sample	  of	  the	  50	  µL	  media	  aliquot	  was	  then	  gently	  loaded	  into	  
the	  side	  of	  the	  test	  strip	  as	  per	  the	  manufacturer	  protocol.	  Glucose	  concentrations	  displayed	  on	  
the	  GlucCell™	  meter	  were	  then	  recorded.	  Fresh	  media	  pre-­‐warmed	  to	  37	  oC	  were	  also	  analysed	  to	  
provide	  a	  benchmark	  for	  initial	  glucose	  concentration.	  
	  
2.1.6.7 Bio-­‐Rad®	  Assay	  for	  Protein	  Quantification	  
The	  Bio-­‐Rad®	  Protein	  Assay	  Dye	  (Bio-­‐Rad,	  500-­‐0006)	  was	  used	  to	  determine	  total	  protein	  content	  
in	   cell	   cultures.	   Cultures	   were	   first	   treated	   with	   a	   standard	   lysis	   buffer.	   Lysate	   solutions	   and	  
scaffolds	   were	   then	   transferred	   into	   an	   eppendorf	   tube	   and	   homogenised	   with	   a	   20-­‐gauge	  
needle.	   Scaffold	   cultures	   were	   also	   subject	   to	   additional	   vortexing	   and	   centrifugation	   steps	   to	  
ensure	   all	   cellular	  material	   was	   extracted	   from	   the	   scaffold	   into	   the	   lysate.	   Lysates	   were	   then	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centrifuged	  at	  10,000	  rpm	  and	  then	  heated	  on	  a	  heating	  block	  at	  95	  oC	  for	  3	  minutes.	  Standards	  of	  
known	   concentrations	   of	   bovine	   serum	   albumin	   (Sigma)	   were	   then	   prepared.	   Samples	   and	  
standards	  were	  then	   incubated	   in	  Bio-­‐Rad®	  Protein	  Assay	  Dye	  and	  the	  absorbance	  measured	  at	  
600	  nm	  using	  a	  BioTek	  ELx800	  plate	  reader.	  A	  standard	  curve	  was	  used	  to	  correlate	  absorbance	  
with	  protein	  quantity	  in	  culture	  samples	  
2.1.6.8 Drug	  Exposure	  Studies	  
Acetaminophen	   (APAP,	   Sigma)	   and	   Gemfibrozil	   (Sigma)	   were	   pre-­‐dissolved	   in	   culture	   media	  
without	   using	   DMSO.	   Rifampicin	   (Sigma)	   was	   pre-­‐dissolved	   in	   pure	   Dimethyl	   Sulfoxide	   (DMSO,	  
Sigma)	  and	  then	  added	  to	  culture	  media	  to	  produce	  a	  final	  concentration	  of	  20	  µM	  rifampicin.	  A	  
DMSO	  control	  was	  therefore	  used	  in	  conjunction	  with	  all	  rifampicin	  studies.	  
2.1.6.9 CYP3A4	  Activity	  
The	   testosterone	   assay	   was	   used	   to	   determine	   CYP3A4	   activity	   by	   exposing	   hepatocytes	   to	  
testosterone	  and	  then	  measuring	  the	  metabolite	  6-­‐β-­‐OH-­‐testosterone	  by	  high	  performance	  liquid	  
chromatography	  analysis	   (HPLC).	  Scaffolds	  were	  removed	  from	   inserts	  and	  placed	   in	  a	   fresh	  12-­‐
well	  plate.	  Samples	  were	  then	  washed	  in	  PBS	  supplemented	  with	  1	  mM	  CaCl2.	  Samples	  were	  then	  
incubated	  in	  PBS	  supplemented	  with	  1	  mM	  CaCl2	  and	  250	  µM	  testosterone	  (Sigma)	  for	  1	  hour	  in	  
an	   incubator.	   The	   supernatants	   were	   then	   transferred	   into	   an	   eppendorf	   tube	   and	   sent	   to	  
Medicyte	   for	   HPLC	   analysis.	  A	   standard	   curve	   using	   known	   6-­‐β-­‐OH-­‐testosterone	   concentrations	  
was	  used	  to	  correlate	  HPLC	  peak-­‐area-­‐ratio	  with	  CYP3A4	  activity	  in	  cell	  culture	  samples.	  	  
2.1.7 Real	  Time	  Quantitative	  Polymerase	  Chain	  Reaction	  
Cells	  cultured	  on	  2D	  and	  on	  scaffolds	  were	  first	   treated	  with	  RLT	  Lysis	  Buffer	   (Qiagen)	  and	  then	  
homogenised	   using	   a	   20-­‐gauge	   needle	   and	   1	   mL	   syringe.	   A	   commercial	   RNA	   spin-­‐column	  
extraction	   kit	   and	   procedure	  was	   then	   followed	   to	   isolate	   the	   RNA	   (Qiagen,	   RNeasy®	  Mini	   Kit,	  
74106).	  DNAse	  digestion	  using	  a	  commercial	  DNAse	  digestion	  kit	  (Qiagen,	  DNAse	  set,	  79254)	  was	  
performed	  as	  part	  of	  this	  RNA	  isolation.	  Quantity	  and	  quality	  of	  isolated	  RNA	  was	  checked	  using	  a	  
Nanodrop	   Spectrophotometer	   (NanoDrop®	  ND-­‐1000).	   Reverse	   transcription	  using	   a	   commercial	  
complementary	   DNA	   (cDNA)	   reverse	   transcription	   kit	   (Applied	   Biosystems,	   4368814)	   and	   a	  
thermal	   cycler	   (Biometra)	   was	   then	   performed	   to	   convert	   RNA	   into	   cDNA.	   All	   cDNA	   was	   then	  
stored	  at	  -­‐20	  oC	  in	  preparation	  for	  analysis.	  
TaqMan®	   gene	   expression	   assays	   were	   used	   in	   all	   real	   time	   quantitative	   polymerase	   chain	  
reaction	   (RT-­‐PCR)	   analysis.	   Table	   2-­‐4	   shows	   the	   different	   genes	   that	   were	   assessed.	   All	   gene	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expression	   assays	   were	   quantified	   against	   the	   housekeeping	   GAPDH	   gene.	   Experiments	   were	  
performed	  on	  an	  Applied	  Biosystems	  7500	  Fast	  RT-­‐PCR	  machine	  and	  analysed	  using	  the	  7500	  Fast	  
System	  software.	  
	  
Table	  2-­‐4	  TaqMan®	  Gene	  Expression	  Assays	  used	  in	  RT-­‐PCR	  Analysis	  
Gene	   Supplier	   Code	  
CYP1A2	   Life	  Technologies	   Hs00167927_m1	  
CYP2E1	   Life	  Technologies	   Hs00559368_m1	  
CYP3A4	   Life	  Technologies	   Hs00604506_m1	  
GSTP1	   Life	  Technologies	   Hs02512067_s1	  
UGT1A1	   Life	  Technologies	   Hs02511055_s1	  
ABCB1	   Life	  Technologies	   Hs00184500_m1	  
ABCC2	   Life	  Technologies	   Hs00166123_m1	  
GAPDH	  (reference	  gene)	   Applied	  Biosystems	   4352934-­‐1001030	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2.2 Procedures	  For	  Materials	  Chemistry	  
For	  simplification	  reasons,	  all	  chemical	  sources/suppliers	  are	  noted	  in	  brackets	  in	  the	  text.	  
2.2.1 Synthesis	  of	  Galactose-­‐Functionalised	  Emulsion	  Templated	  Polystyrene	  Scaffolds	  
This	   study	   employed	   a	   two-­‐step	   strategy	   towards	   the	   fabrication	   of	   galactose-­‐functionalised	  
emulsion	   templated	   polystyrene	   scaffolds.	   The	   first	   step	   involved	   the	   incorporation	   of	   ester	   or	  
acid	  functionality	  into	  the	  scaffold	  surface.	  This	  was	  achieved	  via	  the	  addition	  of	  a	  new	  functional	  
co-­‐monomer	   (ester-­‐containing	   or	   acid-­‐containing)	   into	   the	   pre-­‐polymerised	   HIPE.	   	   The	   second	  
step	  then	  involved	  a	  post-­‐polymerisation	  modification	  reaction	  to	  attach	  galactose	  onto	  the	  new	  
functional	  scaffold.	  	  
2.2.1.1 General	  Procedure	  for	  Synthesising	  Emulsion-­‐Templated	  Polystyrene	  Scaffolds	  
The	  preparation	  of	  emulsion-­‐templated	  polystyrene	  scaffolds	  for	  3D	  cell	  culture	  applications	  has	  
already	  been	  well	  documented143,	  152,	  153.	  Briefly,	  an	  oil	  phase	  consisting	  of	  the	  monomers	  styrene	  
(60	  wt.%	   of	   total	  monomers)	   (STY,	   Sigma),	   divinylbenzene	   	   (10	  wt.%	  of	   total	  monomers)	   (DVB,	  
Sigma,	  Technical	  Grade	  80%),	  2-­‐ethylhexyl	  acrylate	  (30	  wt.%	  of	  total	  monomers)	  (EHA,	  Sigma)	  and	  
the	  surfactant	  Span80™	  (Sigma)	  were	  placed	  in	  a	  250	  mL	  3-­‐necked	  round	  bottom	  flask	  and	  stirred	  
continually	   at	   350	   rpm	   using	   a	   PTFE	   paddle	   connected	   to	   an	   overhead	   stirrer.	   To	   this	   organic	  
phase,	   deionised	  water	   containing	   1	  %	   potassium	   persulfate	   (KPS,	   Sigma)	  was	   slowly	   added	   at	  
room	  temperature	  via	  a	  dropping	  funnel.	  Stirring	  continued	  for	  an	  additional	  2	  minutes	  after	  the	  
last	  water	  droplet	  to	  form	  a	  HIPE.	  The	  HIPE	  was	  then	  transferred	   into	  a	  50	  mL	  Falcon	  Tube	  and	  
placed	   in	   a	   60	   oC	   oven	   for	   24	   hours	   to	   thermally	   polymerise.	   After	   this	   period,	   the	   polymers	  
(polyHIPEs)	  were	  removed	  from	  the	  falcon	  tube	  and	  washed	  in	  acetone	  for	  24	  hours	  using	  soxhlet	  
recirculation.	  The	  materials	  were	  then	  left	  to	  air	  dry	  overnight	  in	  a	  fume	  hood.	  	  
2.2.1.2 Synthesis	  of	  Pentafluorophenyl	  Acrylate	  (PFPA)	  
Pentafluorophenyl	  acrylate	  (PFPA)	  was	  kindly	  donated	  by	  Dr.	  Ahmed	  Eissa	  at	  Durham	  University.	  
Figure	  2.5	  shows	  the	  reaction	  scheme	  he	  used	  for	  the	  synthesis.	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Figure	  2.5	  Reaction	  scheme	  for	  the	  synthesis	  of	  PFPA	  from	  pentafluorophenol.	  
In	   a	   two-­‐neck	   round	  bottomed	   flask,	   1	   g	   (5.43	  mmol)	   of	   pentafluorophenol	   (Sigma)	   and	  0.66	   g	  
(6.52	  mmol)	  of	  triethylamine	  (TEA)	  (Sigma)	  were	  dissolved	  in	  10	  mL	  of	  dry	  diethyl	  ether,	  and	  0.59	  
g	   (6.52	  mmol)	  of	  acryloyl	  chloride	   (Sigma)	  was	  added	  drop-­‐wise	  through	  a	   funnel	  under	  cooling	  
with	  an	  ice	  bath.	  After	  stirring	  for	  an	  additional	  2	  h	  at	  ambient	  temperature,	  the	  precipitated	  salt	  
was	   removed	  by	   filtration.	  After	   evaporation	  of	   the	   solvent,	   the	   residue	  was	   filtered	   again	   and	  
purified	  with	  column	  chromatography	  (column	  material:	  silica	  gel;	  solvent:	  petroleum	  ether).	  	  
0.8	  g	  (74	  %)	  of	  a	  colourless	  liquid	  was	  obtained.	  The	  pure	  PFPA	  was	  stored	  at	  -­‐7	  °C.	  
Characterisation	  data	  of	  the	  PFPA	  are	  shown	  in	  Figure	  2.6,	  Figure	  2.7	  and	  Figure	  2.8.	  
	  
	  
Figure	  2.6	  1H	  NMR	  spectrum	  of	  PFPA.	  The	  molecular	  structure	  is	  shown	  to	  aid	  with	  peak	  assignments.	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Figure	  2.7	  13C	  NMR	  spectrum	  of	  PFPA.	  The	  molecular	  structure	  is	  shown	  to	  aid	  with	  peak	  assignments.	  	  	  
	  
	  
Figure	  2.8	  19F	  NMR	  spectrum	  of	  PFPA.	  The	  molecular	  structure	  is	  shown	  to	  aid	  with	  peak	  assignments.	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2.2.1.3 Preparation	  of	  Ester-­‐Containing	  Polystyrene	  Scaffolds	  
The	  exact	  procedure	  described	   in	  section	  2.2.1.1	  was	  followed,	  but	  with	  two	  exceptions.	  Firstly,	  
PFPA	  was	  included	  as	  an	  additional	  functional	  (ester-­‐containing)	  co-­‐monomer	  and	  was	  added	  to	  
the	  monomeric	  oil	  phase	  prior	  to	  water	  addition.	  Secondly,	  KPS	  was	  absent	  from	  the	  water	  phase	  
and	  0.3	  wt.%	  (of	  total	  emulsion)	  azobisisobutyronitrile	  (AIBN,	  Acros	  Organics)	  was	  dissolved	  in	  the	  
oil	  phase	  prior	  to	  water	  addition.	  AIBN	  was	  first	  recrystallized	  from	  methanol	  before	  use.	  
2.2.1.4 Preparation	  of	  Acid-­‐Containing	  Polystyrene	  Scaffolds	  
The	  exact	  procedure	  described	   in	  section	  2.2.1.1	  was	  followed,	  but	  with	  two	  exceptions.	  Firstly,	  
acrylic	   acid	   (Aa,	   Sigma)	  was	   included	   as	   an	   additional	   functional	   (acid-­‐containing)	   co-­‐monomer	  
and	  was	  added	  to	  the	  aqueous	  phase	  prior	  to	  HIPE	  formation.	  Secondly	  is	  that	  some	  formulations	  
were	  polymerised	  with	  AIBN	  as	  the	  polymerisation	  initiator	  rather	  than	  KPS.	  	  	  
2.2.1.5 Synthesis	  of	  Aminoethyl	  Glycosides	  
2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside	  and	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside	  were	  kindly	  donated	  
by	   Dr.	   Ahmed	   Eissa	   at	   Durham	   University.	   The	   synthetic	   route	   to	   obtaining	   these	   materials	   is	  
shown	   in	   Figure	   2.9.	  Note	   this	   example	   is	   for	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside,	   but	   the	   same	  
principles	  apply	  for	  the	  synthesis	  of	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside.	  
Figure	  2.9	  Synthetic	  route	  to	  obtaining	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside	  employed	  by	  Dr.	  Ahmed	  Eissa	  
at	  Durham	  University.	  Note	  the	  same	  principles	  apply	  for	  obtaining	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside.	  
Characterisation	   data	   for	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside	   and	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐
glucopyranoside	   was	   also	   supplied	   by	   Dr.	   Ahmed	   Eissa.	   Data	   for	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐
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glucopyranoside	   is	   shown	   in	   Figure	   2.10,	   Figure	   2.11,	   Figure	   2.12	   and	   Figure	   2.13.	   Data	   for	   2ʹ′-­‐
aminoethyl-­‐β-­‐D-­‐galactopyranoside	   was	   consistent	   with	   expected	   spectra	   (not	   shown	   for	  
simplicity).	  
	  
Figure	   2.10	   1H	   NMR	   spectra	   for	   the	   synthesis	   of	   2-­‐azidoethanol	   from	   2-­‐chloroethanol.	   Molecular	  
structures	  are	  shown	  to	  aid	  with	  peak	  assignments.	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Figure	   2.1113C	   NMR	   spectra	   for	   the	   synthesis	   of	   2-­‐azidoethanol	   from	   2-­‐chloroethanol.	   Molecular	  
structures	  are	  shown	  to	  aid	  with	  peak	  assignments.	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Figure	   2.12	   1H	   NMR	   spectra	   for	   the	   synthesis	   of	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside	   from	   glucose	  
pentaacetate	  and	  2-­‐azidoethanol.	  Molecular	  structures	  are	  shown	  to	  aid	  with	  peak	  assignments.	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Figure	   2.1313C	   NMR	   spectra	   for	   the	   synthesis	   of	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside	   from	   glucose	  
pentaacetate	  and	  2-­‐azidoethanol.	  Molecular	  structures	  are	  shown	  to	  aid	  with	  peak	  assignments.	  	  	  
2.2.1.6 Attaching	  Galactose	  and	  Glucose	  to	  Ester-­‐Containing	  Polystyrene	  Scaffolds	  
Ester-­‐containing	   polystyrene	   scaffold	   monoliths	   were	   first	   sectioned	   into	   200	   µm	   membranes	  
using	  a	  Leica	  VT1000S	  vibrotome	  and	  then	  cut	  into	  circles	  of	  15	  mm	  diameter	  using	  a	  metal	  bore-­‐
cutter.	   Six	   scaffold	   discs	  were	   then	   placed	   in	   a	   glass	   vial	   containing	   12	  mL	   dimethylformamide	  
(DMF)	   and	   60	   mg	   of	   either	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside	   or	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐
glucopyranoside.	  The	  glass	  vials	  were	  then	  placed	  in	  a	  shaker	  oven	  at	  40	  oC	  for	  48	  hours	  with	  the	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shaker	  operating	   at	   150	   rpm.	  After	   this	  period	   samples	  were	   then	   slowly	   re-­‐hydrated	   though	  a	  
series	   of	   MilliQ	   water-­‐DMF	   gradients	   so	   as	   not	   to	   collapse	   the	   scaffold	   structure	   during	   de-­‐
swelling.	  The	  scaffolds	  were	  then	  washed	  in	  MilliQ	  water	  and	  then	  left	  to	  dry	  before	  analysis.	  
	  
2.2.2 Scanning	  Electron	  Microscopy	  
Scanning	  electron	  microscopy	  (SEM)	  was	  employed	  in	  the	  characterisation	  of	  emulsion	  templated	  
polystyrene	   scaffolds.	   Analysis	  was	   performed	  on	   a	   Phillips	   XL30	   ESEM	  operating	   in	   SEM	  mode	  
between	   10	   kV	   and	   25	   kV.	   Samples	   were	   first	   mounted	   on	   carbon	   fibre	   pads	   pre-­‐adhered	   to	  
aluminium	  stubs	  and	  then	  gold	  coated	  using	  an	  Edwards	  Pirani	  501	  sputter	  coater	  before	  imaging.	  
ImageJ™	  software	  was	  used	  to	  measure	  void	  diameters	  on	  each	  micrograph.	  	  
	  
2.2.3 Mercury	  Intrusion	  Porosimetry	  	  
Mercury	   intrusion	   porosimetry	   was	   employed	   in	   the	   characterisation	   of	   emulsion	   templated	  
polystyrene	  scaffolds.	  A	  Micromeritics	  AutoPore	   IV	  using	  penetrometers	  with	  a	   stem	  volume	  of	  
1.836	  mL	  and	  a	  bulb	  volume	  of	  5	  mL	  was	  employed.	  Analysis	  was	  performed	  from	  0.5	  psi	  to	  1600	  
psi.	  
	  
2.2.4 Attenuated	  Total	  Reflection	  Fourier	  Transform	  Infra	  Red	  Spectroscopy	  
Attenuated	  Total	  Reflection	  Fourier	  Transform	   Infra	  Red	   (ATR-­‐FTIR)	  spectroscopy	  was	  employed	  
in	   the	   characterisation	   of	   functional	   emulsion	   templated	   polystyrene	   scaffolds.	   Spectra	   were	  
recorded	   on	   a	   Perkin	   Elmer	   1600	   Series	   FTIR	   spectrometer	   fitted	   with	   a	   Golden	   Gate™	   ATR	  
element.	  Solid	  samples	  were	  pressed	  using	  a	  spatula	  before	  being	  placed	  on	  the	  crystal.	  Spectra	  
were	  evaluated	  with	  Omnic	  version	  7.3.	  	  
	  
2.2.5 Solid	  State	  Nuclear	  Magnetic	  Resonance	  Spectroscopy	  
Solid	  State	  Nuclear	  Magnetic	  Resonance	  (ssNMR)	  13C	  and	  19F	  spectroscopy	  were	  employed	  in	  the	  
characterisation	  of	  functional	  emulsion	  templated	  polystyrene	  scaffolds.	  13C	  ssNMR	  spectra	  were	  
recorded	   on	   a	   Varian	   VNMRS	   400	   spectrometer	   at	   a	   frequency	   of	   100.56	   MHz	   using	   direct	  
excitation	  with	  proton	  decoupling.	  Spectra	  were	  obtained	  with	  total	  sideband	  suppression	  (TOSS).	  
19F	   ssNMR	   spectra	  were	   recorded	   on	   a	   Varian	  Unity	   Inova	   300	   spectrometer	   at	   a	   frequency	   of	  
282.10	   MHz,	   using	   direct	   polarisation	   and	   no	   decoupling.	   Spectra	   were	   evaluated	   with	  
MestReNova	  version	  8.1.1-­‐11591.	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2.2.6 X-­‐Ray	  Photoelectron	  Spectroscopy	  
X-­‐Ray	   Photoelectron	   Spectroscopy	   (XPS)	   was	   used	   in	   the	   surface-­‐characterisation	   of	   functional	  
emulsion	   templated	   polystyrene	   scaffolds.	   Analysis	   was	   performed	   at	   the	   National	   EPSRC	   XPS	  
User's	   Service	   (NEXUS)	   at	   Newcastle	   University.	   A	   K-­‐Alpha	   instrument	   equipped	   with	  
monochromated	  AlKa	  source	  (Thermo	  Scientific)	  was	  used.	  A	  pass	  energy	  of	  40	  eV	  and	  a	  step	  size	  
of	  0.1	  eV	  was	  used	  for	  high	  resolution	  spectra	  of	  the	  elements	  of	  interest.	  Spectra	  were	  analysed	  
using	  Casa	  XPS	  licensed	  at	  Newcastle	  University.	  
2.2.7 Toluidine	  Blue	  O	  Staining	  
Toluidine	   Blue	   O	   (TBO)	   staining	   was	   employed	   in	   the	   characterisation	   of	   functional	   emulsion	  
templated	  polystyrene	  scaffolds.	  The	  stain	  was	  prepared	  by	  dissolving	  0.002	  g	  of	  the	  stain	   in	  20	  
mL	  of	  water.	  Scaffolds	  were	  then	  submerged	  in	  the	  staining	  solution	  for	  2	  minutes.	  Scaffolds	  were	  
then	  washed	  in	  water	  to	  remove	  excess	  blue	  staining	  solution	  and	  a	  photograph	  taken.	  
2.2.8 Acid-­‐Base	  Back	  Titration	  
Acid-­‐base	  back	  titrations	  were	  employed	  in	  the	  characterisation	  of	  functional	  emulsion	  templated	  
polystyrene	  scaffolds.	  Scaffolds	  (0.6	  g)	  were	  ground	  into	  a	  powder	  using	  a	  mortar	  and	  pestle	  and	  
then	   mixed	   with	   0.2	   M	   NaOH	   solution	   for	   24	   hours.	   This	   solution	   was	   then	   filtered	   and	   then	  
titrated	  against	  0.2	  M	  HCl	  using	  a	  pH	  meter	  (Hanna	  instruments).	  
2.2.9 Scaffold	  Wettability	  By	  Water	  
Scaffold	   wettability	   by	   water	   was	   employed	   in	   the	   characterisation	   of	   functional	   emulsion	  
templated	  polystyrene	  scaffolds.	  Similar	  sized	  scaffold	  samples	  (20	  mm	  x	  20	  mm	  x	  20	  mm)	  were	  
first	  immersed	  in	  deionised	  water	  for	  5	  seconds.	  After	  removing	  from	  the	  water	  solution,	  a	  small	  
water	  droplet	  was	  then	  reapplied	  to	  the	  scaffolds	  and	  a	  photograph	  immediately	  taken	  to	  capture	  
if	  the	  water	  beads	  had	  soaked	  into	  the	  scaffolds.	  	  	  
	   	   	  
	  













Chapter	  3: Hepatocyte	  Growth	  in	  Emulsion	  
Templated	  Polystyrene	  Scaffolds	  Under	  Different	  
Culture	  Conditions	  




As	  discussed	  in	  Chapter	  1,	  there	  is	  now	  significant	  demand	  for	  technologies	  that	  can	  approximate	  
native	   3D	   hepatocyte	   growth	   in	   vitro57,	   58,	   75.	   Emulsion	   templated	   porous	   polymers	   are	   an	  
attractive	  technology	  choice	  to	  achieve	  this	  due	  to	  their	  high	  porosity,	  open-­‐cell	  morphology	  and	  
suitable	   mechanical	   properties161.	   Indeed,	   several	   groups	   have	   already	   demonstrated	   the	  
suitability	  of	  these	  materials	  for	  3D	  hepatocyte	  growth147,	  151,	  159,	  as	  well	  as	  for	  a	  range	  of	  other	  cell	  
types	   including	   osteoblasts143,	   144,	   neurons146	   and	   keratinocytes155.	   In	   particular,	   polystyrene	  
scaffolds	  derived	  from	  emulsion	  templating	  are	  showing	  great	  promise	  as	  potential	  replacements	  
for	  conventional	  2D	  laboratory	  polystyrene150,	  152,	  153,	  159.	  These	  materials	  are	  chemically	  stable	  and	  
inexpensive	   to	   produce.	   They	   also	   possess	   a	   highly	   reproducible	   morphology,	   achieved	   by	  
controlling	   the	   initial	   emulsion	   characteristics	   prior	   to	   polymerisation142.	   Moreover,	   these	  
materials	  are	  now	  commercially	  available	  (Alvetex®Scaffold	  and	  Alvetex®Strata	  by	  Reinnervate154)	  
and	   are	   already	   being	   employed	   by	   several	   research	   groups	   as	   more	   suitable	   substrates	   for	  
routine	  laboratory-­‐based	  molecular	  and	  cancer	  biology	  studies156,	  162,	  163.	  	  
Developing	   and	   optimising	   3D	   hepatocyte	   growth	   in	   polystyrene	   scaffolds	   is	   now	   an	   important	  
next	  step	  if	  the	  materials	  are	  to	  be	  widely	  adopted	  by	  the	  research	  community	  as	  drug	  discovery	  
tools.	  As	  part	  of	   this,	   a	  more	   comprehensive	  understanding	  of	  hepatocyte	  growth	  behaviour	   in	  
the	  scaffold	  microenvironment	  needs	  to	  be	  determined.	  Similarly,	  the	  impact	  of	  different	  scaffold	  
presentations	   and	   culture	   conditions	   also	   needs	   to	   be	   investigated.	   Moreover,	   important	  
optimisations	   previously	   employed	   to	   enhance	   2D	   cultures	   have	   yet	   to	   be	   translated	   into	  
polystyrene	  scaffolds,	  such	  as	  the	  use	  of	  ECM	  coatings	  and	  media	  perfusion.	  Developments	  also	  
need	   to	   be	   made	   in	   extracting	   intact	   hepatocytes	   from	   these	   scaffolds	   for	   subsequent	   3D-­‐3D	  
passaging	   and/or	   analysis,	   an	   important	   aspect	   for	   some	   in	   vitro	   experiments.	   This	   study	  
therefore	   set	   out	   to	   address	   some	   of	   these	   unknowns	   using	   commercial	   Alvetex®Scaffold	   and	  
Alvetex®Strata.	  	  
3.1.2 Alvetex®Scaffold	  and	  Alvetex®Strata.	  
Alvetex®Scaffold	  is	  an	  emulsion	  templated	  polystyrene	  scaffold	  with	  an	  average	  void	  diameter	  of	  
ca.	  42	  µm.	  The	  material	  originally	  stems	  from	  research	  by	  Przyborski	  et	  al.	  and	  Cameron	  et	  al.	  but	  
has	   since	   been	   modified	   and	   commercialised	   by	   Reinnervate	   for	   routine	   laboratory	   use164,	   165.	  
Alvetex®Strata	   is	   also	   an	   emulsion	   templated	   polystyrene	   scaffold	   with	   the	   same	   chemical	  
composition	  as	  Alvetex®Scaffold,	  but	  with	  an	  average	  void	  diameter	  of	  ca.	  12	  µm.	  This	  material	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was	  initially	  developed	  in	  conjunction	  with	  early	  results	  from	  this	  study,	  using	  prototype	  materials	  
supplied	  by	   the	  Cameron	   group	   at	  Durham	  University	   (Dr.	  D.	  W.	   Johnson)	   and	   the	  Reinnervate	  
development	  team	  (Mr.	  Simon	  Padbury).	  A	  full	  structural	  characterisation	  of	  Alvetex®Scaffold	  and	  
Alvetex®Strata	  is	  described	  in	  the	  results	  section	  of	  this	  Chapter.	  	  
	  
3.1.3 Anticipated	  Hepatocyte	  Growth	  on	  Alvetex®Scaffold	  and	  Alvetex®Strata	  
Prior	  to	  this	  study,	  hepatocytes	  had	  not	  been	  grown	  on	  the	  final	  commercial	  Alvetex®Scaffold	  or	  
Alvetex®Strata	  materials.	  However,	   it	  was	  hypothesised	   that	   the	   scaffolds	  would	   create	  a	  more	  
physiologically	  relevant	  (3D)	  growth	  profile	  for	  hepatocytes	  compared	  to	  conventional	  2D	  culture,	  
consistent	  with	  preliminary	  reports	   in	  the	  literature	  using	  similar	  scaffolds147,	  151.	  The	  anticipated	  
growth	  profiles	  for	  hepatocytes	  in	  2D,	  Alvetex®Scaffold	  and	  Alvetex®Strata	  is	  illustrated	  in	  Figure	  
3.1.	   With	   2D	   culture,	   hepatocytes	   were	   expected	   to	   flatten	   into	   a	   distorted	   morphology	   with	  
limited	   opportunity	   for	   cell-­‐cell	   contact,	   far	   removed	   from	   the	   complex	   3D	   liver	   architecture	  
described	   in	   Chapter	   176,	   166.	   For	   Alvetex®Scaffold,	   hepatocytes	   were	   expected	   to	   enter	   the	  
scaffold	  and	  grow	  within	  the	  3D	  microenvironment.	  The	  topology	  of	  the	  scaffold	  was	  expected	  to	  
keep	   cells	   in	   their	   native	   3D	   morphology,	   which	   in	   turn	   would	   increase	   cell-­‐cell	   contact.	   For	  
Alvetex®Strata,	   a	   different	   3D	   growth	  profile	  was	  hypothesised.	   The	   smaller	   void	  diameter	  was	  
expected	  to	  prevent	  hepatocytes	  from	  entering	  the	  scaffold	  but	  actually	  encourage	  growth	  on	  top	  
in	  a	   	   ‘’scaffold-­‐free’’	  manner.	  The	  highly	  uneven	  surface	  topography	  was	  expected	  to	   inhibit	  cell	  
flattening	  during	   initial	   seeding	  and	   so	  preserve	   the	  natural	  3D	  morphology	  of	   the	  cells.	   This	   in	  
turn	  should	  encourage	  cells	  to	  build	  up	  on	  top	  of	  one	  another	  to	  closely	  approximate	  native	  liver	  
density	  and	  organisation.	  	  
Hepatocyte	  growth	  on	  top	  of	  Alvetex®Strata	  was	  expected	  to	  offer	  two	  distinct	  advantages;	  Firstly	  
cells	   would	   have	  maximum	   opportunity	   for	   cell-­‐cell	   contact	   due	   to	   the	   ‘’scaffold-­‐free’’	   growth	  
environment;	   Secondly	   3D	   cell	   growth	   on	   top	   of	   the	   scaffold	   was	   expected	   to	   offer	   new	  
opportunities	  to	  extract	  cells	  for	  subsequent	  3D-­‐3D	  passaging	  and/or	  analysis	  (see	  Figure	  3.2).	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Figure	  3.1	  Illustration	  showing	  the	  anticipated	  growth	  profiles	  of	  hepatocytes	  in	  2D,	  Alvetex®Scaffold	  and	  
Alvetex®Strata.	  (A):	  2D	  hepatocytes	  flattening	  across	  the	  flat	  surface	  (B):	  Alvetex®Scaffold	  accommodating	  
hepatocytes	  within	  the	  scaffold,	  encouraging	  a	  more	  native	  (round)	  morphology	  and	  increased	  opportunity	  
for	   cell-­‐cell	   contact.	   (C):	   Alvetex®Strata	   encouraging	   hepatocytes	   to	   grow	   on	   top	   of	   the	   scaffold.	   This	  
‘’scaffold-­‐free’’	  growth	  profile	  encourages	  maximal	  cell	  contact	  and	  cell	  extraction	  opportunities.	  	  
Figure	  3.2	  Illustration	  of	  extracting	  hepatocytes	  from	  Alvetex®Strata.	  Growing	  hepatocytes	  on	  top	  of	  the	  
scaffold	   rather	   than	   within	   was	   anticipated	   to	   enable	   maximal	   cell	   contact	   as	   well	   as	   cell	   retrieval	  
opportunities	  for	  subsequent	  3D-­‐3D	  passaging	  or	  analysis.	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3.1.4 Scaffold	  Presentation	  and	  Culture	  Conditions	  
It	   was	   expected	   that	   scaffold	   presentation	   and	   culture	   conditions	   would	   influence	   hepatocyte	  
growth	  within	  the	  scaffold,	  with	  some	  scenarios	  favouring	  a	  more	  physiologically	  relevant	  growth	  
profile	  than	  others.	  
Alvetex®Scaffold	   and	   Alvetex®Strata	   are	   supplied	   by	   Reinnervate	   as	   sterile	   200	   µm	   thick	  
membranes,	   15	  mm	   in	  diameter.	   These	  membranes	   can	  be	  placed	   in	   inserts	  or	   clipped	   to	  a	  24	  
welled-­‐plate,	  allowing	  different	  scaffold	  presentations	  to	  be	  investigated	  (see	  Figure	  3.3).	  Inserts	  
can	  create	  systems	  similar	  to	  Transwell®	  cultures	  inside	  a	  Petri	  dish,	  6-­‐well	  plate	  or	  12-­‐well	  plate.	  
Media	   can	  be	   applied	   to	   the	   insert	   to	   either	   fully	   submerge	   the	   scaffold	   or	  merely	   contact	   the	  
scaffold	  membrane	   from	   underneath.	   Fully	   submerged	   scaffold	   inserts	   were	   expected	   to	   offer	  
cells	  maximum	  nutrient	  supply	  as	  media	  could	  access	  the	  cells	  from	  above	  and	  below	  the	  insert.	  
Conversely,	   contact	   scaffold	   inserts	   (media	   underneath	   and	   so	   creating	   air-­‐liquid	   interface	  
cultures)	   were	   expected	   to	   promote	   native	   tissue	   density	   and	   organisation	   due	   to	   increased	  
surface	   tension	   holding	   cells	   together	   and	   the	   absence	   of	   a	   turbulent	   media	   supply.	   This	  
presentation	  was	  anticipated	  to	  be	  particularly	  important	  for	  Alvetex®Strata,	  where	  hepatocytes	  
growing	  on	  top	  of	  the	  scaffold	  were	  expected	  to	  be	  more	  susceptible	  to	  being	  washed	  away	  and	  
lost	  from	  the	  insert	  during	  media	  changes.	  	  
A	   naming	   protocol	   for	   the	   insert	   formats	   was	   developed	   for	   simplicity:	   insert/(insert	  
housing)/(media	   supply).	   For	   example,	   culturing	   hepatocytes	   using	   an	   insert	   housed	   in	   6-­‐well	  
plate	  and	  submerged	  with	  media	  would	  be	  defined	  as:	  insert/6-­‐well	  plate/submerged.	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Figure	  3.3	  Scaffold	  presentations	  using	  inserts	  or	  a	  24	  welled-­‐plate.	  The	  200	  µm	  thick	  scaffold	  membranes	  
(15	  mm	  in	  diameter)	  can	  be	  housed	  in	  either	  an	  insert	  or	  secured	  to	  the	  bottom	  of	  a	  24-­‐well	  plate	  using	  a	  
plastic	  clip.	  Inserts	  can	  be	  placed	  in	  a	  Petri	  dish,	  6-­‐well	  plate	  or	  12-­‐well	  plate.	  The	  insert	  housings	  enable	  the	  
scaffolds	   to	   be	   either	   fully	   submerged	   in	   culture	  media,	   or	   just	   contacted	   by	  media	   from	  underneath	   to	  
create	  air-­‐liquid	  interface	  cultures.	  
	  
3.1.5 The	  Use	  of	  Extracellular	  Matrix	  Proteins	  in	  Hepatocyte	  Culture	  	  
The	  use	  of	  ECM	  components	  in	  general	  cell	  culture	  is	  now	  well	  established167.	  Most	  cells	  generally	  
will	   not	   directly	   adhere	   to	   synthetic	   in	   vitro	   substrates	   such	   as	   polystyrene,	   but	   rely	   on	  
extracellular	  glycoproteins	  to	  enable	  cell	  attachment168.	  These	  glycoproteins,	  such	  as	  fibronectin,	  
are	  present	  in	  the	  serum	  component	  of	  the	  culture	  media	  or	  are	  secreted	  by	  the	  cells	  themselves.	  
Moreover,	  basement	  membrane	  proteins	  such	  as	  collagen	  also	  facilitate	  cell	  adhesion	  and	  growth	  
in	  vitro,	  mainly	  via	  a	  glycoprotein-­‐mediated	  mechanism.	  In	  vivo,	  the	  hepatic	  ECM	  is	  composed	  of	  
various	   collagens,	   fibronectin,	   laminin	   and	   heparin/heparin-­‐sulfate	   proteoglycans12,	   15,	   169.	   This	  
matrix	   plays	   a	   critical	   role	   in	   the	  maintenance	  of	   normal	   hepatic	   structure	   and	   function14.	   As	   a	  
result,	   the	   application	   of	   such	   components	   for	   in	   vitro	   hepatocyte	   culture	   has	   been	   shown	   to	  
enhance	   cell	   adhesion,	   survival	   and	   function	   (see	   discussion	   section	   of	   this	   Chapter).	   Coating	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emulsion	  templated	  polystyrene	  scaffolds	  with	  ECM	  components	  was	  therefore	  hypothesised	  to	  
improve	  the	  physiological	  relevance	  of	  these	  materials	  and	  thus	  was	  investigated	  in	  this	  study.	  
3.1.6 The	  Use	  of	  Media	  Perfusion	  in	  Hepatocyte	  Culture	  
Conventional	   hepatocyte	   cultures	   employ	   a	   static	   media	   supply	   that	   results	   in	   an	   on	   going	  
fluctuation	  of	  media	  quality	  during	  the	  culture	  period.	   In	  between	  media	  changes	  nutrients	  and	  
oxygen	  concentration	  are	  gradually	  depleted.	  Spent	  media	  and	  cellular	  waste	  can	  also	  build	  up.	  
This	  is	  in	  stark	  contrast	  to	  the	  native	  liver	  environment,	  where	  hepatocytes	  experience	  a	  constant	  
replenishing	  blood	  flow	  that	  transports	  nutrients	  and	  waste	  to	  and	  from	  the	  cells.	  Unsurprisingly,	  
the	  employment	  of	  perfused	  media	  supply	  in	  vitro	  has	  been	  shown	  to	  be	  beneficial	  for	  hepatocyte	  
culture.	  Gebhardt	  et	  al.	  demonstrated	  improved	  viability	  and	  metabolic	  activity	  using	  a	  2D	  media	  
perfusion	   system170,	   171.	   Vinci	   et	   al.	   reported	   increased	   expression	   for	   several	   hepatic	  
detoxification	  genes	  when	  employing	  perfused	  sandwich	  cultures172.	  Guzzardi	  et	  al.	  demonstrated	  
enhanced	   HepG2	   function	   using	   the	   commercial	   Quasi-­‐Vivo®	   perfusion	   system	   (Kirkstall)	   in	  
conjunction	   with	   endothelial	   cell	   co-­‐culture173.	   Recent	   work	   is	   also	   now	   turning	   to	   advanced	  
microfluidic	   and	   biochip	   systems	   that	   offer	   small-­‐scale	   high	   throughput	   media	   perfusions174.	  
Recognising	   these	   advancements,	   this	   study	   attempted	   to	   develop	   a	   3D	   perfusion	  model	   using	  
Alvetex®Scaffold.	  
3.1.7 Sources	  of	  Hepatocytes	  for	  In	  Vitro	  Use	  
A	   broad	   range	   of	   hepatocyte	   sources	   are	   available	   for	   in	   vitro	   experimentation,	   summarised	  
recently	  by	   two	  comprehensive	   review	  articles32,	  175.	   Freshly	   isolated	  primary	  hepatocytes	  direct	  
from	  liver	  tissue	  are	  generally	  regarded	  as	  the	  current	   ‘gold	  standard’	   for	  mimicking	  native	   liver	  
function	   in	   the	   laboratory33.	   These	   cells	   are	   obtained	   by	   collagenase	   digestion	   of	   liver	   tissue	  
followed	  by	  multiple	  density-­‐gradient	  centrifugations.	  If	  placed	  in	  appropriate	  culture	  conditions	  
immediately	   after	   isolation,	   the	   cells	   display	   the	  majority	   of	   native	   hepatic	   functions,	   including	  
albumin	   synthesis,	   urea	   synthesis,	   cytochrome	   P450	   activity	   and	   evidence	   of	   drug	   transporter	  
proteins176.	   However	   there	   are	   several	   limitations	   with	   using	   these	   cells	   for	   routine	   in	   vitro	  
studies;	  First	   is	   that	   terminally	  differentiated	  hepatocytes	  have	  almost	  no	  proliferative	  capacity,	  
which	   currently	   restricts	   primary	   culture	   to	   short-­‐term	   studies	   (typically	   days);	   Second	   is	  
availability:	   To	   obtain	   freshly	   isolated	   hepatocytes	   researchers	   either	   need	   close	   access	   to	  
hospital	   surgeries	   or	   animal	   houses.	   Furthermore,	   tissue	   from	   animal	   houses	   is	   not	   always	  
appropriate	  due	  to	  reported	  inter-­‐species	  differences	   in	   in	  vitro	  hepatocyte	  function177,	  178;	  Third	  
issue	   is	   reproducibility:	   Differences	   between	   donors	   can	   often	   vary	   significantly	   making	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experimental	   results	   more	   difficult	   to	   interpret.	   To	   help	   overcome	   two	   of	   these	   challenges	  
(availability	   and	   reproducibility),	   cryopreserved	   primary	   hepatocytes	   have	   been	   developed	   by	  
commercial	   vendors	   such	   as	   Life	   Technologies	   and	   Biopredic	   International.	   These	   hepatocytes	  
display	   many	   of	   the	   functions	   of	   freshly	   isolated	   hepatocytes,	   but	   can	   be	   stored	   at	   low	  
temperatures	   (-­‐140	   oC)	   for	   future	   use	   and	   transport179-­‐181.	   Furthermore,	   multiple	   vials	   of	  
hepatocytes	  from	  the	  same	  donor	  can	  be	  purchased	  to	  improve	  experimental	  reproducibility.	  This	  
study	   employed	   cryopreserved	   primary	   rat	   hepatocytes	   (Biopredic)	   as	   one	   of	   the	   hepatocyte	  
sources	  for	  culture	  on	  Alvetex®Scaffold	  and	  Alvetex®Strata.	  
Immortalised	  hepatocyte-­‐derived	  cell	  lines	  such	  as	  HepG2,	  C3A,	  HepaRG	  and	  Fa2N-­‐4	  are	  another	  
common	  source	  of	  hepatocyte	  material	  used	  for	  in	  vitro	  studies182.	  Typically	  these	  cells	  possess	  a	  
potentially	  limitless	  growth	  capacity	  making	  them	  easy	  and	  inexpensive	  to	  handle.	  However	  these	  
cells	   often	   carry	  mutations	   that	   produce	   phenotypes	   different	   to	   native	   tissue,	   especially	   with	  
regards	  to	  drug	  metabolism	  capacity.	  Probably	  the	  most	  popular	  and	  well-­‐characterised	  cell	  line	  is	  
the	   HepG2	   cell	   line	   (ATCC®,	   HB-­‐8065™).	   This	   cell	   line	   derives	   from	   a	   human	   hepatocellular	  
carcinoma,	   but	   still	   displays	   several	   hepatocyte	   functions	   including	   plasma	   protein	   synthesis183,	  
bile	  acid	  secretion184	  and	  expression	  of	  receptors	  such	  as	  the	  asialoglycoprotein	  receptor	  (ASGP-­‐
R)185.	   However,	   the	   transcription	   levels	   and	   protein	   activity	   levels	   of	   most	   drug	   metabolising	  
enzymes	   are	   significantly	   lower	   compared	   to	   primary	   hepatocytes	   and	   so	   HepG2	   cells	   are	   not	  
used	  extensively	   for	  drug	   toxicity	   screening186,	  187.	  Nonetheless,	   this	   study	   still	   employed	  HepG2	  
cells	   as	   a	   readily	   available	   hepatocyte	   source,	   particularly	   for	   exploring	   the	   growth	   profile	   on	  
Alvetex®Scaffold	  and	  Alvetex®Strata	  under	  numerous	  culture	  conditions.	  	  
The	   third	   source	   of	   hepatocyte	   material	   used	   in	   this	   study	   was	   the	   recently	   commercialised	  
cryopreserved	   Upcyte®	   hepatocyte	   cell	   strain	   (Medicyte)188.	   These	   cells	   originated	   as	   primary	  
human	  hepatocytes	   from	  a	   single	   donor,	   but	   have	  been	   transduced	  with	   proliferative	   genes	   to	  
enable	   a	   small	   proliferation	   capacity	   (2-­‐5	   population	   doublings).	   The	   cells	   display	  many	   of	   the	  
features	   of	   primary	   human	   hepatocytes,	   including	   albumin	   synthesis,	   urea	   synthesis,	   glycogen	  
storage	   and	   an	   almost	   normal	   phase	   I	   and	   II	   drug	   metabolising	   capacity.	   These	   cells	   were	  
therefore	  employed	  as	  a	  third	  hepatocyte	  source	  in	  this	  study.	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3.2 Aims	  and	  Objectives	  
The	  overall	  aim	  of	  this	  Chapter	  was	  to	  explore	  the	  growth	  of	  hepatocytes	  in	  emulsion	  templated	  
polystyrene	  scaffolds	  to	  understand	  if	  native	  liver	  density	  and	  architecture	  could	  be	  approximated	  
using	   these	   materials.	   This	   included	   an	   assessment	   of	   different	   culture	   conditions,	   scaffold	  
presentations,	  scaffold	  coatings	  and	  media	  perfusion	  to	  identify	  the	  most	  physiologically	  relevant	  
growth	  profiles.	  
	  
The	  main	  objectives	  were	  to:	  	  
	  
• Assess	  2D	  growth	  characteristics	  of	  HepG2	  cells,	  Upcyte®	  cells	  and	  primary	  rat	  hepatocytes	  
prior	  to	  growing	  on	  3D	  scaffolds	  and	  compare	  with	  in	  vivo.	  
• Fully	  characterise	  Alvetex®Scaffold	  and	  Alvetex®Strata.	  	  
• Explore	   hepatocyte	   growth	   in	   Alvetex®Scaffold	   and	   Alvetex®Strata	   using	   different	   scaffold	  
presentations.	  
• Investigate	   ECM	   protein	   coatings	   to	   optimise	   hepatocyte	   growth	   in	   the	   3D	   scaffold	  
microenvironment.	  
• Investigate	   media	   perfusion	   to	   optimise	   hepatocyte	   growth	   in	   the	   3D	   scaffold	  
microenvironment.	  
• Attempt	   to	   extract	   intact	   hepatocytes	   from	   the	   scaffold	  microenvironment	   for	   subsequent	  
3D-­‐3D	  passaging	  and	  analysis.	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3.3 Results	  
3.3.1 Hepatocyte	  Growth	  in	  2D	  
Prior	   to	   culturing	   hepatocytes	   on	   Alvetex®Scaffold	   and	   Alvetex®Strata	   it	   was	   first	   necessary	   to	  
understand	  the	  growth	  characteristics	  of	  these	  cells	  in	  conventional	  2D	  culture.	  Collagen	  I	  coated	  
(50	   µg/mL)	   conventional	   12-­‐well	   cell	   culture	   plates	   were	   used	   for	   this	   experiment.	   Figure	   3.4	  
shows	  HepG2	  cells	  and	  Upcyte®	  cells	  growing	  on	  the	  2D	  plastic,	  taken	  24	  hours	  after	  seeding	  and	  
staining	   using	   H&E.	   Cells	   appear	   healthy	   and	   have	   flattened	   out	   across	   the	   plastic	   to	   form	   a	  
monolayer.	   The	   severity	   of	   Upcyte®	   flattening	   is	   shown	   in	   Figure	   3.5,	   which	   displays	   a	   cross-­‐
sectional	   image	   of	   several	   Upcyte®	   cells	   cultured	   in	   2D	   and	   stained	   with	   TBO.	   ImageJ™	  
measurements	  of	   these	  2D	  Upcyte®	  cells	   show	   that	   the	  average	  cell	  height	   is	  2.8	  µm	  ±	  0.3	  µm	  
(n=20),	  even	  though	  the	  average	  cell	  diameter	  is	  56.1	  µm	  ±	  3.1	  µm	  (n=20).	  
Figure	   3.6	   shows	   the	   growth	   of	   primary	   rat	   hepatocytes	   on	   2D	   plastic	   (24	   hours	   culture)	   in	  
comparison	  to	  native	  human	   liver	  tissue	  taken	  from	   in	  vivo	   (both	  H&E	  stained).	  The	  primary	  rat	  
cells	  have	  also	  formed	  a	  2D	  monolayer	  with	  most	  of	  the	  cells	  appearing	  healthy.	  However	  some	  
notable	   signs	   of	   cell	   death	   are	   observed,	   indicated	   by	   the	   dark	   condensed	   nuclei	   lacking	   a	  
cytoplasm	  (white	  arrows	  in	  Figure	  3.6C).	  Cells	  in	  the	  human	  liver	  tissue	  are	  very	  densely	  packed,	  
with	   almost	   the	   entire	   field	   of	   view	   being	   filled	   with	   cells.	   Furthermore,	   this	   high	   cell	   density	  
enables	  extensive	  cell-­‐cell	  contact	  in	  multiple	  directions.	  Consequently,	  achieving	  high	  cell	  density	  
with	   opportunity	   for	   multiple	   surface	   interactions	   should	   be	   a	   target	   for	   in	   vitro	   hepatocyte	  
growth.	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Figure	  3.4	  Growth	  of	  HepG2	  cells	  and	  Upcyte®	  cells	  on	  2D	  plastic.	  (A,C):	  HepG2	  cells.	  (B,D):	  Upcyte®	  cells.	  
Most	  cells	  appear	  healthy	  and	  have	  flattened	  out	  across	  the	  plastic	  creating	  a	  monolayer.	  Images	  represent	  
H&E	  staining	  of	  fixed	  cells	  24	  hours	  after	  seeding.	  Scale	  bars:	  A,B	  =	  100	  µm,	  C,D	  =	  50	  µm.	  
	  
	  
Figure	  3.5	  Cross-­‐sectional	  image	  of	  Upcyte®	  hepatocytes	  cultured	  in	  2D	  and	  stained	  using	  TBO.	  A	  severely	  
flattened	   morphology	   is	   observed	   consistent	   with	   the	   H&E	   images.	   Cell	   height	   is	   2.8	   µm	   ±	   0.3	   µm,	  
compared	  to	  56.1	  µm	  ±	  3.1	  µm	  for	  cell	  diameter.	  Scale	  bar	  	  =	  20	  μm.	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Figure	  3.6	  Growth	  of	  primary	  rat	  hepatocytes	  on	  2D	  plastic	  compared	  to	  native	  in	  vivo	  liver	  tissue.	  (A,C):	  
Primary	  rat	  cells	  (Biopredic	  International)	  after	  24	  hours	  culture.	  (B,D):	  In	  vivo	  (human)	  liver	  tissue	  (abcam®	  
ab4348).	  The	  primary	  rat	  cells	  also	  spread	  out	  across	  the	  plastic	  towards	  a	  monolayer,	  similar	  to	  HepG2	  and	  
Upcyte®	  cells.	  Most	  of	  the	  primary	  rat	  cells	  appear	  viable,	  although	  some	  signs	  of	  cell	  necrosis	  are	  present	  
(white	  arrows	  in	  C	  indicate	  condensed	  nuclei	  lacking	  a	  cytoplasm).	  Conversely	  no	  signs	  of	  cell	  necrosis	  are	  
apparent	  in	  the	  in	  vivo	  tissue.	  Scale	  bars:	  A,B	  =	  100	  µm,	  C,D	  =	  50	  µm.	  
ImageJ™	  measurements	  of	  all	  H&E	  images	  in	  Figure	  3.4	  and	  Figure	  3.6	  were	  employed	  to	  estimate	  
the	  average	  cell	  diameter	  (greatest	  width)	  of	  2D	  HepG2,	  Upcyte®	  and	  primary	  rat	  hepatocytes	  in	  
comparison	  to	  in	  vivo	  hepatocytes	  (see	  Figure	  3.7	  and	  Table	  3-­‐1).	  The	  average	  cell	  diameter	  for	  2D	  
in	   vitro	   hepatocytes	   is	   significantly	  greater	   compared	   to	   in	   vivo	   hepatocytes;	  HepG2:	  40.0	  ±	  2.9	  
µm	  (n=20);	  Upcyte®:	  56.1	  ±	  3.1	  µm	  (n=20);	  Primary	  rat:	  49.0	  ±	  1.8	  µm	  (n=20);	   In	  vivo	  18.5	  ±	  1.0	  
µm	   (n=20).	   These	   data	   strongly	   support	   the	   spreading	   out	   of	   hepatocytes	   across	   2D	   plastic	   to	  
create	  cell	  architectures	  that	  are	  very	  different	  from	  cells	  in	  the	  native	  liver	  scenario.	  
	   	   	  
	  
	   75	  
	  
Figure	   3.7	   Quantifying	   cell	   diameter	   of	   2D	   HepG2	   cells,	   Upcyte®	   cells	   and	   primary	   rat	   hepatocytes	   in	  
comparison	   to	   in	   vivo	   hepatocytes	  by	   ImageJ™	  analysis	  of	  H&E	   images.	   (A):	   Illustration	  of	  cell	  diameter	  
employed	   in	   the	   ImageJ™	  analysis.	   (B):	  Average	  cell	  diameter	  plot.	  A	   significantly	  greater	   cell	  diameter	   is	  
observed	  for	  all	  2D	   in	  vitro	  hepatocytes	  compared	  to	   in	  vivo	  hepatocytes	   (*denotes	  p<0.005	  according	  to	  
the	  Student’s	  t-­‐test).	  Data	  represent	  mean	  ±	  s.e.m	  (n=20).	  	  
	  
Table	  3-­‐1	  Average	  Cell	  Diameter	  of	  2D	  Hepatocytes	  Compared	  to	  In	  vivo	  hepatocytes	  by	  ImageJ™	  Analysis	  
of	  H&E	  images	  
Cell	  diameter	  (µm)	  
2D	  HepG2	   2D	  Upcyte®	   2D	  Primary	  Rat	   In	  Vivo	  
40.0	  ±	  2.9	   56.1	  ±	  3.1	   49.0	  ±	  1.8	   18.5	  ±	  1.0	  
	  
The	   MTT	   assay	   measures	   the	   cellular	   metabolism	   of	   a	   tetrazolium	   dye	   into	   a	   blue	   formazan	  
product	  that	  is	  subsequently	  quantified	  by	  the	  absorbance	  intensity	  at	  570	  nm.	  2D	  cell	  metabolic	  
activity	  was	  measured	  using	  the	  MTT	  assay	  for	  each	  hepatocyte	  source	  across	  a	  period	  of	  7	  days	  
(Figure	   3.8).	   HepG2	   cells	   are	   the	  most	  metabolically	   active	   (being	   tumour-­‐derived)	   and	   show	   a	  
steady	   increase	   in	   MTT	   absorbance	   throughout	   the	   culture	   period,	   consistent	   with	   their	  
proliferative	   nature.	   Upcyte®	   cells	   are	   less	   active	   compared	   to	   HepG2	   cells,	   which	   is	   to	   be	  
expected	  as	  they	  originate	  from	  a	  primary	  hepatocyte	  source.	  They	  show	  a	  slight	  decreasing	  trend	  
in	  MTT	  absorbance	  as	   the	  culture	  period	  progresses,	  however	  cells	  are	   still	  metabolically	  active	  
after	   7	   days.	   Primary	   rat	   hepatocytes	   are	   the	   least	   viable	   in	   2D.	   Even	   after	   3	   days	   the	   MTT	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absorbance	  is	  much	  lower	  compared	  to	  HepG2	  cells	  and	  Upcyte®	  cells.	  After	  5	  days	  the	  cells	  are	  
almost	  completely	  metabolically	  inactive.	  
Figure	   3.8	   Metabolic	   activity	   of	   2D	   hepatocytes	   by	   the	   MTT	   assay.	   HepG2	   cells	   show	   an	   increase	   in	  
absorbance	   across	   the	   culture	   period	   unlike	   Upcyte®	   cells	   and	   primary	   rat	   hepatocytes.	   Data	   represent	  
mean	  ±	  s.e.m	  (n=2).	  
In	  summary,	  this	  results	  section	  has	  shown	  that	  all	  three	  in	  vitro	  hepatocyte	  sources	  adhere	  to	  2D	  
collagen	  I	  coated	  plastic	  and	  grow	  in	  a	  monolayer.	  They	  adopt	  a	  flattened	  structure	  that	  is	  greatly	  
removed	   from	   that	   of	   cells	   in	   the	   liver	   in	   vivo.	   HepG2	   cells	   are	   proliferative	   in	   2D,	   whereas	  
Upcyte®	  cells	  and	  primary	  rat	  hepatocytes	  have	  limited	  or	  no	  proliferative	  capacity	  in	  2D.	  	  
3.3.2 Characterisation	  of	  Alvetex®Scaffold	  and	  Alvetex®Strata	  
Alvetex®Scaffold	   and	   Alvetex®Strata	   were	   supplied	   as	   thin	   circular	   membranes,	   15	   mm	   in	  
diameter,	  from	  Reinnervate.	  Characterisation	  of	  these	  membranes	  was	  performed	  using	  scanning	  
electron	   microscopy	   (SEM)	   and	   mercury	   intrusion	   porosimetry	   to	   confirm	   morphology	   and	  
porosity.	  The	  SEM	  micrographs	   in	  Figure	  3.9	  show	  that	  both	  membranes	  are	  approximately	  200	  
µm	  in	  thickness.	  The	  morphology	  of	  each	  membrane	  is	  highly	  open-­‐cell,	  with	  clearly	  defined	  voids	  
(red	  circles)	  and	  interconnecting	  windows	  (blue	  circles).	  Both	  membranes	  also	  appear	  reasonably	  
homogenous	   with	   regards	   to	   their	   void	   and	   interconnect	   diameter	   distribution.	   As	   expected,	  
Alvetex®Scaffold	  displays	  noticeably	  larger	  voids	  and	  interconnects	  compared	  to	  Alvetex®Strata.	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Figure	   3.9	   Morphology	   of	   Alvetex®Scaffold	   and	   Alvetex®Strata	   by	   SEM.	   (A):	   Alvetex®Scaffold.	   (B):	  
Alvetex®Strata.	   Each	  membrane	   is	   approximately	  200	  µm	  thick.	  Both	  materials	  display	   a	  highly	  open-­‐cell	  
morphology	  with	  clearly	  defined	  voids	  (red	  circles)	  and	  interconnecting	  windows	  (blue	  circles).	  A	  larger	  void	  
and	  interconnect	  diameter	  can	  be	  seen	  for	  Alvetex®Scaffold	  compared	  to	  Alvetex®Strata.	  Scale	  bars	  =	  100	  
µm.	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Void	   diameters	   were	   quantified	   by	   ImageJ™	   analysis	   of	   SEM	   micrographs	   (Figure	   3.10A).	  
Alvetex®Scaffold	  displays	  an	  average	  void	  diameter	  of	  42.0	  µm	  ±	  1.6	  µm	  (n=65),	  compared	  to	  11.7	  
µm	  ±	   0.6	  µm	   (n=65)	   for	   Alvetex®Strata.	   Interconnect	   diameters	  were	   estimated	   using	  mercury	  
intrusion	  porosimetry	  (Figure	  3.10B).	  Alvetex®Scaffold	  displays	  an	  average	  interconnect	  diameter	  
of	  ca.	  15	  µm,	  compared	  to	  ca.	  5	  µm	  for	  Alvetex®Strata	  (n=1).	  	  
	  
	  
Figure	  3.10	  Quantifying	  void	  and	  interconnect	  diameters	  for	  Alvetex®Scaffold	  and	  Alvetex®Strata.	  White	  
points	   =	   Alvetex®Scaffold.	   Black	   points	   =	   Alvetex®Strata.	   (A):	   Void	   diameter	   distribution	   determined	   by	  
ImageJ™	   analysis	   of	   SEM	   micrographs	   (n=67).	   (B):	   Interconnect	   diameter	   distribution	   determined	   by	  
mercury	   intrusion	   porosimetry	   (n=1).	   A	   larger	   average	   void	   and	   interconnect	   diameter	   is	   observed	   for	  
Alvetex®Scaffold	  compared	  to	  Alvetex®Strata.	  
	  
Table	   3-­‐2	   summarises	   the	   physical	   characteristics	   of	   Alvetex®Scaffold	   and	   Alvetex®Strata.	   The	  
porosity	  of	  Alvetex®Scaffold,	  determined	  by	  mercury	   intrusion	  porosimetry,	  was	  found	  to	  be	  ca.	  
93	  %,	  compared	  to	  ca.	  90	  %	  for	  Alvetex®Strata	  (n=1).	  Both	  of	  these	  values	  are	  highly	  suitable	  for	  





Table	  3-­‐2	  Summary	  of	  Alvetex®Scaffold	  and	  Alvetex®Strata	  Physical	  Characteristics	  





Alvetex®Scaffold	   42.0	  ±	  1.6	   15	   93	  
Alvetex®Strata	   11.7	  ±	  0.6	   5	   90	  
In	  summary,	  this	  results	  section	  has	  characterised	  the	  different	  3D	  scaffold	  microenvironments	  of	  
Alevex®Scaffold	  and	  Alvetex®Strata.	  Whilst	  the	  porosities	  of	  the	  scaffolds	  are	  similar,	  the	  average	  
void	  and	   interconnect	  diameter	   is	  much	  greater	  for	  Alvetex®Scaffold.	  This	   is	  consistent	  with	  the	  
anticipated	   growth	   of	   hepatocytes	   within	   Alvetex®Scaffold,	   compared	   to	   on	   top	   for	  
Alvetex®Strata.	  
3.3.3 Hepatocyte	  Growth	  on	  Alvetex®Scaffold	  
HepG2	  cells	  were	  chosen	   for	  preliminary	  growth	  assessments	  with	  Alvetex®Scaffold	  as	   they	  are	  
more	  robust	  and	  less	  valuable	  compared	  to	  Upcyte®	  cells	  and	  primary	  rat	  hepatocytes.	  	  
The	   first	   experiment	   using	   HepG2	   cells	   and	   Alvetex®Scaffold	   employed	   the	   insert/Petri-­‐
dish/submerged	   format.	  This	  was	  chosen	   for	   the	   large	  culture	  media	  capacity	   (70	  mL)	  and	   thus	  
was	  expected	   to	  be	   the	  most	  beneficial	   for	   encouraging	  hepatocyte	   growth	   and	   viability	   in	   the	  
scaffold	  microenvironment.	  Prior	  to	  seeding	  the	  HepG2	  cells,	  Alvetex®Scaffold	  was	  first	  rendered	  
hydrophilic	  by	  treatment	  with	  70	  %	  ethanol	  followed	  by	  extensive	  washing	  in	  phosphate-­‐buffered	  
saline	   (PBS)	   solution.	   This	  was	   required	   before	   every	   cell	   culture	   experiment	   and	   so	   should	   be	  
assumed	   common	   practice	   from	   this	   point.	   A	   cell	   suspension	   of	   0.5	   million	   cells	   in	   100	   µL	   of	  
Minimum	  Essential	  Medium	  (MEM)	  was	  then	  applied	  to	  the	  wet	  membranes	  and	  cells	  were	  left	  to	  
adhere	  for	  2	  hours	  at	  37	  oC	  and	  5	  %	  CO2.	  Following	  this	  adhesion	  period,	  70	  mL	  of	  culture	  media	  
was	  added	  to	  the	  Petri	  dish	  housing	  x3	  scaffold	  inserts.	  Cell	  growth	  was	  assessed	  at	  days	  2,	  7	  and	  
14. Culture	  media	  was	  changed	  every	  3	  days.
Figure	  3.11A	  shows	  that	  after	  2	  days	  culture	  there	  is	  an	  abundance	  of	  cells	  near	  the	  top	  portion	  of	  
the	  material,	  suggesting	  successful	  adhesion.	  As	  the	  culture	  period	  progresses	  onto	  7	  and	  14	  days,	  
cells	  gradually	  proliferate	  and	  migrate	   into	  the	  material	   (Figure	  3.11B,C).	  Certainly	  by	  day	  7,	  the	  
growth	  profile	  of	  the	  HepG2	  cells	  is	  fairly	  homogeneous,	  with	  an	  approximately	  equal	  cell	  density	  
and	   penetration	   distance	   across	   the	   majority	   of	   the	   membrane	   diameter.	   Figure	   3.11D,E	   are	  
higher	   magnification	   images	   of	   cells	   cultured	   after	   14	   days.	   Cells	   appear	   closely	   packed	   with	  
plenty	  of	  opportunity	  for	  cell-­‐cell	  interaction.	  Cells	  also	  appear	  healthy	  with	  no	  signs	  of	  necrosis,	  
suggesting	   that	   the	   scaffold	   is	   a	   suitable	   growth	   environment	   for	   prolonged	   culture	   periods.	  
Importantly,	   unlike	   the	   2D	   scenario,	   cells	   are	   not	   unnecessarily	   stretched;	   with	   individual	   cell	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diameters	  being	  less	  spread	  out	  and	  more	  3D	  in	  structure	  like	  that	  of	  the	  in	  vivo	  scenario.	  This	  is	  
quantified	  in	  Figure	  3.12	  and	  Table	  3-­‐3,	  showing	  3D	  HepG2	  cell	  diameter	  to	  be	  much	  closer	  to	  in	  
vivo	  hepatocytes	  compared	  to	  2D	  (3D	  HepG2:	  13.6	  ±	  0.6	  µm;	  In	  vivo	  18.5	  ±	  1.0	  µm,	  n=20).	  	  
Figure	  3.11	  Growth	  of	  HepG2	  cells	  in	  Alvetex®Scaffold	  by	  H&E	  staining.	  (A-­‐C):	  Low	  magnification	  montage	  
images	   at	   2,	   7	   and	   14	   days.	   Cells	   appear	   to	   adhere	   to	   the	   scaffold	   and	  migrate	   into	   the	   scaffold	   as	   the	  
culture	   period	   progresses.	   Scale	   bars	   =	   400	   µm.	   (D,E):	   High	   magnification	   images	   after	   14	   days	   culture	  
showing	  cells	  are	  healthy	  with	  no	  signs	  of	  necrosis.	  Scale	  bars	  =	  50	  µm.	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Figure	  3.12	  Quantifying	  cell	  diameter	  of	  3D	  HepG2	  cells	  in	  comparison	  to	  2D	  and	  in	  vivo	  cells	  by	  ImageJ™	  
analysis	  of	  H&E	  images.	  A	  similar	  cell	  diameter	  is	  observed	  between	  3D	  HepG2	  cells	  in	  Alvetex®Scaffold	  and	  
those	   in	   vivo.	  On	   the	   contrary	   2D	  HepG2	   cells	   have	   a	   larger	   cell	   diameter.	  Data	   represent	  mean	   ±	   s.e.m	  
(n=20).	  	  
	  
Table	  3-­‐3	  Average	  Cell	  Diameter	  of	  3D	  HepG2	  Cells	  and	  2D	  HepG2	  Cells	  Compared	  to	  In	  vivo	  by	  ImageJ™	  
Analysis	  of	  H&E	  images	  
Cell	  diameter	  (µm)	  
2D	  HepG2	   3D	  HepG2	  (Alvetex®Scaffold)	   In	  Vivo	  
40.0	  ±	  2.9	   13.6	  ±	  0.6	   18.5	  ±	  1.0	  
	  
Figure	   3.13	   quantifies	   the	  metabolic	   activity	   of	   HepG2	   cells	   in	   Alvetex®Scaffold	   throughout	   the	  
culture	   period	   using	   the	  MTT	   assay.	   An	   increase	   in	  MTT	   absorbance	   is	   observed	   as	   the	   culture	  
period	  progresses,	  suggesting	  that	  the	  3D	  scaffold	  microenvironment	  also	  supports	  proliferation	  
of	  HepG2	  cells	  in	  a	  similar	  manner	  to	  2D.	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Figure	   3.13	   Metabolic	   activity	   (MTT	   assay)	   across	   the	   culture	   period	   for	   3D	   HepG2	   cells	   in	  
Alvetex®Scaffold.	  Data	  represent	  mean	  ±	  s.e.m	  (n=3).	  
The	   above	   results	   show	   that	   HepG2	   cells	   successfully	   adhere,	   migrate	   and	   proliferate	   in	  
Alvetex®Scaffold	   during	   a	   14	   day	   culture	   period	   using	   the	   insert/Petri-­‐dish/submerged	   format.	  
Furthermore	   cells	   appear	   healthy	   and	   to	   be	   adopting	   a	   structure	   close	   to	   that	   of	   in	   vivo	  
hepatocytes.	   However,	   the	   Petri-­‐dish	   format	   may	   not	   be	   ideally	   suited	   for	   all	   cell	   culture	  
applications.	  The	  large	  volumes	  of	  culture	  media	  required	  for	  each	  dish	  (70	  mL)	  can	  be	  expensive	  
if	  using	  specialised	  media.	  Similarly	   the	  sharing	  of	  media	  between	  three	  scaffold	   inserts	  may	  be	  
problematic	   for	   certain	   media-­‐based	   assays.	   Consequently,	   offering	   alternative,	   more	   high-­‐
throughput	   formats	   of	   the	   scaffold	   could	   be	   beneficial.	   HepG2	   growth	  was	   therefore	   assessed	  
using	  Alvetex®Scaffold	  in	  the	  insert/6-­‐well	  plate/submerged	  format,	  which	  employs	  only	  8	  mL	  of	  
culture	  media	  per	  scaffold	  insert.	  
Figure	  3.14	  shows	  the	  growth	  profile	  of	  HepG2	  cells	  in	  the	  insert/6-­‐well	  plate/submerged	  format	  
after	  14	  days	  culture.	  HepG2	  cells	   in	   the	  6-­‐well	  plate	  appear	  healthy	  with	  no	  signs	  of	  cell	  death	  
(Figure	  3.14A),	  similar	  to	  that	  of	  the	  Petri	  dish	  (Figure	  3.14B).	  A	  small	  decrease	  in	  cell	  penetration	  
(ca.	   40	   %	   vs.	   55	   %)	   and	   density	   can	   be	   seen	   for	   the	   6-­‐well	   plate	   compared	   to	   the	   Petri-­‐dish,	  
suggesting	   that	   volume	   and/or	   sharing	   of	   media	   supply	   enhances	   HepG2	   migration	   and	  
proliferation	  in	  the	  scaffold.	  The	  metabolic	  activity	  of	  the	  cells	  (Figure	  3.14C),	  determined	  by	  the	  
MTT	  assay,	  is	  very	  similar	  between	  the	  two	  formats.	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Figure	   3.14	   HepG2	   growth	   in	   Alvetex®Scaffold	   after	   14	   days	   using	   an	   insert/6-­‐well	   plate/submerged	  
format	  compared	  to	  insert/Petri-­‐dish/submerged	  format.	  (A,B):	  H&E	  staining	  showing	  a	  slight	  decrease	  in	  
HepG2	  penetration	  (ca.	  40	  %	  vs.	  55	  %)	  for	  the	  6-­‐well	  plate	  compared	  to	  the	  Petri-­‐dish.	  Scale	  bars	  =	  50	  µm.	  
(C):	   MTT	   assay	   showing	   a	   similar	   absorbance	   between	   the	   two	   formats.	   Data	   represents	   mean	   ±	   s.e.m	  
(n=3).	  
Additional	   scaffold	   presentations	   employing	   even	   smaller	   volumes	   of	   culture	  media	  were	   then	  
investigated,	  namely;	   (1)	   insert/12-­‐well	  plate/submerged	   (4mL),	   (2)	   insert/12-­‐well	  plate/contact	  
(2	  mL)	  and	  (3)	  24-­‐well	  plate	  (1	  mL).	  Figure	  3.15	  shows	  the	  growth	  of	  HepG2	  cells	  under	  each	  of	  
these	  culture	  conditions	  after	  2,	  7	  and	  14	  days	  culture.	  All	  insert	  formats	  show	  a	  gradual	  increase	  
in	  cell	  penetration	  into	  the	  membrane	  as	  the	  culture	  period	  progresses,	  consistent	  with	  the	  above	  
experiments.	  Cells	  in	  the	  insert/12-­‐well	  plate/submerged	  format	  appear	  healthy	  with	  no	  signs	  of	  
necrosis	  (Figure	  3.15B,J,F),	  suggesting	  that	  as	   little	  as	  4	  mL	  of	  media	  (changed	  every	  2-­‐3	  days)	   is	  
sufficient	  to	  support	  extensive	  3D	  HepG2	  growth.	  However,	  a	  slightly	  lower	  penetration	  and	  cell	  
density	   is	   observed	   for	   the	   insert/12-­‐well	   plate/submerged	   format	   compared	   to	   that	   of	   the	  
insert/Petri-­‐dish/submerged	  format	  (see	  Figure	  3.17).	  It	  can	  therefore	  be	  assumed	  that	  the	  large	  
volume	  of	  media	  offered	  by	  the	  Petri	  dish	   is	  not	  critical	   for	  healthy	  3D	  HepG2	  growth,	  but	  does	  
offer	  an	  environment	  for	  increased	  proliferation	  and	  migration	  that	  may	  be	  more	  suited	  to	  3D	  cell	  
migration	  and	  invasion	  models.	  	  
Surprisingly,	   a	   noticeably	   higher	   cell	   density	   was	   observed	   for	   the	   insert/12-­‐well	   plate/contact	  
format	  compared	  to	  the	  other	   insert	   formats	  after	  14	  days	   (see	  Figure	  3.15K	  and	  Figure	  3.17B),	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even	   though	   this	   format	   only	   employs	   2	  mL	   of	  media	   from	  underneath	   the	   insert.	   Cells	   in	   this	  
format	  appear	  very	  tightly	  packed	  with	  extensive	  opportunity	  for	  cell-­‐cell	  contact,	  approximating	  
native	   liver	   tissue	   density.	   This	   growth	   profile	  may	   be	   explained	   by	   surface	   tension	   at	   the	   air-­‐
liquid	   interface	   that	   serves	   to	  pull	   cells	   together.	  Alternatively,	   reduced	  cell	   loss	   from	  turbulent	  
media	   changes	  may	   also	   contribute.	  However,	   possible	   cell	   necrosis	   is	   observed	   after	   7	   and	  14	  
days	   culture	   using	   this	   scaffold	   presentation,	   seen	   by	   the	   condensed	   nuclei	   and	   increased	  
eosinophilia	  near	  the	  top	  portion	  of	  the	  membrane	  (see	  white	  arrows	  in	  Figure	  3.15G,K	  and	  the	  
higher	  magnification	  image	  of	  Figure	  3.16).	  It	  is	  likely	  this	  is	  due	  to	  restricted	  media	  supply,	  with	  
those	  cells	   close	   to	   the	  media	   supply	   restricting	  nutrients	  and	  oxygen	   from	  reaching	   those	  cells	  
growing	  above.	  	  
Unlike	   the	   insert	   formats,	   the	   24-­‐well	   plate	   format	   does	   not	   appear	   to	   encourage	   a	   gradual	  
increase	  in	  cell	  penetration,	  with	  cells	  remaining	  in	  the	  top	  20	  -­‐	  40	  %	  of	  the	  membrane	  even	  after	  
7	   and	  14	  days	   (Figure	  3.15H,L).	   Indeed,	   growth	   in	   this	   format	  does	  not	   effectively	   approximate	  
native	   liver	   growth	  after	  7	  days	  due	   to	   the	   low	  cell	   density	   and	  poor	  migration.	   This	  behaviour	  
may	   be	   explained	   by	   the	   absence	   of	   culture	  media	   entering	   from	   underneath	   the	  membrane,	  





th	  in	  different	  Alvetex®Scaffold	  product	  presentations	  after	  2,	  7	  and	  14	  days	  culture	  by	  H
&
E	  staining.	  A	  general	  increase	  in	  cell	  penetration	  




at	  encourages	  particularly	  high	  cell	  densities	  
but	  at	  the	  expense	  of	  possible	  cell	  necrosis	  (w
hite	  arrow
s	  in	  G
,K).	  Scale	  bars	  =	  50	  µm
.	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Figure	  3.16	  HepG2	  necrosis	  in	  Alvetex®Scaffold	  using	  the	  insert/12well	  plate/contact	  format	  after	  14	  days	  
culture.	  Possible	  necrotic	  cells	  close	  to	  the	  air-­‐liquid	  interface	  (above	  the	  white	  dotted	  line)	  are	  observed,	  
evident	  by	  the	  condensed	  nuclei	  and	  increased	  eosinophilia	  of	  these	  cells.	  Scale	  bar	  =	  50	  µm.	  
Figure	   3.17	   Quantification	   of	   HepG2	   penetration	   and	   density	   obtained	   from	   measurements	   of	   H&E	  
images	   in	   Figure	   3.15.	   (A):	  HepG2	  penetration	   showing	   that	   insert	   cultures	   support	  penetration	   into	   the	  
scaffold	  whereas	  24-­‐well	   plate	   cultures	  do	  not.	   (B):	  HepG2	  density	   (nuclei	  per	   field	  of	   view)	   showing	   the	  
insert/12-­‐well	  plate/contact	  culture	  has	  the	  highest	  cell	  density	  after	  14	  days.	  The	  24-­‐well	  plate	  format	  has	  
the	   lowest	   cell	   density	   out	   of	   all	   the	   formats	   and	   does	   not	   effectively	   approximate	   in	   vivo	   density.	   Data	  
represents	  mean	  ±	  s.e.m	  (n=15).	  
Having	   successfully	   grown	   HepG2	   cells	   on	   Alvetex®Scaffold,	   Upcyte®	   cells	   were	   then	   assessed.	  
The	   insert/6-­‐well	   plate/submerged	   format	   was	   chosen	   for	   this	   experiment.	   Cells	   were	   thawed	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from	  frozen	  and	  then	  seeded	  onto	  Alvetex®Scaffold	  at	  a	  density	  of	  0.5	  million	  cells	  in	  100	  µL.	  Cells	  
were	  left	  for	  2	  hours	  to	  adhere	  and	  then	  8	  mL	  of	  Upcyte®	  Culture	  Media	  was	  added.	  Cells	  were	  
cultured	  for	  up	  to	  21	  days	  and	  the	  growth	  profile	  assessed.	  	  
Figure	  3.18	  shows	  the	  histological	  analysis	  of	  Upcyte®	  hepatocytes	  growing	  on	  Alvetex®Scaffold.	  
Most	   cells	   appeared	   healthy	   after	   3	   and	   7	   days	   culture,	   suggesting	   that	   the	   scaffold	  
microenvironment	  is	  suitable	  for	  Upcyte®	  adhesion	  and	  survival.	  However	  after	  14	  days	  culture,	  a	  
few	  necrotic	  cells	  were	  observed	   (black	  arrow	   in	  Figure	  3.18C).	  This	  may	  be	  expected	  given	   the	  
limited	   proliferation	   capacity	   of	   these	   cells	   observed	   after	   7	   days	   culture	   in	   2D.	   Additional	  
histological	   analysis	   was	   performed	   using	   thin	   (1	  µm)	   sections	   and	   TBO	   staining.	   The	   image	   in	  
Figure	  3.18D	  shows	  a	  higher	  magnification	  image	  of	  the	  cells	  after	  7	  days	  culture.	  The	  majority	  of	  
cells	  appear	  healthy,	  with	  only	  a	  small	  number	  of	  necrotic	  cells	  being	  observed	  (white	  arrows	  in	  
Figure	   3.18D).	   Encouragingly,	   the	   cells	   are	   adopting	   several	   polygonal	   shapes	   that	   offer	  
opportunity	  for	  multi-­‐directional	  communication	  with	  other	  cells.	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Figure	  3.18	  Growth	  of	  Upcyte®	  hepatocytes	  in	  Alvetex®Scaffold	  by	  histological	  analysis.	  (A-­‐C):	  H&E	  images	  
showing	   that	  most	   cells	   appear	   healthy	   after	   3	   and	   7	   days,	   however	   after	   14	   days	   several	   necrotic	   cells	  
appear	   (black	   arrow	   in	   C	   indicates	   three	   necrotic	   cells).	   Scale	   bars	   =	   50	   µm.	   (D):	   Higher	   magnification	  
montage	  of	  1	  µm	  sections	  stained	  with	  Toluidine	  Blue	  O	   (7	  days	  culture).	  Most	  cells	  appear	  healthy	  with	  
only	  the	  occasional	  necrotic	  cell	  present	  (white	  arrows).	  Scale	  bar	  	  =	  20	  µm.	  (E):	  Outline	  of	  cell	  boundaries	  
showing	  the	  polygonal	  cell	  shapes	  adopted	  by	  the	  cells	  in	  the	  3D	  microenvironment.	  	  
	  
Quantification	  of	  Upcyte®	  cell	  diameter	  from	  ImageJ™	  analysis	  of	  H&E	  images	  is	  shown	  in	  Figure	  
3.19	  and	  Table	  3-­‐4.	  The	  3D	  cells	  were	   found	   to	  have	  a	  morphology	   that	   is	   very	   close	   to	   in	   vivo	  
cells,	  unlike	  2D	  Upcyte®	  cells.	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Figure	   3.19	   Quantifying	   cell	   diameter	   of	   3D	   Upcyte®	   cells	   in	   comparison	   to	   2D	   and	   in	   vivo	   cells	   by	  
ImageJ™	   analysis	   of	   H&E	   images.	   A	   similar	   cell	   diameter	   is	   observed	   between	   3D	   Upcyte®	   cells	   in	  
Alvetex®Scaffold	  and	  those	  in	  vivo.	  Data	  represent	  mean	  ±	  s.e.m	  (n=20).	  
	  
Table	  3-­‐4	  Average	  Cell	  Diameter	  of	  2D	  Upcyte®	  and	  3D	  Upcyte®	  Compared	  to	  In	  vivo	  by	  ImageJ™	  Analysis	  
of	  H&E	  images	  
Cell	  diameter	  (µm)	  
2D	  Upcyte®	   3D	  Upcyte®	  (Alvetex®Scaffold)	   In	  Vivo	  
56.1	  ±	  3.1	   17.3	  ±	  1.2	   18.5	  ±	  1.0	  
	  
Upcyte®	  metabolic	   activity	   in	   Alvetex®Scaffold	   throughout	   the	   culture	   is	   shown	   in	   Figure	   3.20.	  
Interestingly,	   total	   cell	   metabolic	   activity	   remains	   reasonably	   constant	   throughout	   the	   culture	  
period,	  even	  after	  21	  days.	  This	   suggests	   that	   the	  scaffold	  microenvironment	  can	  support	   some	  
proliferation	  of	  Upcyte®	  cells,	  even	  though	  older	  cells	  will	  inevitably	  die	  during	  the	  culture	  period.	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Figure	   3.20	   Metabolic	   activity	   (MTT	   assay)	   across	   the	   culture	   period	   for	   3D	   Upcyte®	   cells	   in	  
Alvetex®Scaffold.	   A	   reasonably	   constant	   metabolic	   activity	   is	   observed	   throughout	   the	   culture	   period	  
suggesting	  that	  the	  scaffold	  can	  support	  some	  cell	  proliferation.	  Data	  represent	  mean	  ±	  s.e.m	  (n=2).	  
	  
Primary	   rat	   hepatocytes	   were	   then	   seeded	   onto	   Alvetex®Scaffold	   and	   cultured	   using	   the	  
insert/12-­‐well	   plate/submerged	   and	   insert/12-­‐well	   plate/contact	   formats	   for	   2	   days.	   This	   short	  
culture	  period	  was	   chosen	  due	   to	   the	   short	   survival	   observed	   in	   2D	   culture	   (Figure	  3.8).	   Figure	  
3.21	   shows	  all	   cells	   to	  be	  healthy	  and	  viable	  after	   this	   short	  period.	   Interestingly	   the	   insert/12-­‐
well	   plate/contact	   format	   encouraged	   a	   growth	   profile	   of	   closely	   packed	   cells,	   approximating	  
native	   human	   liver	   tissue	   density	   observed	   in	   section	   3.3.1	   (Figure	   3.21A),	   whereas	   the	  
submerged	  format	  did	  not	  (Figure	  3.21B).	  Quantification	  of	  3D	  primary	  rat	  hepatocyte	  diameter	  
from	  ImageJ™	  analysis	  of	  H&E	  images	  is	  shown	  in	  Figure	  3.21C	  and	  Table	  3-­‐5.	  The	  3D	  cells	  were	  
found	  to	  have	  a	  morphology	  that	  is	  very	  close	  to	  in	  vivo	  cells,	  unlike	  2D	  primary	  cells.	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Figure	  3.21	  Growth	  of	  primary	  rat	  hepatocytes	  in	  Alvetex®Scaffold.	  (A,B):	  H&E	  images	  after	  2	  days	  culture	  
showing	   most	   cells	   are	   viable.	   The	   insert/12-­‐well	   plate/contact	   appears	   more	   effective	   at	   encouraging	  
native	   tissue	   density	   and	   organisation.	   Scale	   bars	   =	   50	   µm.	   (C):	   Quantification	   of	   3D	   cell	   diameter	   in	  
comparison	  to	  2D	  and	   in	  vivo	  cells	  by	  ImageJ™	  analysis	  of	  H&E	  images.	  A	  similar	  cell	  diameter	  is	  observed	  
between	  3D	  cells	  in	  Alvetex®Scaffold	  and	  those	  in	  vivo.	  Data	  represent	  mean	  ±	  s.e.m	  (n=20).	  
	  
Table	  3-­‐5	  Average	  Cell	  Diameter	  of	  2D	  Primary	  Rat	  Cells	  and	  3D	  Primary	  Rat	  Cells	  Compared	  to	  In	  vivo	  by	  
ImageJ™	  Analysis	  of	  H&E	  images	  
Cell	  diameter	  (µm)	  
2D	  Rat	   3D	  Rat	  (Alvetex®Scaffold)	   In	  Vivo	  
49.0	  ±	  1.8	   18.0	  ±	  0.8	   18.5	  ±	  1.0	  
	  
In	   summary,	   this	   results	   section	  has	   shown	   that	  HepG2	  cells,	  Upcyte®	  hepatocytes	  and	  primary	  
rat	   hepatocytes	   can	   all	   grow	   and	   survive	   within	   the	   3D	   scaffold	   microenvironment	   and	  
approximate	   in	  vivo	  cell	  shape.	  The	  insert	  presentation	  seems	  to	  encourage	  HepG2	  proliferation	  
and	   migration	   into	   the	   material	   to	   promote	   a	   3D	   tissue	   type	   organisation.	   The	   24-­‐well	   plate	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format	   supports	   healthy	   cell	   growth,	   but	   does	   not	   effectively	   encourage	   migration	   and	  
proliferation	   of	   HepG2	   cells.	   Interestingly,	   contact	   insert	   cultures	   encourage	   cells	   to	   grow	   in	   a	  
tightly	  packed	  manner	  that	  approximates	  native	  human	  liver	  tissue	  density	  observed	  in	  Figure	  3.6.	  	  
	  
3.3.4 Hepatocyte	  Growth	  on	  Alvetex®Strata	  
Unlike	   Alvetex®Scaffold,	   at	   the	   start	   of	   this	   thesis	   Alvetex®Strata	   had	   not	   been	   developed	   by	  
Reinnervate.	   Indeed	   the	   initial	   cell	   culture	   experiments	   that	   led	   to	   the	   commercial	   (quality-­‐
controlled)	   development	   of	   Alvetex®Strata	   came	   from	   this	   study	   using	   prototype	   materials	  
supplied	   by	   the	   Cameron	   group	   at	   Durham	   University	   (courtesy	   of	   Dr.	   D.	   W.	   Johnson)	   or	   the	  
Reinnervate	   development	   team	   (courtesy	   of	  Mr.	   S.	   Padbury).	   These	   prototypes	  were	   therefore	  
used	  in	  preliminary	  HepG2	  growth	  experiments	  until	  the	  commercial	  material	  became	  available.	  	  
The	   first	   experiment	   involved	   culturing	  HepG2	   cells	   on	   a	  prototype	  material	   using	   the	   insert/6-­‐
well	  plate/contact	  format.	  The	  contact	  format	  was	  chosen	  to	  prevent	  those	  cells	  growing	  on	  top	  
of	   the	   membrane	   from	   being	   washed	   away	   during	   turbulent	   media	   changes.	   As	   with	  
Alvetex®Scaffold,	   the	  material	   had	   to	   be	   first	   rendered	   hydrophilic	  with	   70	  %	   ethanol	   and	   PBS	  
washing	  before	  seeding	  cells.	  Cells	  were	  then	  seeded	  at	  a	  density	  of	  0.5	  million	  cells	   in	  25	  µL	  of	  
MEM.	  This	  low	  seeding	  volume	  of	  25	  µL	  (compared	  to	  100	  µL	  for	  Alvetex®Scaffold)	  was	  chosen	  in	  
an	  attempt	  to	  aggregate	  cells	  as	  quickly	  as	  possible	  and	  thus	  prevent	  cells	  from	  penetrating	  into	  
the	  material.	  Cells	  were	  left	  to	  adhere	  for	  2	  hours	  at	  37	  oC	  and	  5	  %	  CO2	  before	  4	  mL	  of	  MEM	  was	  
added	  from	  underneath	  to	  contact	  the	  membrane.	  
Figure	  3.22	  shows	  the	  growth	  profile	  of	  HepG2	  cells	  cultured	  for	  up	  to	  14	  days	  on	  Alvetex®Strata	  
using	  the	  insert/6-­‐well	  plate/contact	  format.	  Cells	  grow	  on	  top	  of	  the	  membrane	  in	  a	  thick	  tissue-­‐
like	   structure,	   closely	   resembling	   in	   vivo	   liver	   tissue	   density.	   The	   cells	   are	   densely	   packed	  with	  
significant	   opportunity	   for	   cell-­‐cell	   interaction.	   As	   the	   culture	   period	   progresses	   the	   average	  
thickness	  of	   the	  tissue	  structure	   increases	   from	  47	  ±	  3.5	  µm	  (day	  2)	   to	  109	  ±	  3.6	  µm	  (day	  7)	   to	  
180.0	  ±	  3.8	  µm	   (day	  14)	   (n=10	  at	   each	   time	  point),	   as	   shown	   in	   Figure	  3.23.	  However,	   signs	  of	  
necrosis	  are	  present	  at	  day	  7	  and	  day	  14,	  evident	  by	   the	   increased	  eosinophilia	  and	  condensed	  
nuclei	  (Figure	  3.24).	  These	  necrotic	  cells	  are	  near	  the	  top	  portion	  of	  the	  tissue	  structure,	  furthest	  
from	  the	  media	  supply	  and	  closest	  to	  the	  air-­‐liquid	  interface.	  The	  white	  dotted	  lines	  in	  Figure	  3.24	  
show	   the	   distinct	   interface	   between	   healthy	   and	   necrotic	   cells.	   As	   with	   contact	   cultures	   using	  
Alvetex®Scaffold,	  it	  is	  expected	  that	  restricted	  media	  supply	  is	  the	  cause	  of	  this	  cell	  necrosis.	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Figure	  3.22	  Growth	  of	  HepG2	  cells	  on	  Alvetex®Strata	  using	  the	  insert/6-­‐well	  plate/contact	  format.	  (A-­‐C):	  
Montage	  images	  showing	  HepG2	  cells	  growing	  on	  top	  of	  the	  material	  forming	  a	  tissue-­‐type	  structure.	  The	  
thickness	  of	  the	  tissue	  increases	  as	  the	  culture	  period	  progresses.	  Scale	  bars	  =	  200	  µm.	  	  	  
	  
	  
Figure	  3.23	  HepG2	  tissue	  structure	  thickness	  on	  top	  of	  Alvetex®Strata	  measured	  from	  H&E	  images	  using	  
the	  insert/12-­‐well	  plate/contact	  format.	  	  Data	  represent	  mean	  ±	  s.e.m	  (n=10).	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Figure	  3.24	  HepG2	  necrosis	  in	  Alvetex®Strata	  using	  the	  insert/12well	  plate/contact	  format.	  (A):	  Necrotic	  
cells	   closest	   to	   the	   air-­‐liquid	   interface	   are	   observed	   by	   the	   condensed	   nuclei	   and	   increased	   eosinophilia	  
(data	   represents	   14	   days).	   (B,C):	   Day	   7	   and	   day	   14	   cultures	   at	   lower	  magnification	   showing	   signs	   of	   cell	  
necrosis.	  The	  white	  dotted	  line	  represents	  an	  interface	  between	  healthy	  and	  necrotic	  cells.	  Scale	  bar	  =	  50	  
µm.	  
	  
To	  confirm	  that	  the	  cells	  near	  the	  top	  portion	  of	  the	  membrane	  are	  non-­‐proliferative	  (therefore	  
potentially	  dying),	  immunofluorescence	  staining	  for	  Ki-­‐67	  (proliferation	  marker)	  was	  employed.	  It	  
was	   hypothesised	   that	   those	   cells	   that	   appear	   necrotic	   in	   the	   H&E	   images	   would	   not	   be	  
proliferating	   and	   would	   also	   show	   condensed	   nuclei	   via	   DAPI,	   or	   Hoechst	   33342	   (Life	  
Technologies)	   counterstaining.	   HepG2	   cells	   were	   therefore	   cultured	   for	   2,	   7	   and	   14	   days	   on	  
prototype	  Alvetex®Strata	  and	  then	  processed	  for	  Ki-­‐67	  immunofluorescence	  staining.	  AlexaFluor®	  
488	  (Life	  Technologies)	  was	  used	  as	  the	  secondary	  antibody	  for	  the	  Ki-­‐67	  antibody.	  
Figure	  3.25	  shows	  the	  Ki-­‐67	  immunofluorescence	  data.	  At	  2	  days	  culture	  (average	  tissue	  thickness	  
of	  47	  ±	  3.5	  µm)	  all	  nuclei	  appear	  normal	  and	  there	  is	  positive	  Ki-­‐67	  staining	  throughout	  the	  tissue	  
structure	  (Figure	  3.25D).	  The	  staining	  at	  day	  7	  is	  very	  similar	  (average	  tissue	  thickness	  of	  109	  ±	  3.6	  
µm,	   although	   this	   particular	   sample	   used	   for	   staining	   has	   a	   greater	   tissue	   thickness	   than	   the	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average;	   believed	   to	   be	   due	   a	   slanted	   sample	   mounting	   during	   histological	   processing).	  
Encouragingly,	  positive	  Ki-­‐67	  staining	   is	  observed	  throughout	  the	  majority	  of	  the	  tissue	  at	  day	  7	  
(Figure	  3.25E).	  However,	  a	  significant	  change	  is	  observed	  at	  day	  14	  (Figure	  3.25F).	  Nuclei	  near	  the	  
top	  portion	  of	  the	  tissue	  are	  very	  condensed,	  further	  supporting	  that	  these	  are	  necrotic.	  The	  Ki-­‐67	  
staining	   is	   also	   restricted	   to	   the	   bottom	   portion	   of	   the	   tissue,	   supporting	   the	   hypothesis	   that	  
those	  cells	  near	  the	  air-­‐liquid	  interface	  are	  necrotic.	  	  
	  
	  
Figure	  3.25	  Ki-­‐67	  expression	  in	  HepG2	  cells	  growing	  on	  top	  of	  Alvetex®Strata.	  (A-­‐C):	  DAPI	  counterstaining	  
of	  HepG2	  nuclei.	   (D-­‐F):	   Ki-­‐67	   staining	  where	  positive	   green	  dots	   correspond	   to	  proliferating	  nuclei.	   (G-­‐H)	  
Negative	  controls.	  At	  day	  2	  (A,D)	  and	  day	  7	  (B,E)	  proliferating	  cells	  appear	  throughout	  the	  tissue	  structure.	  
However	  at	  day	  14	  (C,	  F),	  proliferating	  cells	  are	  restricted	  to	  the	  bottom	  portion	  of	  the	  tissue	  that	  is	  closest	  
to	  the	  media	  supply.	  Smaller,	  condensed	  nuclei	  are	  observed	   in	  the	  top	  portion	  of	   image	  C	  which	  further	  
supports	  cell	  necrosis	  of	  cells	  close	  to	  the	  air-­‐liquid	  interface.	  Scale	  bars	  =	  50	  µm.	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The	  formation	  of	  a	  thick	  hepatocyte	  tissue	  structure	  on	  the	  top	  of	  Alvetex®Strata	  that	  resembles	  
native	   liver	   growth	   could	   be	   highly	   beneficial	   for	   enhancing	   cell-­‐cell	   contact	   and	   thus	   cellular	  
function	   in	   vitro.	   However,	   for	   longer-­‐term	   cultures	   necrotic	   cells	   near	   the	   top	   portion	   of	   the	  
tissue	  are	  undesirable.	   In	  an	  attempt	   to	   reduce	  cell	  necrosis	  near	   the	   top	  portion	  of	   the	   tissue,	  
two	  strategies	  were	  employed.	  Firstly,	  the	  thickness	  of	  Alvetex®Strata	  was	  reduced	  from	  200	  µm	  
to	   150	  µm,	   100	  µm	  or	   60	  µm	   to	   potentially	   increase	   the	   amount	   of	  media	   reaching	   the	   cells.	  
Secondly,	   submerged	   cultures	   were	   employed.	   Submerged	   insert	   cultures	   were	   expected	   to	  
produce	  healthy	  cell	  growth	  (based	  on	  previous	  results	  with	  Alvetex®Scaffold),	  although	  were	  also	  
expected	   to	   reduce	   dense-­‐tissue	   formation	   due	   to	   loss	   of	   surface	   tension	   and/or	   increased	  
turbulent	  media	  changes.	  The	  outcomes	  of	  these	  two	  strategies	  to	  reduce	  cell	  necrosis	  will	  now	  
be	  discussed.	  
The	   Reinnervate	   development	   team	   provided	   prototype	   Alvetex®Strata	   sectioned	   into	  
membranes	  of	  thickness	  150	  µm,	  100	  µm	  and	  60	  µm.	  HepG2	  cells	  were	  then	  cultured	  on	  these	  
materials	   for	   7	   and	   14	   days	   using	   the	   insert/6-­‐well	   plate/contact	   format	   and	   assessed	   for	   cell	  
necrosis.	  	  
Figure	   3.26	   show	   that	   all	   cultures,	   including	   those	   on	   thin	   60	  µm	  membranes,	   display	   signs	   of	  
necrosis	  after	  7	  and	  14	  days.	  Similar	  to	  200	  µm	  membranes,	  necrotic	  cells	  are	  restricted	  to	  the	  top	  
portion	   of	   the	   tissue,	   furthest	   away	   from	   the	   culture	  media.	   These	   data	   suggest	   that	   reducing	  
Alvetex®Strata	  membrane	  thickness	  has	   little	  effect	  on	  preventing	  cell	  necrosis.	  Once	  more,	  the	  
thinner	   membranes	   were	   more	   difficult	   to	   process	   for	   histology	   compared	   to	   the	   200	   µm	  
membranes	   (increased	   fragility).	   Consequently	   a	   decision	   was	   made	   to	   keep	   the	   membrane	  
thickness	  at	  200	  µm.	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Figure	  3.26	  Effect	  of	  Alvetex®Strata	  membrane	  thickness	  on	  HepG2	  necrosis.	   (A-­‐C):	  H&E	  staining	  after	  7	  
days	  culture.	  (D-­‐F):	  H&E	  staining	  after	  14	  days	  culture.	  All	  cultures	  show	  signs	  of	  necrosis	  in	  the	  top	  portion	  
of	   the	   tissue	   (above	  white	  dotted	   lines),	   suggesting	   that	   reduced	  membrane	  thickness	  has	   little	  effect	  on	  
reducing	  cell	  necrosis.	  Scale	  bars	  =	  50	  µm.	  
The	   second	   strategy	   to	   reduce	   cell	   necrosis	   on	   Alvetex®Strata	   was	   to	   employ	   an	   insert/6-­‐well	  
plate/submerged	  format.	  It	  was	  hypothesised	  that	  supplying	  culture	  media	  from	  above	  and	  below	  
the	  membrane	  would	  prolong	  the	  survival	  of	  healthy	  cells	  growing	  in	  the	  tissue	  structure.	  Figure	  
3.27	  shows	  the	  growth	  profile	  after	  2,	  7	  and	  14	  days	  culture.	  All	  cells	  appear	  healthy	  with	  no	  signs	  
of	  necrosis,	  even	  after	  14	  days	  culture.	  However,	  unlike	   the	  contact	  cultures,	  very	   few	  cells	  are	  
present	  on	  top	  of	  the	  material.	  The	  only	  cells	  that	  remain	  are	  those	  that	  have	  penetrated	  into	  the	  
top	  portion	  of	  the	  material,	  giving	  a	  growth	  profile	  similar	  to	  Alvetex®Scaffold.	  Quantification	  of	  
tissue	  thickness	  and	  cell	  density	  between	  the	  contact	  and	  submerged	  cultures	  are	  shown	  in	  Figure	  
3.28.	  A	  significantly	  smaller	  (p<0.005)	  tissue	  thickness	  is	  observed	  for	  the	  submerged	  format	  that	  
is	  amplified	  as	   the	  culture	  period	  progresses.	  The	  number	  of	  cell	  nuclei	  per	   field	  of	  view	   is	  also	  
smaller	  for	  the	  submerged	  culture,	  which	  again	  is	  amplified	  as	  the	  culture	  period	  progresses.	  	  
	  
	  	   98	  
	  
Figure	  3.27	  Growth	  of	  HepG2	  cells	  on	  Alvetex®Strata	  using	  the	  insert/6-­‐well	  plate/submerged	  format.	  (A-­‐
C):	  H&E	  images	  after	  2,	  7	  and	  14	  days	  culture.	  Unlike	  contact	  cultures,	  very	  few	  cells	  are	  growing	  on	  top	  of	  
the	  membrane.	  (D):	  Higher	  magnification	  H&E	  image	  after	  14	  days	  culture.	  All	  cells	  appear	  healthy	  but	  very	  
little	  growth	  on	  top	  of	  the	  scaffold	  is	  occurring.	  Scale	  bars	  =	  50	  µm.	  
	  
	  	   99	  
	  
Figure	   3.28	   Quantification	   of	   HepG2	   growth	   profiles	   using	   submerged	   and	   contact	   cultures	   on	  
Alvetex®Strata.	   (A):	   Tissue	   structure	   thickness	   showing	   that	   contact	   cultures	   enable	   much	   thicker	   cell	  
growth	   on	   top	   of	   the	   scaffold.	   Data	   represent	  mean	   ±	   s.e.m	   (n=10).	   *Denotes	   p<0.005	   according	   to	   the	  
Student’s	  t-­‐test.	   (B):	  Cell	  nuclei	  per	  field	  of	  view	  showing	  a	  much	  greater	  cell	  density	  for	  contact	  cultures.	  
Data	  represent	  mean	  ±	  s.e.m	  (n=5).	  
	  
To	   help	   understand	   the	   difference	   in	   tissue	   structure	   thickness	   and	   cell	   density	   between	  
submerged	   cultures	   and	   contact	   cultures,	   the	   bottom	  of	   the	   6-­‐well	   plates	   housing	   the	   scaffold	  
inserts	  were	  analysed	  for	  residual/lost	  cells	  after	  a	  media	  change.	  Figure	  3.29	  shows	  the	  Neutral	  
Red	   (Sigma)	   staining	   of	   the	   plates	   used	   to	   house	   submerged	   and	   contact	   scaffold	   inserts.	   The	  
submerged	  format	  shows	  an	  abundance	  of	  cells	  on	  the	  bottom	  of	  the	  6-­‐well	  plate,	  suggesting	  that	  
the	  media	  change	  has	  washed	  cells	  from	  the	  Alvetex®Strata	  insert.	  Conversely	  no	  cells	  were	  found	  
on	   the	  bottom	  of	   the	  6-­‐well	  plate	   for	   the	   contact	   format.	  This	   indicates	   that	   submerged	  media	  
changes	  contribute	  to	  cell	  loss,	  which	  may	  be	  due	  to	  media	  turbulence	  or	  lack	  of	  surface	  tension	  
that	   serves	   to	   keep	   cells	   in	   a	  more	   robust	   organisation.	   Note	   that	   both	   inserts	  were	   placed	   in	  
fresh,	  clean	  6-­‐well	  plate	  prior	  to	  the	  media	  change.	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Figure	  3.29	  Residual	  HepG2	  cells	   found	  on	  the	  bottom	  of	  a	  6-­‐well	  plate	  after	  culture	  on	  Alvetex®Strata	  
using	   insert/6-­‐well	   plate/submerged	   and	   insert/6-­‐well	   plate/contact	   formats.	   (A):	   Illustration	   showing	  
what	  is	  being	  assessed	  (blue	  circle	  is	  bottom	  of	  the	  6-­‐well	  plate).	  (B,C):	  Neutral	  red	  staining	  of	  HepG2	  cells	  
on	  the	  bottom	  of	  the	  6-­‐well	  plate.	  More	  cells	  are	  found	  for	  the	  submerged	  cultures	  (B)	  compared	  to	  contact	  
cultures	   (C),	   suggesting	  more	   cells	   are	   being	   washed	   off	   the	   insert	   in	   submerged	   cultures	   during	  media	  
changes.	  
	  
Primary	   rat	   hepatocytes	  were	   also	   cultured	   on	   Alvetex®Strata	   and	   the	   growth	   profile	   assessed	  
after	   2	   days,	   as	   shown	   in	   Figure	   3.30.	   All	   cells	   appear	   healthy	   and	   are	   growing	   on	   top	   of	   the	  
membrane	  in	  a	  similar	  manner	  to	  HepG2.	  
	  
Figure	  3.30	  Growth	  of	  primary	  rat	  hepatocytes	  on	  Alvetex®Strata	  after	  2	  days	  culture.	  (A,B):	  H&E	  images	  
showing	  cells	  are	  viable.	  The	   insert/12-­‐well	  plate/contact	  appears	  much	  more	  effective	  at	  preserving	  cell	  
density	  and	  organisation.	  Scale	  bars	  =	  50	  µm.	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In	  summary,	  this	  section	  has	  shown	  that	  Alvetex®Strata	  can	  enable	  dense	  in	  vivo	  type	  hepatocyte	  
growth	   on	   top	   of	   the	  membrane,	   providing	   that	   a	   contact	  media	   supply	  method	   is	   employed.	  
However,	  after	  7	  and	  14	  days	  culture,	  cells	  in	  the	  top	  portion	  of	  the	  tissue	  display	  signs	  of	  necrosis	  
(furthest	   from	  media	   and	   closest	   to	   the	   air-­‐liquid	   interface),	  which	   is	   undesirable.	   Prior	   to	   this	  
cells	  appear	  healthy	  and	  so	  this	  culture	  method	  could	  offer	  a	  viable	  short-­‐term	  3D	  in	  vitro	  model	  
with	  extensive	  opportunity	  for	  cell-­‐cell	  contact.	  Reducing	  the	  thickness	  of	  the	  membrane	  does	  not	  
reduce	   this	   necrosis	   at	   the	   air-­‐liquid	   interface.	   Unfortunately	   submerged	   cultures	   do	   not	  
encourage	  thick	  tissue	  structures	  on	  top	  of	  the	  membrane.	  	  
	  
3.3.5 Optimising	  the	  Scaffold	  Microenvironment	  with	  Protein	  Coatings	  
It	   was	   hypothesised	   that	   coating	   the	   scaffold	   surface	   with	   proteins	   found	   in	   the	   hepatic	   ECM	  
would	  provide	  a	  more	  physiologically	  relevant	  microenvironment	  for	  hepatocyte	  growth.	  The	  two	  
most	   abundant	   hepatic	   ECM	   proteins	   are	   fibronectin	   and	   collagen	   I.	   Consequently,	  
Alvetex®Scaffold	  was	  coated	  with	  these	  proteins	  and	  then	  assessed	  for	  residual	  protein.	  
Alvetex®Scaffold	  was	  first	  rendered	  hydrophilic	  and	  washed	  extensively	   in	  PBS.	  After	  removal	  of	  
excess	  PBS,	  200	  µL	  of	  protein	  solution	  was	  applied	  to	  the	  membrane	  and	  left	  for	  1	  hour.	  Different	  
concentrations	  of	  protein	  solutions	  were	  applied,	  from	  1000	  µg/mL	  to	  50	  µg/mL.	  After	  1	  hour	  the	  
membranes	  were	   re-­‐washed	   in	  PBS	  and	   then	  assessed	   for	   residual	   protein	   via	   (1)	   blue	   staining	  
with	   Coomassie	   Brilliant	   Blue	   G-­‐250	   (Bio-­‐Rad),	   (2)	   SEM	   imaging	   and	   (3)	   confocal	  
immunofluorescence	   staining	  using	   antibodies	   for	   fibronectin	   and	   collagen	   I.	   Figure	  3.31	   shows	  
the	   Coomassie	   Brilliant	   Blue	  G-­‐250	   staining	   across	   the	   fibronectin	   and	   collagen	   I	   concentration	  
range.	  Membranes	  coated	  with	  fibronectin	  show	  a	  gradual	  increase	  in	  blue	  staining	  as	  the	  coating	  
concentration	   is	   increased,	   suggesting	   an	   increase	   in	   deposition	   of	   the	   protein	   with	   increasing	  
coating	   concentration.	   Conversely	   membranes	   coated	   with	   collagen	   I	   show	   overall	   weaker	  
staining	   and	   only	   a	   slight	   increase	   in	   deposition	   with	   increasing	   coating	   concentration.	   This	  
suggests	  that	   less	  collagen	  I	   is	  deposited	  onto	  the	  membrane	  compared	  to	  fibronectin,	  and	  that	  
higher	  coating	  concentrations	  do	  not	  necessarily	  increase	  protein	  deposition.	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Figure	   3.31	   Coomassie	   Brilliant	   Blue	   G-­‐250	   detection	   of	   residual	   fibronectin	   and	   collagen	   I	   on	  
Alvetex®Scaffold	  after	  applying	  a	  coating	  solution.	  (A):	  Fibronectin	  coatings	  showing	  a	  gradual	  increase	  in	  
blue	   staining	   (protein	   deposition)	  with	   increasing	   coating	   concentration.	   (B):	   Collagen	   I	   coatings	   showing	  
much	   weaker	   staining	   and	   less	   of	   an	   increase	   in	   staining	   with	   increasing	   coating	   concentration.	   All	  
membranes	  were	  treated	  with	  Coomassie	  Brilliant	  Blue	  G-­‐250	  for	  1	  hour	  and	  then	  left	  in	  de-­‐stain	  solution	  
overnight	  before	  taking	  images.	  	  
SEM	  analysis	  of	  the	  coated	  scaffolds	  is	  shown	  in	  Figure	  3.32.	  Thin	  films	  appear	  to	  span	  the	  voids	  of	  
the	   membrane	   at	   fibronectin	   coating	   concentrations	   of	   1000	   µg/mL	   and	   500	   µg/mL	   that	   are	  
absent	   in	   the	   uncoated	   control.	  With	   1000	  µg/mL,	   this	   film	   is	  mainly	   intact,	   however	  with	   500	  
µg/mL	   the	   film	   has	  multiple	   tears	   and	   holes	   (white	   arrows	   in	   Figure	   3.32B).	  Only	   small	   spindle	  
structures	   appear	   to	   be	   present	  with	   a	   fibronectin	   coating	   concentration	   of	   250	  µg/mL.	   These	  
data	  are	  consistent	  with	  the	  Coomassie	  Brilliant	  Blue	  G-­‐250	  staining	  for	  fibronectin,	  in	  that	  higher	  
coating	  concentrations	   lead	  to	   increased	  protein	  deposition	  on	  the	  material.	  Collagen	   I	  coatings	  
do	  not	  produce	   film	  or	  spindle	  structures,	  but	   leave	  small	  granule-­‐type	  deposits	  on	  the	  scaffold	  
walls	  that	  are	  absent	  on	  the	  uncoated	  control	  (white	  arrows	  in	  Figure	  3.32D,E).	  A	  similar	  amount	  
of	  these	  deposits	  were	  found	  for	  coating	  concentrations	  of	  1000	  µg/mL	  and	  50	  µg/mL.	  This	  is	  also	  
consistent	  with	   the	  Coomassie	  Brilliant	  Blue	  G-­‐250	  staining	   for	  collagen	   I,	   in	   that	  higher	  coating	  
concentrations	  do	  not	  appear	  to	  lead	  to	  increased	  protein	  deposition	  on	  the	  material.	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Figure	   3.32	   SEM	   analysis	   of	   deposited	   fibronectin	   and	   collagen	   I	   on	   Alvetex®Scaffold	   after	   applying	   a	  
coating	   solution.	   (A-­‐C):	   Fibronectin	   deposition	   gradually	   decreases	  with	   lower	   concentrations	   of	   coating	  
solution.	  Higher	   concentrations	   show	   film-­‐like	   structures	  whereas	   lower	   concentrations	   show	  spindle-­‐like	  
structures.	  (D-­‐E):	  Collagen	  I	  deposition	  appears	  similar	  for	  the	  different	  coating	  concentrations	  tested	  (1000	  
µg/mL	  and	  50	  µg/mL).	  (F):	  Uncoated	  scaffold	  control.	  Scale	  bars	  =	  20	  µm.	  
Final	   confirmation	   of	   deposited	   fibronectin	   and	   collagen	   I	   was	   performed	   using	   confocal	  
immunofluorescence.	  Membranes	  were	   coated	   either	  with	   1000	  µg/mL	   fibronectin,	   500	  µg/mL	  
fibronectin	  or	  50	  µg/mL	  collagen	  I	  and	  then	  processed	  for	  immunofluorescence	  using	  antibodies	  
for	  fibronectin	  (Sigma)	  and	  collagen	  I	  (Sigma).	  AlexaFluor®	  488	  (Life	  Technologies)	  was	  used	  as	  the	  
secondary	   antibody.	   Figure	   3.33	   shows	   the	   confocal	   microscopy	   images	   after	  
immunofluorescence	   processing.	   A	   green	   film	   (positive	   staining)	   can	   be	   seen	   for	   fibronectin	  
coating	   concentrations	   of	   1000	   µg/mL	   and	   500	   µg/mL	   that	   are	   not	   present	   on	   the	   negative	  
control,	  confirming	  that	  fibronectin	  has	  deposited.	  Note	  that	  for	  fibronectin	  immunofluorescence	  
Nile	  Red	  (Sigma)	  was	  used	  as	  a	  hydrophobic	  dye	  to	  stain	  the	  scaffold	  red	  so	  that	  the	  fibronectin	  
films	   could	   be	   more	   easily	   distinguished.	   A	   more	   sporadic	   positive	   green	   staining	   pattern	   is	  
observed	   for	   collagen	   I	   immunofluorescence,	   consistent	   with	   the	   SEM	   data.	   Whilst	   no	   film	   or	  
spindle	   structures	   are	   observed,	   the	   data	   confirms	   collagen	   I	   deposition	   on	   the	   walls	   of	   the	  
material.	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Figure	   3.33	   Confocal	   immunofluorescence	   analysis	   of	   deposited	   fibronectin	   and	   collagen	   I	   on	  
Alvetex®Scaffold	  after	  applying	  a	  coating	  solution.	   (A-­‐C):	  Fibronectin	  deposition	  observed	  by	  the	  positive	  
green	  film-­‐like	  structures	  which	  are	  absent	  on	  the	  negative	  control.	  Nile	  Red	  was	  used	  as	  a	  hydrophobic	  dye	  
to	  stain	  the	  scaffold	  red	  so	  that	  the	  film	  structures	  could	  be	  more	  easily	  distinguished.	  Scale	  bars	  =	  20	  µm.	  
(D-­‐E):	   Collagen	   I	   deposition	   observed	   by	   the	   patchy	   green	   staining.	   Scale	   bars	   =	   50	   µm.	   All	   images	   are	  
merged	  optical	  z-­‐stacks	  of	  ca.	  20	  µm.	  
In	   summary,	   this	   section	   has	   shown	   that	   Alvetex®Scaffold	   can	   be	   coated	   with	   fibronectin	   or	  
collagen	   I,	  potentially	   increasing	  the	  biochemical	   relevance	  of	   the	  material.	  Fibronectin	  coatings	  
appear	  to	  leave	  film	  or	  spindle	  structures	  that	  span	  the	  voids	  of	  the	  scaffold,	  whereas	  collagen	  I	  
coatings	  appear	  to	  leave	  deposited	  granular	  structures	  on	  the	  walls	  of	  the	  scaffold.	  Increasing	  the	  
concentration	  of	  fibronectin	  seems	  to	  increase	  the	  amount	  of	  deposited	  fibronectin.	  Conversely,	  
little	   difference	   in	   collagen	   I	   deposition	   is	   observed	   between	   high	   (1000	   µg/mL)	   and	   low	   (50	  
µg/mL)	  coating	  concentrations.	  
	  
Having	  demonstrated	   that	  Alvetex®Scaffold	   can	  be	   coated	  with	   fibronectin	  or	   collagen	   I,	   it	  was	  
then	  necessary	  to	  assess	  the	  impact	  on	  hepatocyte	  growth.	  A	  fibronectin	  coating	  concentration	  of	  
1000	  µg/mL	  was	  chosen,	  as	  this	  was	  believed	  to	  deposit	  the	  maximum	  amount	  of	  fibronectin	  onto	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the	   scaffold.	  Conversely	  only	  a	  50	  µg/mL	  collagen	   I	   coating	   concentration	  was	  employed,	   given	  
that	  very	  little	  difference	  in	  collagen	  I	  deposition	  was	  observed	  for	  higher	  coating	  concentrations.	  
The	   coatings	   were	   applied	   to	   four	   Alvetex®Scaffold	   product	   formats,	   namely:	   (1)	   insert/Petri-­‐
dish/submerged,	  (2)	  insert/12-­‐well	  plate/submerged,	  (3)	  insert/12-­‐well	  plate/contact	  and	  (4)	  24-­‐
well	  plate.	  HepG2	  cells	  were	  cultured	   for	  2,	  7	  and	  14	  days	  and	  cell	  penetration	  and	  cell	  density	  
assessed.	  
Figure	  3.34	  shows	  the	   impact	  of	   fibronectin	  and	  collagen	   I	  coatings	  on	  HepG2	  growth	  using	  the	  
insert/Petri-­‐dish/submerged	  format.	  All	  cells	  appear	  healthy	  with	  no	  signs	  of	  necrosis,	  confirming	  
that	   the	   deposited	   proteins	   do	   not	   hinder	   cell	   survival.	   At	   day	   2,	   HepG2	   cells	   have	   penetrated	  
much	   further	   into	   the	   collagen	   I	   scaffold	   compared	   to	   the	   fibronectin	   and	   uncoated	   scaffolds.	  
Only	  a	  slight	  increase	  in	  cell	  penetration	  can	  be	  observed	  for	  the	  fibronectin	  scaffold	  compared	  to	  
the	  uncoated.	  At	  day	  7,	  HepG2	  cells	  have	  already	  penetrated	  all	   the	  way	  through	  the	  collagen	   I	  
scaffold,	   unlike	   the	   fibronectin	   and	   uncoated	   scaffolds.	   These	   data	   strongly	   suggest	   collagen	   I	  
enhances	   HepG2	  migration	   throughout	   the	  material.	   At	   day	   14,	   HepG2	   cells	   in	   the	   fibronectin	  
scaffold	  appear	   to	  have	  penetrated	   further	   than	   the	  uncoated	   scaffold,	  but	   still	   less	   than	   those	  
cells	  in	  the	  collagen	  I	  scaffold.	  	  
Figure	  3.35	  shows	  the	   impact	  of	   fibronectin	  and	  collagen	   I	  coatings	  on	  HepG2	  growth	  using	  the	  
insert/12-­‐well	   plate/submerged	   format.	   An	   almost	   identical	   penetration	   profile	   is	   observed	   to	  
that	   of	   the	   insert/Petri-­‐dish/submerged	   format.	   All	   HepG2	   cells	   appear	   healthy	   and	   penetrate	  
furthest	   into	   collagen	   I	   coated	   scaffolds,	   followed	   by	   fibronectin	   and	   then	   finally	   the	   uncoated	  
control.	  
Figure	  3.36	  shows	  the	   impact	  of	   fibronectin	  and	  collagen	   I	  coatings	  on	  HepG2	  growth	  using	  the	  
insert/12-­‐well	  plate/contact	   format.	  As	  with	   the	   submerged	   insert	   cultures,	   collagen	   I	   seems	   to	  
drive	  the	  furthest	  penetration,	  however	  the	  effect	  is	  much	  lower	  for	  these	  contact	  cultures.	  It	   is	  
hypothesised	   that	  collagen	   I	  may	  not	  be	  necessary	   to	  drive	  penetration	   in	   this	  case	  as	  cells	  will	  
already	   want	   to	   move	   downwards	   towards	   the	   media	   supply	   entering	   from	   underneath.	  
Unfortunately	   a	   significant	   amount	   of	   cell	   necrosis	   is	   again	   observed	   after	   14	   days	   culture	   for	  
those	  cells	  growing	  furthest	  from	  the	  media	  supply,	  indicated	  by	  the	  white	  circles.	  	  
Figure	  3.37	  shows	  the	   impact	  of	   fibronectin	  and	  collagen	   I	  coatings	  on	  HepG2	  growth	  using	  the	  
24-­‐well	   plate	   format.	   Unlike	   the	   submerged	   insert	   cultures,	   collagen	   I	   only	   drives	   a	   very	   small	  
increase	   in	  cell	  penetration.	   It	   is	  expected	  that	   the	   lack	  of	  media	  entering	   from	  underneath	   the	  
membrane	   still	   hinders	   cells	   from	   penetrating	   downwards,	   even	   in	   the	   presence	   of	   an	   ECM	  
coating.	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Figure	  3.34	  H&E	  staining	  of	  HepG2	  growth	  in	  Alvetex®Scaffold	  coated	  with	  either	  fibronectin	  or	  collagen	  I	  
using	   the	   insert/Petri-­‐dish/submerged	   format.	   (A-­‐C):	   Day	   2.	   (D-­‐F):	   Day	   7.	   (G-­‐I):	   Day	   14.	   Scaffolds	   were	  
either	  left	  uncoated	  (A,D,G),	  coated	  with	  fibronectin	  (B,E,H)	  or	  coated	  with	  collagen	  I	  (C,F,I).	  All	  cells	  appear	  
healthy	  with	  no	  signs	  of	  necrosis.	  Cells	  appear	  to	  have	  migrated	  furthest	  into	  the	  collagen	  I	  coated	  scaffold,	  
followed	  by	  fibronectin	  and	  the	  finally	  the	  uncoated	  scaffold.	  Scale	  bars	  =	  50	  µm.	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Figure	  3.35	  H&E	  staining	  of	  HepG2	  growth	  in	  Alvetex®Scaffold	  coated	  with	  either	  fibronectin	  or	  collagen	  I	  
using	  the	  insert/12-­‐well	  plate/submerged	  format.	  (A-­‐C):	  Day	  2.	  (D-­‐F):	  Day	  7.	  (G-­‐I):	  Day	  14.	  Scaffolds	  were	  
either	  left	  uncoated	  (A,D,G),	  coated	  with	  fibronectin	  (B,E,H)	  or	  coated	  with	  collagen	  I	  (C,F,I).	  All	  cells	  appear	  
healthy	  with	  no	  signs	  of	  necrosis.	  Cells	  appear	  to	  have	  migrated	  furthest	  into	  the	  collagen	  I	  coated	  scaffold,	  
followed	  by	  fibronectin	  and	  the	  finally	  the	  uncoated	  scaffold.	  Scale	  bars	  =	  50	  µm.	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Figure	  3.36	  H&E	  staining	  of	  HepG2	  growth	  in	  Alvetex®Scaffold	  coated	  with	  either	  fibronectin	  or	  collagen	  I	  
using	   the	   insert/12-­‐well	   plate/contact	   format.	   (A-­‐C):	   Day	   2.	   (D-­‐F):	   Day	   7.	   (G-­‐I);	   Day	   14.	   Scaffolds	   were	  
either	   left	   uncoated	   (A,D,G),	   coated	   with	   fibronectin	   (B,E,H)	   or	   coated	   with	   collagen	   I	   (C,F,I).	   Collagen	   I	  
seems	  to	  be	  the	  most	  effective	  at	  driving	  penetration	  into	  the	  material,	  however	  the	  effect	  is	  less	  than	  for	  
submerged	  cultures.	  A	  significant	  amount	  of	  cell	  necrosis	  appears	  after	  14	  days	  culture,	  particularly	  for	  the	  
collagen	  I	  scaffold,	  indicated	  by	  the	  white	  circles.	  Scale	  bars	  =	  50	  µm.	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Figure	  3.37	  H&E	  staining	  of	  HepG2	  growth	  in	  Alvetex®Scaffold	  coated	  with	  either	  fibronectin	  or	  collagen	  I	  
using	   24-­‐well	   plate	   format.	   (A-­‐C):	  Day	  2.	   (D-­‐F):	  Day	  7.	   (G-­‐I):	  Day	   14.	   Scaffolds	  were	   either	   left	   uncoated	  
(A,D,G),	   coated	  with	   fibronectin	   (B,E,H)	  or	  coated	  with	  collagen	   I	   (C,F,I).	  Collagen	   I	   seems	   to	  encourage	  a	  
slight	  increase	  in	  cell	  penetration,	  but	  much	  less	  than	  for	  insert	  (submerged)	  cultures.	  Scale	  bars	  =	  50	  µm.	  
	  
Figure	   3.38	  quantifies	   the	   cell	   penetration	  observed	   from	   the	  H&E	   images	   for	   each	  of	   the	   four	  
product	   formats	   coated	   with	   fibronectin	   or	   collagen	   I.	   Fibronectin	   seems	   to	   have	   only	   a	   small	  
effect	   on	   cell	   penetration	   across	   all	   formats.	   Conversely	   collagen	   I	   clearly	   increases	   cell	  
penetration,	  particularly	  for	  insert/submerged	  cultures.	  For	  insert/contact	  cultures,	  collagen	  I	  still	  
has	  an	  effect,	  however	  it	   is	  much	  lower	  compared	  to	  the	  submerged	  cultures,	  probably	  because	  
media	  attraction	  from	  underneath	  the	  membrane	  is	  already	  a	  dominant	  factor	  in	  promoting	  cell	  
migration.	  Collagen	  I	  also	  helped	  to	  increase	  penetration	  with	  the	  24-­‐well	  plate	  format,	  although	  
the	  overall	  penetration	  remained	  much	  lower	  compared	  to	  the	  insert	  cultures.	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Figure	  3.38	  Quantification	  of	  HepG2	  penetration	   into	   fibronectin	  or	  collagen	   I	   coated	  Alvetex®Scafffold	  
using	  different	  product	  formats.	  (A):	  insert/Petri-­‐dish/submerged.	  (B):	  insert/12-­‐well	  plate/submerged.	  (C):	  
insert/12-­‐well	   plate/contact.	   (D):	   24-­‐well	   plate.	   Collagen	   I	   seems	   to	   be	   the	  most	   effective	   at	   driving	   cell	  
penetration,	  followed	  by	  fibronectin.	  Data	  represent	  mean	  ±	  s.e.m	  (n=15).	  
	  
The	  similarity	  in	  cell	  penetration	  between	  fibronectin	  coated	  scaffolds	  and	  uncoated	  scaffolds	  was	  
surprising	  given	  that	  a	  significant	  amount	  of	  fibronectin	  was	  expected	  to	  be	  on	  the	  scaffold.	  As	  a	  
result,	   total	   cell	   metabolic	   activity	   and	   total	   dsDNA	   were	   compared	   between	   fibronectin	   and	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uncoated	  scaffolds	  to	  further	  probe	  if	  fibronectin	  coatings	  offered	  any	  advantage	  for	  cells	  growing	  
on	  Alvetex®Scafffold.	  
Figure	   3.39	   shows	   the	   total	  HepG2	  metabolic	   activity	   for	   cells	   cultured	  on	   a	   fibronectin	   coated	  
scaffold	  (1000	  µg/mL)	  compared	  to	  an	  uncoated	  scaffold,	  using	  the	   insert/Petri-­‐dish/submerged	  
format.	  A	  significant	  increase	  (p<0.005)	  was	  observed	  after	  2	  days	  culture	  for	  the	  coated	  scaffold,	  
suggesting	   that	   fibronectin	   increases	   HepG2	   adhesion	   onto	   the	   scaffold	   and/or	   promotes	  
increased	   cellular	   activity.	   However,	   as	   the	   culture	   period	   progresses	   onto	   7	   and	   14	   days,	   no	  
difference	  in	  total	  metabolic	  activity	  is	  observed.	  To	  help	  understand	  if	  the	  difference	  at	  day	  2	  can	  
be	   attributed	   to	   increased	   cell	   adhesion	   or	   increased	   cellular	   activity,	   total	   cell	   number	   was	  
quantified.	   This	   was	   achieved	   by	   measuring	   dsDNA	   content	   using	   the	   Quant-­‐iT™	   PicoGreen®	  
reagent	   (Life	  Technologies).	   Firstly,	  a	   series	  of	  known	  HepG2	  cell	  numbers	  were	  prepared	   in	  2D	  
pre-­‐culture.	  These	  known	  cell	  numbers	  were	  then	  treated	  with	  the	  Quant-­‐iT™	  PicoGreen®	  reagent	  
to	  measure	   dsDNA	   content	   and	   thus	   create	   a	   calibration	   curve	  of	   fluorescence	   intensity	  versus	  
cell	  number	   (Figure	  3.40A).	  A	  good	  correlation	  between	  cell	  number	  and	   fluorescence	   intensity	  
was	   observed	   (R2	   =	   0.987).	   Following	   this,	   HepG2	   cells	   cultured	   on	   either	   uncoated	  
Alvetex®Scaffold	   or	   fibronectin	   coated	   Alvetex®Scaffold	   were	   then	   lysed	   and	   homogenised	   to	  
extract	  dsDNA	  and	  then	  treated	  with	  the	  Quant-­‐iT™	  PicoGreen®	  reagent.	  Fluorescence	  intensities	  
were	   then	   converted	   into	   cell	   numbers	   using	   the	   calibration	   curve.	   Figure	   3.40B	   shows	   no	  
difference	   in	   cell	   number	   between	   the	   two	   scaffolds,	   suggesting	   that	   fibronectin	   does	   not	  
enhance	   adhesion	  onto	   the	  material.	   These	  data	   are	   consistent	  with	   the	  previous	  H&E	   images,	  
where	  no	  noticeable	  differences	  in	  cell	  density	  were	  observed.	  
	  
Figure	  3.39	  Impact	  of	  fibronectin	  coated	  Alvetex®Scaffold	  on	  HepG2	  total	  metabolic	  activity.	  A	  significant	  
increase	   is	  observed	  after	  2	  days	  culture,	  however	  no	  difference	   is	  observed	  after	  7	  and	  14	  days	  culture.	  
Data	  obtained	  using	  the	  MTT	  assay.	  Data	  represent	  mean	  ±	  s.e.m	  (n=	  7).	  *	  denotes	  p<0.005	  as	  determined	  
by	  the	  Student’s	  t-­‐test.	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Figure	   3.40	   Analysis	   of	   total	   cell	   number	   from	   HepG2	   dsDNA	   obtained	   from	   culture	   on	   uncoated	   and	  
fibronectin	   coated	   Alvetex®Scaffolds.	   The	   Quant-­‐iT™	   PicoGreen®	   reagent	   was	   used	   to	   correlate	   dsDNA	  
(fluorescence)	  with	  cell	  number.	  (A):	  Cell	  number	  –	  fluorescence	  calibration	  curve.	  (B):	  Cell	  number	  showing	  
no	  significant	  differences.	  Data	  represent	  mean	  ±	  s.e.m	  (n=3).	  
In	   summary,	   this	   section	   has	   shown	   that	   coating	   Alvetex®Scaffold	   with	   50	   µg/mL	   collagen	   I	  
solution	   helps	   to	   drive	  HepG2	  migration	   into	   the	  material	   for	   insert/submerged	   cultures	  which	  
could	  potentially	  lead	  to	  more	  extensive	  3D	  tissue	  constructs	  throughout	  the	  scaffold.	  Conversely	  
for	  insert/contact	  cultures	  and	  the	  24-­‐well	  plate,	  a	  collagen	  I	  coating	  only	  slightly	  improves	  HepG2	  
migration	  into	  the	  material.	  Coating	  Alvetex®Scaffold	  with	  1000	  µg/mL	  fibronectin	  has	  very	  little	  
impact	  on	  HepG2	  migration	  or	  adhesion.	  However,	  a	  fibronectin	  coating	  may	  help	  to	  increase	  the	  
initial	  metabolic	  activity	  of	  the	  cells	  during	  the	  early	  stages	  of	  the	  culture	  period.	  
	  
3.3.6 Optimising	  the	  Scaffold	  Microenvironment	  with	  Media	  Perfusion	  
A	  media	  perfusion	  model	  was	  developed	   in	   collaboration	  with	  Reinnervate	   for	  3D	  culture	  using	  
scaffold	   inserts.	   The	  media	  perfusion	  was	   set	  up	  as	   shown	   in	   Figure	  3.41.	  Alvetex®Scaffold	  was	  
used	   in	   an	   insert	   format	   so	   that	  media	   could	   perfuse	   above	   and	  below	   the	   scaffold.	   A	  Watson	  
Marlow	  multichannel	  cassette	  pump	  was	  used	  to	  pump	  media	   from	  a	  reservoir	  stock	  through	  a	  
specifically	   designed	  plate	  housing	   the	   inserts.	   The	  plate	  was	  designed	  by	  Reinnervate	   and	  was	  
based	  on	  a	  modified	  6-­‐well	  plate,	  using	  a	   standard	  6-­‐well	  plate	   ringed-­‐lid.	  However,	   in	  place	  of	  
two	   of	   the	  wells	   are	   inlet	   and	   outlet	   ports	   for	   securing	   luer	   locks	   to	   then	   attach	  media/pump	  
tubing.	  Four	  inserts	  can	  be	  used	  to	  hang	  in	  the	  remaining	  wells	  of	  the	  plate.	  Two	  pump	  heads	  are	  
required	  per	  plate,	  one	  to	  push	  media	  from	  the	  reservoir	  into	  the	  plate,	  the	  other	  to	  pull	  media	  
from	  the	  plate	  back	  to	  the	  reservoir.	  The	  reservoir	  is	  a	  small	  (125	  mL)	  media	  bottle	  containing	  130	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mL	  media	  per	  plate,	  although	  approximately	  30	  mL	  of	  this	  is	  in	  the	  plate	  at	  any	  one	  time.	  A	  sterile	  
0.22	  µm	  filter	  was	  used	  to	  provide	  an	  air	  release	  with	  the	  atmosphere	  so	  that	  the	  bottle	  does	  not	  
deform	  under	  the	  pump	  action.	  Finally,	  the	  plate	  was	  raised	  to	  a	  similar	  height	  of	  the	  pump	  head	  
so	   that	   gravity	   does	   not	   severely	   disrupt	   the	   flow	   (although	   some	   gravitational	   forces	   are	  
inevitable).	  	  
	  
Figure	   3.41	   Set	   up	   for	   media	   perfusion	   through	   the	   Alvetex®Scaffold	   microenvironment	   using	   the	  
Reinnervate	  Perfusion	  Plate.	   (A):	  Schematic	  of	  media	   flow	  across	   the	  scaffold	  within	   the	  perfusion	  plate.	  
(B):	   Media	   circuit	   using	   the	   Reinnervate	   Perfusion	   Plate.	   (C):	   6-­‐well	   plate	   ringed-­‐lid.	   (D):	   Reinnervate	  
Perfusion	   Plate	   based	   on	   a	   modified	   standard	   6-­‐well	   plate.	   (E):	   Reinnervate	   Perfusion	   Plate	   housing	   4	  
Alvetex®Scaffold	  membrane	  inserts.	  (F):	  Pump	  head	  cassette	  with	  tubing	  passing	  through.	  (G):	  Media	  bottle	  
and	  media	  cap	  showing	  tubing	  and	  air	  vent.	  (H):	  Complete	  set	  up.	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Prior	   to	   achieving	   this	   set-­‐up	   for	   perfusion	   experiments,	   several	   practical	   problems	   had	   to	   be	  
resolved	  during	  development.	  These	  are	  captured	  in	  Table	  3-­‐6	  
	  
Table	  3-­‐6	  Troubleshooting	  Issues	  for	  the	  Development	  of	  the	  Perfusion	  System.	  
Problem	   Solution	  
Leakage	  of	  media	  from	  in/out	  ports	   Port	  alteration	  on	  plate.	  Specific	  luer	  lock	  identified.	  
Overflow	  issues	   Raising	  plate	  to	  pump	  head	  height.	  Ensuring	  tube	  
distance	  transferring	  media	  to	  the	  plate	  is	  longer	  (60	  
cm)	  than	  the	  tube	  distance	  carrying	  media	  from	  the	  
plate	  (35	  cm).	  
Deformation	  of	  media	  reservoir	  bottle	   Sterile	  filter	  valve	  employed	  in	  media	  reservoir	  cap	  to	  
provide	  an	  air	  vent.	  
Slippage	  of	  tubing	  through	  the	  pump	  head	   Use	  of	  tube-­‐to-­‐tube	  connectors	  to	  prevent	  slippage	  
	  
Previous	  work	  within	   the	   Przyborski	   group	   using	   the	  Quasi	   Vivo	   (Kirkstall)	   bioreactor	   identified	  
that	   a	   re-­‐circulated	   flow	   rate	   of	   200	  µL/min	  was	   sufficient	   for	   hepatocytes	   (unpublished	   data).	  
This	  was	  therefore	  employed	  for	  this	  system	  by	  setting	  the	  pump	  to	  2	  rpm	  (calibration	  data	  not	  
shown).	  	  
The	   first	   experiment	   employed	   HepG2	   cells	   to	   check	   that	   cells	   could	   survive	   under	   the	  media	  
perfusion	  conditions	  employed.	  Figure	  3.42	  shows	  that	  the	  total	  metabolic	  activity	  is	  comparable	  
between	  static	  and	  perfused	  cultures	  after	  4	  and	  7	  days	  culture.	  It	  is	  hypothesised	  that	  for	  HepG2	  
cells,	  which	  are	  already	  a	  robust	  and	  proliferative	  cell	  line,	  the	  media	  conditions	  employed	  by	  the	  
static	  culture	  are	  already	  sufficient	  for	  optimal	  HepG2	  growth	  in	  the	  scaffold.	  Consequently	  media	  
perfusion	   was	   attempted	   using	   the	   more	   delicate	   Upcyte®	   cells	   and	   primary	   rat	   hepatocytes.	  
Figure	   3.43	   compares	   the	   total	   metabolic	   activity	   of	   Upcyte®	   hepatocytes	   and	   primary	   rat	  
hepatocytes	  under	  static	  and	  perfused	  conditions	  (up	  to	  7	  days	  culture).	  	  For	  Upcyte®	  cells,	  after	  7	  
days	  culture	  there	  appears	  to	  be	  an	  increase	  in	  metabolic	  activity	  for	  perfused	  cells.	  This	  could	  be	  
consistent	  with	  better	  nutrient	  quality	  throughout	  the	  culture	  period.	  For	  primary	  rat	  hepatocytes	  
there	   is	   increased	  metabolic	  activity	   for	   the	  perfused	  cells	  after	  3	  days	  culture,	  however	  after	  5	  
days	   the	   activity	   of	   the	  perfused	   cells	   is	   reduced	   to	  be	  parity	  with	   the	   static	   cells.	   This	  may	  be	  
explained	   by	   a	   gradual	   cell	   loss	   from	   the	   scaffold	   throughout	   the	   perfusion	   period,	   given	   that	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Figure	  3.42	  Media	  perfusion	  of	  HepG2	  cells	  cultured	  on	  Alvetex®Scaffold	  using	  the	  Reinnervate	  Perfusion	  
Plate.	   The	  MTT	   assay	  was	   used	   to	   assess	   total	  metabolic	   activity.	   It	   is	   hypothesised	   that	   standard	   static	  
culture	   conditions	   are	   already	   sufficient	   for	   the	   highly	   robust	   and	   proliferative	   HepG2	   cell	   line.	   Data	  
represent	  mean	  ±	  s.e.m	  (n=2).	  
	  
	  
Figure	  3.43	  Metabolic	  activity	  of	  hepatocytes	  cultured	  in	  the	  perfusion	  model	  compared	  to	  static	  media	  
conditions.	  (A):	  Upcyte®	  cells	  showing	  an	  increase	  for	  perfused	  conditions	  after	  7	  days.	  (B):	  Primary	  rat	  cells	  
showing	  an	  increase	  for	  perfused	  conditions	  after	  3	  days	  but	  not	  5	  days.	  Data	  represent	  mean	  ±	  s.e.m	  (n=2).	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3.3.7 Extracting	  Intact	  Hepatocytes	  from	  the	  Scaffold	  Microenvironment	  
One	  of	  the	  main	  advantages	  of	  cell	  growth	  on	  Alvetex®Strata	   is	  that	  the	  cells	  can	  potentially	  be	  
extracted	  and	  then	  used	  for	  3D	  passaging	  or	  subsequent	  analysis.	  To	  assess	  the	  feasibility	  of	  this,	  
HepG2	   cells	   were	   first	   cultured	   on	   Alvetex®Strata	   for	   2,	   7	   and	   14	   days	   using	   the	   insert/6-­‐well	  
plate/contact	   format.	   After	   each	   time	   point,	   the	   membranes	   were	   removed	   from	   their	   insert	  
housings	   and	   placed	   in	   a	   new	   6-­‐well	   plate	   containing	   2	   mL	   of	   Trypsin-­‐EDTA	   (Sigma)	   and	   then	  
incubated	  for	  15	  mins	  at	  37	  oC	  and	  5	  %	  CO2.	  After	  this	  period,	  1	  mL	  of	  MEM	  was	  added	  and	  a	  cell	  
scraper	   was	   gently	   applied	   to	   the	   membrane.	   The	   Trypsin-­‐EDTA/MEM	   solution	   was	   then	   re-­‐
suspended	   in	   MEM	   and	   either	   analysed	   using	   flow	   cytometry	   or	   re-­‐seeded	   onto	   fresh	  
Alvetex®Strata	  membranes	  for	  3D	  passaging.	  
Figure	   3.44	   shows	   the	   HepG2	   growth	   on	   the	   membrane	   before	   and	   after	   cell	   extraction.	  
Encouragingly,	   nearly	   all	   of	   the	   cells	   growing	   on	   top	   of	   the	  membrane	  were	   extracted	   at	   each	  
time	  point.	  Some	  cells	  that	  penetrated	  into	  the	  material,	  particularly	  after	  14	  days	  culture,	  were	  
not	  removed	  and	  remained	  in	  the	  top	  portion	  of	  the	  membrane.	  This	  is	  surprising	  given	  the	  small	  
void	   diameter	   of	   Alvetex®Strata,	   and	   suggests	   that	   HepG2	   cells	   are	   willing	   to	   alter	   their	  
morphology	   to	  move	   closer	   towards	   the	  media	   supply	   in	   this	   environment.	   Note	   that	   residual	  
cells	   left	   on	   the	   membrane	   means	   that	   the	   extracted	   cells	   are	   not	   fully	   representative	   of	   the	  
entire	  cell	  population.	  Hence	  care	  should	  be	  taken	  when	  interpreting	  subsequent	  analysis	  data.	  	  
	  	   117	  
	  
Figure	  3.44	  Extracting	  HepG2	  cells	  from	  Alvetex®Strata.	  (A,C,E):	  Before	  treatment	  with	  Trypsin-­‐EDTA	  and	  a	  
cell	  scraper.	  (B,D,F):	  After	  treatment	  with	  Trypsin-­‐EDTA	  and	  a	  cell	  scraper.	  The	  extraction	  process	  removes	  
the	  majority	  of	  cells,	  although	  after	  14	  days	  culture	  those	  cells	  that	  have	  penetrated	  into	  the	  material	  are	  
not	  removed.	  Scale	  bars	  =	  400	  µm.	  
Having	   successfully	   extracted	   the	   majority	   of	   cells	   from	   Alvetex®Strata,	   the	   cells	   were	   then	  
analysed	  using	   flow	  cytometry	  and	   the	  Guava	  Nexin®	   reagent	   (Millipore).	   This	   is	   a	   reagent	   that	  
detects	   (1):	   external	   Annexin	   V	   (a	   calcium-­‐dependent	   phospholipid	   binding	   protein)	   as	   an	  
indicator	  of	  early-­‐apoptotic	  cells	  and	  (2):	  cell	  membrane	  integrity	  using	  7-­‐aminoactinomycin	  D	  (7-­‐
AAD)	  as	  an	  indicator	  of	  necrotic/late	  apoptotic	  cells.	  As	  a	  result,	  three	  cell	  states	  can	  be	  analysed	  
simultaneously:	  (1)	  viable	  ceIls	  being	  (-­‐)	  Annexin	  V	  and	  (-­‐)	  7-­‐AAD.	  (2)	  early	  apoptotic	  cells	  being	  (+)	  
Annexin	  V	  and	  (-­‐)	  7-­‐AAD.	  (3)	  Necrotic/late	  apoptotic	  cells	  being	  (+)	  Annexin	  V	  and	  (+)	  7-­‐AAD.	  The	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(+)	  Annexin	  V	  gate	  on	  the	  flow	  cytometer	  was	  set	  using	  HepG2	  cultures	  that	  were	  treated	  with	  2	  
µM	  staurosporine	  for	  18	  hours	  (an	  inducer	  of	  apoptosis).	  The	  (+)	  7-­‐AAD	  gate	  was	  set	  on	  the	  flow	  
cytometer	  using	  HepG2	  cultures	  that	  were	  heated	  treated	  at	  58	  oC	  for	  20	  mins.	  	  
Figure	   3.45	   shows	   the	   results	   of	   the	   flow	   cytometric	   analysis	   of	   the	   extracted	   cells	   using	   the	  
Guava	  Nexin®	  reagent.	  After	  2	  days	  culture	  on	  Alvetex®Strata	  the	  majority	  of	  cells	  appear	  to	  be	  (-­‐)	  
Annexin	  V/(-­‐)	  7-­‐AAD.	  This	  is	  consistent	  with	  H&E	  staining	  showing	  healthy	  and	  viable	  cells.	  After	  7	  
days	   culture,	   a	   slight	   shift	  occurs	   towards	   (+)	  Annexin	  V/(-­‐)	   7-­‐AAD	  and	   (+)	  Annexin	  V/(+)	  7-­‐AAD	  
cells.	   At	   day	   14,	   most	   of	   the	   extracted	   cells	   are	   (+)	   Annexin	   V/(+)	   7-­‐AAD,	   consistent	   with	   the	  
substantial	  cell	  necrosis	  observed	  in	  the	  H&E	  staining.	  	  
	  
	  
Figure	   3.45	   Flow	   cytometric	   analysis	   of	   HepG2	   cells	   extracted	   from	   Alvetex®Strata	   obtained	   using	   the	  
Guava	  Nexin®	  reagent.	  (A):	  Day	  2	  data	  showing	  the	  majority	  of	  cells	  to	  be	  (-­‐)	  Annexin	  V	  and	  (-­‐)	  7-­‐AAD.	  (B):	  
Day	   7	   data	   showing	   a	   slight	   shift	   towards	   (+)	   Annexin	   V	   and	   (+)	   7-­‐AAD.	   (C):	   Day	   14	   data	   showing	   the	  
majority	  of	  cells	  to	  be	  (+)	  Annexin	  V	  and	  (+)	  7-­‐AAD.	  
Quantification	  of	   the	   flow	  cytometry	  data	   is	  shown	   in	  Figure	  3.46.	  A	  comparison	  with	  extracted	  
cells	  taken	  from	  submerged	  cultures	  is	  made	  to	  help	  normalise	  the	  severity	  of	  necrosis	  occurring	  
in	  contact	  cultures.	  As	  expected,	  a	  steep	  drop	  in	  cell	  viability	  and	  increase	  in	  necrosis	  is	  observed	  
for	   contact	   cultures	   as	   time	   progresses.	   This	   is	   consistent	   with	   previous	   histology	   images.	  
Submerged	  cultures	  show	  less	  of	  a	  decline	  in	  cell	  viability,	  although	  this	  does	  still	  drop,	  with	  more	  
cells	  becoming	  apoptotic	  or	  necrotic.	  	  
	  	   119	  
	  
Figure	  3.46	  Quantifying	  flow	  cytometry	  data	  for	  HepG2	  cells	  extracted	  from	  Alvetex®Strata	  and	  analysed	  
using	  the	  Guava	  Nexin®	  reagent.	  (A):	  %	  viable	  cells.	  A	  significant	  decrease	  in	  HepG2	  viability	  is	  observed	  for	  
contact	   cultures	   compared	   to	   submerged	   cultures	   across	   the	   culture	   period.	   (B):	  %	   early	   apoptotic	   cells.	  
Interestingly	   submerged	   cultures	   show	   an	   increase	   in	   apoptosis	   as	   the	   culture	   period	   progress.	   (C):	   %	  
necrotic	   cells.	   A	   significant	   increase	   in	   necrotic	   cells	   is	   observed	   for	   contact	   cultures	   compared	   to	  
submerged	  cultures.	  (D):	  Number	  of	  intact	  cells	  extracted	  from	  Alvetex®Strata	  at	  different	  time	  points.	  Data	  
represent	  mean	  ±	  s.e.m.	  (n=2-­‐9).	  *	  denotes	  p<0.005	  as	  determined	  by	  the	  Student’s	  t-­‐test.	  
	  
In	   addition	   to	   flow	   cytometric	   analysis,	   the	   extracted	   cells	   were	   also	   re-­‐seeded	   on	   new	  
Alvetex®Strata	  membranes	  for	  subsequent	  culture	  (3D	  passaging).	  HepG2	  cells	  were	  first	  cultured	  
on	  Alvetex®Strata	   for	  7	  days	  using	  the	   insert/6-­‐well	  plate/contact	   format.	  After	   this	  period	  cells	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were	   extracted	   and	   re-­‐seeded	   onto	   fresh	  Alvetex®Strata	   and	   cultured	   for	   an	   additional	   4	   days.	  
The	  growth	  of	  these	  3D-­‐passaged	  cells	  was	  compared	  against	  cells	  with	  a	  2D	  pre-­‐culture	  history,	  
as	  shown	  in	  Figure	  3.47.	  Cells	  with	  a	  2D	  history	  were	  found	  to	  grow	  in	  the	  familiar	  homogeneous	  
manner	   to	   form	   a	   tissue-­‐structure	   near	   the	   top	   portion	   of	   the	   scaffold.	   Some	   cells	   actually	  
penetrated	   into	   the	  material.	   Conversely	   those	   cells	   with	   an	   Alvetex®Strata	   pre-­‐culture	   history	  
were	  found	  to	  grow	  in	  tightly	  packed	  aggregates,	  with	  very	  few	  cells	  entering	  the	  scaffold.	  These	  
data	  suggest	  that	  3D	  pre-­‐culture	  may	  have	  an	  important	  effect	  on	  programing	  cell	  structure	  and	  
growth	  characteristics	  in	  subsequent	  experiments.	  	  
	  
	  
Figure	  3.47	  The	  impact	  of	  2D	  and	  3D	  pre-­‐culture	  on	  HepG2	  growth	  on	  top	  of	  Alvetex®Strata.	  HepG2	  cells	  
were	  either	  pre-­‐cultured	  in	  T75	  flasks	  (2D)	  or	  Alvetex®Strata.	  Cells	  were	  then	  extracted	  and	  re-­‐seeded	  onto	  
new	  Alvetex®Strata	   and	   cultured	   for	   4	   days.	   (A):	  Growth	   after	   2D	  pre-­‐culture	   showing	   cells	   growing	   in	   a	  
homogeneous	  manner	  near	  the	  top	  portion	  of	   the	  membrane,	  with	  some	  cells	  entering	  the	  material.	   (B):	  
Growth	   after	   Alvetex®Strata	   pre-­‐culture	   showing	   cells	   have	   aggregated	   together	   and	   not	   entered	   the	  
membrane.	  Scale	  bars	  =	  50	  µm.	  	  
In	   summary,	   this	   section	   has	   shown	   that	   the	   majority	   of	   HepG2	   cells	   growing	   on	   top	   of	  
Alvetex®Strata	   can	   be	   extracted.	   These	   cells	   can	   be	   used	   for	   subsequent	   analysis,	   such	   as	  
determining	  cell	  viability	  using	  flow	  cytometry.	  Most	  of	  the	  cells	  extracted	  are	  viable	  up	  to	  7	  days	  
culture,	  whereby	  a	  noticeable	  increase	  in	  necrotic	  cells	  is	  observed.	  In	  comparison,	  extracted	  cells	  
from	  submerged	  cultures	  remain	  viable	  for	  longer.	  Finally,	  extracted	  cells	  can	  be	  re-­‐seeded	  onto	  
new	  Alvetex®Strata	  membranes	  and	  used	   for	  3D	  passaging.	  The	  growth	  profiles	  of	   cells	   coming	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3.4 Discussion	  
Replicating	  native	   tissue	  density	   and	  architecture	   in	   vitro	   is	   expected	   to	   improve	   the	  predictive	  
accuracy	   of	   in	   vitro	   models.	   Consequently	   many	   groups	   are	   assessing	   the	   growth	   of	   cells	   in	  
different	  3D	  technologies	  in	  an	  attempt	  to	  re-­‐create	  in	  vivo	  growth	  patterns	  (see	  Chapter	  1	  for	  a	  
review	   of	   different	   3D	   technologies).	   For	   example,	   MacNeil	   et	   al.	   have	   explored	   electrospun	  
scaffolds	  to	  approximate	  native	  geometries	  and	  cell-­‐cell	  interactions	  in	  vitro103.	  Other	  groups	  have	  
explored	   protein	   hydrogels	   to	   mimic	   native	   3D	   cell-­‐ECM	   interactions189.	   This	   study	   aimed	   to	  
understand	   if	   emulsion	   templated	   polystyrene	   scaffolds	   could	   re-­‐create	   native	   liver	   tissue	  
architecture	  and	  density	  by	  exploring	  hepatocyte	  growth	  under	  different	  culture	  conditions	  and	  
scaffold	   presentations.	   It	   also	   aimed	   to	   optimise	   the	   scaffold	   microenvironment	   through	   ECM	  
coatings	   and	   media	   perfusion,	   as	   well	   as	   exploring	   new	   avenues	   to	   extract	   intact	   cells	   for	  
subsequent	  analysis.	  
	  
Prior	   to	   the	   growth	   assessment	   in	   polystyrene	   scaffolds,	   hepatocytes	  were	   first	   cultured	   in	   2D.	  
Under	   conventional	   2D	   culture	   conditions,	   all	   three	   hepatocyte	   sources	   employed	   in	   this	   study	  
displayed	   a	   severely	   flattened	   morphology	   towards	   a	   monolayer,	   consistent	   with	   previous	  
literature	   reports	   using	   2D	   substrates76,	  166.	   Indeed,	   the	  diameter	   of	   hepatocytes	   cultured	   in	   2D	  
was	  found	  to	  be	  much	  greater	  than	  hepatocytes	  in	  vivo,	  supporting	  existing	  literature	  that	  cells	  in	  
2D	  spread	  out	  into	  unrealistic	  geometries.	  Moreover,	  the	  majority	  of	  the	  cell	  surface	  was	  found	  to	  
be	   in	  contact	  with	  either	  2D	  plastic	  or	   the	  culture	  media,	  with	  only	  a	  small	  portion	  coming	   into	  
contact	  with	   other	   cells.	   As	   described	   in	   Chapter	   1,	   this	   limited	   cell-­‐cell	   contact	   is	   far	   removed	  
from	  the	  complex	  3D	  interactions	  found	  in	  vivo	  that	  govern	  tissue	  homeostasis190.	  Indeed,	  in	  vivo	  
human	   liver	   tissue	   was	   densely	   packed	   with	   cells	   with	   extensive	   opportunity	   for	   cell-­‐cell	  
interaction	  in	  multiple	  directions.	  
	  
To	  explore	  hepatocyte	  growth	  in	  polystyrene	  scaffolds,	  Alvetex®Scaffold	  and	  Alvetex®Strata	  were	  
employed.	   Characterisation	   of	   these	  materials	   confirmed	   that	   Alvetex®Scaffold	   has	   an	   average	  
void	  diameter	  of	  ca.	  42	  µm,	  whereas	  Alvetex®Scaffold	  has	  an	  average	  void	  diameter	  of	  ca.	  12	  µm.	  
Both	  materials	  display	  porosities	  of	  ca.	  90	  %.	  
	  
HepG2	   cells	   entered	   the	   top	   portion	   of	   Alvetex®Scaffold	   and	   adhered	   without	   issue.	   It	   is	  
hypothesised	   that	   the	   adherence	   mechanism	   is	   similar	   to	   that	   for	   2D	   polystyrene,	   where	  
glycoproteins	   such	   as	   fibronectin	   (from	   serum	   or	   the	   cells	   themselves)	   first	   adsorb	   onto	   the	  
polystyrene	  to	  facilitate	  cell	  attachment168.	  Once	  adhered,	  cells	  on	  Alvetex®Scaffold	  adopted	  a	  cell	  
diameter	   much	   closer	   to	   that	   of	   the	   in	   vivo	   scenario.	   This	   is	   consistent	   with	   previous	   reports	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demonstrating	   that	   hepatocytes	   adopt	   a	   more	   natural	   3D	   morphology	   in	   emulsion	   templated	  
scaffolds	  compared	  to	  2D	  substrates159.	  
	  
The	   presentation	   of	   Alvetex®Scaffold	   was	   found	   to	   influence	   HepG2	   growth	   in	   the	   material.	  
Submerged	   insert	   cultures	   encouraged	   cells	   to	   migrate	   and	   proliferate	   into	   the	   scaffold	   to	  
produce	  multidirectional	  3D	  growth	  similar	  to	  in	  vivo,	  although	  dense	  in	  vivo	  like	  packing	  was	  not	  
observed.	  Importantly,	  no	  signs	  of	  necrosis	  were	  observed	  even	  after	  14	  days,	  suggesting	  that	  the	  
porosity	  of	   the	   scaffold	   can	   support	  effective	  nutrient	   transfer	   to	   cells.	   This	  offers	  an	  attractive	  
advantage	   over	   many	   other	   3D	   cell	   culture	   substrates	   such	   as	   hydrogels,	   where	   poor	   media	  
diffusion	   can	   often	   restrict	   nutrient	   supply	   to	   cells	   growing	   in	   the	   centre	   of	   the	   substrate.	  
Conversely,	   the	   24-­‐well	   plate	   presentation	   did	   not	   encourage	   HepG2	   migration	   in	  
Alvetex®Scaffold	  and	  the	  growth	  profile	  of	  cells	  lacked	  the	  high	  density	  associated	  with	  in	  vivo.	  It	  
is	   hypothesised	   this	   is	   due	   to	   the	   lower	  media	   supply	   of	   a	   24-­‐well	   plate	   in	   comparison	   to	   the	  
insert	  presentation.	  Interestingly,	  contact	  insert	  cultures	  (air-­‐liquid	  interface)	  produced	  a	  densely	  
packed	  3D	  cell	  organisation	  within	  the	  material,	  almost	  entirely	  approximating	  in	  vivo	  density	  and	  
cell-­‐cell	  interaction.	  This	  is	  consistent	  with	  other	  reports	  that	  have	  employed	  hepatocyte	  air-­‐liquid	  
interface	   cultures	   and	   observed	   a	   similar	   tightly	   clustered	   3D	   cell	   organisation191,	   192.	   Indeed,	  
similar	   air-­‐liquid	   interface	   liver	   slice	   cultures	   have	   also	   been	   proposed	   as	   suitable	   in	   vitro	   liver	  
models	  for	  fibrosis193.	  The	  precise	  reason	  as	  to	  why	  cells	  pack	  tightly	  during	  contact	  (air-­‐interface)	  
cultures	   remains	   unknown,	   although	   it	   may	   be	   due	   to	   surface-­‐tension	   effects	   pulling	   cells	  
together	  and/or	  reducing	  cell	  loss	  from	  the	  insert	  during	  turbulent	  media	  changes.	  One	  advantage	  
of	   this	   dense	   growth	   behaviour	   is	   the	   opportunity	   for	   multicellular	   contact	   within	   the	  
microenvironment,	   re-­‐creating	   important	   cell-­‐cell	   and	   cell-­‐ECM	   communication	   present	   in	   vivo.	  
However	   a	  major	   disadvantage	   of	   contact	   cultures	   is	   the	   cell	   death	   that	   occurs	   for	   those	   cells	  
closest	  to	  the	  air	  interface	  after	  prolonged	  culture	  periods.	  	  
	  
Similar	   to	  HepG2	   cells,	   Upcyte®	   hepatocytes	   and	   primary	   rat	   hepatocytes	   also	   entered	   the	   top	  
portion	  of	  Alvetex®Scaffold	  and	  adhered.	  They	  also	  displayed	  a	  similar	  cell	  diameter	  to	  the	  in	  vivo	  
dimension.	   Upcyte®	   hepatocytes,	   having	   some	   proliferative	   capacity,	   seemed	   to	   remain	   viable	  
after	  21	  days	  culture	  and	  slowly	  migrated	  into	  the	  material	  to	  approximate	   in	  vivo	  cell	  density	  in	  
the	   top	   portion	   of	   the	   scaffold.	   Primary	   rat	   cells,	   having	   limited	   proliferative	   capacity	   did	   not	  
migrate	   into	   the	  material	   and	   remained	   in	   the	   top	  portion	  of	   the	   scaffold.	  Employing	  a	   contact	  
insert	  presentation	  formed	  an	  impressive	  densely	  packed	  growth	  profile	  of	  these	  cells,	  similar	  to	  
the	  profile	  of	  HepG2	  cells.	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HepG2	  cells	  adhered	  on	   top	  of	  Alvetex®Strata	  and	  did	  not	   initially	  enter	   the	   scaffold.	  A	  contact	  
insert	  scaffold	  presentation	  formed	  a	  dense	  tissue	  structure,	  consistent	  with	  other	  reports	  of	  air-­‐
liquid	   hepatocyte	   cultures191,	   192.	   As	   the	   culture	   period	   progressed	   the	   thickness	   of	   the	   tissue-­‐
structure	   increased,	  starting	  at	  ca.	  47	  µm	  (day	  2)	  and	  moving	  up	  to	  ca.	  180	  µm	  (day	  14).	  This	   is	  
highly	  advantageous	  in	  replicating	  native	  liver	  tissue	  density	  and	  organisation,	  particularly	  as	  this	  
culture	   condition	   is	   essentially	   scaffold-­‐less.	  However,	   a	   significant	   amount	   of	   cell	   necrosis	  was	  
observed	   in	   the	   top	  portion	  of	   the	   tissue-­‐structure	  after	  prolonged	  culture,	   likely	  due	   to	  media	  
starvation.	   Attempts	   to	   prevent	   this	   cell	   necrosis	   were	   unsuccessful.	   It	   was	   hypothesised	   that	  
reducing	  the	  membrane	  thickness	  of	  the	  scaffold	  would	  increase	  media	  access	  to	  cells,	  however	  
significant	   cell	   necrosis	  was	   still	   observed	   even	   on	  membranes	   as	   thin	   as	   60	  µm.	  Alternatively,	  
employing	   insert	   submerged	   cultures	  did	  enable	  healthy	   cell	   growth,	  but	   completely	  prevented	  
the	   formation	  of	   a	   tissue-­‐structure	   on	   top	  of	   the	  membrane.	   Indeed,	   after	   14	   days	   culture	   the	  
thickness	  of	  the	  cell	  population	  was	  still	  only	  ca.	  41	  µm,	  in	  comparison	  to	  ca.	  180	  µm	  for	  contact	  
cultures.	   It	   is	  postulated	  that	  submerged	  cultures	   lack	  sufficient	  surface	  tension	  to	  densely	  pack	  
the	  cells	  and	  make	  cells	  growing	  on	  top	  of	   the	  scaffold	  more	  susceptible	  to	  being	  washed	  away	  
during	  media	  changes.	  The	  ‘’washing	  away’’	  effect	  was	  supported	  by	  observing	  significantly	  more	  
cells	  outside	  of	  the	  insert	  for	  submerged	  cultures	  compared	  to	  contact	  cultures.	  
	  
The	  hepatic	   ECM	  plays	   a	   crucial	   role	   in	  maintaining	  normal	   hepatocyte	   survival	   and	   function	   in	  
vivo14.	   Extensive	   reports	   have	   therefore	   employed	   hepatic	   ECM	   components	   for	   in	   vitro	  
hepatocyte	  culture.	  For	  example,	  2D	  plastic	  coated	  with	  fibronectin	  has	  been	  shown	  to	  increase	  
hepatocyte	  adhesion	  and	  spreading194,	  195.	  Sandwich	  cultures	  derived	  from	  collagen,	  fibronectin	  or	  
Matrigel™	   have	   been	   shown	   to	   prolong	   hepatocyte	   viability,	   cytochrome	   P450	   activity	   and	   cell	  
polarisation76,	  79,	  80.	  Similarly	  there	  have	  been	  numerous	  reports	  describing	  the	  use	  of	  ECM-­‐based	  
hydrogels	  for	  3D	  hepatocyte	  culture91.	  	  
In	   this	   study,	   Alvetex®Scaffold	   was	   coated	   with	   fibronectin	   and	   collagen	   I	   in	   an	   attempt	   to	  
improve	  the	  biological	  relevance	  of	  the	  scaffold	  to	  promote	  cell	  adhesion	  and	  function	  via	  offering	  
native	   ECM	   mimics.	   Fibronectin	   coatings	   deposited	   thin	   films	   or	   spindles	   of	   protein	   on	   the	  
scaffold.	   Generally	   an	   increase	   in	   protein	   coating	   concentration	   resulted	   in	   an	   increase	   in	  
fibronectin	   deposition.	   A	   solution	   concentration	   of	   1000	   µg/mL	   was	   therefore	   selected	   as	  
optimum.	  Conversely	  collagen	  I	  coating	  solutions	  deposited	  more	  granular-­‐type	  structures	  on	  the	  
walls	   of	   the	   scaffold.	   Furthermore,	   increasing	   the	   concentration	   of	   coating	   solution	   did	   not	  
proportionally	   increase	   the	   amount	   of	   collagen	   I	   deposited	   on	   the	   scaffold.	   Consequently	   a	  
solution	  of	  50	  µg/mL	  was	  chosen	  as	  optimum.	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Culturing	  HepG2	  cells	  on	  collagen	  I	  coated	  Alvetex®Scaffolds	  improved	  migration	  into	  the	  scaffold,	  
suggesting	   opportunity	   to	   form	   extensive	   3D	   constructs	   or	   suitability	   for	   liver	   cancer	  migration	  
assays.	  Migration	  was	  more	  profound	  for	   insert/submerged	  cultures	  compared	  to	  insert/contact	  
and	  24	  welled-­‐plate	  cultures.	  On	  the	  contrary,	  fibronectin	  coatings	  had	  only	  a	  slight	  impact	  on	  cell	  
migration	   and	   proliferation	   compared	   to	   uncoated	   scaffolds.	   However,	   fibronectin	   did	   increase	  
the	  initial	  total	  metabolic	  activity	  of	  the	  cells	  (day	  2),	  suggesting	  that	  fibronectin	  may	  be	  involved	  
in	  specific	  functional	  pathways	  during	  the	  3D	  adhesion	  period.	  	  
	  
Media	  perfusion	  through	  an	  emulsion	  templated	  polystyrene	  scaffold	  combines	  a	  more	  suitable	  
physical	  environment	  with	  a	  more	  representative	  media	  supply	  that	  potentially	  mimics	  aspects	  of	  
native	   liver	   vascularisation.	   In	   this	   study,	   a	   media	   perfusion	   system	   was	   developed	   for	  
Alvetex®Scaffold	   using	   the	   Reinnervate	   Perfusion	   Plate.	   Several	   practical	   challenges	   were	  
overcome	  during	  the	  development	  of	  the	  perfusion	  system,	  including	  media	  leakages,	  flow	  issues	  
and	   tubing	   slippage	   issues.	   Once	   the	   issues	   were	   rectified,	   the	   perfusion	   system	   showed	  
enhanced	  metabolic	  activity	  of	  Upcyte®	  cells	  after	  7	  days	  culture	  and	  enhanced	  metabolic	  activity	  
of	  primary	  rat	  hepatocytes	  after	  3	  days	  culture	  compared	  to	  static	  3D	  cultures.	  This	  is	  consistent	  
with	  other	  perfusion	  models	  reported	  in	  the	  literature	  (see	  section	  3.1.6).	  In	  addition,	  preliminary	  
experiments	  with	  Alvetex®Scaffold	  and	  the	  commercial	  Quasi-­‐Vivo®	  perfusion	  kit	  (Kirkstall)	  were	  
performed	  alongside	  this	  study	  by	  the	  Reinnervate	  development	  team	  (Dr.	  Frederique	  Tholozan)	  
and	  observed	  similar	  results	  (data	  not	  yet	  published).	  That	  study	  also	  observed	  that	  Upcyte®	  cells	  
were	  more	  viable	  after	  7	  days	  culture	  in	  the	  Quasi-­‐Vivo®	  system	  compared	  to	  static	  3D	  cultures.	  
	  
One	  of	   the	   limitations	  of	  3D	   cell	   culture	   substrates	  may	  be	   the	  difficulty	   in	  extracting	   the	   cells.	  
Cells	  that	  are	  densely	  packed	  into	  a	  3D	  structure	  will	  secrete	  their	  own	  ECM	  to	  anchor	  themselves	  
to	  one	  another	  and	  to	  the	  3D	  substrate.	  In	  addition,	  most	  3D	  substrates	  cannot	  be	  easily	  opened	  
or	   disrupted,	   especially	   chemically	   cross-­‐linked	   hydrogels,	   electrospun	   fibres	   and	   polymeric	  
scaffolds.	  As	  a	  result,	   the	  short	   incubation	  times	  with	  proteases	  such	  as	  trypsin-­‐EDTA	  that	  were	  
suitable	  for	  retrieving	  cells	  from	  2D	  cultures	  are	  much	  less	  effective	  in	  3D.	  
Whilst	   full	   cell	   retrieval	   may	   not	   be	   an	   issue	   for	   tissue	   engineering	   or	   regenerative	   medicine	  
applications,	  where	  the	  biodegradable	  material	   is	   intended	  to	  be	   implanted	   into	  the	  body	  along	  
with	   the	   cells,	   it	   does	   pose	   an	   issue	   for	   in	   vitro	   cell	   culture	   applications.	   Not	   being	   able	   to	  
continually	  passage	  proliferative	  cells	   in	  3D	   is	  a	  major	  challenge,	   in	   that	  cells	   stocks	  need	   to	  be	  
pre-­‐cultured	   in	   2D	   before	   being	   applied	   to	   3D	   experiments.	   Similarly	   many	   in	   vitro	   biological	  
techniques	   require	   cells	   to	   be	   extracted	   from	   the	   substrate,	   including	   flow	   cytometry	   or	   using	  
transfection	  kits.	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Growing	  cells	  on	  top	  of	  Alvetex®Strata	  was	  found	  to	  be	  a	  highly	  effective	  route	  to	  extracting	  intact	  
hepatocytes.	  Applying	  a	  Trypsin-­‐EDTA	  incubation	  followed	  by	  cell	  scraping	  was	  found	  to	  retrieve	  
most	  cells,	  particularly	  for	  up	  to	  7	  days	  culture.	   Importantly,	  the	  extracted	  cells	  were	  viable	  and	  
could	  be	  subsequently	  cultured	  on	  fresh	  Alvetex®Strata	  membranes,	  offering	  one	  of	  the	  first	  tools	  
to	   enable	   3D-­‐3D	   passaging.	   Once	   more,	   extracted	   cells	   could	   also	   be	   analysed	   using	   flow	  
cytometry.	   This	  method	   allowed	   confirmation	   of	   cell	   viability	   differences	   between	   contact	   and	  
submerged	  cultures	  using	  the	  Guava	  Nexin®	  reagent.	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3.5 Conclusions	  
The	  following	  conclusions	  can	  be	  made	  from	  the	  results	  of	  this	  Chapter:	  
	  
• Hepatocytes	   in	   vivo	   are	   densely	   packed	   and	   experience	   cell-­‐cell	   contact	   in	   multiple	  
directions.	  
	  
• When	   grown	   on	   2D	   plastic,	   HepG2	   cells,	   Upcyte®	   hepatocytes	   and	   primary	   rat	  
hepatocytes	   spread	   out	   and	   flatten,	   severely	   deviating	   from	   their	   native	   geometry	   and	  
architecture.	  Note	  that	  Chapter	  4	  probes	  in	  more	  detail	  into	  the	  structural	  consequences	  
of	  2D	  and	  3D	  cell	  culture.	  	  
	  
• Hepatocytes	  cultured	  on	  emulsion	  templated	  polystyrene	  scaffolds	  can	  adhere	  onto	  the	  
scaffold	  and	  penetrate	   into	   the	  voids	  of	   the	   scaffold	   to	   form	  a	  3D	  cell	   shape	   that	  more	  
closely	   resembles	   in	   vivo.	   Furthermore,	   hepatocytes	   can	   remain	   viable	   for	   prolonged	  
periods	  and	  can	  approximate	  native	  liver	  tissue	  density	  and	  cellular	  interaction.	  
	  
• The	  presentation	  of	  Alvetex®Scaffold	  impacts	  HepG2	  growth	  characteristics	  and	  viability.	  
Scaffold	  insert	  cultures	  encourage	  cell	  migration	  into	  the	  scaffold,	  whereas	  scaffold	  plate	  
cultures	  do	  not.	  Submerging	  scaffold	  inserts	  in	  culture	  media	  leads	  to	  healthy	  hepatocyte	  
growth	   throughout	   the	   culture	   period.	   Conversely,	   only	   supplying	   culture	   media	   from	  
below	  the	  insert	  leads	  to	  densely	  packed	  cell	  growth,	  but	  with	  signs	  of	  cell	  necrosis	  near	  
the	  air-­‐liquid	  interface.	  
	  
• Hepatocytes	  cultured	  on	  Alvetex®Strata	  have	  a	  tendency	  to	  grow	  on	  top	  of	  the	  scaffold	  to	  
re-­‐create	  a	  thick	  tissue	  mass	  very	  similar	  to	  native	   liver	   in	  terms	  of	  cell	  density	  and	  cell-­‐
cell	  contact.	  Supplying	  media	  from	  underneath	  Alvetex®Strata	  inserts	  lead	  to	  thick	  tissue-­‐
like	  structures	   that	  build	  up	  on	   top	  of	   the	  scaffold.	  However,	   substantial	   cell	  necrosis	   is	  
observed	  in	  this	  tissue-­‐structure	  for	  those	  cells	  close	  to	  the	  air-­‐liquid	  interface.	  Employing	  
thinner	   scaffold	   membranes	   still	   encourages	   tissue-­‐structures	   to	   grow	   on	   top	   of	   the	  
scaffold,	   but	   does	   little	   to	   prevent	   cell	   necrosis.	   Employing	   submerged	   cultures	   with	  
Alvetex®Strata	   does	   not	   enable	   the	   formation	   of	   extensive	   cell	   growth	   on	   top	   of	   the	  
scaffold.	  It	  is	  therefore	  hypothesised	  that	  surface	  tension	  and/or	  a	  lack	  of	  turbulent	  media	  
supply	  is	  required	  to	  form	  thick	  tissue-­‐like	  structures	  on	  top	  of	  Alvetex®Strata.	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• Alvetex®Scaffold	  can	  be	  coated	  with	  collagen	  I	  or	  fibronectin	  to	  increase	  the	  biochemical	  
relevance	   of	   the	   scaffold.	   Collagen	   I	   coatings	   increase	   HepG2	   migration	   into	  
Alvetex®Scaffold	   throughout	   the	   culture	   period.	   Fibronectin	   coatings	   do	   little	   to	   help	  
HepG2	  migration,	   however	   preliminary	   evidence	   suggests	   that	   fibronectin	  may	   help	   to	  
increase	  the	  metabolic	  activity	  of	  the	  cells	  during	  the	  early	  stages	  of	  the	  culture	  period.	  
	  
• A	   3D	  media	   perfusion	  model	   that	   re-­‐creates	   aspects	   of	   native	   liver	   vascularisation	   has	  
been	   developed	   with	   polystyrene	   scaffolds.	   Preliminary	   results	   suggests	   this	   perfusion	  
model	  may	  hep	  to	  enhance	  viability	  of	  Upcyte®	  cells	  and	  primary	  rat	  hepatocytes	  growing	  
in	  scaffolds.	  
	  
• Intact	  healthy	  hepatocytes	  can	  be	  extracted	  from	  Alvetex®Strata.	  These	  can	  be	  used	  for	  




































Chapter	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4.1 Introduction	  
4.1.1 Overview	  
Chapter	  3	  introduced	  emulsion	  templated	  polystyrene	  scaffolds	  and	  assessed	  hepatocyte	  growth	  
in	   these	   materials	   under	   different	   culture	   conditions.	   This	   Chapter	   probes	   in	   more	   detail	   the	  
structural,	   functional	   and	   genetic	   consequences	   of	   culturing	   hepatocytes	   in	   these	   scaffolds.	   A	  
comparison	  with	  conventional	  2D	  hepatocyte	  culture	   is	  made,	  along	  with	  an	   in	  vivo	  comparison	  
where	  possible.	  	  
	  
4.1.2 Previous	  Reports	  on	  Hepatocyte	  Structure,	  Function	  and	  Gene	  Expression	  in	  
Emulsion	  Templated	  Polystyrene	  Scaffolds	  	  
Przyborski	  and	  Cameron	  had	  previously	  published	  two	  reports	  on	  HepG2	  structure	  and	  function	  in	  
emulsion	   templated	   polystyrene	   scaffolds150,	   151.	   These	   reports	   showed	   that	   HepG2	   cells	   in	  
scaffolds	  displayed	  a	  higher	  level	  of	  albumin	  synthesis	  compared	  to	  2D	  HepG2	  cultures.	  They	  also	  
showed	   that	   HepG2	   cells	   cultured	   in	   scaffolds	   displayed	   increased	   resistance	   to	   the	   drug	  
methotrexate	  compared	  to	  2D,	  suggesting	  a	  more	  drug-­‐resistant	  cancerous	  cell	  line	  is	  established	  
in	  the	  3D	  microenvironment.	  These	  reports	  also	  featured	  some	  preliminary	  ultrastructural	  images	  
of	   HepG2	   cells	   in	   scaffolds;	   showing	   the	   formation	   of	   bile	   canaliculi	   and	   the	   presence	   of	   some	  
surface	  microvilli.	  However,	  these	  reports	  only	  provide	  an	   initial	   insight	   into	  some	  of	  the	  critical	  
questions	  regarding	  HepG2	  structure,	  function	  and	  gene	  expression	  in	  polystyrene	  scaffolds.	  For	  
example,	   cell	   morphology	   had	   not	   been	   fully	   compared	   between	   2D	   and	   3D	   using	   advanced	  
techniques	  such	  as	  confocal	  immunofluorescence.	  Similarly	  a	  detailed	  ultrastructural	  comparison	  
with	   2D	   cultures	   and	   in	   vivo	   tissue	   had	   not	   been	   performed.	  Moreover,	   the	   toxicity	   profiles	   of	  
other	  drugs	  and	  gene	  expression	  differences	  with	  2D	  had	  also	  not	  been	  explored	  for	  HepG2	  cells.	  
Only	  one	  report	  has	  described	  the	  culture	  of	  Upcyte®	  hepatocytes	  in	  polystyrene	  scaffolds188.	  This	  
report	   showed	   that	   cytochrome	   P450	   activity	   was	   enhanced	   for	   the	   cells	   when	   cultured	   in	  
scaffolds	   compared	   to	   2D.	   However,	   no	   indication	   of	   cell	   morphology,	   structure	   and	   gene	  
expression	   was	   described.	   Similarly,	   only	   one	   reported	   described	   the	   culture	   of	   primary	   rat	  
hepatocytes	   in	   polystyrene	   scaffolds159.	   This	   report	   demonstrated	   that	   cells	   in	   the	   scaffold	  
adopted	   a	   more	   rounded	   morphology	   compared	   to	   2D	   culture.	   They	   also	   showed	   increased	  
cytochrome	  P450	  activity	  and	  increased	  sensitivity	  to	  the	  drug	  acetaminophen	  (APAP).	  However,	  
no	  reports	  had	  described	  primary	  rat	  ultrastructure	  in	  scaffolds,	  nor	  had	  they	  investigated	  typical	  
primary	  hepatocyte	  functions	  such	  as	  albumin	  synthesis	  or	  urea	  conversion.	  Table	  4-­‐1	  summarises	  
the	  known	  and	  unknown	  pieces	  of	  data	  for	  hepatocytes	  cultured	  in	  polystyrene	  scaffolds	  prior	  to	  
starting	   this	   study.	   Accordingly,	   this	   study	   attempted	   to	   address	   some	   of	   these	   unknown	   data	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points	  to	  develop	  a	  more	  comprehensive	  understanding	  of	  how	  3D	  scaffold	  cultures	  compare	  to	  
2D	  cultures	  and	  in	  vivo	  liver	  tissue.	  
	  
Table	  4-­‐1	  Summary	  of	  Hepatocyte	  Data	  Previously	  Reported	  for	  Polystyrene	  Scaffolds	  
	  
4.1.3 Acetaminophen	  and	  Gemfibrozil	  Metabolism	  
Understanding	  if	  hepatocytes	  cultured	  in	  scaffolds	  display	  a	  more	  realistic	  metabolism	  of	  drugs	  is	  
a	  key	  part	  of	  this	  study.	  Two	  model	  drugs	  were	  chosen	  to	  probe	  this;	  acetaminophen	  (APAP)	  and	  
Gemfibrozil.	   APAP	   (paracetamol)	   is	   a	   common	   mild	   analgesic	   often	   used	   for	   hepatotoxicity	  
studies.	  It	  is	  metabolised	  by	  the	  UGT	  and	  SULT	  enzyme	  families	  into	  polar,	  non-­‐toxic	  compounds	  
that	  are	  transported	  to	  the	  kidneys	  and	  subsequently	  excreted	  from	  the	  body.	  However,	  APAP	  is	  
also	  metabolised	  by	  the	  cytochrome	  P450	  enzymes	  into	  a	  minor	  but	  toxic	  metabolite	  known	  as	  N-­‐
acetyl-­‐p-­‐benzo-­‐quinone	   imine	   (NAPQI).	  Under	   therapeutic	   doses	  of	  APAP,	   any	  NAPQI	   formed	   is	  
quickly	   detoxified	   by	   a	   coupling	   reaction	  with	   glutathione	   via	   the	  GST	   enzymes.	  However,	  with	  
overdose	  levels	  of	  APAP,	  glutathione	  stores	  are	  eventually	  depleted	  allowing	  a	  build	  up	  of	  NAPQI	  
and	   thus	   cellular	   toxicity	   (Figure	   4.1).	   Importantly,	   many	   in	   vitro	   hepatocyte	   models	   fail	   to	  
replicate	  the	  suitable	  enzyme	  levels	  required	  for	  native	  (predictive)	  APAP	  metabolism.	  
	  
	  
	   HepG2	   Upcyte®	  Hepatocytes	   Primary	  Rat	  Hepatocytes	  
Cell	  morphology	  	   Unknown	   Unknown	  
Scaffold	  produces	  a	  
more	  rounded	  cell	  
shape159	  
Cell	  ultrastructure	  
Key	  organelles	  are	  
present.	  Some	  bile	  
canaliculi	  are	  observed150,	  
151	  
Unknown	   Unknown	  
Albumin	  synthesis	   Increased	  vs.	  2D150,	  151	   Unknown	   Unknown	  
Urea	  synthesis	   N/A	   Unknown	   Unknown	  
Drug	  toxicity	   Increased	  resistance	  to	  methotrexate	  vs.	  2D151	  
Increased	  CYP	  activity	  
vs.	  2D188	  
Increased	  sensitivity	  to	  
acetaminophen	  vs.	  
2D159	  Increased	  CYP	  
activity	  vs.	  2D159	  
Gene	  expression	   Unknown	   Unknown	   Increased	  vs.	  2D	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Figure	  4.1	  APAP	  metabolism	  by	  the	  hepatic	  drug	  metabolising	  enzymes.	  APAP	  is	  metabolised	  by	  the	  UGT	  
or	   SULT	   enzymes	   into	   polar	   non-­‐toxic	   compounds	   that	   are	   excreted	   from	   the	   body.	   APAP	   is	   also	  
metabolised	  by	  the	  cytochrome	  P450	  enzymes	  into	  the	  toxic	  intermediate	  NAPQI.	  At	  therapeutic	  doses	  of	  
APAP,	   NAPQI	   is	   detoxified	   by	   glutathione	   conjugation.	   However,	   once	   cellular	   glutathione	   is	   depleted	  
(overdose	  conditions),	  NAPQI	  can	  build	  up	  within	  cells	  and	  cause	  cellular	  toxicity.	  
Gemfibrozil	   is	  a	  common	  lipid-­‐lowering	  drug	  and	  is	  also	  metabolised	  by	  hepatocytes	  in	  the	  liver.	  
The	  drug	  is	  first	  metabolised	  by	  the	  UGT	  enzymes	  to	  form	  Gemfibrozil	  1-­‐O-­‐β-­‐glucuronide196.	  This	  
metabolite	   can	   then	   undergo	   oxidation	   with	   the	   cytochrome	   P450	   enzymes	   to	   form	  
hydrodroxylated	  Gemfibrozil	  1-­‐O-­‐β-­‐glucuronide.	  
	  
4.1.4 Probing	  Structure,	  Function	  and	  Gene	  Expression	  in	  3D	  
Materials	   that	   offer	   a	   3D	   interface	   for	   cell	   growth	   must	   still	   allow	   researchers	   to	   obtain	  
information	  about	  the	  biological	  status	  of	   the	  cells	  during	  and	  after	   the	  growth	  period.	  There	   is	  
little	   point	   culturing	   in	   3D	   if	   a	   researcher	   cannot	   ‘talk’	   or	   ‘listen’	   to	   cells	   in	   that	   environment.	  
Being	   able	   to	   image	   cells,	   examine	   their	   cell	   structure,	   assess	   function	   and	   quantify	   gene	  
expression	  are	  just	  some	  of	  the	  crucial	  needs	  of	  researchers	  working	  in	  the	  field	  of	  3D	  hepatocyte	  
models	  for	  drug	  discovery	  applications.	  However,	  this	  is	  not	  entirely	  straightforward;	  
	  
• Imaging	  cells	   in	  3D	   is	  difficult.	  3D	  cultures	  approximate	   the	  complexity	  and	  structure	  of	  
native	   tissue,	   creating	   issues	   with	   light	   scattering	   and	   thus	   preventing	   clear,	   crisp	   cell-­‐
imaging.	  Furthermore,	  many	  scaffolds	  are	  not	  transparent,	  which	  again	   limits	  the	  use	  of	  
conventional	  bright	  field	  microscopes	  for	  direct	  live-­‐cell	  imaging.	  	  
	  
• Comparing	  functional	  data	  between	  2D	  and	  3D	  requires	  some	  form	  of	  normalisation	  due	  
to	   differences	   in	   cell	   adhesion,	   proliferation	   and	   viability.	   Normalisation	   against	   cell	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number,	  protein	  content	  or	  DNA	  then	  requires	  extensive	  method	  development	  to	  ensure	  
all	  appropriate	  biological	  material	  is	  extracted	  from	  the	  3D	  scaffold	  to	  ensure	  a	  fair	  test.	  
Due	   to	   the	   challenges	   above,	   a	   significant	   proportion	   of	   this	   thesis	   involved	   method/protocol	  
development	  in	  order	  to	  effectively	  compare	  2D,	  3D	  and	  in	  vivo	  hepatocyte	  behaviour.	  Outcomes	  
of	   these	   method	   developments	   formed	   part	   of	   the	   commercial	   protocols	   associated	   with	  
Alvetrex®Scaffold,	   currently	   available	   on	   the	   Reinnervate	   website	  
(http://reinnervate.com/science-­‐technical-­‐resources/application-­‐notes/).	  
	   	  
	  	   133	  
4.2 Aims	  and	  Objectives	  
The	  overall	  aim	  of	  this	  Chapter	  was	  to	  assess	  the	  structural,	  functional	  and	  genetic	  consequences	  
of	   culturing	   hepatocytes	   in	   emulsion	   templated	   polystyrene	   scaffolds.	   Chapter	   3	   showed	   that	  
hepatocytes	  in	  emulsion	  templated	  polystyrene	  scaffolds	  could	  approximate	  native	  tissue	  density	  
and	   cell-­‐cell	   contact	   under	   specific	   culture	   conditions	   and	   scaffold	   presentations.	   This	   Chapter	  
therefore	   aimed	   to	   understand	   if	   the	   structure-­‐function-­‐genetic	   relationships	   of	   hepatocytes	   in	  
polystyrene	  scaffolds	  are	  more	  physiologically	  relevant.	  
	  
The	  main	  objectives	  are	  to:	  
	  
• Compare	   the	  morphology	   of	   individual	   hepatocyte	   cells	   cultured	   in	   scaffolds	   versus	   2D	  
using	  confocal	  immunofluorescence	  microscopy.	  
• Use	  SEM	  to	  obtain	  high	  resolution	  images	  of	  hepatocyte	  structure	  in	  scaffolds	  versus	  2D	  
versus	  in	  vivo	  mouse	  tissue.	  
• Probe	   hepatocyte	   ultrastructure	   (bile	   canaliculi,	   surface	   microvilli,	   tight	   junctions)	   in	  
scaffolds	   versus	   2D	   versus	   in	   vivo	   mouse	   tissue.	   Use	   confocal	   immunofluorescence	   to	  
target	  specific	  bile	  canaliculi	  markers.	  
• Compare	   hepatocyte	   function	   in	   scaffolds	   versus	   2D	   (under	   static	   media	   conditions).	  
Include	  specific	  hepatocyte	   functional	   tests	   (albumin	  synthesis,	  urea	  conversion)	  as	  well	  
as	  preliminary	  assessments	  of	  drug	  toxicity	  using	  APAP	  and	  Gemfibrozil.	  	  
• Compare	  hepatocyte	  function	  in	  scaffolds	  for	  static	  versus	  perfused	  media	  conditions.	  Use	  
CYP3A4	  activity	  as	  a	  representative	  measure	  of	  drug	  metabolism	  capacity.	  
• Assess	   the	   genetic	   differences	   between	   hepatocytes	   cultured	   in	   scaffolds	   versus	   2D.	  
Target	  genes	  that	  are	  associated	  with	  hepatic	  drug	  metabolism	  (genes	  coding	  for	  enzymes	  
involved	  in	  phase	  I,	  phase	  II	  and	  phase	  III	  (transporter)	  drug	  metabolism).	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4.3 Results	  
4.3.1 Hepatocyte	  Morphology	  
Chapter	   3	   employed	   ImageJ™	   analysis	   of	   histology	   images	   to	   show	   that	   the	   XY	   diameter	   of	  
hepatocytes	  cultured	  in	  emulsion	  templated	  polystyrene	  scaffolds	  more	  closely	  resembles	  the	  XY	  
diameter	  of	  hepatocytes	  found	  in	  vivo.	  The	  same	  method	  also	  showed	  that	  hepatocytes	  cultured	  
in	  2D	  display	  an	  unusually	  large	  XY	  diameter	  as	  they	  flatten	  out	  across	  the	  2D	  surface.	  However,	  
to	   fully	   understand	   hepatocyte	  morphology	   in	   emulsion	   templated	   polystyrene	   scaffolds,	   laser	  
scanning	  confocal	  microscopy	  was	  employed.	  This	  technique	  uses	  optical	  depth	  sections	  (Z-­‐stacks)	  
to	  obtain	  cell	  dimensions	  in	  the	  XYZ	  plane,	  as	  opposed	  to	  simply	  measuring	  XY	  diameters.	  	  
Hepatocytes	   were	   cultured	   on	   Alvetex®Scaffold,	   Alvetex®Strata	   and	   2D	   glass	   coverslips	   for	   24	  
hours.	   Alvetex®Scaffold	   was	   presented	   in	   the	   insert/12-­‐well	   plate/submerged	   format,	   whereas	  
Alvetex®Strata	  was	  presented	  in	  the	  insert/12-­‐well	  plate/contact	  format.	  After	  the	  culture	  period	  
cells	   were	   fixed	   and	   processed	   for	   confocal	   microscopy.	   Cells	   were	   stained	   for	   F-­‐actin	  
(cytoskeleton	   marker)	   and	   DAPI	   (nuclei	   stain).	   Imaging	   of	   the	   cells	   was	   taken	   directly	   on	   the	  
scaffolds	  and	  glass	  coverslips.	  
Figure	   4.2	   shows	   the	   XYZ	  morphology	   differences	   of	   HepG2	   cells	   cultured	   on	   Alvetex®Scaffold,	  
Alvetex®Strata	  and	  2D	  glass	  coverslips.	  For	  2D	  culture,	  the	  cell	  nuclei	  and	  cytoskeleton	  flatten	  out	  
across	  the	  plastic,	  consistent	  with	  the	  ImageJ™	  analysis	  performed	  in	  Chapter	  3.	  HepG2	  cell	  length	  
(longest	   distance	   in	   XY	  plane)	   is	   48	  µm,	  however	   the	  height	   (z	   plane)	   is	   only	   6	  µm.	  Conversely	  
HepG2	  cells	   cultured	  on	  Alvetex®Scaffold	  and	  Alvetex®Strata	  are	  much	  more	   rounded,	  with	  cell	  
length,	  width	  and	  height	  being	  approximately	  the	  same.	  For	  Alvetex®Scaffold	  the	  length	  of	  the	  3D	  
cell	  cytoskeleton	  is	  28	  µm	  and	  the	  height	  is	  28	  µm.	  Similarly	  for	  Alvetex®Strata	  the	  length	  of	  the	  
3D	  cell	  cytoskeleton	  is	  21	  µm	  and	  the	  height	  is	  25	  µm.	  Interestingly,	  for	  Alvetex®Strata	  the	  F-­‐actin	  
filaments	  appeared	   to	  have	   localised	  at	   the	   joining	  membranes	  of	   cell-­‐cell	   junctions,	   suggesting	  
abundant	   cell-­‐cell	   adhesions	   in	   this	   microenvironment.	   Table	   4-­‐2	   summarises	   the	   HepG2	   cell	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Figure	   4.2	   HepG2	   morphology	   by	   F-­‐actin/DAPI	   staining	   and	   imaging	   using	   laser-­‐scanning	   confocal	  
microscopy.	  (A-­‐D):	  HepG2	  cells	  grown	  on	  2D	  glass	  coverslips.	  (E-­‐H):	  HepG2	  cells	  grown	  on	  Alvetex®Scaffold.	  
(I-­‐L):	   HepG2	   cells	   grown	   on	  Alvetex®Strata.	   Cells	  were	   cultured	   for	   24	   hours	   and	   then	   stained	   for	   nuclei	  
(DAPI:	  blue)	  and	  F-­‐actin	  (Phalloidin:	  green).	  2D	  HepG2	  cells	  show	  a	  flat	  morphology	  with	  a	  cell	  height	  of	  only	  
6	   µm.	   F-­‐actin	   filaments	   appeared	   to	   have	   crawled	   out	   across	   the	   plastic	   creating	   a	   very	   large,	   flat	   cell	  
surface.	  Cells	  grown	  within	  the	  Alvetex®Scaffold	  are	  more	  rounded,	  with	  the	  cell	  height	  being	  almost	  equal	  
to	  the	  width	  and	  length.	  Cells	  grown	  on	  top	  of	  the	  Alvetex®Strata	  also	  display	  a	  more	  rounded	  morphology.	  
Furthermore	  the	  F-­‐actin	  staining	  in	  Alvetex®Strata	  shows	  extensive	  membrane	  localisation,	  demonstrating	  
the	  formation	  of	  cytoskeleton-­‐linked	  cell	  junctions.	  Scale	  bars	  =	  20	  µm.	  
Table	  4-­‐2	  Dimensions	  of	  HepG2	  Cytoskeletons	  Observed	  by	  Confocal	  Microscopy	  	  
	   Length	  (µm)	   Width	  (µm)	   Height	  (µm)	  
2D	   48	   34	   6	  
Alvetex®Scaffold	   28	   16	   28	  
Alvetex®Strata	   21	   16	   25	  
	  
Figure	   4.3	   shows	   the	   morphology	   of	   Upcyte®	   cells	   cultured	   on	   Alvetex®Scaffold	   and	   2D	   glass	  
coverslips	   after	   24	   hours	   using	   confocal	   microscopy.	   Alvetex®Scaffold	   was	   presented	   in	   the	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insert/12-­‐well	   plate/submerged	   format.	   Similar	   to	   the	   HepG2	   morphology	   data	   above,	   2D	  
cultures	   displayed	   extensive	   flattening.	   Actin	   filaments	   are	   visible	   and	   are	  mostly	   stress	   fibres.	  
Upcyte®	  cell	  length	  (longest	  distance	  in	  XY	  plane)	  is	  60	  µm,	  however	  the	  height	  (z	  plane)	  is	  only	  5	  
µm.	  Conversely,	  Upcyte®	  cells	  cultured	  on	  Alvetex®Scaffold	  display	  a	  cell	   length	  of	  19	  µm	  and	  a	  
cell	  height	  of	  approximately	  16	  µm.	  Table	  4-­‐3	  summarises	  the	  Upcyte®	  cell	  dimensions	  obtained	  
from	  the	  confocal	  microscopy	  images.	  
	  
	  
Figure	   4.3	   Upcyte®	   morphology	   by	   F-­‐actin/DAPI	   staining	   and	   imaging	   using	   laser-­‐scanning	   confocal	  
microscopy.	   (A,B):	   Upcyte®	   cells	   grown	   on	   2D	   glass	   coverslips.	   (C,D):	   Upcyte®	   cells	   grown	   on	  
Alvetex®Scaffold.	   Cells	   were	   cultured	   for	   24	   hours	   and	   then	   stained	   for	   nuclei	   (DAPI:	   blue)	   and	   F-­‐actin	  
(Phalloidin:	   green).	   2D	   Upcyte®	   cells	   show	   a	   flat	   morphology	   with	   a	   cell	   height	   of	   only	   5	   µm.	   F-­‐actin	  
filaments	  are	  visible	  and	  appear	  as	  stress	  fibres.	  Cells	  grown	  within	  the	  Alvetex®Scaffold	  are	  more	  rounded,	  
with	  the	  cell	  height	  being	  almost	  equal	  to	  the	  width	  and	  length.	  Scale	  bars	  =	  10	  µm.	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Table	  4-­‐3	  Some	  Typical	  Dimensions	  of	  Upcyte®	  Cytoskeletons	  by	  Confocal	  Microscopy	  	  
	   Length	  (µm)	   Width	  (µm)	   Height	  (µm)	  
2D	   60	   37	   5	  
Alvetex®Scaffold	   19	   9	   16	  
	  
SEM	  was	  employed	  as	  an	  additional	  technique	  to	  visualise	  cell	  morphology	  directly	  on	  the	  growth	  
substrate.	  Figure	  4.4	  shows	  SEM	  micrographs	  of	  HepG2	  cells	  cultured	  on	  2D,	  Alvetex®Scaffold	  and	  
Alvetex®Strata	  after	  7	  days.	  An	  SEM	  image	  of	  adult	  male	  nude	  (nu/nu)	  mouse	  liver	  tissue	  is	  shown	  
for	   comparison	   (tissue	   kindly	   donated	   by	   Eleanor	   Knight	   at	   Durham	  University	   and	   obtained	   in	  
accordance	  with	   UK	   Home	  Office	   guidelines).	   Alvetex®Scaffold	  was	   presented	   in	   the	   insert/12-­‐
well	   plate/submerged	   format,	   whereas	   Alvetex®Strata	   was	   presented	   in	   the	   insert/12-­‐well	  
plate/contact	  format.	  
HepG2	   cells	   in	   2D	   are	   extremely	   flat,	   consistent	   with	   the	   histological	   analysis	   and	   confocal	  
microscopy	  data.	  At	  this	  confluence	  there	  are	  also	  lots	  of	  open	  gaps	  where	  cells	  are	  not	  in	  contact	  
with	  their	  neighbours	  (white	  arrows	  in	  Figure	  4.4A).	  HepG2	  cells	  in	  Alvetex®Scaffold	  have	  filled	  up	  
the	  structure	  and	  appear	  to	  have	  adopted	  a	  rounded/elliptical	  morphology	  (white	  dotted	  circles	  
in	   Figure	   4.4B).	   Some	   gaps	   still	   remain	   in	   the	   structure	   where	   cells	   are	   not	   in	   contact	   with	  
neighbours	   (white	   arrows	   in	   Figure	   4.4B).	   For	   Alvetex®Strata	   a	   thick	   mass	   of	   3D	   cell	   tissue	   is	  
observed	   on	   top	   of	   the	   structure.	   It	   is	   difficult	   to	   visualise	   individual	   cells	   as	   the	   tissue	   is	   so	  
densely	   packed.	   The	   mouse	   tissue	   is	   similar	   to	   Alvetex®Strata;	   a	   thick	   mass	   of	   3D	   cells	   with	  
maximum	  cell-­‐cell	  contact.	  	  
Upcyte®	  cells	  in	  Alvetex®Scaffold	  were	  also	  imaged	  using	  SEM.	  Cells	  were	  grown	  for	  7	  days	  in	  the	  
insert/12-­‐well	   plate/submerged	   format.	   Figure	   4.5	   shows	   that	   individual	   Upcyte®	   cells	   in	  
Alvetex®Scaffold	   adopt	   a	   round	   (almost	   spherical)	   morphology.	   Moreover,	   abundant	   microvilli	  
can	  be	  found	  on	  the	  cell	  surface	  (Figure	  4.5E-­‐H).	  This	  suggests	  that	  the	  cells	  have	  retained	  some	  
polarisation	  within	  Alvetex®Scaffold	  throughout	  the	  culture	  period	  employed.	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Figure	  4.4	  SEM	   images	  of	  HepG2	  cells	   cultured	   in	  2D,	  Alvetex®Scaffold	  and	  Alvetex®Strata	  after	  7	  days	  
compared	  to	  mouse	  liver	  tissue.	  (A):	  2D	  cells.	  The	  white	  arrows	  show	  regions	  lacking	  cell-­‐cell	  contact.	  (B):	  
3D	  cells	  filling	  Alvetex®Scaffold	  adopting	  an	  elliptical	  shape	  (white	  dotted	  lines).	  Some	  regions	  still	  lack	  cell-­‐
cell	  contact	  (white	  arrows).	  (C):	  3D	  cells	  on	  top	  of	  Alvetex®Strata	  forming	  a	  dense	  tissue	  mass.	  (D):	   In	  vivo	  
mouse	  liver	  control	  with	  maximum	  cell-­‐cell	  contact.	  Scale	  bars	  =	  50	  µm.	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Figure	  4.5	  SEM	  images	  of	  Upcyte®	  cells	  cultured	  in	  Alvetex®Scaffold	  for	  7	  days.	  (A-­‐D):	  Individual	  cells	  show	  
a	  rounded	  morphology.	  (E-­‐H):	  Abundant	  microvilli	  are	  present	  on	  the	  cell	  surface	  suggesting	  maintenance	  
of	  polarisation	  throughout	  the	  culture	  period.	  Scale	  bars:	  A	  =	  5	  µm,	  B	  =	  10	  µm,	  C	  =	  5	  µm,	  D	  =	  20	  µm,	  E	  =	  2	  
µm,	  F	  =	  500	  nm,	  G	  =	  500	  nm,	  H	  =	  2	  µm.	  
	  	   140	  
4.3.2 Hepatocyte	  Ultrastructure	  
As	  discussed	   in	  Chapter	   1,	   hepatocyte	  ultrastructure	   is	   crucial	   for	   function.	   Sinusoidal	  microvilli	  
and	  bile	  canaliculi	  are	  particularly	  important	  for	  drug	  uptake	  and	  elimination.	  This	  study	  assessed	  
the	  ability	  of	  scaffold	  cultures	   to	   form	  these	  structures	  using	  confocal	   immunofluorescence	  and	  
transmission	  electron	  microscopy	  (TEM).	  
Tight	   junctions	   (zonula	   occludens,	   Zo)	   are	   required	   for	   the	   formation	   of	   sinusoidal	  microvilli	   as	  
well	   as	   bile	   canaliculi.	   Furthermore,	   drug	   transporter	   proteins	   such	   as	   MDR1	   and	   MRP2	   are	  
localised	  at	  the	  bile	  canaliculi	  membranes.	   Immunofluorescence	  staining	  using	  antibodies	   for	  Zo	  
(ZO1,	   Life	   Technologies),	  MRP2	   (abcam)	   and	  MDR1	   (abcam)	   was	   therefore	   employed	   to	   probe	  
hepatocyte	  ultrastructure.	  
HepG2	  cells	  were	  cultured	  for	  3	  days	  on	  2D	  glass	  coverslips,	  Alvetex®Scaffold	  and	  Alvetex®Strata	  
and	   then	   processed	   for	   immunofluorescence.	   Alvetex®Scaffold	  was	   presented	   in	   the	   insert/12-­‐
well	   plate/submerged	   format,	   whereas	   Alvetex®Strata	   was	   presented	   in	   the	   insert/12-­‐well	  
plate/contact	   format.	  Confocal	   imaging	  was	  performed	  directly	  on	   the	  growth	   substrate.	  Figure	  
4.6	   shows	   that	   most	   positive	   green	   staining	   for	   ZO1	   occurs	   for	   HepG2	   cells	   cultured	   on	  
Alvetex®Strata.	  This	  is	  to	  be	  expected	  and	  is	  consistent	  with	  the	  previous	  histology	  and	  SEM	  data	  
showing	  maximum	  cell-­‐cell	  contact	  for	  Alvetex®Strata.	  Alvetex®Scaffold	  displays	  the	  second	  most	  
positive	  green	  staining	  for	  ZO1,	  whereas	  2D	  cultures	  show	  the	  least.	  Indeed,	  the	  2D	  culture	  shows	  
only	  faint	  green	  staining	  for	  ZO1	  (white	  dotted	  line	  in	  Figure	  4.6A	  represents	  cell	  boundaries).	  	  
HepG2	   cells	   cultured	   on	   Alvetex®Strata	   also	   showed	   the	   most	   positive	   staining	   for	   MRP2	   and	  
MDR1.	  Alvetex®Scaffold	  and	  2D	  cultures	  did	  show	  signs	  of	  positive	  MRP2	  staining,	  however	  this	  
was	  noticeably	  less	  compared	  to	  Alvetex®Strata.	  Very	  little	  positive	  MDR1	  staining	  was	  observed	  
for	  Alvetex®Scaffold	  and	  2D.	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Figure	  4.6	   Immunofluorescence	  staining	  for	  ZO1,	  MRP2	  and	  MDR1	  for	  HepG2	  cells	  cultured	  on	  2D	  glass	  
coverslips,	  Alvetex®Scaffold	  and	  Alvetex®Strata.	  (A-­‐D):	  Cells	  grown	  on	  2D	  plastic.	  Only	  faint	  green	  staining	  
is	  observed.	  The	  white	  dotted	   line	   in	   (A)	   represents	  cell	  boundaries.	  Very	   little	  positive	  green	  staining	   for	  
MRP2	   and	   MDR1	   is	   observed.	   (E-­‐H):	   Cells	   grown	   on	   Alvetex®Scaffold.	   More	   positive	   ZO1	   staining	   is	  
observed	   compared	   to	   2D,	   however	   positive	   green	   staining	   for	   MRP2	   and	  MDR1	   is	   still	   low.	   (I-­‐L):	   Cells	  
grown	  on	  Alvetex®Strata.	  Abundant	  positive	  green	  staining	  for	  ZO1	  is	  observed.	  There	  is	  also	  some	  staining	  
for	  MRP2	  and	  MDR1.	  Cells	  were	  cultured	   for	  3	  days	  before	  processing.	  The	  negative	  control	  micrographs	  
represent	  secondary	  antibody	  staining	  only.	  Scale	  bar	  =	  20µm.	  
	  
For	  TEM	  analysis,	  adult	  male	  nude	  (nu/nu)	  mouse	   liver	  tissue	  was	  used	  as	  an	   in	  vivo	  control	   for	  
the	   study	   (tissue	   kindly	   donated	   by	   Eleanor	   Knight	   at	   Durham	   University	   and	   obtained	   in	  
accordance	  with	  UK	  Home	  Office	  guidelines).	  Figure	  4.7	  and	  Figure	  4.8	  show	  the	  ultrastructure	  of	  
the	  mouse	  liver	  tissue	  by	  TEM.	  As	  expected,	  most	  key	  hepatocyte	  organelles	  are	  present	  including	  
the	   nucleus	   (NU),	   mitochondria	   (Mt),	   rough	   endoplasmic	   reticulum	   (RER)	   and	   lipid	   storing	  
droplets	  (LD)	  (see	  Figure	  4.7).	  Cell	  shape	  in	  Figure	  4.8A	  is	  almost	  rectangular,	  translating	  into	  an	  
expected	   cuboidal	   shape	   in	   3D.	   Hepatocytes	   at	   the	   sinusoidal	   interface	   are	   observed	   in	   Figure	  
4.8B	  and	  Figure	  4.8C.	  Here	  a	  Kupffer	  cell	  (KC)	  is	  in	  close	  contact	  with	  the	  hepatocytes,	  along	  with	  
liver	   sinusoidal	   cells	   (LSECs)	   and	   erythrocyte	   cells	   (EC).	   Abundant	   microvilli	   (MV)	   can	   be	   seen	  
protruding	   into	   the	   Space	   of	   Disse	   (SoD).	   Figure	   4.8D	   shows	   the	   cell-­‐cell	   adhesions	   forming	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between	  two	  adjacent	  hepatocytes.	  Desmosomes	  (D)	  are	  observed	  by	  the	  wide	  and	  dense	  protein	  
shadows	   in	   the	  TEM	  micrograph.	  Next	   to	   the	  desmosomes	  are	   zonula	  adherens	   (Za)	  and	   finally	  
zonula	  occludens	  (Zo)	  to	  form	  a	  tight	  junction	  (TJ)	  complex	  between	  the	  two	  cells.	  Bile	  canaliculi	  
can	  be	  seen	  in	  Figure	  4.8E	  and	  Figure	  4.8F.	  These	  form	  between	  adjacent	  hepatocytes,	  using	  Zo	  




Figure	   4.7	   TEM	  analysis	   of	  mouse	   liver	   tissue	   extracted	   from	   adult	  male	   nude	   (nu/nu)	  mice.	  Most	  key	  
hepatocyte	   organelles	   can	   be	   seen,	   including	   the	   nucleus	   (NU),	   mitochondria	   (Mt),	   rough	   endoplasmic	  
reticulum	  (RER)	  and	  lipid	  storing	  droplets	  (LD).	  Scale	  bar	  =	  2	  µm.	  The	  pre-­‐fixed	  mouse	  liver	  tissue	  was	  kindly	  
donated	  by	  Eleanor	  Knight	  at	  Durham	  University	  and	  was	  obtained	  with	  guidelines	  and	  permission	  from	  the	  
UK	  Home	  Office.	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Figure	  4.8	  TEM	  analysis	  of	  mouse	  liver	  tissue	  extracted	  from	  adult	  male	  nude	  (nu/nu)	  mice.	  (A):	  A	  single	  
hepatocyte	   adopting	   an	   almost	   rectangular	   shape.	   The	   white	   lines	   represent	   the	   boundaries	   between	  
adjacent	  cells.	  Scale	  bar	  =	  5	  µm.	  (B):	  Hepatocytes	  at	  the	  sinusoidal	  interface	  in	  close	  contact	  with	  a	  Kupffer	  
cell	  (KC).	  Scale	  bar	  =	  5	  µm.	  (C):	  Sinusoidal	  interface	  of	  a	  hepatocyte	  cell	  with	  its	  microvilli	  (MV)	  protruding	  
into	  the	  Space	  of	  Disse	  (SoD).	  Liver	  sinusoidal	  endothelial	  cells	  (LSECs)	  and	  blood	  erythrocyte	  cells	  (EC)	  are	  
also	   present.	   Scale	   bar	   =	   1	   µm	   (D):	   Cell-­‐cell	   junction	   between	   two	   adjacent	   hepatocytes	   containing	  
desmosomes	  (D),	  zonula	  adherens	  (Za)	  and	  zonula	  occludens	  (Zo).	  Scale	  bar	  =	  400	  nm	  (E-­‐F):	  Bile	  canaliculi	  
(BC)	  between	  adjacent	  hepatocytes.	  Scale	  bar	  in	  E	  =	  2	  µm.	  Scale	  bar	  in	  F	  =	  500	  nm.	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TEM	   images	  of	  HepG2	   cells	   cultured	  on	  2D	   glass	   coverslips	   for	   3	   days	   are	   shown	   in	   Figure	   4.9.	  
Most	  key	  hepatocyte	  organelles	  can	  be	  seen	  including	  the	  nucleus	  (NU),	  mitochondria	  (Mt),	  rough	  
endoplasmic	   reticulum	   (RER)	   and	   lipid	   storing	   droplets	   (LD).	   Some	  microvilli	   (MV)	   can	   be	   seen	  
protruding	   from	  the	  surface	  of	   the	  cells,	  however	   these	  are	  sparse	  and	  quite	  elongated.	  All	   the	  
cells	   and	   cell	   nuclei	   are	   extremely	   flattened,	   in	   contrast	   to	   the	   rectangular	   hepatocyte	   shapes	  
observed	   in	  the	  mouse	  tissue	  TEM	  images.	  Furthermore,	  there	   is	  very	   little	  opportunity	  for	  cell-­‐
cell	   contact,	   to	   the	   extent	   that	   hepatocytes	   appear	   to	   be	   wrapping	   around	   one	   another	   to	  
maximise	   cell-­‐cell	   contact	   (black	   arrows	   in	   Figure	  4.9E).	   Importantly	  no	  advanced	  bile	   canaliculi	  
were	  observed	  in	  this	  experiment	  (see	  Figure	  4.13).	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Figure	  4.9	  TEM	  analysis	  of	  HepG2	  ultrastructure	  when	  cultured	  on	  2D	  glass	  coverslips	   for	  3	  days.	   (A):	  A	  
severely	   flattened	  morphology	   is	  observed.	  Only	  sparse	  and	  elongated	  microvilli	   (MV)	  are	  present	  on	   the	  
cell	  surface.	  Scale	  bar	  =	  8	  µm.	  (B,C):	  Cell	  nuclei	  (NU)	  are	  also	  forced	  into	  a	  flattened	  shape.	  Scale	  bar	  =	  4	  µm.	  
(D):	  Most	  key	  hepatocyte	  organelles	  are	  still	  present	  in	  2D	  including	  mitochondria	  (Mt),	  rough	  endoplasmic	  
reticulum	  (RER)	  and	   lipid	  storing	  droplets	   (LD).	  Scale	  bar	  =	  2	  µm.	  (E):	  Cells	  appear	  to	  be	  wrapping	  around	  
one	  another	  to	  maximise	  cell-­‐cell	  contact	  (black	  arrows).	  Scale	  bar	  =	  2	  µm.	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TEM	   images	   of	  HepG2	   cells	   cultured	   in	  Alvetex®Scaffold	   (insert/12-­‐well	   plate/submerged)	   for	   4	  
days	   are	   shown	   in	   Figure	   4.10	   and	   Figure	   4.11.	   Most	   key	   hepatocyte	   organelles	   can	   be	   seen	  
including	   the	   nucleus	   (NU),	   mitochondria	   (Mt),	   rough	   endoplasmic	   reticulum	   (RER)	   and	   lipid	  
storing	  droplets	  (LD).	  The	  image	  in	  Figure	  4.10	  further	  illustrates	  the	  round	  morphology	  of	  HepG2	  
cells	  cultured	  in	  Alvetex®Scaffold,	  consistent	  with	  previous	  data.	  
	  
	  
Figure	  4.10	  TEM	  analysis	  of	  HepG2	  ultrastructure	  when	  cultured	  in	  Alvetex®Scaffold	  for	  4	  days	  using	  the	  
insert/12-­‐well	  plate/submerged	  format.	  Most	  key	  hepatocyte	  organelles	  can	  be	  seen	  including	  the	  nucleus	  
(NU),	  mitochondria	   (Mt),	   rough	  endoplasmic	   reticulum	   (RER)	  and	   lipid	   storing	  droplets	   (LD).	  Cell	   shape	   is	  
round.	  Scale	  bar	  =	  1	  µm.	  	  
	  
Figure	  4.11A-­‐E	  highlights	  how	  the	  scaffold	  (SC)	  structure	  supports	  cells	  into	  a	  3D	  shape.	  Nearly	  all	  
cells	   are	   encouraged	   into	   a	   round	   shape	   by	   the	   scaffold	   walls.	   Interestingly,	   the	   cell	   in	   Figure	  
4.11C	  seems	  to	  be	  modifying	  its	  structure	  to	  squeeze	  through	  an	  interconnecting	  window	  in	  the	  
scaffold	  (white	  dotted	  circle).	  This	   is	  consistent	  with	  data	  in	  Chapter	  3	  showing	  that	  HepG2	  cells	  
can	  migrate	   through	   the	   scaffold	   structure.	   From	   an	   ultrastructural	   standpoint,	   HepG2	   cells	   in	  
Alvetex®Scaffold	   display	   abundant	   microvilli	   (MV),	   as	   shown	   in	   Figure	   4.11B	   and	   Figure	   4.11E.	  
There	  is	  also	  evidence	  of	  bile	  canaliculi	  (see	  Figure	  4.11F	  and	  Figure	  4.13).	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Figure	  4.11	  TEM	  analysis	  of	  HepG2	  ultrastructure	  when	  cultured	  in	  Alvetex®Scaffold	  for	  4	  days	  using	  the	  
insert/12-­‐well	  plate/submerged	  format.	  (A-­‐E):	  Scaffold	  (SC)	  walls	  seem	  to	  encourage	  HepG2	  cells	  into	  a	  3D	  
morphology.	  One	  hepatocyte	  cell	  appears	  to	  be	  altering	  its	  structure	  to	  squeeze	  through	  an	  interconnecting	  
window	   on	   the	   scaffold	   (white	   dotted	   circles	   in	   C).	   Abundant	  microvilli	   are	   observed	   in	   B	   and	   F.	   A	   bile	  
canaliculus	  can	  also	  be	  seen	  in	  F.	  Scale	  bar	  A	  =	  8	  µm.	  Scale	  bars	  B,C	  =	  5	  µm.	  Scale	  bars	  D,E,F	  =	  2	  µm.	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Figure	  4.12	  shows	   the	  ultrastructure	  of	  HepG2	  cells	   cultured	  on	  Alvetex®Strata	   for	  4	  days	  using	  
the	   insert/12-­‐well	   plate/contact	   format.	   As	   with	   2D	   and	   Alvetex®Scaffold,	   HepG2	   cells	   on	  
Alvetex®Strata	  display	  most	  of	  the	  key	  organelles,	  including	  the	  nucleus	  (NU),	  mitochondria	  (Mt),	  
rough	  endoplasmic	  reticulum	  (RER)	  and	  lipid	  storing	  droplets	  (LD).	  Cells	  are	  very	  densely	  packed	  
and	   grow	   in	   an	   almost	   ‘’scaffold-­‐less’’	   manner	   on	   top	   of	   Alvetex®Strata.	   Some	   signs	   of	   cell	  
necrosis	  are	  observed	   for	  cells	   closest	   to	   the	  air-­‐liquid	   interface,	  evident	  by	   the	  decaying	  nuclei	  
and	   faint	   cytoplasm	   in	   Figure	   4.12B.	   Nonetheless,	   for	   healthy	   cells	   closer	   to	   the	  media	   supply	  
there	   is	   extensive	   opportunity	   for	   cell-­‐cell	   contact.	   These	   cells	   also	   seem	   to	   protrude	  microvilli	  
into	   a	   lumen-­‐type	   structure,	   suggesting	   early	   signs	   of	   structural	   re-­‐organisation	   towards	   the	  
native	  sinusoidal	  domains	  (Figure	  4.12D).	  	  
	  
The	  formation	  of	  bile	  canaliculi	   is	  crucial	   for	  normal	  hepatocyte	  function.	  Figure	  4.13	  shows	  the	  
features	   attributable	   to	   bile	   canaliculi	   formation	   for	   HepG2	   cells	   in	   2D,	   Alvetex®Scaffold	   and	  
Alvetex®Strata	   by	   TEM	   imaging.	   For	   2D,	   no	   convincing	   bile	   canaliculi	   features	   were	   observed,	  
except	  for	  small	  lumen	  structures	  (see	  Figure	  4.13A).	  However	  these	  were	  often	  lacking	  microvilli	  
and/or	   tight	   junctions.	   Conversely	   Alvetex®Scaffold	   did	   show	   some	   signs	   of	   advanced	   bile	  
canaliculi	   with	   appropriate	  microvilli	   and	   tight	   junctions,	   albeit	   infrequently	   (see	   Figure	   4.13B).	  
Alvetex®Strata	   displayed	   even	  more	   evidence	   of	   bile	   canaliculi	   formation	   (see	   Figure	   4.13C-­‐E).	  
These	   features	   were	   abundant	   throughout	   the	   healthy	   tissue	   mass	   and	   always	   displayed	  
appropriate	  microvilli	  and	  tight	  junctions.	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Figure	  4.12	  TEM	  analysis	  of	  HepG2	  ultrastructure	  when	  cultured	  on	  Alvetex®Strata	  for	  4	  days	  using	  the	  
insert/12-­‐well	  plate/contact	   format.	   (A):	  Cell	  growth	  is	  almost	   ‘’scaffold-­‐less’’,	  with	  the	  scaffold	  (SC)	  only	  
visible	  in	  the	  lower	  portion	  of	  the	  cell	  mass.	  (B):	  Cell	  necrosis	  is	  present	  near	  the	  top	  portion	  of	  the	  tissue	  
mass	   even	   after	   4	   days,	   evident	   by	   the	   decaying	   nuclei	   and	   the	   faint	   cytoplasms.	   The	   black	   dotted	   line	  
indicates	   the	   boundary	   between	   healthy	   and	   necrotic	   cells.	   (C):	   Several	   HepG2	   cells	   in	   contact	  with	   one	  
another	  demonstrating	  the	  significant	  opportunity	  for	  cell-­‐cell	  contact.	  (D):	  Three	  cells	  joining	  together	  and	  
protruding	  microvilli	   (MV)	   into	   a	   lumen-­‐type	   structure.	   (E-­‐F):	  Most	   of	   the	   key	   hepatocyte	   organelles	   are	  
present	  including	  the	  nucleus	  (NU),	  mitochondria	  (Mt),	  rough	  endoplasmic	  reticulum	  (RER)	  and	  lipid	  storing	  
droplets	  (LD).	  Scale	  bars	  A,B	  =	  10	  µm.	  Scale	  bar	  C	  =	  5	  µm.	  Scale	  bars	  D,E	  =	  2	  µm.	  	  Scale	  bar	  F	  =	  1	  µm.	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Figure	   4.13	   Evidence	   of	   bile	   canaliculi	   formation	   for	   HepG2	   cells	   cultured	   on	   2D	   glass	   coverslips,	  
Alvetex®Scaffold	  and	  Alvetex®Strata.	  (A):	  HepG2	  cells	  cultured	  on	  2D	  show	  features	  that	  could	  be	  assumed	  
to	   be	   bile	   canaliculi,	   however	   these	   are	   not	   entirely	   convincing	   due	   to	   a	   lack	   of	   microvilli	   and/or	   tight	  
junctions	   (zonula	   occludens,	   Zo).	   (B):	   HepG2	   cells	   cultured	   on	   Alvetex®Scaffold	   show	   promising	   signs	   of	  
advanced	  bile	  canaliculi	  formation,	  albeit	  infrequently.	  Evidence	  of	  desmosomes	  (D),	  zonula	  adherens	  (Za)	  
and	  Zo	  were	  present	  along	  with	  microvilli	  suggesting	  the	  features	  were	  indeed	  bile	  canaliculi	  (BC).	  (C-­‐F):	  An	  
abundance	  of	  BC	  were	  observed	  for	  HepG2	  cells	  cultured	  on	  top	  of	  Alvetex®Strata.	  Scale	  bar	  A	  =	  500	  nm.	  
Scale	  bar	  B	  =	  300	  nm.	  Scale	  bars	  C,	  D,	  E	  =	  1	  µm.	  Scale	  bar	  F	  =	  2	  µm.	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Upcyte®	   hepatocytes	   were	   also	   investigated	   by	   TEM.	   Prior	   to	   this	   study	   there	   had	   been	   no	  
ultrastructural	  assessment	  of	  these	  cells	  in	  2D	  or	  3D	  culture.	  Figure	  4.14	  and	  Figure	  4.15	  show	  the	  
ultrastructure	  of	  Upcyte®	  cells	  cultured	  in	  Alvetex®Scaffold	  (insert/12-­‐well	  plate/submerged)	  for	  4	  
days.	   Cells	   appear	   healthy	   with	   most	   key	   organelles	   observable,	   including	   the	   nucleus	   (NU),	  
mitochondria	  (Mt),	  rough	  endoplasmic	  reticulum	  (RER),	  smooth	  endoplasmic	  reticulum	  (SER)	  and	  
lipid	  storing	  droplets	  (LD).	  There	  is	  also	  evidence	  of	  surface	  microvilli	  (MV).	  There	  are	  also	  signs	  of	  
glycogen	  storage	  (GLY)	  within	  the	  hepatocytes.	  
	  
	  
Figure	   4.14	   Ultrastructural	   features	   of	   Upcyte®	   cells	   in	   Alvetex®Scaffold	   by	   TEM	   (high	   power).	  All	   key	  
organelles	   appear	   normal	   and	   healthy:	   nucleus	   (NU),	   mitochondria	   (Mt),	   rough	   endoplasmic	   reticulum	  
(RER),	  smooth	  endoplasmic	  reticulum	  (SER),	  lipid	  droplets	  (LD)	  and	  cytoskeletal	  proteins	  (CP).	  There	  is	  also	  
evidence	   of	   cell-­‐surface	  microvilli	   (MV)	   and	   glycogen	   (GLY).	   Two	   cells	   are	   separated	   by	   a	   cell	  membrane	  
(CM).	  Scale	  bar	  =	  500	  nm.	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Importantly	  the	  ultrastructural	  shape	  of	  the	  cells	  is	  almost	  rectangular	  (Figure	  4.15),	  which	  would	  
be	  expected	  to	  translate	  into	  a	  cuboidal	  shape	  in	  3D.	  As	  for	  HepG2	  cells,	  evidence	  of	  the	  scaffold	  
(SC)	  supporting	  cell	  shape	  is	  also	  observed	  (Figure	  4.15B,D).	  
	  
	  
Figure	   4.15	   Ultrastructural	   features	   of	   Upcyte®	   cells	   in	   Alvetex®Scaffold	   by	   TEM	   (low	   power).	   (A,B):	  A	  
rectangular	  cell	  shape	  is	  observed	  for	  cells	  in	  the	  scaffolds.	  Scale	  bars	  =	  2	  µm.	  (C):	  Cells	  appear	  healthy	  and	  
seem	  to	  protrude	  microvilli	   from	  the	  cell	  surface.	  Scale	  bar	  500	  nm.	  (D):	  The	  wall	  of	  Alvetex®Scaffold	  (SC)	  
can	  be	  seen	  to	  be	  supporting	  the	  weight	  of	  an	  Upcyte®	  cell.	  Scale	  bar	  =	  2	  µm.	  
	  
The	  ultrastructure	  of	  Upcyte®	  cells	  cultured	  in	  2D	  is	  shown	  in	  Figure	  4.16	  and	  Figure	  4.17.	  Most	  
key	   organelles	   can	   be	   seen,	   including	   the	   nucleus	   (NU),	  mitochondria	   (Mt),	   rough	   endoplasmic	  
reticulum	   (RER)	   and	   lipid	   storing	   droplets	   (LD).	   However,	   cells	   and	   organelles	   are	   extremely	  
flattened.	  Similar	   to	  HepG2	  cells,	   there	   is	  very	   little	  opportunity	   for	  cell-­‐cell	   contact.	  Where	  cell	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edges	   do	  meet,	   the	   cells	   seem	   to	   wrap	   around	   one	   another	   as	  much	   as	   possible	   to	  maximise	  
contact	  (Figure	  4.16B,C).	  
	  
Figure	   4.16	   Ultrastructural	   features	   of	   Upcyte®	   cells	   cultured	   on	   2D	   glass	   coverslips	   (part	   1).	   (A):	  
Cytoskeletal	  proteins	  (CP)	  appear	  to	  be	  stretching	  horizontally.	  	  Some	  mitochondria	  (Mt)	  are	  present.	  Scale	  
bar	  =	  2	  μm.	  (B):	  A	  cell	  is	  wrapping	  around	  another	  to	  maximise	  contact.	  Possible	  attempts	  at	  bile	  canaliculi	  
(BC)	  are	  being	  made,	  although	   there	   is	  a	  noticeable	  absence	  of	   tight	   junctions	  between	  cells.	  Scale	  bar	  =	  
500	  nm.	  (C):	  Another	  example	  of	  two	  cells	  wrapping	  around	  one	  another	  to	  maximize	  cell-­‐cell	  contact.	  Scale	  
bar	  =	  500	  nm.	  (D):	  Example	  of	  limited	  cell-­‐cell	  contact	  between	  two	  cells.	  Some	  signs	  of	  tight	  junctions	  (TJ)	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Figure	   4.17	   Ultrastructural	   features	   of	   Upcyte®	   cells	   cultured	   on	   2D	   glass	   coverslips	   (part	   2).	   (A):	   Low	  
power	  image	  of	  three	  Upcyte®	  cells	  grown	  on	  2D	  coverslips.	  Cells	  appear	  viable	  but	  are	  extremely	  flattened.	  
Cells	  2	  spans	  approximately	  50	  μm,	  with	  only	  a	  tiny	  portion	  of	   its	  cell	  surface	  being	   in	  contact	  with	  Cell	  1	  
and	  Cell	  3.	  A	  noticeable	   lack	  of	  microvilli	  on	  the	  hepatocyte	  surface	  is	  observed.	  Scale	  bar	  =	  10	  μm.	  (B,C):	  
Medium	  power	  images.	  Some	  microvilli	  (MV)	  can	  be	  seen.	  Scale	  bars	  =	  2	  μm.	  	  
	  
4.3.3 Hepatocyte	  Function	  (3D	  Static	  versus	  2D	  Static)	  
Hepatocyte	  function	  was	  compared	  between	  2D	  and	  3D	  cultures	  under	  static	  media	  conditions	  to	  
provide	   a	   correlation	   with	   the	   above	   structural	   differences.	   Glucose	   consumption	   between	   2D	  
and	   3D	   cultures	   was	   first	   compared.	   Primary	   rat	   hepatocytes	   were	   seeded	   onto	   fibronectin	  
coated	  12-­‐well	  plates	  (2D)	  and	  Alvetex®Scaffold	  (insert/12-­‐well	  plate/submerged)	  at	  a	  density	  of	  
0.2	  million	   cells.	  Media	  was	   brought	   up	   to	   4	  mL	   and	   the	   cells	  were	   cultured	   for	   2	   days.	  Media	  
samples	  were	  taken	  throughout	  the	  culture	  period	  to	  monitor	  glucose	  consumption.	  Figure	  4.18	  
shows	   the	   change	   in	   media	   glucose	   (per	   hour)	   throughout	   the	   culture	   period.	   A	   significantly	  
greater	  consumption	  of	  glucose	  is	  observed	  for	  3D	  cultures	  compared	  to	  2D	  cultures.	  	  
	  	   155	  
	  
Figure	  4.18	  Hourly	   change	   in	  media	  glucose	   for	  primary	  hepatocytes	   cultured	   in	  2D	  and	  3D.	  Cells	  were	  
seeded	  at	  equal	  density	  between	  2D	  and	  3D	  (0.8	  million)	  and	  cultured	  in	  4	  mL	  of	  media	  for	  2	  days.	  A	  greater	  
consumption	   of	   glucose	   is	   observed	   for	   3D	   compared	   to	   2D	   suggesting	   that	   these	   cells	   are	   more	  
metabolically	   active.	   Data	   represents	   mean	   ±	   s.e.m.	   (n=3).	   *	   denotes	   p	   <	   0.05	   as	   determined	   by	   the	  
Student’s	  t-­‐test.	  
	  
Drug	  toxicity	  is	  a	  key	  functional	  response	  for	  hepatocytes.	  Indeed,	  comparing	  drug	  metabolism	  of	  
3D	   cultures	  versus	   2D	   cultures	   is	   one	  of	   the	   key	   aims	  of	   this	   project.	  HepG2	   cells	  were	   seeded	  
onto	   fibronectin	   coated	   12-­‐well	   plates	   (2D)	   and	   Alvetex®Scaffold	   (insert/12-­‐well	  
plate/submerged)	   at	   a	   density	   of	   0.3	  million	   cells.	   Cells	  were	   cultured	   for	   24	  hours	   in	   standard	  
culture	  media	  before	  being	  treated	  with	  APAP-­‐containing	  media	  for	  an	  additional	  24	  hours.	  Cell	  
metabolic	  activity	  (MTT	  assay)	  was	  assessed	  for	  each	  APAP	  treatment.	  
Figure	  4.19	   shows	   the	   results	  of	   the	  MTT	  assay	   for	   the	  APAP	  dose	   response	   in	  2D	  and	  3D.	   	   2D	  
cultures	  gradually	  show	  a	  decline	   in	  metabolic	  activity	  as	  APAP	   is	   increased,	  suggesting	  that	  the	  
cells	   are	   sensitive	   to	   the	   drug.	   Conversely,	   3D	   cells	   in	   Alvetex®Scaffold	   appear	   much	   more	  
resistant	   to	   higher	   concentrations	   of	   the	   drug,	   even	   displaying	   an	   enhanced	  metabolic	   activity	  
compared	  to	  the	  nil-­‐APAP	  control.	  This	  suggests	  that	  the	  3D	  cells	  are	  more	  capable	  of	  detoxifying	  
the	  drug	  compared	  to	  2D	  cultures.	  
	  
	  
	  	   156	  
	  
Figure	  4.19	  HepG2	  response	  to	  acetaminophen	  (APAP)	  in	  2D	  and	  3D	  cultures.	  The	  MTT	  assay	  was	  used	  to	  
determine	   cell	   activity/viability	   under	   different	   drug	   concentrations.	   2D	   cultures	   (12-­‐well	   plate)	   appear	  
more	  sensitive	  to	  the	  drug,	  evident	  by	  the	  gradual	  decrease	  in	  viability	  with	  increasing	  APAP	  concentration.	  
Conversely	  3D	  cultures	  appear	  resistant	  to	  the	  drug,	  with	  even	  an	  increase	  in	  activity/viability	  compared	  to	  
the	  nil-­‐APAP	  control	  observed.	  Data	  represents	  24	  hours	  culture	  in	  standard	  culture	  media	  followed	  by	  24	  
hours	  culture	  in	  APAP-­‐containing	  culture	  media.	  Data	  represents	  mean	  ±	  s.e.m.	  (n=3).	  	  
	  
Gemfibrozil	   was	   employed	   as	   a	   second	   model	   drug	   to	   probe	   2D	   and	   3D	   function.	   In	   this	  
experiment	   HepG2	   cells	   were	   seeded	   onto	   fibronectin	   coated	   12-­‐well	   plates	   (2D)	   and	  
Alvetex®Scaffold	   (insert/12-­‐well	   plate/submerged)	   at	   a	   density	   of	   0.25	  million	   cells.	   Cells	   were	  
cultured	   for	   2	  days	   in	   standard	   culture	  media	  before	  being	   treated	  with	  Gemfibrozil-­‐containing	  
media	   for	   an	   additional	   24	   hours.	   Cell	   metabolic	   activity	   (MTT	   assay)	   was	   assessed	   for	   each	  
Gemfibrozil	  treatment.	  Figure	  4.20	  shows	  that	  3D	  cells	  are	  generally	  more	  resistant	  to	  Gemfibrozil	  
compared	   to	  2D	  cultures,	   although	   the	  differences	  between	   the	   two	  cultures	  are	  much	   smaller	  
compared	  to	  the	  APAP	  data	  above.	  In	  the	  case	  of	  Gemfibrozil,	  both	  2D	  and	  3D	  metabolic	  activity	  
is	  gradually	  reduced	  upon	  increasing	  drug	  exposure,	  with	  the	  3D	  cells	  only	  having	  a	  slightly	  higher	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Figure	  4.20	  HepG2	  response	  to	  Gemfibrozil	  in	  2D	  and	  3D	  cultures.	  The	  MTT	  assay	  was	  used	  to	  determine	  
cell	  activity/viability	  under	  different	  drug	  concentrations.	  2D	  cultures	   (12-­‐well	  plate)	  appear	  slightly	  more	  
sensitive	  to	  the	  drug,	  evident	  by	  the	  gradual	  decrease	  in	  viability	  with	  increasing	  Gemfibrozil	  concentration.	  
Conversely	  3D	  cultures	  appear	  more	  resistant	  to	  the	  drug,	  but	  still	  show	  a	  gradual	  decrease	  in	  viability	  with	  
increasing	  Gemfibrozil	  concentration.	  Data	  represents	  2	  days	  culture	  in	  standard	  culture	  media	  followed	  by	  
24	  hours	  culture	  in	  Gemfibrozil-­‐containing	  culture	  media.	  Data	  represents	  mean	  ±	  s.e.m.	  (n=3).	  
Albumin	  and	  urea	   synthesis	  were	   compared	   for	  primary	   rat	   cells	   cultured	   in	  2D	  and	  3D.	   In	   this	  
experiment	  primary	  rat	  hepatocytes	  were	  seeded	  onto	  fibronectin	  coated	  12-­‐well	  plates	  (2D)	  and	  
Alvetex®Scaffold	   (insert/12-­‐well	   plate/submerged)	   at	   a	   density	   of	   0.3	   million	   cells.	   Cells	   were	  
cultured	  for	  2	  days	  in	  Rat	  Culture	  Media.	  After	  this	  period	  culture	  media	  samples	  were	  assessed	  
for	   albumin	   and	   urea.	   Data	   was	   normalised	   against	   total	   DNA	   extracted	   from	   the	   2D	   and	   3D	  
samples	   using	   the	   PicoGreen®	   assay.	   Figure	   4.21	   shows	   the	   albumin	   production	   of	   2D	   and	   3D	  
primary	   rat	   hepatocytes	   determined	   by	   a	   rat-­‐albumin	   specific	   ELISA.	   A	   greater	   production	   of	  
albumin	   synthesis	   for	   3D	   hepatocytes	   is	   observed	   after	   2	   days	   culture	   compared	   to	   2D.	   Figure	  
4.22	  shows	  the	  urea	  synthesis	  of	  2D	  and	  3D	  primary	  rat	  hepatocytes	  determined	  by	  a	  colorimetric	  
urea	   assay.	   A	   greater	   production	   of	   urea	   for	   3D	   hepatocytes	   is	   observed	   after	   2	   days	   culture	  
compared	  to	  2D.	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Figure	   4.21	  Albumin	   synthesis	   of	   primary	   rat	   hepatocytes	   cultured	   in	   2D	   and	   3D	   determined	   by	   a	   rat-­‐
specific	  albumin	  ELISA.	  Cells	  were	  cultured	  for	  2	  days	  before	  analysis.	  (A):	  Standard	  curve	  using	  known	  rat-­‐
albumin	  concentrations	  used	  to	  correlate	  absorbance	  with	  albumin	  level.	  (B):	  Albumin	  levels	  for	  2D	  and	  3D	  
cultures.	   Data	   was	   normalised	   against	   total	   DNA,	   quantified	   using	   the	   PicoGreen®	   assay.	   A	   significantly	  
greater	  amount	  of	  albumin	  was	  produced	  for	  3D	  cultures	  compared	  to	  2D.	  Data	  represents	  mean	  ±	  s.e.m.	  
(n=3).	  *	  denotes	  p	  <	  0.05	  as	  determined	  by	  the	  Student’s	  t-­‐test.	  
	  
Figure	   4.22	   Urea	   synthesis	   of	   primary	   rat	   hepatocytes	   cultured	   in	   2D	   and	   3D	   determined	   by	   a	   urea	  
colorimetric	   assay.	  Cells	  were	   cultured	   for	   2	  days	  before	   analysis.	   (A):	   Standard	   curve	  using	   known	  urea	  
concentrations	  used	  to	  correlate	  absorbance	  with	  urea	  level.	  (B):	  Urea	  levels	  for	  2D	  and	  3D	  cultures.	  Data	  
was	  normalised	  against	  total	  DNA,	  quantified	  using	  the	  PicoGreen®	  assay.	  A	  significantly	  greater	  amount	  of	  
urea	  was	  produced	   for	  3D	  cultures	  compared	   to	  2D.	  Data	   represents	  mean	  ±	  s.e.m.	   (n=3).	  *	  denotes	  p	  <	  
0.05	  as	  determined	  by	  the	  Student’s	  t-­‐test.	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4.3.4 Hepatocyte	  Function	  (3D	  Static	  versus	  3D	  Perfused)	  
Hepatocyte	   function	  was	   also	   compared	   between	   3D	   static	   and	   3D	   perfused	  media	   conditions.	  
Upcyte®	   hepatocytes	  were	   seeded	   onto	  Alvetex®Scaffold	   (insert/12-­‐well	   plate/submerged)	   at	   a	  
density	  of	  0.5	  million	  cells	  and	  the	  culture	  was	  allowed	  to	  establish	  for	  24	  hours.	  Media	  perfusion	  
was	  then	  applied	  using	  the	  Reinnervate	  Perfusion	  Plate	  with	  a	  media	  flow	  of	  200	  µL/min.	  Samples	  
were	  either	  treated	  with	  0.1	  %	  DMSO	  or	  0.1	  %	  DMSO	  +	  20	  µM	  rifampicin	  (an	  inducer	  of	  CYP3A4	  
activity).	  Cells	  were	  cultured	  for	  7	  days	  under	  perfused	  and	  static	  conditions.	  Figure	  4.23	  shows	  
the	   difference	   in	   glucose	   consumption	   across	   the	   entire	   culture	   period.	   The	   greater	   volume	   of	  
culture	  media	  offered	  by	  the	  perfused	  conditions	  compared	  to	  the	  static	  (120	  mL	  compared	  to	  4	  
mL)	   ensures	   that	   the	   hourly	   change	   in	   media	   glucose	   is	   smaller	   for	   the	   perfused	   system.	   This	  
suggests	  that	  a	  more	  steady	  state	  glucose	  environment	  is	  offered	  by	  the	  perfused	  media	  culture.	  
	  
Figure	  4.23	  Hourly	   change	   in	  media	  glucose	   for	  3D	  static	  and	  3D	  perfused	  Upcyte®	  cultures.	  Cells	  were	  
cultured	   for	  7	  days	  and	   the	   change	   in	  glucose	   consumption	  monitored.	  A	  much	  greater	   change	   in	  media	  
glucose	  for	  the	  static	  culture	  (4	  mL	  media)	  is	  observed	  compared	  to	  the	  perfused	  culture	  (120	  mL	  media).	  
This	   suggests	   that	   the	   perfused	   conditions	   offer	   a	   more	   steady	   state	   glucose	   environment	   for	   cells	  
compared	  to	  static	  conditions.	  Data	  represents	  mean	  ±	  s.e.m.	  (n=4).	  *	  denotes	  p	  <	  0.05	  as	  determined	  by	  
the	  Student’s	  t-­‐test.	  
	  
Total	  protein	  was	  compared	  at	  the	  end	  of	  the	  7	  day	  static	  and	  perfused	  culture	  period	  to	  assess	  
differences	   in	  Upcyte®	   proliferation.	   Data	   from	   the	   Bradford	   assay	   is	   shown	   in	   Figure	   4.24.	   No	  
significant	   differences	   were	   observed	   between	   total	   protein	   content	   for	   static	   and	   perfused	  
cultures,	   suggesting	   that	   a	   7	   day	   media	   perfusion	   does	   not	   significantly	   enhance	   Upcyte®	  
proliferation.	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Figure	   4.24	   Total	   protein	   content	   for	   3D	   Upcyte®	   cells	   cultured	   under	   static	   and	   perfused	   media	  
conditions	  on	  Alvetex®Scaffold	  for	  7	  days.	  (A):	  Standard	  curve	  with	  known	  protein	  (Bovine	  Serum	  Albumin,	  
BSA)	  levels	  was	  used	  to	  correlate	  Bradford	  assay	  absorbance	  with	  protein	  content.	  (B):	  Total	  protein	  levels	  
for	  static	  and	  perfused	  media	  conditions.	  Data	  represents	  mean	  ±	  s.e.m.	  (n=2).	  	  
	  
CYP3A4	   activity	   was	   also	   assessed	   under	   static	   and	   perfused	   media	   conditions	   using	   the	  
testosterone	  assay.	  Cells	  were	  cultured	  for	  7	  days	  under	  static	  and	  perfused	  media	  conditions	  and	  
then	   incubated	   in	   250	  µM	   testosterone	   for	   1	   hour.	   Samples	   were	   then	   frozen	   and	   shipped	   to	  
Medicyte	   (Germany)	   for	   analysis	   of	   a	   testosterone	   metabolite	   (6-­‐β-­‐OH-­‐testosterone)	   via	   high	  
performance	   liquid	   chromatography	   (HPLC).	   Figure	   4.25	   shows	   a	   significantly	   higher	   CYP3A4	  
activity	  compared	  to	  static	  cultures	  for	  the	  DMSO	  control.	  This	  difference	  is	  not	  observed	  for	  the	  
induced	   (rifampicin)	   treatments,	   and	   may	   be	   due	   to	   rifampicin	   already	   pushing	   CYP3A4	   up	   to	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Figure	  4.25	  CYP3A4	  activity	  of	  3D	  Upcyte®	  cells	  cultured	  under	  static	  and	  perfused	  media	  conditions	  on	  
Alvetex®Scaffold	   for	   7	   days.	   (A):	   Standard	   curve	   with	   known	   testosterone	   metabolite	   (6-­‐β-­‐OH-­‐
testosterone)	   levels	  used	   to	   correlate	  HPLC	  peak-­‐area-­‐ratio	  with	  CYP3A4	  activity.	   (B):	   CYP3A4	  activity	   for	  
static	   and	   perfused	   media	   conditions.	   Data	   represents	   mean	   ±	   s.e.m.	   (n=4).	   *	   denotes	   p	   <	   0.05	   as	  
determined	  by	  the	  Student’s	  t-­‐test.	  
	  
4.3.5 Hepatocyte	  Gene	  Expression	  
HepG2	   cells	   were	   seeded	   onto	   fibronectin	   coated	   12-­‐well	   plates	   (2D)	   and	   Alvetex®Scaffold	  
(insert/12-­‐well	  plate/submerged)	  at	  a	  density	  of	  0.3	  million	  cells.	  Cells	  were	  cultured	  for	  24	  hours	  
in	  standard	  culture	  media	  before	  being	  treated	  with	  either	  nil-­‐APAP	  media	  (Basal)	  or	  10	  mM	  APAP	  
media	   for	   an	  additional	   24	  hours.	  Cells	  were	   then	  assessed	   for	   gene	  expression	  using	  a	  Qiagen	  
RNA	   isolation	   kit	   and	   TaqMan®	   gene	   expression	   probes	   for	   CYP1A2,	   CYP2E1,	   CYP3A4,	   GSTP1,	  
UGT1A1,	   ABCB1	   and	  ABCC2.	   All	   gene	   expression	   data	  was	   referenced	  versus	   the	   housekeeping	  
gene	  glyceraldehyde	  3-­‐phosphate	  dehydrogenase	  (GAPDH).	  
Figure	  4.26	  shows	  the	  gene	  expression	  of	  CYP1A2,	  CYP2E1	  and	  CYP3A4.	  A	  significant	   increase	   in	  
CYP2E1	  expression	  was	  observed	   for	  3D	  cells	   compared	   to	  2D	   for	  both	  basal	   and	  10	  mM	  APAP	  
conditions.	  However	  this	  difference	  is	  relatively	  small	  (ca.	  a	  2-­‐fold	  increase).	  Relatively	  large	  error	  
bars	  were	  observed	  for	  CYP3A4	  and	  CYP1A2,	  however	  this	  could	  be	  expected	  given	  that	  the	  data	  
represent	  means	  of	  three	  biological	  (external)	  repeats.	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Figure	  4.26	  HepG2	  gene	  expression	  for	  CYP	  enzymes	  when	  cultured	  under	  2D	  and	  3D	  (Alvetex®Scaffold)	  
conditions.	   (A):	  Basal	  media	  supply.	  (B):	  10	  mM	  APAP	  media	  supply.	  A	  significant	  increase	  in	  CYP2E1	  gene	  
expression	   is	  observed	   for	  3D	  cultures	  compared	   to	  2D,	  however	   this	  difference	   is	   relatively	   small	   (ca.	  2-­‐
fold).	  Data	  represents	  mean	  ±	  s.e.m.	  (n=3).	  *	  denotes	  p	  <	  0.05	  as	  determined	  by	  the	  Student’s	  t-­‐test.	  
	  
Figure	  4.27	  shows	   the	  gene	  expression	  of	  GSTP1	  and	  UGT1A1	   for	  2D	  and	  3D	  HepG2	  cultures.	  A	  
significant	  and	  substantial	  increase	  is	  observed	  in	  GSTP1	  for	  3D	  cells	  compared	  to	  2D	  (73-­‐fold	  for	  
basal	  and	  99-­‐fold	  for	  10	  mM	  APAP).	  Similarly,	  a	  significant	  increase	  is	  observed	  in	  UGT1A1	  for	  3D	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Figure	  4.27	  HepG2	  gene	  expression	  for	  phase	  II	  drug	  metabolising	  enzymes	  when	  cultured	  under	  2D	  and	  
3D	   (Alvetex®Scaffold)	   conditions.	   (A):	   Basal	  media	   supply.	   (B):	   10	  mM	  APAP	  media	   supply.	   A	   significant	  
increase	   in	   phase	   II	   drug	   enzyme	   gene	   expression	   is	   observed	   for	   3D	   cultures	   compared	   to	   2D.	   Data	  
represents	  mean	  ±	  s.e.m.	  (n=3).	  *	  denotes	  p	  <	  0.005	  as	  determined	  by	  the	  Student’s	  t-­‐test.	  
Figure	   4.28	   shows	   the	   gene	   expression	   of	   ABCB1	   and	  ABCC2	   for	   2D	   and	   3D	  HepG2	   cultures.	   A	  
significant	   increase	   in	  ABCC2	  expression	   is	  observed	  for	  3D	  cells	  compared	  to	  2D	  for	  both	  basal	  
and	  10	  mM	  APAP	  conditions.	  However	  this	  difference	  is	  relatively	  small	  (less	  than	  2-­‐fold	  increase).	  
	  
	  
Figure	  4.28	  HepG2	  gene	  expression	  for	  phase	  III	  drug	  transporter	  proteins	  when	  cultured	  under	  2D	  and	  
3D	  (Alvetex®Scaffold)	  conditions.	  (A):	  Basal	  media	  supply.	  (B):	  10	  mM	  APAP	  media	  supply.	  A	  significant	  but	  
small	   increase	   in	   gene	   expression	   is	   observed	   for	   3D	   cultures	   compared	   to	   2D.	   Data	   represents	  mean	   ±	  
s.e.m.	  (n=3).	  *	  denotes	  p	  <	  0.05	  as	  determined	  by	  the	  Student’s	  t-­‐test.	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4.4 Discussion	  
It	  is	  known	  that	  cell	  morphology	  influences	  gene	  expression	  and	  function50,	  51.	  Several	  groups	  have	  
demonstrated	   this	   for	   hepatocytes:	   Mooney	   et	   al.	   comprehensively	   showed	   that	   hepatocyte	  
shape	  alone	  can	  influence	  gene	  expression	  and	  protein	  secretion,	  independent	  of	  changes	  to	  cell-­‐
cell	  contact197.	  Pioneering	  work	  from	  LeCluyse	  et	  al.	  and	  Dunn	  et	  al.	  showed	  that	  a	  3D	  hepatocyte	  
morphology	  is	  crucial	  for	  bile	  canaliculi	  formation	  and	  the	  maintenance	  of	  hepatic	  function	  using	  
sandwich	  culture76,	  176.	  Sawamoto	  et	  al.	  showed	  that	  by	  reducing	  hepatocyte	  spreading	  across	  2D	  
polystyrene	  it	  is	  possible	  to	  prolong	  native	  hepatic	  enzyme	  activity198.	  Similarly,	  hepatic	  cell	  lines	  
grown	  in	  hydrogels	  have	  also	  been	  shown	  to	  display	  more	  realistic	  gene	  expression	  levels	  as	  they	  
adopt	  a	  round	  morphology199,	  200.	  	  
This	   study	   compared	   hepatocyte	   morphology	   in	   Alvetex®Scaffold	   and	   Alvetex®Strata	   with	   2D	  
cultures.	   Confocal	   immunofluorescence	   microscopy	   was	   used	   to	   obtain	   optical	   Z-­‐stacks	   to	  
construct	  cell	  morphology	  in	  each	  microenvironment.	  The	  technique	  has	  also	  been	  employed	  by	  
other	  groups	  to	  visualise	  cell	  morphology	  in	  3D	  substrates,	  such	  as	  the	  3D	  shape	  of	  adipose	  stem	  
cells	   in	  3D	  printed	  scaffolds201.	  Results	  from	  this	  study	  showed	  that	  those	  cells	   in	  scaffolds	  were	  
able	   to	   adopt	   a	  more	   rounded	   (cuboidal)	   shape	   that	   is	  more	   consistent	  with	   those	   in	   vivo.	   Cell	  
height	   was	   found	   to	   be	   approximately	   equal	   to	   cell	   length	   and	   width.	   Nuclei	   were	   also	   more	  
rounded	  in	  scaffolds	  compared	  to	  2D.	  The	  F-­‐actin	  filaments	  for	  cells	  in	  Alvetex®Scaffold	  were	  not	  
stretched	  out	  and	  appeared	  to	  wrap	  around	  the	  nuclei	  in	  a	  3D	  manner.	  For	  Alvetex®Strata,	  where	  
there	   is	   an	   abundance	   of	   cell-­‐cell	   contact,	   F-­‐actin	   filaments	   were	   also	   not	   stretched	   and	  were	  
found	  close	  to	  the	  nuclei,	  but	  were	  also	  localised	  at	  the	  junctions	  where	  cells	  are	  in	  contact	  with	  
one	  another.	  On	  the	  contrary,	  F-­‐actin	  filaments	  in	  2D	  cultures	  were	  severely	  stretched	  out	  across	  
the	   XY	   plane.	   Very	   little	   F-­‐actin	   staining	   was	   present	   above	   the	   nuclei	   in	   the	   Z	   plane.	   It	   is	  
hypothesised	   this	   distorted	   F-­‐actin	   arrangement	   in	   2D	   would	   be	   inappropriate	   for	   hepatocyte	  
polarisation	  towards	  surface	  microvilli	  at	  the	  sinusoidal	  domain.	  	  
The	  morphology	  of	  hepatocytes	  in	  scaffolds	  was	  also	  assessed	  via	  SEM.	  Neuhaus	  et	  al.	  used	  SEM	  
to	   show	   that	   hepatocytes	   adopt	   a	   3D	  morphology	   in	   a	  multi-­‐compartment	   system202.	   Similarly	  
Vacanti	  et	  al.	  demonstrated	  that	  hepatocytes	  adopt	  a	  3D	  architecture	  in	  biodegradable	  polymeric	  
scaffolds	  using	  SEM203.	  SEM	  has	  also	  been	  used	  to	  show	  hepatocytes	  adopt	  a	  3D	  morphology	   in	  
electrospun	  scaffolds105.	  This	  study	  used	  SEM	  to	  probe	  hepatocyte	  morphology	  and	  structure	   in	  
2D	   and	   polystyrene	   scaffolds.	   Hepatocytes	   grown	   in	   2D	   severely	   spread	   out	   across	   the	   plastic.	  
Hepatocytes	  in	  Alvetex®Scaffold	  seemed	  to	  display	  a	  more	  rounded	  morphology	  within	  the	  voids	  
of	   the	   scaffold.	   For	   Alvetex®Strata,	   hepatocytes	   formed	   a	   thick	   3D	   tissue	   mass	   on	   top	   of	   the	  
material	  with	  optimal	  cell-­‐cell	  contact,	  very	  similar	  to	  what	  was	  observed	  for	   in	  vivo	  mouse	  liver.	  
The	  formation	  of	  a	  thick	  tissue	  mass	  is	  not	  often	  observed	  for	  other	  3D	  technologies.	  For	  example,	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hepatocytes	  grown	  on	  top	  of	  electrospun	  scaffolds	  still	  only	  managed	  to	  form	  individual	  pockets	  
of	  3D	  cell	  growth	  that	  lacked	  extensive	  3D	  organisation105.	  	  
In	   summary,	   hepatocytes	   in	   Alvetex®Scaffold	   and	   Alvetex®Strata	   adopt	   a	   3D	   morphology	  
representative	   of	   their	   native	   environment.	   As	   cell	   morphology	   is	   important	   for	   normal	  
hepatocyte	   genotype	   and	   phenotype,	   it	   is	   expected	   that	   Alvetex®Scaffold	   and	   Alvetex®Strata	  
should	   help	   to	   improve	   the	   physiological	   relevance	   of	   in	   vitro	   hepatocyte	  models	   used	   in	   drug	  
discovery.	  	  
	  
Hepatocyte	  ultrastructure	  is	  crucial	  for	  function.	  The	  formation	  of	  bile	  canaliculi	  as	  a	  result	  of	  cell	  
polarisation	  plays	  a	  vital	  role	  in	  the	  secretion	  and	  transport	  of	  bile,	  as	  well	  as	  in	  drug	  elimination	  
(see	  Chapter	  1).	  Failure	  to	  form	  these	  structures	  in	  vivo	  results	  in	  cholestasis	  and	  liver	  damage204.	  
Accordingly,	   it	   is	   also	  well	   known	   that	  hepatocytes	   cultured	   in	  2D	   fail	   to	  mimic	   these	  extensive	  
bile	   canaliculi	   networks80.	   This	   is	   therefore	  a	  major	   limitation	   in	   appropriately	  mimicking	  native	  
liver	   function	   using	   2D	   models.	   Unsurprisingly,	   several	   groups	   have	   attempted	   to	   use	   3D	  
substrates	  as	  a	  tool	  to	  encourage	  bile	  canaliculi	  formation	  in	  vitro.	  Sandwich	  cultures	  are	  proving	  
very	   beneficial	   for	   studying	   bile	   canaliculi	   formation	   and	   regulation205.	   Hydrogels	   have	   been	  
shown	   to	   encourage	   bile	   canaliculi	   formation	   for	   HepG2	   cells,	   with	   the	   canaliculi	   containing	  
specific	  drug	  transporter	  proteins	  (MDR1	  and	  MRP2)206.	   Interestingly,	  no	  reports	  could	  be	  found	  
on	  the	  formation	  of	  extensive	  bile	  canaliculi	  networks	  in	  electrospun	  scaffolds,	  probably	  because	  
3D	  cell	  growth	  is	  restricted	  to	  where	  the	  nodes	  of	  the	  fibres	  overlap.	  
This	   study	   used	   TEM	   to	   probe	   for	   hepatocyte	   ultrastructure	   in	   vivo	   and	   in	   vitro.	  As	   expected,	  
mouse	   liver	   appeared	   healthy	   with	   all	   the	   appropriate	   organelles.	   Sinusoidal	   microvilli	   were	  
observed	   protruding	   into	   the	   sinusoidal	   lumen.	   Bile	   canaliculi	   were	   observed	   containing	  
appropriate	  tight	  junction	  complexes	  and	  microvilli.	  Most	  of	  the	  key	  organelles	  appeared	  round.	  
In	   contrast,	   2D	   in	   vitro	   cultures	   displayed	   only	   sparse	   sinusoidal	   microvilli.	   Furthermore,	   no	  
advanced	  bile	  canaliculi	  were	  observed.	  This	  is	  supported	  by	  the	  lack	  of	  positive	  MDR1	  and	  MRP2	  
staining.	   Some	   of	   the	   organelles,	   particularly	   the	   nucleus	   and	   some	   mitochondria,	   appeared	  
flattened	  in	  comparison	  to	  native	  liver	  tissue.	  
Hepatocytes	  grown	  on	  Alvetex®Scaffold	  showed	  frequent	  signs	  of	  sinusoidal	  microvilli.	  They	  also	  
showed	   signs	   of	   bile	   canaliculi,	   consistent	   with	   the	   positive	   staining	   for	   MRP2	   and	   previous	  
reports	   of	   HepG2	   growth	   on	   polystyrene	   scaffolds150.	   The	  morphology	   of	   the	   cells	   and	   internal	  
organelles	   also	   resembled	   the	   round	  morphology	   of	   those	   found	   in	   native	  mouse	   liver.	   It	   was	  
observed	   that	   the	   scaffold	   walls	   were	   able	   to	   support	   hepatocytes	   across	  multiple	   surfaces	   to	  
encourage	  a	  3D	  morphology.	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Hepatocytes	   grown	  on	  Alvetex®Strata	  were	   also	  more	   round	   in	  morphology.	   They	   appeared	   to	  
experience	  extensive	  cell-­‐cell	  contact	  within	  the	  tissue	  mass.	  Abundant	  sinusoidal	  microvilli	  were	  
observed,	   as	   well	   as	   the	   formation	   of	   lumen-­‐type	   structures.	   This	   suggests	   that	   hepatocytes	  
grown	  in	  a	  3D	  scaffold-­‐less	  manner	  may	  be	  capable	  of	  structural	  re-­‐organisation	  towards	  features	  
resembling	   native	   liver.	   Such	   re-­‐organisation	   processes	   towards	   lumen	   and/or	   bile-­‐ductular	  
structures	  have	  previously	  been	   reported	   for	   spheroidal	  aggregate	  cultures82.	  Here	   some	  of	   the	  
cells	   within	   the	   aggregates	   spontaneously	   re-­‐organised	   to	   form	   lumens.	   Not	   only	   this,	   cells	  
displayed	  a	  different	  secretion	  of	  ECM	  components	  depending	  on	  whether	  they	  were	  part	  of	  the	  
lumen	  structure	  or	  not.	  Other	  groups	  have	  also	  reported	  the	  formation	  of	  lumen-­‐type	  structures	  
for	  hepatocytes	  in	  Matrigel®207.	  
An	   abundance	   of	   advanced	   bile	   canaliculi	   features	   were	   observed	   for	   hepatocytes	   in	  
Alvetex®Strata	  for	  those	  cells	  close	  to	  the	  media	  supply	  in	  the	  bottom	  portion	  of	  the	  scaffold.	  This	  
is	  consistent	  with	  the	  observed	  positive	  staining	  for	  MDR1	  and	  MPR2.	  However,	  those	  cells	  near	  
the	  top	  portion	  of	   the	  scaffold	  showed	  clear	  signs	  of	  cell	  necrosis,	  consistent	  with	  the	  histology	  
and	  flow	  cytometry	  data	  shown	  in	  Chapter	  3.	  
	  
Understanding	   if	   the	   structural	  differences	  between	  2D	  and	  3D	  cells	   in	   vitro	   are	   translated	   into	  
functional	   and	   genetic	   improvements	   is	   a	   key	   part	   of	   in	   vitro	  model	   validation.	   This	   study	   first	  
showed	  that	  the	  glucose	  consumption	  between	  2D	  and	  3D	  hepatocyte	  culture	  is	  different.	  Cells	  in	  
3D	   appeared	   to	   consume	  more	   glucose	   than	   their	   2D	   counterparts.	   This	  may	   be	   attributed	   to	  
either	   an	   increase	   in	   respiration	   (metabolic	   activity)	   or	   an	   increase	   in	   glycogen	   synthesis.	   The	  
latter	   of	   these	   has	   previously	   been	   observed	   in	   3D	   cultures208.	   However,	   without	   further	  
experiments	  it	  is	  difficult	  to	  determine	  which	  mechanism	  is	  occurring	  here.	  	  	  	  
Albumin	  synthesis	  and	  urea	  synthesis	  are	  key	  indicators	  of	  hepatic	  function.	  Several	  groups	  have	  
shown	   that	   3D	   cultures	   help	   to	   increase	   albumin	   and	   urea	   compared	   to	   2D.	   For	   example	  
hepatocytes	   grown	   on	   electrospun	   scaffolds	   have	   shown	   enhanced	   albumin	   and	   urea208.	  
Hepatocytes	   grown	   in	   3D	   micro-­‐plates	   have	   shown	   increased	   albumin209.	   Other	   groups	   have	  
explored	  hydrogels	  as	  a	  means	  of	  increasing	  hepatocyte	  albumin	  in	  vitro210.	  In	  this	  study	  we	  have	  
shown	   that	   scaffolds	   such	   as	   the	   Alvetex®Scaffold	   also	   help	   to	   increase	   albumin	   and	   urea	  
synthesis	  over	  conventional	  2D	  cultures.	  
	  
HepG2	   response	   to	   acetaminophen	   (APAP)	   is	   different	   in	   scaffolds	   and	   2D.	   HepG2	   cells	   in	   3D	  
appear	  more	   resistant	   to	   the	   drug,	   suggesting	   an	   increased	   elimination/detoxification	   capacity.	  
Unfortunately	   there	   are	   very	   limited	   in	   vivo	   reports	   of	   how	   hepatocellular	   carcinoma	   patients	  
respond	   to	  APAP,	  however	   some	   reports	  have	  demonstrated	   increased	  elimination	   in	   the	  urine	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via	  an	  up	  regulation	  of	  SULT1A1	  activity211.	  Although	  not	  directly	  comparable,	  this	  does	  provide	  a	  
preliminary	  indication	  that	  3D	  HepG2	  cultures	  are	  at	  least	  moving	  in	  the	  right	  direction	  for	  more	  
predictive	  in	  vivo	  response.	  Interestingly,	  this	  trend	  is	  the	  reverse	  to	  what	  is	  observed	  for	  healthy	  
primary	  hepatocytes	  exposed	  to	  APAP	  in	  2D	  and	  3D.	  Primary	  hepatocytes	  cultured	  in	  collagen	  gels	  
are	   more	   sensitive	   to	   APAP	   compared	   to	   2D212.	   Indeed,	   primary	   hepatocytes	   cultured	   in	  
Alvetex®Scaffold	  are	  also	  more	  sensitive	  to	  APAP	  compared	  to	  2D159.	   	  The	  hypothesis	  as	  to	  why	  
HepG2	  cells	  are	  more	  resistant	  to	  APAP	  in	  3D,	  whereas	  primary	  cells	  are	  more	  sensitive	  to	  APAP	  in	  
3D	  may	  be	  due	  to	  the	  difference	  in	  genotype	  and	  phenotype	  between	  these	  two	  types	  of	  cells.	  It	  
is	   well	   known	   that	   HepG2	   cells	   have	   an	   almost	   negligible	   set	   of	   cytochrome	   P450	   enzymes,	  
whereas	   primary	   cells	   have	   a	   near	   complete	   set187.	   Conversely,	   HepG2	   cells	   have	   reasonable	  
levels	   of	   phase	   II	   enzymes,	   similar	   to	  primary	   cells213.	   It	   can	   therefore	  be	  hypothesised	   that	   3D	  
HepG2	  culture	  serves	   to	   increase	   the	  expression	  and	  activity	  of	  phase	   II	  enzymes,	   leading	   to	  an	  
increased	  drug	  elimination	  process	  compared	  to	  2D.	  With	  primary	  hepatocytes,	   it	   is	  known	  that	  
3D	   culture	   increases	   cytochrome	   P450	   activity32.	   Consequently	   it	   is	   expected	   that	   primary	   3D	  
cultures	  are	  more	  exposed	   to	   the	   formation	  of	   toxic	  NAPQI	  and	  are	   thus	  more	   sensitive	   to	   the	  
drug.	  
HepG2	   response	   to	   Gemfibrozil	   was	   also	   different	   in	   scaffolds	   compared	   to	   2D.	   Cells	   in	   3D	  
appeared	  more	  resistant	  compared	  to	  2D,	  consistent	  with	  the	  APAP	  data.	  As	  Gemfibrozil	   is	   first	  
metabolised	  by	  the	  UGT	  family,	  it	  is	  hypothesised	  that	  3D	  culture	  helps	  to	  increase	  the	  activity	  of	  
the	  phase	  II	  enzymes	  and	  thus	  increase	  the	  ability	  of	  the	  cells	  to	  detoxify	  and	  eliminate	  the	  drug.	  
	  
Gene	  expression	  of	   the	  drug	  metabolising	  enzymes	  was	  compared	  between	  2D	  and	  3D	  cultures	  
for	  HepG2	  cells.	  Some	  small	  increases	  in	  cytochrome	  P450	  enzyme	  expression	  were	  observed	  for	  
3D	   cultures	   compared	   to	  2D.	  However,	   given	   that	  HepG2	  cells	   already	  have	  a	   very	   low	   level	  of	  
these	  enzymes	  to	  begin	  with,	  and	  that	  genetic	  changes	  do	  not	  necessary	  translate	  into	  phenotypic	  
changes,	  it	  is	  not	  expected	  that	  these	  cytochrome	  P450	  changes	  would	  have	  a	  profound	  effect	  on	  
HepG2	  function.	  In	  the	  context	  of	  APAP	  metabolism,	  it	  is	  not	  expected	  that	  these	  small	  increases	  
in	  CYP	  gene	  expression	  would	  lead	  to	  increased	  NAPQI	  formation	  and	  thus	  drug	  toxicity.	  
Conversely,	  large	  increases	  in	  phase	  II	  enzyme	  expression	  was	  observed	  for	  3D	  cultures	  (as	  much	  
as	   100-­‐fold).	   Such	   large	   changes,	   if	   translated	   into	   enzyme	   activity,	   could	   be	   sufficient	   to	   alter	  
cellular	   function.	   In	   the	   context	   of	   APAP	   and	   Gemfibrozil	   metabolism,	   it	   is	   possible	   that	   these	  
increases	  in	  gene	  expression	  could	  be	  sufficient	  to	  increase	  the	  detoxification	  and	  elimination	  of	  
these	  drugs,	  potentially	  explaining	  why	  cells	   in	  3D	  appeared	  to	  be	  more	  resistant	  to	  these	  drugs	  
compared	  to	  their	  2D	  counterparts.	  Only	  small	   increases	  were	  observed	   in	  phase	   III	   transporter	  
proteins.	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This	   study	   also	   compared	   the	   function	   of	   hepatocytes	   cultured	   in	   scaffolds	   under	   static	   and	  
perfused	   media	   conditions.	   Several	   groups	   have	   explored	   this	   using	   other	   3D	   technologies.	  
Perfusion	  through	  3D-­‐printed	  scaffolds	  has	  been	  shown	  to	  enhance	  albumin	  synthesis	  compared	  
to	   static	   media	   conditions214.	   Increased	   albumin	   synthesis	   has	   also	   been	   observed	   for	   3D	  
perfusion	  using	  scaffolds	  fabricated	  from	  gas-­‐foaming215.	  This	  study	  demonstrated	  an	  increase	  in	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4.5 Conclusions	  
The	  following	  conclusions	  can	  be	  made	  from	  the	  results	  of	  this	  Chapter:	  
	  
• Hepatocytes	   cultured	   in	   scaffolds	   adopt	   a	   more	   rounded,	   native-­‐like	   morphology	  
compared	  to	  those	  cultured	  in	  2D.	  Cell	  height	  in	  3D	  culture	  is	  approximately	  equal	  to	  cell	  
width	   and	   length.	   Conversely	   for	   2D	   cell	   culture,	   cell	   height	   is	   much	   smaller	   than	   cell	  
width	  and	  length	  as	  the	  cell	  flattens	  out	  across	  the	  plastic.	  
	  
• Cell-­‐cell	  contact	   increases	  from	  cultures	   in	  2D	  to	  cultures	   in	  Alvetex®Scaffold	  to	  cultures	  
in	  Alvetex®Strata.	   Those	   hepatocytes	   grown	  on	   top	   of	   Alvetex®Strata	   display	  maximum	  
cell-­‐cell	  contact	  across	  all	  cell	  surfaces,	  similar	  to	  hepatocytes	  found	  in	  native	  mouse	  liver.	  
	  
• Evidence	  of	  drug	  transporter	  proteins	  known	  to	  localise	  at	  the	  bile	  canaliculi	  membranes	  
were	  found	  in	  2D	  cultures,	  Alvetex®Scaffold	  and	  Alvetex®Strata.	  Alvetex®Strata	  displayed	  
the	  most	  positive	  staining	  for	  the	  drug	  transporter	  proteins.	  
	  
• TEM	   analysis	   of	   2D	   hepatocyte	   ultrastructure	   revealed	   that	   2D	   cultures	   adopt	   a	   flat	  
morphology	   with	   distorted	   organelles.	   Cells	   showed	   only	   sporadic	   surface	   microvilli.	  
There	  was	  a	  noticeable	  absence	  of	  advanced	  bile	   canaliculi	   containing	  appropriate	   tight	  
junctions	  and	  microvilli.	  Cell	  contact	  was	  restricted	  to	  the	  edges	  of	  the	  cells	  to	  the	  extent	  
where	  cells	  appeared	  to	  crawl	  around	  one	  another	  to	  improve	  cell-­‐cell	  contact.	  	  
	  
• TEM	   analysis	   of	   hepatocytes	   in	   Alvetex®Scaffold	   showed	   that	   the	   shape	   of	   cells	   and	  
organelles	  were	  representative	  of	  in	  vivo.	  Moreover,	  this	  cell	  shape	  was	  supported	  by	  the	  
scaffold	   architecture.	   Surface	   microvilli	   were	   frequently	   observed	   for	   cells	   in	  
Alvetex®Scaffold.	  Advanced	  bile	  canaliculi	  features	  containing	  appropriate	  tight	  junctions	  
and	  microvilli	  were	  also	  observed.	  
	  
• TEM	  analysis	  of	  hepatocytes	  on	  Alvetex®Strata	  also	   showed	   that	   the	   shape	  of	   cells	   and	  
organelles	   were	   representative	   of	   in	   vivo.	   Abundant	   surface	   microvilli	   were	   observed	  
protruding	   into	   lumen-­‐type	   structures,	   suggesting	   some	   primitive	   signs	   of	   structural	  
reorganisation.	  Abundant	  bile	  canaliculi	  were	  observed	  for	  hepatocytes	  in	  Alvetex®Strata.	  
	  	  
• Hepatocyte	   function	   is	   different	   in	   scaffolds	   compared	   to	   2D	   culture.	   HepG2	   cells	   are	  
more	   resistant	   to	   acetaminophen	   and	   Gemfibrozil	   in	   scaffolds	   compared	   to	   2D.	   This	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correlates	  to	  increased	  gene	  expression	  of	  the	  phase	  II	  drug	  metabolising	  enzymes	  in	  3D	  
compared	   to	   2D.	   It	   is	   hypothesised	   that	   the	   increased	   gene	   expression	   translates	   into	  
increased	   enzyme	   activity	   and	   thus	   a	   greater	   capacity	   of	   the	   cells	   to	   detoxify	   and	  
eliminate	  the	  drug.	  
	  
• Primary	  rat	  cells	  show	  increased	  albumin	  and	  urea	  synthesis	  in	  scaffolds	  compared	  to	  2D.	  
This	  is	  consistent	  with	  data	  from	  other	  3D	  hepatocyte	  culture	  systems.	  
	  
• Hepatocytes	   cultured	   in	   scaffolds	   under	   perfused	   media	   conditions	   appear	   to	   show	  
increased	  basal	  CYP3A4	  activity	  compared	  to	  static	  cultures	  after	  7	  days	  culture.	  Inducing	  
CYP3A4	  activity	   in	   the	  3D	  cultures	   removes	  any	  difference	  between	  perfused	  and	   static	  
cultures	  with	  regards	  to	  CYP3A4	  activity.	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5.1 Introduction	  
5.1.1 Overview	  
One	  of	  the	  potential	  limitations	  of	  emulsion	  templated	  polystyrene	  scaffolds	  as	  substrates	  for	  3D	  
cell	  growth	  is	  surface	  chemistry.	  Cells	  in	  vivo	  are	  surrounded	  by	  a	  complex	  ECM	  that	  contributes	  
to	  cell	  anchorage,	  survival	  and	  function216.	  They	  also	  receive	  a	  plethora	  of	  biochemical	  cues	  from	  
molecules	  such	  as	  carbohydrates	  and	  proteins	  that	  serve	  to	  regulate	  normal	  cell	  behaviour.	  As	  the	  
surface	   of	   synthetic	   polystyrene	   is	   far	   removed	   from	   this,	   the	   ability	   to	   introduce	   ECM	  mimics	  
onto	   the	   scaffold	   surface	   is	   therefore	   an	   attractive	   prospect	   for	   improving	   the	   biochemical	  
relevance	  of	  the	  materials.	  
In	   vivo,	   galactose	   is	   often	   the	   terminal	   carbohydrate	   for	   many	   glycoproteins.	   Hepatocytes	  
specifically	  recognise	  galactose	  via	  the	  asialoglycoprotein	  receptor	  (ASGP-­‐R)217,	  a	  mechanism	  used	  
to	   remove	   various	   glycoproteins	   from	   circulation.	   In	   vitro,	   galactose	   is	   often	   employed	   as	   a	  
surface	  ligand	  for	  enhanced	  hepatocyte	  adhesion	  and	  function	  with	  several	  substrates,	  including	  
2D	   films,	  electrospun	  scaffolds	  and	  hydrogel	   sponges.	  However,	   there	  have	  been	  no	   reports	  on	  
the	   functionalisation	   of	   emulsion	   templated	   polystyrene	   scaffolds	   with	   galactose,	   even	   though	  
these	  materials	  are	  gaining	  significant	  attention	  as	  suitable	  substrates	  for	  3D	  cell	  growth.	  
This	   Chapter	   therefore	   describes	   the	   surface-­‐functionalisation	   of	   an	   emulsion	   templated	  
polystyrene	   scaffold	   with	   galactose	   to	   improve	   the	   biochemical	   relevance	   of	   the	   material,	   as	  
illustrated	   in	  Figure	  5.1.	  Two	  different	   routes	   towards	  galactose	   functionalisation	  are	  described,	  
one	   employing	   ester	   functionalisation	   of	   the	   scaffold	   and	   the	   other	   acid	   functionalisation.	   The	  
ester-­‐functionalised	   polystyrene	   scaffold	   was	   then	   reacted	   with	   a	   galactose-­‐amine	   to	   render	  
galactose	   functionality	   on	   the	   scaffold	   surface.	   The	   impact	   of	   this	   galactose	   functionality	   on	  
hepatocyte	  adhesion	  and	  function	  was	  then	  explored.	  
	  
	  
Figure	   5.1	   Illustration	   of	   an	   emulsion	   templated	   polystyrene	   scaffold	   functionalised	   with	   galactose.	  
Pendent	  galactose	  residues	  (yellow	  circles)	  on	  the	  scaffold	  surface	  were	  hypothesised	  to	  act	  as	  a	  ligand	  for	  
the	  hepatocyte	  ASGP-­‐R,	  improving	  the	  biochemical	  relevance	  of	  the	  material.	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5.1.2 Composition	  of	  Emulsion	  Templated	  Polystyrene	  Scaffolds	  	  
Emulsion	  templated	  polystyrene	  scaffolds	  used	  for	  3D	  cell	  growth	  applications	  are	  prepared	  from	  
water-­‐in-­‐oil	   (w/o)	   HIPEs.	   For	   scaffolds	   like	   the	   Alvetex®Scaffold,	   three	   hydrophobic	   monomers	  
constitute	  the	  external	  oil	  phase	  of	  the	  HIPE,	  namely:	  styrene	  (STY),	  divinylbenzene	  (DVB)	  and	  2-­‐
ethylhexyl	  acrylate	  (EHA)164,	  165.	  STY	  is	  the	  primary	  monomer,	  constituting	  ca.	  60	  wt%	  of	  the	  total	  
monomer	  mixture.	  DVB	  is	  present	  at	  ca.	  10	  wt%	  to	  offer	  chemical	  cross-­‐linking,	  which	   increases	  
the	  mechanical	   strength	  of	   the	  material.	  EHA	   is	  also	  present	  at	  ca.	  30	  wt%	  to	   increase	  polymer	  
elasticity	  by	  reducing	  the	  polymer	  Tg.	  	  The	  non-­‐ionic	  surfactant	  Span80™	  (Sigma)	   is	  often	  used	  to	  
form	  the	  HIPE	  as	  it	  has	  low	  solubility	  in	  the	  aqueous	  droplet	  phase	  and	  so	  inhibits	  emulsion	  phase	  
separation.	   Typically,	   the	   materials	   are	   fabricated	   with	   potassium	   persulfate	   (KPS)	   as	   the	   free	  
radical	   initiator,	   which	   being	   water-­‐soluble,	   favours	   polymerisation	   of	   any	  monomers	   found	   in	  
excess	  at	  the	  interface.	  However,	  alternative	  initiators	  that	  reside	  in	  the	  external	  oil	  phase	  of	  the	  
HIPE	   are	   also	   sometimes	   employed,	   such	   as	   the	   hydrophobic	   initiator	   azobisisobutyronitrile	  
(AIBN).	  	  
	  
5.1.3 Synthetic	  Strategy	  
Attaching	  galactose	  directly	  onto	  the	  surface	  of	  emulsion	  templated	  polystyrene	  scaffolds	  (post-­‐
polymerisation)	   is	   challenging	   due	   to	   the	   relatively	   inert	   nature	   of	   polystyrene.	   This	   study	  
therefore	   employed	   an	   indirect	   route	   to	   galactose	   functionalisation	   via	   first	   incorporating	  
additional	  functionality	  into	  the	  pre-­‐polymerised	  material.	  Pentafluorophenyl	  acrylate	  (PFPA)	  was	  
incorporated	   into	   the	   HIPE	   external	   oil	   phase	   to	   introduce	   pendent	   ester	   functionality	   on	   the	  
scaffold	  surface.	  Alternatively,	  acrylic	  acid	   (Aa)	  was	   incorporated	   into	  the	  HIPE	   internal	  aqueous	  
phase	   to	   introduce	  pendent	  carboxylic	  acid	   functionality	  on	   the	  scaffold	   surface.	  Attachment	  of	  
galactose	   residues	   was	   then	   achieved	   by	   a	   facile	   coupling	   reaction	   between	   the	   ester-­‐
functionalised	   scaffold	   and	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside,	   as	   shown	   in	   Figure	   5.2.	   Note	  
that	   a	   similar	   surface	   reaction	   with	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside	   was	   also	   employed	   to	  
render	  pendent	  glucoses	  to	  provide	  a	  selective	  control	  for	  studies	  with	  the	  hepatocyte	  ASGP-­‐R.	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Figure	  5.2	  Illustration	  showing	  the	  indirect	  strategy	  to	  functionalise	  a	  polystyrene	  scaffold	  with	  galactose.	  
Aa	  or	  PFPA	  were	  incorporated	  into	  the	  styrene	  (STY)	  based	  HIPE	  prior	  to	  polymerisation	  to	  leave	  functional	  
reactive	  sites	  on	  the	  polymeric	  scaffold.	  These	  reactive	  sites	  were	  then	  used	  to	  undergo	  a	   facile	  coupling	  
reaction	  with	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside	  (1)	  to	  render	  pendent	  galactose	  on	  the	  surface.	  A	  similar	  
reaction	  with	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside	  (2)	  was	  used	  to	  render	  pendent	  glucose	  on	  the	  material	  to	  
provide	  a	  useful	   selective	   control	   for	   subsequent	  hepatocyte	  culture	  experiments.	  Reaction	  conditions	   (i)	  
and	  (ii)	  are	  described	  in	  detail	  in	  Chapter	  2.	  	  
	  
PFPA	  was	   chosen	   as	   a	   suitable	   functional	   co-­‐monomer	   to	   introduce	   ester	   reactive	   sites	   on	   the	  
polystyrene	   surface	   for	   three	   reasons.	   Firstly,	   it	   has	   a	   similar	   hydrophobicity	   to	   STY	   (log	   PPFPA	   =	  
2.55	  and	  log	  PSTY	  =	  2.95)	  and	  thus	  was	  expected	  to	  be	  sufficiently	  soluble	  in	  the	  external	  oil	  phase	  
of	   the	   HIPE,	   as	   illustrated	   in	   Figure	   5.3A.	   Secondly,	   PFPA	   contains	   5	   fluorine	   atoms	   that	   are	  
conveniently	   detectable	   by	   NMR	   and	   x-­‐ray	   photoelectron	   spectroscopy	   (XPS),	   making	   surface	  
characterisation	  experiments	  easier.	  Thirdly	  is	  that	  PFPA	  has	  been	  previously	  reported	  to	  undergo	  
facile	   coupling	   reactions	   with	   amines	   when	   incorporated	   into	   photopolymerised	   polyacrylate	  
polyHIPEs218,	  as	  well	  as	  when	  polymerised	  as	  a	  poly(PFPA)	  homopolymer219	  .	  
Aa	  was	  chosen	  as	  a	  suitable	  hydrophilic	  functional	  co-­‐monomer	  to	  introduce	  acid	  reactive	  sites	  on	  
the	  polystyrene	  surface	  for	  two	  reasons.	  Firstly	  is	  that	  is	  it	  completely	  miscible	  in	  water	  and	  thus	  
was	  expected	   to	   reside	   in	   the	   internal	   aqueous	  phase	  of	   the	  HIPE,	   as	   illustrated	   in	   Figure	  5.3B.	  
This	  was	  hypothesised	   to	  be	  particularly	  beneficial,	  as	   the	  Aa	  would	  most	   likely	  be	  polymerised	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into	   the	   polymer	   at	   the	   emulsion	   interface	   and	   thus	   localise	   the	   carboxylic	   acid	   groups	   on	   the	  
scaffold	   surface.	   Secondly,	   Aa	   has	   been	   previously	   reported	   to	   undergo	   facile	   surface	   coupling	  
reactions	  with	  amines	  when	  polymerised	  as	  polyacrylic	  acid220.	  
	  
	  
Figure	  5.3	  Illustration	  showing	  the	  expected	  location	  of	  the	  PFPA	  and	  Aa	  co-­‐monomers	   in	  the	  STY-­‐DVB-­‐
EHA	  HIPE.	  (A):	  PFPA	  (red	  molecule)	  has	  a	  similar	  hydrophobicity	  to	  STY	  and	  thus	  was	  expected	  to	  reside	  in	  
the	  external	  oil	  phase	  of	  the	  emulsion	  along	  with	  the	  other	  hydrophobic	  monomers.	  (B):	  Aa	  (red	  molecule)	  
is	   completely	   miscible	   in	   water	   and	   thus	   was	   expected	   to	   reside	   in	   the	   internal	   aqueous	   phase	   of	   the	  
emulsion.	  	  
	  
In	   this	   study,	   2ʹ′-­‐Aminoethyl-­‐β-­‐D-­‐galactopyranoside	   and	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐glucopyranoside	  were	  
chosen	   for	   reaction	   with	   the	   ester-­‐functionalised	   scaffold.	   These	   aminoethyl	   glycosides	   were	  
chosen	   over	   galactosamine	   and	   glucosamine	   in	   order	   to	   lock	   the	   carbohydrate	   in	   the	   beta	  
conformation	  after	  coupling.	  With	  galactosamine	  and	  glucosamine,	  the	  amine	  group	   is	  attached	  
to	   the	   2-­‐carbon	   leaving	   the	   1-­‐carbon	   free.	   This	   can	   therefore	   lead	   to	   ring	   opening	   of	   the	  
carbohydrate	  into	  the	  open-­‐chair	  form	  and	  thus	  the	  subsequent	  cyclic	  rearrangement	  into	  alpha,	  
beta	  and	  furanoside	  forms	  that	  may	  jeopardise	  binding	  with	  the	  ASGP-­‐R.	  
Span80™	  was	  used	   as	   the	   surfactant	   throughout	   the	   study.	   KPS	   and	  ABIN	  were	   investigated	   as	  
suitable	  initiators	  to	  preserve	  scaffold	  morphology.	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5.2 Aims	  and	  Objectives	  
The	  overall	  aim	  of	   this	  Chapter	  was	   to	  surface	   functionalise	  an	  emulsion	   templated	  polystyrene	  
scaffold	   with	   galactose	   whilst	   still	   preserving	   scaffold	   morphology	   and	   porosity.	   It	   was	  
hypothesised	   that	   the	   surface	   galactose	   would	   act	   as	   a	   ligand	   for	   the	   hepatocyte	   ASGP-­‐R,	  
mimicking	  the	  glycoprotein-­‐cell	   interactions	  found	  in	  native	   liver	  and	  thus	  further	   improving	  the	  
biochemical	  relevance	  of	  the	  scaffold.	  	  
	  
The	  main	  objectives	  were	  to:	  
	  
• Fabricate	   a	   suitable	   ester-­‐functionalised	   polystyrene	   scaffold	   by	   adding	   PFPA	   as	   an	  
additional	  co-­‐monomer	  into	  the	  HIPE	  external	  phase	  	  
• Characterise	   the	   ester-­‐functionalised	   scaffold	   and	   investigate	   the	   suitability	   for	   3D	  
hepatocyte	  growth	  
• Demonstrate	  the	  attachment	  of	  pendent	  galactose	  residues	  onto	  the	  ester-­‐functionalised	  
scaffold	  via	  coupling	  with	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside	  	  
• Explore	  the	  impact	  of	  pendent	  galactose	  on	  hepatocyte	  adhesion	  and	  function	  	  
• Fabricate	   a	   suitable	   acid-­‐functionalised	   polystyrene	   scaffold	   by	   adding	   Aa	   as	   a	   co-­‐
monomer	  in	  the	  HIPE	  internal	  phase	  	  





	   	  
	  	   177	  
5.3 Results	  
5.3.1 Sample	  Naming	  Protocol	  
The	   sample	   naming	   protocol	   for	   the	   incorporation	   of	   a	   functional	   co-­‐monomer	   is	   as	   follows:	  
poly[xCo-­‐monomer-­‐SDE(initiator)],	  where	  (i)	  x	  =	  wt%	  co-­‐monomer	  out	  of	  total	  monomer	  mixture,	  
(ii)	   co-­‐monomer	   =	   PFPA	   or	   Aa,	   (iii)	   SDE	   =	   STY,	  DVB	   and	   EHA	   coming	   from	   the	   parent	   scaffold	  
formulation	   and	   (iv)	   initiator	   =	   KPS	   or	   AIBN.	   For	   example,	   poly[26PFPA-­‐SDE(AIBN)]	   refers	   to	   a	  
scaffold	  prepared	  using	  26	  wt%	  PFPA	  as	  a	  co-­‐monomer	  and	  AIBN	  initiation.	  
Subsequent	   attachment	   of	   galactose	   to	   the	   appropriate	   functional	   scaffold	   is	   therefore	   termed	  
GAL-­‐poly[xCo-­‐monomer-­‐SDE(initiator)].	  Similarly,	  attachment	  of	  glucose	  (a	  control	  carbohydrate)	  
is	  termed	  GLU-­‐poly[xCo-­‐monomer-­‐SDE(initiator)].	  
	  
5.3.2 Incorporating	  PFPA	  as	  a	  Functional	  Co-­‐Monomer	  
Table	   5-­‐1	   shows	   the	   different	   HIPE	   formulations	   used	   to	   create	   the	   poly[xPFPA-­‐SDE(AIBN)]	  
materials.	  An	  oil	   phase	  was	  prepared	   containing	   the	  organic	  monomers	   (STY,	  DVB,	   EHA,	  PFPA),	  
AIBN	  and	  Span80™.	  AIBN	  was	  employed	  as	   the	   initiator	   in	   this	  case	  as	   the	   interfacial	  activity	  of	  
PFPA	  compared	  to	  the	  other	  monomers	  was	  unknown.	  Water	  was	  added	  to	  the	  oil	  phase	  and	  the	  
mixture	   stirred	   vigorously	   to	   form	   a	   HIPE.	   A	   morphological	   control	   (a	   formulation	   similar	   to	  
Alvetex®Scaffold)	  was	  also	  included	  in	  the	  study:	  poly[0PFPA-­‐SDE(KPS)].	  
	  
Table	  5-­‐1	  HIPE	  Formulations	  used	  to	  Prepare	  Poly[xPFPA-­‐SDE(AIBN)]	  Materials	  
	   Wt.	  %	  in	  HIPE	  
%	  
PFPAb	  	   Oil	   Aq.	  
HIPE	  formulation	   STY	   DVB	   EHA	   PFPAa	   Span80	   AIBN	   H2O	   KPS	  
0PFPA-­‐SDE(KPS)	   4.1	   0.7	   2.1	   0.0	   2.4	   0	   88.8	   1.0	   0	  
10PFPA-­‐SDE(AIBN)	   3.9	   0.7	   2.0	   0.7	   2.3	   0.3	   90.1	   0.0	   9.6	  
20PFPA-­‐SDE(AIBN)	   3.7	   0.6	   1.8	   1.5	   2.1	   0.3	   90.0	   0.0	   19.7	  
26PFPA-­‐SDE(AIBN)	   3.5	   0.6	   1.8	   2.1	   2.1	   0.3	   89.6	   0.0	   26.3	  
33PFPA-­‐SDE(AIBN)	   3.3	   0.6	   1.7	   2.8	   1.9	   0.3	   89.4	   0.0	   33.3	  
43PFPA-­‐SDE(AIBN)	   3.0	   0.5	   1.5	   3.8	   1.8	   0.3	   89.1	   0.0	   43.2	  
aPFPA	  was	  added	  to	  a	  stock	  SDE	  mixture.	  bPFPA	  percentage	  in	  total	  monomer	  mixture	  
	  
All	   formulations	   formed	   a	   stable	   HIPE	   with	   no	   apparent	   signs	   of	   phase	   separation.	   The	   HIPE	  
mixtures	  were	  then	  thermally	  polymerised	  at	  60	   oC	  for	  24	  hours	  to	   form	  poly[xPFPA-­‐SDE(AIBN)]	  
materials.	  Each	  polyHIPE	  was	  then	  soxhlet	  washed	  in	  acetone	  for	  24	  hours	  and	  then	  left	  to	  dry	  in	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a	   fume	   hood.	   Figure	   5.4	   is	   a	   photograph	   of	   the	   dried	   polyHIPEs	   after	   washing.	   A	   stable	   (non-­‐
deformed)	  monolith	  was	  observed	  for	  each	  polyHIPE,	  suggesting	  that	  PFPA	  does	  not	  significantly	  
disrupt	   scaffold	   morphology	   and	   thus	   is	   a	   potentially	   suitable	   functional	   co-­‐monomer	   for	   this	  
study.	  	  	  
	  
	  
Figure	   5.4	   Resulting	   polyHIPE	  monoliths	   after	   polymerising	   the	   HIPE	   formulations	   shown	   in	   Table	   5-­‐1.	  
Stable	   (non-­‐deformed)	   monoliths	   were	   observed	   for	   each	   formulation	   suggesting	   that	   PFPA	   does	   not	  
significantly	  disrupt	  the	  HIPE	  stability.	  Note	  that	  x	  corresponds	  to	  the	  %	  PFPA	  in	  the	  total	  monomer	  mixture.	  
Scale	  bar	  =	  4	  cm.	  
	  
The	   morphologies	   of	   the	   poly[xPFPA-­‐SDE(AIBN)]	   materials	   are	   shown	   in	   Figure	   5.5.	   A	   typical	  
polystyrene	  scaffold	  morphology	  was	  observed	  for	  all	  poly[xPFPA-­‐SDE(AIBN)]	  materials	  except	  for	  
the	  poly[43PFPA-­‐SDE(AIBN)]	  material.	  The	  morphology	  of	  this	  material	  was	  found	  to	  be	  collapsed	  
and	  with	  unidentifiable	  voids.	  For	  the	  other	  materials,	  an	  overall	  decrease	   in	  void	  diameter	  was	  
observed	  with	  increasing	  PFPA	  concentration	  (quantified	  in	  Table	  5-­‐2	  by	  ImageJ™	  analysis	  of	  the	  
SEM	  images).	  This	  trend	  towards	  smaller	  void	  sizes	  suggests	  an	  increase	  in	  emulsion	  stability	  with	  
higher	  PFPA	  incorporation,	  which	  is	  likely	  the	  result	  of	  the	  higher	  organic	  content	  helping	  to	  form	  
wider	   and	   more	   robust	   continuous	   phase	   films	   around	   the	   internal	   phase	   droplets.	   This	  
hypothesis	   is	  supported	  in	  the	  case	  of	  the	  poly[43PFPA-­‐SDE(AIBN)],	  where	  the	  strut	  thickness	  of	  
the	   material	   is	   visibly	   larger	   than	   those	   polyHIPEs	   with	   lower	   PFPA	   content	   (Figure	   5.5	   white	  
arrow).	  
Table	   5-­‐2	   also	   shows	   that	   the	   average	   interconnect	   diameter	   decreases	   with	   increasing	   PFPA	  
content,	   which	   is	   to	   be	   expected	   given	   that	   void	   diameter	   decreases.	   The	   degree	   of	  
interconnectivity	   (<d>/<D>)	   increases	   with	   increasing	   PFPA	   content,	   which	   would	   generally	  
suggest	  an	  increase	  in	  emulsion	  stability.	  Figure	  5.6	  shows	  the	  interconnect	  diameter	  distribution	  
for	  the	  poly[xPFPA-­‐SDE(AIBN)]	  materials.	  Generally,	  a	  wider	  distribution	  in	  interconnect	  diameter	  
was	  observed	  with	  higher	   levels	  of	  PFPA	   incorporation.	  The	  porosities	  of	  all	  materials	   remained	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high	   (ca.	   90	   %),	   although	   a	   general	   decreasing	   trend	   was	   observed	   with	   increasing	   PFPA	  
concentration	  (Table	  5-­‐2),	  which	  is	  to	  be	  expected	  with	  an	  increasing	  organic	  phase	  content	  and	  
therefore	  a	  lowered	  internal	  phase	  volume	  fraction.	  
	  
Table	  5-­‐2	  Physical	  Characteristics	  of	  the	  Poly[xPFPA-­‐SDE(AIBN)]	  Materials	  
	   <D>	  (µm)
a	   <d>	  (µm)b	   <d>/<D>	   Porosity	  (%)	  
poly[0PFPA-­‐SDE(KPS)]	   69	   15	   0.21	   92	  
poly[10PFPA-­‐SDE(AIBN)]	   46	   10	   0.22	   93	  
poly[20PFPA-­‐SDE(AIBN)]	   37	   10	   0.27	   92	  
poly[26PFPA-­‐SDE(AIBN)]	   33	   10	   0.30	   92	  
poly[33PFPA-­‐SDE(AIBN)]	   28	   11	   0.39	   89	  
poly[43PFPA-­‐SDE(AIBN)]	   /	   5	   /	   85	  
aAverage	  void	  diameter	  determined	  by	  ImageJ™	  analysis	  of	  the	  SEM	  images.	  bAverage	  interconnect	  
diameter	  determined	  by	  mercury	  porosimetry.	  /	  =	  data	  unobtainable	  due	  to	  deformed	  nature	  of	  material.	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Figure	  5.5	  Morphology	  of	  the	  poly[xPFPA-­‐SDE(AIBN)]	  materials	  by	  SEM.	  (A-­‐F):	  Increasing	  concentrations	  of	  
PFPA	  in	  the	  monomer	  mixture	  from	  0	  %	  control	  (A)	  to	  43	  %	  (F).	  All	  materials	  resemble	  a	  typical	  polystyrene	  
scaffold	   morphology	   with	   the	   exception	   of	   the	   poly[43PFPA-­‐SDE(AIBN)]	   material,	   which	   has	   a	   slightly	  
deformed	   structure	   with	   unidentifiable	   voids.	   The	   white	   arrow	   in	   F	   indicates	   noticeable	   thicker	   scaffold	  
walls	  compared	  to	  the	  other	  materials.	  Scale	  bars	  =	  50	  µm.	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Figure	  5.6	  Interconnect	  size	  distribution	  for	  the	  poly[xPFPA-­‐SDE(AIBN)]	  materials	  derived	  from	  the	  HIPE	  
formulations	   in	   Table	   5-­‐1.	  Generally	   a	  wider	  distribution	   is	  observed	  with	   increased	  PFPA	  content.	  Note	  
that	  x	  corresponds	  to	  the	  %	  PFPA	  in	  the	  total	  monomer	  mixture.	  For	  x	  =	  0	  this	  corresponds	  to	  the	  control	  
poly[0PFPA-­‐SDE(KPS)]	  formulation.	  
	  
The	   poly[26PFPA-­‐SDE(AIBN)]	   material	   appeared	   to	   display	   optimum	   physical	   characteristics	   for	  
the	  maximum	  theoretical	  PFPA	  loading.	  The	  material	  has	  an	  average	  void	  diameter	  of	  33	  µm	  and	  
an	  average	   interconnect	  diameter	  of	  10	  µm,	  compared	  to	  69	  µm	  and	  15	  µm	  respectively	   in	   the	  
control	  poly[PFPA-­‐SDE(KPS)]	  material	  (the	  control	  being	  representative	  of	  Alvetex®Scaffold).	  This	  
difference	  was	  deemed	  acceptable,	  given	  that	  many	  cells	  have	  diameters	  in	  the	  region	  of	  15	  µm	  
to	   25	   µm,	   therefore	   sufficiently	   smaller	   than	   the	   33	   µm	   voids	   in	   poly[26PFPA-­‐SDE(AIBN)].	  
Furthermore,	  the	  commercial	  Alvetex®Scaffold	  has	  an	  average	  void	  diameter	  of	  42	  µm.	  To	  check	  
the	   suitability	   of	   the	   poly[26PFPA-­‐SDE(AIBN)]	  material	   for	   3D	   scaffold	   applications,	  HepG2	   cells	  
were	  cultured	  on	  the	  material	  and	  the	  growth	  characteristics	  compared	  against	  Alvetex®Scaffold.	  	  	  
The	   poly[26PFPA-­‐SDE(AIBN)]	   material	   was	   sectioned	   into	   200	   µm	   membranes	   (15	   mm	   in	  
diameter)	   and	   housed	   in	   the	   insert/12-­‐well	   plate/submerged	   format.	   Alvetex®Scaffold	  
membranes	  were	  housed	   in	   the	   same	   format	   for	   control	   purposes.	  Membranes	  were	   rendered	  
hydrophilic	  through	  immersion	  in	  70	  %	  ethanol	  and	  PBS	  washing.	  HepG2	  cells	  were	  then	  seeded	  
onto	  the	  scaffolds	  at	  a	  density	  of	  0.4	  million	  cells	  in	  100	  µL	  and	  cultured	  for	  5	  days	  at	  37	  oC	  and	  5	  
%	  CO2	  in	  4	  mL	  of	  MEM.	  Figure	  5.7	  shows	  a	  histological	  cross-­‐section	  of	  the	  cells	  after	  the	  growth	  
period.	  HepG2	  cells	  appeared	  to	  have	  anchored	  onto	  the	  PFPA-­‐functionalised	  scaffold	  in	  a	  similar	  
manner	  to	  Alvetex®Scaffold,	  and	  formed	  a	  tissue-­‐like	   layer	   in	  the	  top	  portion	  of	  the	  membrane.	  
Encouragingly,	   all	   cells	   appear	   healthy	   and	   viable	   on	   the	   poly[26PFPA-­‐SDE(AIBN)]	   material,	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suggesting	   that	   the	  material	   is	  not	  detrimental	   to	  cell	   survival.	  The	  penetration	  of	  cells	   into	   the	  
material	   was	   slightly	   less	   compared	   to	   Alvetex®Scaffold	   (35	   µm	   compared	   to	   55	   µm).	   This	   is	  
expected	  given	  that	  Alvetex®Scaffold	  has	  a	  slightly	  larger	  average	  void	  diameter	  and	  thus	  is	  more	  
likely	   to	   allow	   cells	   to	  migrate	   into	   the	  material.	   Nonetheless,	   cells	   still	   managed	   to	   enter	   the	  
PFPA-­‐functionalised	  material	  after	  only	  5	  days	  culture	  and	  adopt	  a	  structure	  almost	   identical	   to	  
those	  cells	   cultured	  on	  Alvetex®Scaffold,	  evident	  by	   the	  similar	   cell	  dimensions	   shown	   in	  Figure	  
5.7C.	  
Albumin	   synthesis	   was	   also	   assessed	   for	   HepG2	   cells	   growing	   on	   poly[26PFPA-­‐SDE(AIBN)]	  
compared	  to	  Alvetex®Scaffold,	  as	  shown	  in	  Figure	  5.8.	  A	  very	  slight	  decrease	  in	  albumin	  synthesis	  
was	   observed	   for	   the	   poly[26PFPA-­‐SDE(AIBN)]	   material	   after	   4	   days	   culture	   compared	   to	  
Alvetex®Scaffold.	  This	  may	  be	  because	  cells	  have	  not	  penetrated	  as	  far	  into	  the	  material	  and	  thus	  
are	  more	  susceptible	  to	  being	  washed	  away	  during	  media	  changes.	  Alternatively	  it	  could	  be	  that	  
the	  PFPA	  functionality	  does	  directly	  reduce	  albumin	  synthesis.	  Nonetheless	  the	  decrease	  in	  total	  
albumin	  synthesis	   is	  small	  and	  so	  a	  decision	  was	  made	  to	  progress	   this	  material	   for	  subsequent	  
attachment	  of	  galactose	  molecules.	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Figure	  5.7	  Growth	  of	  HepG2	   cells	   in	  poly[26PFPA-­‐SDE(AIBN)]	   compared	   to	  Alvetex®Scaffold.	   (A,B):	  H&E	  
staining	  after	  5	  days	  culture.	  Cells	   in	   the	  poly[26PFPA-­‐SDE(AIBN)]	  material	  have	  adhered	  well	  and	  appear	  
healthy	  with	  no	  signs	  of	  necrosis,	   similar	   to	  cells	   in	  Alvetex®Scaffold.	  Cell	  penetration	   is	  slightly	   lower	   for	  
the	   poly[26PFPA-­‐SDE(AIBN)]	  material	   compared	   to	   Alvetex®Scaffold,	  which	   is	   expected	   given	   the	   smaller	  
void	  diameter.	  Scale	  bars	  =	  20	  µm.	  (C):	  Quantification	  of	  cell	  structure	  on	  the	  two	  scaffolds	  showing	  very	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Figure	   5.8	   Total	   albumin	   synthesis	   of	   HepG2	   cells	   growing	   on	   poly[26PFPA-­‐SDE(AIBN)]	   compared	   to	  
Alvetex®Scaffold.	  (A):	  Standard	  curve	  used	  to	  calibrate	  measured	  absorbances	  from	  the	  ELISA	  with	  known	  
albumin	  levels.	  (B):	  Total	  HepG2	  albumin	  levels	  showing	  only	  a	  slight	  decrease	  in	  measured	  albumin	  for	  the	  
poly[26PFPA-­‐SDE(AIBN)]	  material	  after	  4	  days	  culture.	  	  Data	  represents	  mean	  ±	  s.e.m	  (n	  =	  3).	  
	  
5.3.3 Attaching	  Galactose	  onto	  Poly[26PFPA-­‐SDE(AIBN)]	  
For	   coupling	   with	   2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside	   (and	   the	   glucose	   control),	   the	  
poly[26PFPA-­‐SDE(AIBN)]	  material	  was	  first	  sectioned	  into	  200	  µm	  membranes	  and	  cut	   into	  discs	  
of	  15	  mm	  in	  diameter.	  These	  discs	  were	  then	  mixed	  with	  a	  solution	  of	  the	  aminoethyl	  glycoside	  in	  
dimethylformamide	  (DMF)	  for	  48	  hours	  at	  40	  oC	  under	  constant	  agitation.	  The	  resulting	  materials,	  
termed	  either	  GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  or	  GLU-­‐poly[26PFPA-­‐SDE(AIBN)]	  due	   to	  galactose	  or	  
glucose	  coupling	  respectively,	  were	  then	  slowly	  re-­‐hydrated	  and	  washed	  extensively	  with	  MilliQ	  
water	  before	  characterisation.	  
	  
Figure	  5.9	  shows	  the	  ATR-­‐FTIR	  spectra	  for	  poly[26PFPA-­‐SDE(AIBN)]	  along	  with	  GAL-­‐poly[26PFPA-­‐
SDE(AIBN)]	   	   and	  GLU-­‐poly[26PFPA-­‐SDE(AIBN)].	   All	  materials	   contain	   a	   peak	   at	   1732	   cm-­‐1,	  which	  
corresponds	   to	   the	   EHA	   carbonyl	   group	   from	   the	   parent	   polystyrene	   scaffold	   formulation	   (EHA	  
ester	  C=O	  stretching).	  The	  presence	  of	  PFPA	  in	  the	  poly[26PFPA-­‐SDE(AIBN)]	  material	   is	   indicated	  
by	  the	  peaks	  at	  996	  cm-­‐1	  (C-­‐F	  stretching),	  1520	  cm-­‐1	  (Ar	  C=C	  stretching)	  and	  1786	  cm-­‐1	  (PFPA	  ester	  
C=O	   stretching).	   For	   the	   carbohydrate-­‐functionalised	   materials,	   these	   three	   peaks	   almost	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disappear,	  which	  is	  consistent	  with	  the	  loss	  of	  pentafluorophenol	  during	  nucleophilic	  substitution.	  
The	  spectra	  of	  the	  carbohydrate-­‐functionalised	  materials	  also	  have	  additional	  peaks	  at	  1658	  cm-­‐1	  




Figure	   5.9	   ATR-­‐FTIR	   spectra	   of	   poly[26PFPA-­‐SDE(AIBN)],	   GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	   and	   GLU-­‐
poly[26PFPA-­‐SDE(AIBN)].	  The	  presence	  of	  PFPA	  in	  poly[26PFPA-­‐SDE(AIBN)]	  is	  indicated	  by	  peaks	  at	  996	  cm-­‐
1	   (C-­‐F),	   1520	   cm-­‐1	   (Ar	   C=C)	   and	   1786	   cm-­‐1	   (ester	   C=O).	   These	   almost	   disappear	   after	   coupling	   with	  
carbohydrate	  and	   two	  new	  peaks	  are	  observed	   that	   suggest	   carbohydrate	  attachment:	  1658	  cm-­‐1	   (amide	  
C=O)	  and	  3400	  cm-­‐1	  (O-­‐H).	  	  
	  
Figure	   5.10	   shows	   the	   solid	   state	   NMR	   spectra	   (13C	   and	   19F)	   for	   poly[26PFPA-­‐SDE(AIBN)]	   along	  
with	  GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  and	  GLU-­‐poly[26PFPA-­‐SDE(AIBN)].	   	  A	  new	  carbon	  peak	  occurs	  
at	  ca.	  70	  ppm	   in	   the	   13C	  spectra	  of	   the	  carbohydrate-­‐functionalised	  materials	   (C-­‐OH)	   that	   is	  not	  
present	   in	   the	  starting	  poly[26PFPA-­‐SDE(AIBN)]	  material.	  Similarly,	  a	  complete	  disappearance	  of	  
fluorine	   peaks	   is	   observed	   in	   the	   19F	   spectra	   for	   both	   carbohydrate	   functionalised	   materials,	  
suggesting	  a	  near	  complete	  conversion	  to	  the	  amide-­‐carbohydrate.	  
	  	  
	  	   186	  
	  
Figure	  5.10	  Solid-­‐State	  NMR	  spectra	  of	  poly[26PFPA-­‐SDE(AIBN)],	  GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  and	  GLU-­‐
poly[26PFPA-­‐SDE(AIBN)].	  (A):	  13C	  spectra	  showing	  the	  appearance	  of	  a	  new	  peak	  at	  ca.	  70	  ppm	  (C-­‐OH)	  for	  
the	   carbohydrate-­‐functionalised	   materials	   that	   is	   absent	   on	   poly[26PFPA-­‐SDE(AIBN)].	   (B):	   19F	   spectra	  
showing	   the	   presence	   of	   fluorine	   in	   poly[26PFPA-­‐SDE(AIBN)]	   which	   is	   absent	   on	   the	   carbohydrate-­‐
functionalised	  materials.	  	  	  	  
	  
XPS	   was	   used	   to	   quantify	   the	   amount	   of	   PFPA	   and	   carbohydrate	   on	   the	   surface	   of	   the	  
poly[26PFPA-­‐SDE(AIBN)],	   GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	   and	   GLU-­‐poly[26PFPA-­‐SDE(AIBN)]	  
materials.	  Table	  5-­‐3	   shows	   the	  surface	  atomic	  concentrations	   (%)	  obtained	   from	  survey	   spectra	  
for	   the	   three	  materials.	   The	   poly[26PFPA-­‐SDE(AIBN)]	  material	   surface	   contains	   1.86	   %	   fluorine	  
whereas	   the	   carbohydrate-­‐functionalised	   materials	   contain	   only	   negligible	   fluorine	   levels.	  
Moreover,	   the	   carbohydrate-­‐functionalised	   materials	   contain	   increased	   surface	   oxygen	   and	  
nitrogen	  compared	   to	   the	  poly[26PFPA-­‐SDE(AIBN)]	  material.	  Note	   that	   traces	  of	   calcium,	   silicon	  
and	  sulphur	  were	  also	  found	  on	  the	  samples	  that	  are	  believed	  to	  be	  from	  surface	  contamination.	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Table	   5-­‐3	   Surface	   Atomic	   Concentrations	   (%)	   Obtained	   From	   XPS	   Survey	   Spectra	   For	   Poly[26PFPA-­‐
SDE(AIBN)],	  GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  and	  GLU-­‐poly[26PFPA-­‐SDE(AIBN)]	  
	   Surface	  atomic	  concentration	  (%)	  
	   C	   F	   O	   Ca	   N	   Si	   S	  
poly[26PFPA-­‐SDE(AIBN)]	   91.02	   1.86	   6.83	   0.30	   0.00	   0.00	   0.00	  
GLU-­‐poly[26PFPA-­‐SDE(AIBN)]	   89.53	   0.00	   9.21	   0.31	   0.62	   0.32	   0.00	  
GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	   89.36	   0.10	   8.76	   0.65	   0.37	   0.68	   0.09	  
	  
Figure	  5.11	  shows	  the	  peak-­‐fitted	  high	  resolution	  C1s	  spectra	  for	  the	  three	  scaffolds.	  Peaks	  were	  
fitted	  for	  (a)	  C-­‐C,	  C=C	  at	  a	  binding	  energy	  (BE)	  of	  285.11	  eV,	  (b)	  C-­‐OH,	  C-­‐OC	  at	  a	  BE	  of	  286.00	  eV,	  
(c)	  C-­‐O-­‐C=O	  at	  BE’s	  of	  286.81	  eV	  and	  288.93	  eV,	  (d)	  C-­‐F	  at	  BE	  of	  287.12	  eV	  and	  (e)	  O=C-­‐N	  at	  BE	  of	  
288.13	   eV.	   Noticeably	   larger	   peak	   areas	   for	   C-­‐F	   and	   C-­‐O-­‐C=O	   are	   observed	   for	   poly[26PFPA-­‐
SDE(AIBN)]	   material	   compared	   to	   the	   carbohydrate-­‐functionalised	   materials.	   Quantification	   of	  
peak	  areas	   show	  that	   the	  poly[26PFPA-­‐SDE(AIBN)]	  material	   contains	  ca.	  9	  %	  PFPA,	  whereas	   the	  
GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	   and	   GLU-­‐poly[26PFPA-­‐SDE(AIBN)]	   contain	   ca.	   0	   %.	   Both	  
carbohydrate-­‐functionalised	  materials	  display	  new	  peak	  areas	  for	  C-­‐OH/C-­‐OC	  and	  O=CN	  that	  are	  
absent	  in	  the	  poly[26PFPA-­‐SDE(AIBN)]	  material.	  Quantification	  of	  these	  peak	  areas	  show	  that	  the	  
materials	  contain	  between	  ca.	  7	  %	  	  and	  9	  %	  carbohydrate,	  	  suggesting	  a	  near	  complete	  conversion	  
from	  ester	  to	  amide	  under	  the	  reaction	  conditions	  employed.	  
	  
	  
Figure	   5.11	   High	   resolution	   peak-­‐fitted	   C1s	   spectra	   for	   poly[26PFPA-­‐SDE(AIBN)],	   GAL-­‐poly[26PFPA-­‐
SDE(AIBN)]	   and	   GLU-­‐poly[26PFPA-­‐SDE(AIBN)].	   (A):	   Poly[26PFPA-­‐SDE(AIBN)]	   spectrum	   showing	   relatively	  
large	   peaks	   for	   C-­‐F	   and	   C-­‐O-­‐C=O	   corresponding	   to	   PFPA	   on	   the	   material	   surface.	   (B,C):	   Carbohydrate-­‐
functionalised	  spectra	  showing	  new	  C-­‐OH/C-­‐O-­‐C	  and	  O=CN	  peaks,	  as	  well	  as	  a	  reduction	  in	  C-­‐O-­‐C=O	  peaks	  
corresponding	  to	  the	  attachment	  of	  carbohydrate	  on	  the	  material	  surface.	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Figure	   5.12	   shows	   the	   high	   resolution	   F1s	   and	   N1s	   spectra	   for	   the	   three	   scaffolds.	   Fluorine	   is	  
present	   on	   the	   poly[26PFPA-­‐SDE(AIBN)]	   material	   but	   not	   the	   carbohydrate-­‐functionalised	  
materials.	  Furthermore,	  nitrogen	  is	  present	  on	  the	  carbohydrate	  functionalised	  materials	  but	  not	  
the	  poly[26PFPA-­‐SDE(AIBN)]	  material.	  	  
	  
	  
Figure	   5.12	   High	   resolution	   F1s	   and	   N1s	   spectra	   for	   poly[26PFPA-­‐SDE(AIBN)],	   GAL-­‐poly[26PFPA-­‐
SDE(AIBN)]	   and	   GLU-­‐poly[26PFPA-­‐SDE(AIBN)].	   (A,D):	   Poly[26PFPA-­‐SDE(AIBN)]	   spectra	   showing	   the	  
presence	   of	   fluorine	   but	   not	   nitrogen	   on	   the	   material	   surface.	   (B,C,E,F):	   Carbohydrate-­‐functionalised	  
spectra	  showing	  the	  absence	  of	  fluorine	  but	  the	  presence	  of	  nitrogen.	  	  
	  
5.3.4 Assessing	  Hepatocyte	  Function	  on	  GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  	  
To	   assess	   the	   accessibility	   and	   selectivity	   of	   the	   pendent	   galactose	   residues	   on	   the	   GAL-­‐
poly[26PFPA-­‐SDE(AIBN)]	  material,	  primary	  rat	  hepatocytes	  were	  cultured	  for	  up	  to	  24	  hours.	  The	  
poly[26PFPA-­‐SDE(AIBN)]	   and	   GLU-­‐poly[26PFPA-­‐SDE(AIBN)]	   materials	   were	   used	   as	   controls	   for	  
the	  experiment.	  
	  	   189	  
The	   24-­‐well	   plate	   format	   was	   used.	   Scaffold	  membranes	   (200	  µm	   thick	   and	   15	  mm	   diameter)	  
were	   first	   rendered	   hydrophilic	   via	   immersion	   in	   70	   %	   ethanol	   and	   PBS	   washing.	   Primary	   rat	  
hepatocytes	  were	  then	  seeded	  on	  the	  materials	  via	  0.2	  million	  cells	  in	  1	  mL	  of	  culture	  media.	  Note	  
that	  culture	  media	  contained	  serum	  proteins	  which	  were	  expected	  to	  adsorb	  non-­‐specifically	  onto	  
the	   scaffold	   surface	  and	   thus	  mask	   some	  of	   the	  galactose	   sites.	  However,	   completely	   removing	  
serum	   proteins	   from	   the	   culture	  media	   raised	   concern	   over	   cell	   survival	   and	   so	   they	  were	   not	  
removed.	  
Figure	   5.13	   shows	   the	   albumin	   synthesis	   of	   the	   cells	   during	   the	   culture	   period.	   A	   significantly	  
larger	   amount	   of	   albumin	   was	   measured	   for	   hepatocytes	   growing	   on	   the	   GAL-­‐poly[26PFPA-­‐
SDE(AIBN)]	   material	   compared	   to	   the	   poly[26PFPA-­‐SDE(AIBN)]	   material	   and	   GLU-­‐poly[26PFPA-­‐
SDE(AIBN)]	  after	  3	  hours	  culture.	  This	  suggests	  that	   the	  pendent	  galactose	   is	  accessible	  and	  can	  
maintain	  selectivity	  with	   the	  ASGP-­‐R.	  However,	  as	   the	  culture	  period	  progressed,	   this	  enhanced	  
albumin	   synthesis	   was	   lost,	   potentially	   due	   to	   non-­‐selective	   hepatocyte	   adherence	   onto	   the	  
scaffold	  via	  a	  serum	  protein	  coating.	  
	  
	  
Figure	  5.13	  Total	  albumin	  synthesis	  of	  primary	  rat	  hepatocytes	  growing	  on	  GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  
compared	   to	   GLU-­‐poly[26PFPA-­‐SDE(AIBN)]	   and	   poly[26PFPA-­‐SDE(AIBN)].	   (A):	   Standard	   curve	   used	   to	  
calibrate	  measured	  absorbances	  from	  the	  ELISA	  with	  known	  albumin	  levels.	  (B):	  Total	  primary	  rat	  albumin	  
levels	   showing	   a	   significant	   increase	   in	   albumin	   synthesis	   for	   cells	   on	   the	   GAL-­‐poly[26PFPA-­‐SDE(AIBN)]	  
material	   after	   3	   hours	   culture	   (crucial	   adhesion	   period).	   After	   24	   hours	   culture	   no	   difference	   in	   albumin	  
synthesis	  is	  observed.	  Data	  represents	  mean	  ±	  s.e.m	  (n	  =	  3).	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5.3.5 Incorporating	  Aa	  as	  a	  Functional	  Co-­‐Monomer	  
Table	   5-­‐4	   shows	   the	   different	   HIPE	   formulations	   used	   to	   prepare	   poly[xAa-­‐SDE(AIBN	   or	   KPS)]	  
materials.	  	  Note	  that	  Aa	  functionalisations	  were	  attempted	  using	  both	  AIBN	  and	  KPS	  as	  initiators.	  
The	   [0Aa-­‐SDE(KPS)]	   formulation	   represents	   a	   typical	   polystyrene	   scaffold	   formulation	   and	  
therefore	  serves	  as	  a	  morphological	  control	   for	  the	  study.	  The	  [0Aa-­‐SDE(AIBN)]	  formulation	  was	  
used	  as	  an	  additional	  morphological	  and	  chemical	  control.	  	  
	  
Table	  5-­‐4	  HIPE	  Formulations	  used	  to	  Prepare	  Poly[xAa-­‐SDE(AIBN	  or	  KPS)]	  Materials	  
	   Wt.	  %	  in	  HIPE	  
%	  Aaa	  	   Oil	   Aq.	  
HIPE	  Formulation	   STYb	   DVBb	   EHAb	   Span80	   AIBN	   Aa	   H2O	   KPS	  
[0Aa-­‐SDE(KPS)]	   4.1	   0.7	   2.0	   2.4	   0.0	   0.0	   89.8	   1.0	   0	  
[3Aa-­‐SDE(KPS)]	   4.1	   0.7	   2.0	   2.4	   0.0	   0.2	   89.6	   1.0	   3	  
[13Aa-­‐SDE(KPS)]	   4.1	   0.7	   2.0	   2.4	   0.0	   1.0	   88.8	   1.0	   13	  
[0Aa-­‐SDE(AIBN)]	   4.1	   0.7	   2.1	   2.4	   0.3	   0.0	   90.4	   0.0	   0	  
[13Aa-­‐SDE(AIBN)]	   4.1	   0.7	   2.1	   2.4	   0.3	   1.0	   89.4	   0.0	   13	  
aWeight	  percentage	  of	  total	  monomer	  mixture;	  bmolar	  quantities	  of	  monomers	  in	  oil	  phase	  as	  a	  percentage	  
of	  total	  (oil	  phase)	  monomer	  content:	  STY	  –	  70.6%;	  DVB	  –	  9.4%;	  EHA	  –	  20.0%.	  
	  
HIPEs	   were	   formed	   by	   adding	   an	   aqueous	   water	   phase	   to	   the	   oil	   phase	   and	   then	   stirring	  
vigorously	   for	   2	  minutes.	   Aa	  was	   added	   to	   the	   aqueous	   phase	   prior	   to	   HIPE	   formation	   for	   the	  
three	   formulations	   containing	   Aa.	   Stable	   HIPEs	   were	   formed	   for	   all	   formulations	   with	   the	  
exception	  of	  [13Aa-­‐SDE(KPS)],	  which	  phase	  separated	  after	  approximately	  1	  hour.	  Encouragingly,	  
the	   [13Aa-­‐SDE(AIBN)]	   formulation	   displayed	   a	   typical	   STY-­‐DVB-­‐EHA	   HIPE	   viscosity	   and	  
appearance.	  Figure	  5.14	  shows	  the	  appearance	  of	  thermally	  cured	  HIPEs	  described	  in	  Table	  5-­‐4.	  A	  
typical	   polystyrene	   scaffold	  monolith	  was	   produced	   for	   the	   [13Aa-­‐SDE(AIBN)]	   formulation	   after	  
curing.	  On	  the	  contrary,	  both	  [3Aa-­‐SDE(KPS)]	  and	  [13Aa-­‐SDE(KPS)]	  formulations	  did	  not	  produce	  a	  
typical	   scaffold	   monolith.	   The	   poly[3Aa-­‐SDE(KPS)]	   material	   displayed	   large	   (0.5	   mm)	  
heterogeneous	   holes	   throughout	   the	   structure,	   whereas	   the	   [13Aa-­‐SDE(KPS)]	   formulation	  
remained	  as	  a	  phase	  separated	  liquid.	  These	  data	  suggest	  that	  KPS	  is	  not	  a	  suitable	  initiator	  for	  Aa	  
functionalisations	  of	  STY-­‐DVB-­‐EHA	  scaffolds,	  and	  that	  AIBN	  appears	  to	  be	  the	  better	  choice.	   It	   is	  
hypothesised	   this	   is	   because	   the	  Aa	   serves	   to	   decrease	   emulsion	   stability,	   and	   that	   KPS,	  which	  
preferentially	  polymerises	  monomers	  in	  the	  hydrophilic	  phase,	  kinetically	  cannot	  polymerise	  the	  
majority	  of	  the	  organic	  monomers	  before	  phase	  separation	  occurs.	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Figure	  5.14	  Resulting	  polyHIPE	  monoliths	  after	  polymerising	  the	  HIPE	  formulations	  shown	  in	  Table	  5-­‐4.	  As	  
expected,	  the	  control	  poly[0Aa-­‐SDE(KPS)]	  material	  formed	  a	  stable	  (non-­‐deformed)	  monolith.	  However	  the	  
addition	  of	  Aa	  to	  KPS	  initiated	  HIPEs	  did	  not	  produce	  suitable	  monoliths:	  poly[3Aa-­‐SDE(KPS)]	  displayed	  huge	  
heterogeneous	  voids	  and	  poly[13Aa-­‐SDE(KPS)]	  remained	  as	  two	  phase	  separated	  liquids.	  Using	  AIBN	  as	  the	  
HIPE	  initiator	  produced	  stable	  monoliths,	  even	  for	  the	  poly[13Aa-­‐SDE(AIBN)]	  material.	  	  Scale	  bar	  =	  3	  cm.	  
	  
The	   morphology	   of	   each	   monolith	   was	   investigated	   using	   SEM,	   as	   shown	   in	   Figure	   5.15.	   As	  
expected,	  the	  morphology	  of	  the	  poly[0Aa-­‐SDE(KPS)]	  control	  was	  typical	  to	  that	  of	  a	  polystyrene	  
scaffold	   used	   in	   3D	   cell	   culture	   applications,	   with	   clear	   open-­‐cell	   voids	   and	   a	   high	   degree	   of	  
interconnectivity.	   The	   poly[13Aa-­‐SDE(AIBN)]	   material	   also	   exhibited	   a	   typical	   polyHIPE	  
morphology,	   indicating	   the	   fabrication	   of	   a	   functional	   material	   with	   desirable	   scaffold	  
characteristics.	  It	  is	  hypothesised	  that	  AIBN,	  a	  hydrophobic	  initiator,	  is	  able	  to	  polymerise	  the	  STY-­‐
DVB-­‐EHA	   monomers	   before	   phase	   separation	   can	   occur,	   thus	   producing	   a	   typical	   polystyrene	  
scaffold	   morphology.	   Interestingly,	   the	   unfunctionalised	   AIBN	   control,	   poly[0Aa-­‐SDE(AIBN)],	  
showed	   low	   interconnectivity,	  visibly	   thicker	  scaffold	  walls	  and	  signs	  of	  deformation.	  Finally	   the	  
poly[3Aa-­‐SDE(KPS)]	  material	   did	   not	   display	   a	   polyHIPE	  morphology,	  with	   the	   large	   voids	   being	  
filled	  with	  a	  gel-­‐like	  material	  that	  is	  likely	  to	  be	  a	  polyacrylic	  acid	  hydrogel.	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Figure	   5.15	  Morphology	   of	   the	   poly[xAa-­‐SDE(AIBN	   or	   KPS)]	   materials	   by	   SEM.	   (A):	   Poly[0Aa-­‐SDE(KPS)]	  
control	  showing	  a	  typical	  open-­‐cell	  scaffold	  morphology.	  Scale	  bar	  =	  100	  µm.	  (B):	  Poly[13Aa-­‐SDE(AIBN)]	  also	  
showing	   an	   open-­‐cell	  morphology.	   Scale	   bar	   =	   20	  µm.	   (C)	   Poly[0Aa-­‐SDE(AIBN)]	   showing	   a	   deformed	   and	  
less-­‐open	  morphology.	  Scale	  bar	  =	  20	  µm	  (D):	  Poly[3Aa-­‐SDE(KPS)]	  	  showing	  extremely	  large	  voids	  filled	  with	  
a	  gel-­‐type	  material	  that	  can	  be	  assumed	  to	  be	  polyacrylic	  acid.	  Scale	  bar	  =	  500	  µm.	  	  
	  
The	   physical	   characteristics	   of	   the	   poly[13Aa-­‐SDE(AIBN)]	   material	   in	   comparison	   with	   the	  
poly[0Aa-­‐SDE(KPS)]	   control	   is	   shown	   in	   Table	  5-­‐5.	   The	  average	   void	  diameter	  of	   the	  poly[13Aa-­‐
SDE(AIBN)]	  material	  was	  found	  to	  be	  19	  μm,	  compared	  to	  60	  μm	  for	  poly[0Aa-­‐SDE(KPS)]	  control	  
(obtained	  from	  ImageJ™	  analysis	  of	  SEM	  micrographs).	  	  
Mercury	  intrusion	  porosimetry	  showed	  that	  the	  average	  interconnect	  diameter	  for	  the	  poly[13Aa-­‐
SDE(AIBN)]	  material	  was	   6	  µm,	   in	   comparison	   to	   15	  µm	   for	   poly[0Aa-­‐SDE(KPS)]	   control.	   This	   is	  
expected	  given	  the	  reduction	  in	  void	  diameter.	  The	  interconnect	  diameter	  distribution	  was	  found	  
to	  be	  narrow	  for	  the	  poly[13Aa-­‐SDE(AIBN)]	  material,	  as	  shown	  in	  Figure	  5.16.	  Encouragingly,	  the	  
porosity	  of	  the	  poly[13Aa-­‐SDE(AIBN)]	  	  material	  was	  89	  %	  porous,	  in	  comparison	  to	  92	  %	  porosity	  
for	  the	  poly[0Aa-­‐SDE(KPS)]	  control.	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Table	  5-­‐5	  Physical	  Characteristics	  of	  poly[13Aa-­‐SDE(AIBN)]	  in	  comparison	  to	  poly[0Aa-­‐SDE(KPS)]	  
	   <D>	  (µm)
a	   <d>	  (µm)b	   <d>/<D>	   Porosity	  (%)	  
poly[0Aa-­‐SDE(KPS)]	   60	   15	   0.25	   92	  
poly[13Aa-­‐SDE(AIBN)]	   19	   6	   0.32	   89	  
aAverage	   void	   diameter	   from	   ImageJ™	   analysis	   of	   SEM	   images.	   bAverage	   interconnect	   diameter	   from	  
mercury	  intrusion	  porosimetry.	  
	  
	  
Figure	  5.16	  Interconnect	  diameter	  distribution	  for	  the	  poly[13Aa-­‐SDE(AIBN)]	  in	  comparison	  to	  poly[0Aa-­‐
SDE(KPS)].	   A	   narrow	   distribution	   is	   observed	   even	   though	   the	   average	   void	   diameter	   is	   lower	   for	   the	  
poly[13Aa-­‐SDE(AIBN)]	  material.	  
	  
The	  initial	  detection	  of	  surface	  carboxylic	  acid	  groups	  on	  the	  poly[13Aa-­‐SDE(AIBN)]	  material	  was	  
performed	   by	   Toluidine	   Blue	   O	   (TBO)	   staining.	   TBO	   is	   a	   basic	   blue	   dye	   often	   used	   to	   detect	  
carboxylic	   acid	   functionality221.	   Scaffolds	   were	   immersed	   in	   a	   TBO	   solution	   (0.1	   mg/mL)	   for	   2	  
minutes	   and	   then	   washed	   extensively	   with	   distilled	   water.	   Figure	   5.17	   shows	   a	   significantly	  
greater	   uptake	   of	   the	   basic	   dye	   for	   the	   poly[13Aa-­‐SDE(AIBN)]	   material	   compared	   to	   the	  
unfunctionalised	  poly[0Aa-­‐SDE(AIBN)]	  control,	   indicating	   the	  presence	  of	  acid	   functionality	   from	  
Aa	  incorporation	  at	  the	  polymerising	  interface.	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Figure	  5.17	  Detection	  of	  surface	  carboxylic	  acid	  groups	  on	  the	  poly[13Aa-­‐SDE(AIBN)]	  material	  using	  the	  
basic	   TBO	   stain.	   A	   significant	   uptake	   of	   the	   blue	   TBO	   stain	   is	   observed	   for	   the	   poly[13Aa-­‐SDE(AIBN)]	  
material,	  whereas	  no	  staining	  is	  observed	  for	  the	  poly[0Aa-­‐SDE(AIBN)]	  control.	  Scale	  bar	  =	  3	  cm.	  
	  
To	   further	   demonstrate	   the	   presence	   of	   surface	   carboxylic	   acid	   groups	   on	   the	   poly[13Aa-­‐
SDE(AIBN)]	   scaffold	   wettability	   by	   water	   was	   assessed.	   After	   fully	   submerging	   the	   material	   in	  
water	  for	  5	  seconds	  and	  then	  re-­‐applying	  a	  water	  droplet,	  the	  poly[13Aa-­‐SDE(AIBN)]	  scaffold	  was	  
found	  to	  be	  wettable.	  On	  the	  contrary,	  the	  poly[0Aa-­‐SDE(AIBN)]	  control	  remained	  non-­‐wettable	  
after	  pre-­‐submerging	  in	  water	  (Figure	  5.18).	  	  
	  
	  
Figure	  5.18	  Wettability	  by	  water	  of	  the	  poly[13Aa-­‐SDE(AIBN)]	  material.	  After	  submerging	  the	  material	  in	  
water	  the	  material	  became	  wettable	  by	  water.	  On	  the	  contrary	  the	  poly[0Aa-­‐SDE(AIBN)]	  material	  remained	  
non-­‐wettable	  by	  water.	  Scale	  bar	  =	  3	  cm.	  
	  
Attempts	  at	  quantifying	  the	  amount	  of	  carboxylic	  acid	  on	  the	  poly[13Aa-­‐SDE(AIBN)]	  scaffold	  was	  
first	  performed	  using	  an	  acid-­‐base	  back	  titration.	  The	  scaffold	  was	  ground	  into	  a	  powder	  and	  then	  
treated	  with	  0.2	  M	  NaOH	  solution	  for	  24	  hours.	  This	  NaOH	  solution	  was	  then	  filtered	  and	  titrated	  
against	   0.2	  M	  HCl	   solution	   to	   determine	   original	   acid	   concentration	   on	   the	   scaffold.	   The	   same	  
treatment	  was	  applied	  to	  the	  poly[0Aa-­‐SDE(AIBN)]	  control.	  Figure	  5.19	  shows	  that	  a	  lower	  volume	  
of	   HCl	  was	   required	   to	   neutralise	   the	   NaOH	   solution	   pre-­‐exposed	   to	   the	   poly[13Aa-­‐SDE(AIBN)]	  
polyHIPE	  compared	  to	  the	  unfunctionalised	  poly[0Aa-­‐SDE(AIBN)]	  control,	  indicating	  the	  presence	  
of	  acid	  in	  the	  original	  scaffold.	  However,	  issues	  such	  as	  poor	  scaffold-­‐NaOH	  mixing,	  potential	  EHA	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hydrolysis	   (disrupting	   acid	   concentrations)	   and	   sample	   loss	   during	   filtration	   unfortunately	  
prevented	  accurate	  carboxylic	  acid	  quantification	  using	  this	  method.	  As	  a	  result	  XPS	  was	  used	  to	  
quantify	  surface	  carboxylic	  acid	  groups.	  	  
	  
	  
Figure	   5.19	   Acid-­‐base	   back	   titration	   of	   an	   NaOH	   solution	   pre-­‐exposed	   to	   poly[13Aa-­‐SDE(AIBN)]	   and	  
poly[0Aa-­‐SDE(AIBN)].	  The	  NaOH	  solution	  pre-­‐exposed	  to	  poly[13Aa-­‐SDE(AIBN)]	   (white	  dots)	   required	   less	  
acid	   for	   neutralisation	   compared	   to	   the	  NaOH	   solution	   pre-­‐exposed	   to	   poly[0Aa-­‐SDE(AIBN)]	   (black	   dots).	  
This	  indicates	  the	  presence	  of	  acid	  on	  poly[13Aa-­‐SDE(AIBN)],	  however	  quantification	  was	  not	  applied	  due	  to	  
several	  practical	  issues.	  	  
	  
XPS	  was	  used	   to	  quantify	   the	  amount	  of	   surface	  carboxylic	  acid	   functionality	  on	   the	  poly[13Aa-­‐
SDE(AIBN)]	  material	   compared	   to	   the	  poly[0Aa-­‐SDE(AIBN)]	   control.	   Table	  5-­‐6	   shows	   the	   surface	  
atomic	   concentrations	   (%)	   obtained	   from	   survey	   spectra	   for	   the	   two	   materials.	   A	   noticeable	  
decrease	   in	   carbon	   concentration	   and	   increase	   in	   oxygen	   concentration	   is	   observed	   for	  
poly[13Aa-­‐SDE(AIBN)]	   compared	   to	   poly[0Aa-­‐SDE(AIBN)],	   suggesting	   a	   displacement	   of	   organic	  
monomers	  with	  Aa	  at	  the	  polymerising	  interface	  for	  the	  functionalised	  material.	  Small	  quantities	  
of	  Ca,	  Si	  and	  S	  were	  found	  on	  both	  materials	  and	  are	  likely	  from	  surface	  contamination.	  	  
	  
Table	   5-­‐6	   Surface	   Atomic	   Concentrations	   (%)	   Obtained	   From	   XPS	   Survey	   Spectra	   For	   Poly[13Aa-­‐
SDE(AIBN)]	  And	  Poly[0A-­‐SDE(AIBN)]	  Materials.	  
	   Surface	  atomic	  concentration	  (%)	  
	   C	   O	   Ca	   Si	   S	  
poly[0Aa-­‐SDE(AIBN)]	   89.6	   8.4	   0.5	   1.3	   0.2	  
poly[13Aa-­‐SDE(AIBN)]	   79.2	   19.6	   0.1	   1.1	   0.0	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Figure	   5.20	   shows	   the	   high	   resolution	   C1s	   spectra	   for	   poly[13Aa-­‐SDE(AIBN)]	   and	   poly[0Aa-­‐
SDE(AIBN)]	  with	  peak	   fitting.	   Both	   spectra	  were	   fitted	  with	   three	   components:	   (i)	   C-­‐C,	  C=C	  at	   a	  
binding	  energy	  (BE)	  of	  285.0	  eV,	  (ii)	  C-­‐O	  at	  a	  BE	  of	  286.3	  eV	  and	  (iii)	  COOH	  at	  a	  BE	  of	  289.2	  eV.	  The	  
peak	  area	   for	   the	  carboxylic	  acid	   functional	  group	   (289.2	  eV)	   is	  7.5	  %	  for	  poly[13Aa-­‐SDE(AIBN)].	  
The	   same	  area	   for	  poly[0Aa-­‐SDE(AIBN)]	   is	   0.0%.	  We	  can	   therefore	   conclude	   that	   approximately	  
half	  of	   the	  original	  13	  %	  Aa	  monomer	  was	   incorporated	   into	  the	  scaffold	  surface.	  Note	  that	  the	  
peak	  area	  of	  the	  C-­‐O	  functional	  group	  (286.3	  eV)	  is	  19.2	  %	  for	  poly[0Aa-­‐SDE(AIBN)]	  and	  19.4	  %	  for	  
poly[13Aa-­‐SDE(AIBN)].	   It	   is	   hypothesised	   that	   this	   comes	   from	   residual	   Span80	   left	   on	   each	  
scaffold	  after	  washing.	  
	  
	  
Figure	  5.20	  High	   resolution	  peak-­‐fitted	  C1s	   spectra	   for	  poly[0Aa-­‐SDE(AIBN)]	   and	  poly[13Aa-­‐SDE(AIBN)].	  
(A):	   Poly[0Aa-­‐SDE(AIBN)]	   spectrum	   showing	   an	   absence	   of	   a	   COOH	   peak.	   (B):	   Poly[13Aa-­‐SDE(AIBN)]	  
spectrum	  showing	  a	  COOH	  peak	  and	  thus	  confirming	  the	  presence	  of	  Aa	  in	  the	  material.	  	  
	  
As	  with	  the	  PFPA-­‐functionalised	  scaffold,	  it	  was	  hypothesised	  that	  the	  carboxylic	  acid	  functionality	  
on	   the	   surface	   of	   the	   poly[13Aa-­‐SDE(AIBN)]	   material	   could	   provide	   a	   useful	   reactive	   site	   for	  
subsequent	   galactose	   attachment	   using	   galactose-­‐amines.	   A	   preliminary	   assessment	   of	   the	  
biocompatibility	   of	   this	   precursor	   material	   for	   3D	   cell	   growth	   was	   therefore	   performed	   using	  
Upcyte®	   cells	   and	   assessing	   adhesion	   on	   the	  material	   after	   2	   hours	   culture.	   Figure	   5.21	   shows	  
adhered	  cells	  (green	  dots)	  on	  poly[13Aa-­‐SDE(AIBN)]	  and	  Alvetex®Scaffold	  after	  seeding	  the	  same	  
cell	   number.	   No	   significant	   difference	   was	   observed	   for	   the	   number	   of	   cells	   adhered	   to	   the	  
poly[13Aa-­‐SDE(AIBN)]	   material	   compared	   to	   Alvetex®Scaffold.	   These	   preliminary	   data	   indicate	  
that	   the	   precursor	   scaffold	  may	   provide	   a	   suitable	   environment	   for	   the	   attachment	   of	   human	  
hepatocytes	   and	   indicates	   its	   suitability	   as	   a	   precursor	   scaffold	   for	   subsequent	   galactose	  
attachment	  by	  reaction	  with	  galactose-­‐amines.	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Figure	  5.21	  Adhesion	  of	  Upcyte®	  hepatocytes	  onto	  poly[13Aa-­‐SDE(AIBN)]	  compared	  to	  Alvetex®Scaffold.	  
(A,B):	  Staining	  cells	  with	  phalloidin	  (green	  dots)	  and	  imaging	  using	  a	  fluorescence	  microscope.	  Scale	  bars	  =	  
200	  µm.	  (C):	  Quantification	  of	  adherent	  cells	  per	  field	  of	  view	  showing	  no	  difference	  between	  the	  number	  
of	  cells	  on	  poly[13Aa-­‐SDE(AIBN)]	  and	  Alvetex®Scaffold.	  Data	  represent	  mean	  ±	  s.e.m	  (5	  fields	  per	  replicate,	  
n	  =	  3).	  
	  
5.3.6 Additional	  Attempts	  at	  Incorporating	  Aa	  using	  KPS	  Initiation	  
The	   previous	   data	   indicated	   that	   KPS	   is	   not	   a	   suitable	   initiator	   for	   incorporating	   Aa	   into	   an	  
emulsion	  templated	  polystyrene	  scaffold.	  To	  further	  investigate	  this,	  additional	  Aa	  concentrations	  
were	   explored	   for	   completion.	   Figure	   5.22	   shows	   the	   resulting	   materials	   for	   Aa	   incorporation	  
when	  x	  ≤	  3	  using	  KPS	  as	  the	  initiator.	  As	  shown	  previously,	  when	  x	  =	  3	  large	  heterogeneous	  holes	  
are	   visible	   in	   the	  monolith.	   However,	   even	   when	   x	   <	   3	   the	  monoliths	   have	   deformed,	   further	  
supporting	  that	  KPS	  is	  an	  unsuitable	  initiator	  for	  Aa	  incorporation.	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Figure	  5.22	  Resulting	  monoliths	  for	  low	  levels	  of	  Aa	  incorporation	  into	  polystyrene	  scaffolds	  using	  KPS	  as	  
the	   initiator.	   Even	   when	   x	   <	   3	   monoliths	   deform,	   further	   demonstrating	   the	   unsuitability	   of	   KPS	   as	   an	  
initiator	  for	  Aa	  incorporation.	  Scale	  bar	  =	  4	  cm.	  
	  
Figure	   5.23	   shows	   the	   resulting	   materials	   for	   Aa	   incorporation	   when	   x	   ≥	   13	   using	   KPS	   as	   the	  
initiator.	  As	  shown	  previously,	  when	  x	  =	  13	  the	  HIPE	  phase	  separates	  and	  remains	  as	  two	  liquids	  
after	  polymerisation.	  This	  is	  also	  the	  case	  when	  x	  =	  22.	  Interestingly,	  when	  x	  ≥	  33	  a	  gel	  is	  formed,	  
as	   shown	   in	   Figure	   5.23B,C.	   This	   demonstrates	   the	   unsuitability	   of	   KPS	   as	   an	   initiator	   for	   Aa	  
incorporation	  in	  polystyrene	  scaffolds.	  
	  
	  
Figure	  5.23	  Resulting	  materials	  for	  high	  levels	  of	  Aa	  incorporation	  into	  polystyrene	  scaffolds	  using	  KPS	  as	  
the	   initiator.	   (A):	   When	   x	   ≥	   13	   the	   resulting	   materials	   are	   either	   phase	   separated	   liquids	   or	   gels	   post-­‐
polymerisation.	   (B):	  Photograph	  confirming	  that	  when	  x	  =	  42	  a	  gel	   is	   formed.	   	   (C):	  SEM	   image	  confirming	  
that	  when	  x	  =	  42	  a	  gel	  is	  formed.	  	  Scale	  bar	  	  =	  1	  mm.	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5.4 Discussion	  
For	  a	  cell	  to	  successfully	  attach	  and	  survive	  on	  a	  synthetic	  scaffold	  there	  usually	  needs	  to	  be	  the	  
appropriate	  biochemical	  ligands	  present	  on	  the	  material	  surface	  for	  integrin-­‐mediated	  recognition	  
and	  binding.	   That	   is,	   the	   synthetic	   scaffold	   needs	   to	   be	   rendered	  biochemically	   relevant.	  Often	  
this	  is	  achieved	  through	  proteins	  such	  as	  fibronectin	  present	  in	  the	  serum	  or	  secreted	  by	  the	  cells	  
themselves	  pre-­‐adsorbing	  onto	  the	  substrate	  prior	  to	  cell	  attachment.	  However,	  this	  process	  can	  
often	  be	  non-­‐specific	  and	  dependent	  on	  the	  scaffolds	  affinity	  for	  protein	  deposition.	  
Scaffold	   surface	   modification	   through	   atmospheric	   plasma	   treatment	   to	   introduce	   hydrophilic	  
functionality	  is	  one	  method	  of	  aiding	  cell	  attachment	  and	  function	  in	  vitro222.	  Indeed,	  reports	  have	  
shown	   that	   plasma	   treated	   surfaces	   can	   either	   directly	   accommodate	   cell	   adhesion	   without	  
serum223	  or	   facilitate	  serum	  protein	  deposition	  to	  aid	   in	  cell	  attachment224.	  However,	  one	  major	  
limitation	   of	   plasma	   treatment	   is	   that	   the	   effect	   is	   temporary,	   such	   that	   the	  modified	   surface	  
slowly	   reverts	  back	   to	   the	  original	   state	  over	   time.	  Another	   limitation	   is	   that	  plasma	   treatment	  
does	   not	   always	   deliver	   a	   uniform	   surface	   modification,	   particularly	   for	   3D	   scaffolds.	  
Consequently,	  many	   researchers	   have	   found	   that	   covalently	   immobilising	   specific	   biomolecules	  
present	   in	  vivo	  onto	   the	  scaffold	  surface	   is	  a	  very	  effective	  approach	   to	   improving	  selective	  cell	  
adhesion	  and	  overall	  function	  in	  vitro225-­‐227.	  For	  example,	  scaffolds	  modified	  with	  specific	  peptide	  
motifs	  have	  been	   shown	   to	  greatly	  enhance	   cell	   attachment228,	  229.	   Immobilising	   specific	   growth	  
factors	   onto	   scaffolds	   has	   been	   shown	   to	   influence	   stem	   cell	   differentiation230,	   231.	   Electrospun	  
scaffolds	  surface-­‐modified	  with	  gelatin	  improved	  cell	  adhesion	  and	  viability232.	  Recognising	  these	  
benefits	  researchers	  are	  now	  striving	  towards	  3D	  scaffolds	  that	  present	  appropriate	  biochemical	  
ligands	  to	  re-­‐create	  native	  cell-­‐ECM	  interactions	  in	  vitro.	  
	  
Several	   groups	   have	   utilised	   galactose	   as	   a	   surface	   ligand	   to	   improve	  hepatocyte	   adhesion	   and	  
function	   in	   vitro,	   given	   the	   specificity	   with	   the	   hepatic	   ASGP-­‐R.	   For	   example,	   2D	   poly(ethylene	  
terephthalate)	   (PET)	   films	   have	   been	   functionalised	   with	   galactose	   and	   found	   to	   increase	  
hepatocyte	   adhesion	   and	   function	   compared	   to	   unfunctionalised	   films220,	   233.	   Chan	   et	   al.	  
demonstrated	  that	  galactose	  immobilised	  onto	  2D	  coverslips	  could	  be	  used	  to	  control	  hepatocyte	  
spreading	  and	  adhesion	  dynamics	  on	  a	  2D	  surface234.	  Galactose-­‐functionalised	  3D	  substrates	  have	  
also	   recently	  gained	  significant	  attention	  and	  review235,	  236.	  Park	  et	  al.	  galactose-­‐functionalised	  a	  
gas-­‐foamed	  PLGA	  scaffold	  and	  found	  that	  hepatocyte	  adhesion	  and	  albumin	  synthesis	  was	  greatly	  
enhanced215.	   Mao	   et	   al.	   galactose-­‐functionalised	   an	   electrospun	   scaffold	   derived	   from	  
poly(caprolactone-­‐co-­‐ethyl	   ethylene	   phosphate)	   (PCLEEP)	   and	   subsequently	   demonstrated	   its	  
suitability	   for	   primary	   rat	   hepatocyte	   culture105.	   Similarly,	   Börner	   et	   al.	   recently	   prepared	   a	  
galactose-­‐functionalised	  electrospun	  scaffold	  composed	  of	  poly(pentafluorophenyl	  methacrylate)	  
	  	   200	  
(PPfpMA)	  and	  PCL237.	  Gu	  et	  al.	  showed	  that	  galactosylated	  chitosan	  could	  be	  electrospun	  into	  3D	  
scaffolds	   that	   were	   found	   to	   increase	   hepatocyte	   albumin	   synthesis,	   urea	   synthesis	   and	  
cytrochrome	   P450	   activity	   compared	   to	   chitosan	   scaffolds106.	  Moreover,	   Yu	   et	   al.	   developed	   a	  
hydrogel-­‐based	   soft	   sponge	   conjugated	   with	   galactose	   that	   was	   found	   to	   enhance	   hepatocyte	  
adhesion	  and	  function	  over	  conventional	  collagen	  I	  sandwich	  cultures238.	  	  
	  
Despite	   the	   extensive	   reports	   described	   above,	   prior	   to	   this	   study	   there	   had	   been	   no	  
developments	   on	   the	   functionalisation	   of	   emulsion	   templated	   polystyrene	   scaffolds	   with	  
galactose.	  One	  potential	  reason	  for	  this	  is	  that	  polystyrene	  is	  relatively	  inert,	  making	  any	  surface	  
modifications	   challenging.	   Indeed,	   most	   polystyrene	   functionalisations	   first	   require	   the	  
incorporation	   of	   additional	   functional	   groups	   (e.g.	   acids,	   esters,	   amines,	   alkyl	   halides)	   onto	   the	  
surface	  to	  act	  as	  reactive	  sites	  for	  subsequent	  modifications.	  One	  route	  to	  adding	  new	  functional	  
groups	   onto	   polystyrene	   is	   post-­‐polymerisation	   modification.	   For	   example,	   Deleuze	   et	   al.	  
described	  several	  routes	  to	  additional	  functionality	  using	  the	  pendent	  vinyl	  groups	  in	  the	  polymer	  
via	   reactions	   such	   as	   bromination	   or	   hydroboration239.	   Similarly	   Sherrington	   et	   al.	   reported	  
successful	   electrophilic	   aromatic	   substitutions	   of	   the	   free	   benzene	   rings	  with	   reactions	   such	   as	  
sulfonation,	   nitration	   and	   bromination	   reactions240.	   However,	   nearly	   all	   of	   these	   post-­‐
polymerisation	  modifications	  reactions	  employ	  harsh	  reaction	  conditions	  with	  multiple	  synthesis	  
and	  washing	  steps.	  A	  more	  attractive	  route	  to	  adding	  functionality	  onto	  polystyrene	  scaffolds	  is	  to	  
include	  a	  functional	  co-­‐monomer	  into	  the	  initial	  HIPE	  mixture	  as	  a	  means	  of	  providing	  a	  reactive	  
site	  for	  subsequent	  galactose	  attachment	  post-­‐polymerisation.	  	  
	  
In	  this	  study,	  PFPA	  was	  added	  to	  the	  HIPE	  external	  phase	  to	  form	  a	  scaffold	  with	  pendent	  ester	  
functionality.	  Suitable	  open-­‐cell	  scaffolds	  were	  formed	  with	  up	  to	  33	  wt%	  PFPA	  in	  the	  monomer	  
mixture,	   however	   concentrations	   higher	   then	   this	   seemed	   to	   cause	   scaffold	   deformation	   and	   a	  
less	  open-­‐cell	  morphology.	  In	  this	  study,	  26	  wt%	  PFPA	  in	  the	  monomer	  mixture	  seemed	  to	  offer	  
the	  optimal	  scaffold	  characteristics	  for	  maximum	  PFPA	  loading.	  The	  scaffold	  displayed	  an	  average	  
void	   diameter	   of	   33	  µm	  and	   a	   porosity	   of	   92	  %,	   both	   highly	   suitable	   characteristics	   for	   3D	   cell	  
culture	   applications.	   Indeed,	   the	  material	   supported	   the	   3D	   growth	   of	   HepG2	   cells	   in	   a	   similar	  
manner	   to	  Alvetex®Scaffold.	  XPS	  analysis	   revealed	   that	   ca.	  9	  %	  of	   the	   scaffold	   surface	  could	  be	  
attributed	  to	  the	  PFPA	  ester	  reactive	  site.	  This	  loss	  of	  PFPA	  compared	  to	  the	  original	  26	  wt%	  in	  the	  
initial	   emulsion	  has	  also	  been	  observed	   in	  other	  polyHIPE	   systems218,	   and	  may	  be	  attributed	   to	  
either	  partial	  PFPA	  solubility	   in	  the	  aqueous	  phase,	  hydrolysis	  of	  the	  pentafluorophenyl	  ester	  or	  
incomplete	  PFPA	  polymerisation.	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The	   incorporation	   of	   PFPA	   into	   an	   emulsion	   templated	   polystyrene	   scaffold	   is	   consistent	   with	  
other	   literature	   reports	   employing	   similar	   hydrophobic	   functional	   co-­‐monomers	   into	   the	   pre-­‐
polymerised	   HIPE.	   For	   example,	   Heise	   et	   al.	   incorporated	   amino	   functionality	   via	   adding	   4-­‐
vinylbenzylphthalimide	   into	   the	   external	   oil	   phase241.	   Furthermore	   the	   resulting	   polyHIPE	   was	  
then	  used	  to	  subsequently	  attach	  peptide	  brushes	  for	  bioseparation	  applications242.	  Krajnc	  et	  al.	  
demonstrated	  that	  methacrylic	  acid	  could	  be	  incorporated,	  again	  adding	  the	  co-­‐monomer	  via	  the	  
oil	   phase243.	   Other	   groups	   have	   also	   added	   4-­‐vinylbenzyl	   chloride	   (VBC)	   into	   the	   oil	   phase	   to	  
deliver	  pendent	  benzyl	  chloride	  functionality	  244-­‐246.	  	  
	  
The	   pendent	   PFPA	   ester	   groups	   on	   the	   poly[26PFPA-­‐SDE(AIBN)]	  material	  were	   reacted	  with	   2ʹ′-­‐
aminoethyl-­‐β-­‐D-­‐galactopyranoside	   to	   attach	   pendent	   galactose	   residues,	   similar	   to	   the	   strategy	  
described	  by	  Boyer	  and	  Davis	  for	  solution-­‐based	  glycopolymer	  synthesis247-­‐249.	  XPS	  revealed	  that	  
ca.	  7	  –	  9	  %	  of	  the	  surface	  could	  be	  attributed	  to	  carbohydrate.	  However,	   it	   is	  hypothesised	  that	  
this	  could	  be	  significantly	  increased	  if	  amines	  carrying	  multiple	  galactose	  residues	  were	  employed.	  
The	  accessibility	  and	  selectivity	  of	  the	  pendent	  galactose	  residues	  on	  the	  poly[26PFPA-­‐SDE(AIBN)]	  
material	  was	  assessed	  via	  primary	   rat	  hepatocyte	  culture.	  During	   the	  crucial	  adhesion	  period,	  a	  
significant	   increase	   in	  albumin	   synthesis	  was	  observed	   for	   the	  galactose-­‐functionalised	   scaffold,	  
consistent	  with	  the	  reports	  described	  above	  for	  other	  2D	  and	  3D	  galactose-­‐functionalised	  in	  vitro	  
substrates.	   However,	   as	   the	   culture	   period	   progressed	   the	   albumin	   increase	   diminished.	   It	   is	  
hypothesised	   that	   the	   serum	   proteins	   are	   able	   to	   deposit	   onto	   the	   scaffold	   and	   offer	   non-­‐
selective	  binding	  of	  hepatocytes	  onto	  the	  scaffold.	  	  
	  
Aa	  was	  also	   incorporated	   into	  an	  emulsion	   templated	  polystyrene	  scaffold	  via	  addition	   into	   the	  
HIPE	   aqueous	   droplet	   phase.	  With	   this	   approach,	   a	   suitable	   scaffold	  morphology	  was	   observed	  
using	  13	  wt%	  Aa	  and	  AIBN	  as	  the	  initiator.	  The	  material	  displayed	  an	  average	  void	  diameter	  of	  19	  
µm	  and	  a	  porosity	  of	  89	  %.	  XPS	  analysis	  of	  the	  poly[13Aa-­‐SDE(AIBN)]	  scaffold	  showed	  that	  ca.	  7.5	  
%	   of	   the	   material	   surface	   could	   be	   attributed	   to	   acrylic	   acid,	   approximately	   half	   of	   what	   was	  
added	   to	   the	   HIPE	   mixture.	   Interestingly,	   using	   KPS	   as	   the	   initiator	   was	   not	   suitable	   for	   Aa	  
functionalisation	  of	  polystyrene	  scaffolds.	  This	  is	  entirely	  consistent	  with	  the	  literature.	  Silverstein	  
et	  al.	  demonstrated	  that	  acrylamide	  added	  via	  the	  aqueous	  phase	  and	  using	  KPS	  as	  the	  initiator	  
produced	   non-­‐polyHIPE	  morphologies	   	   (such	   as	   bicontinuous	   hydrophilic-­‐hydrophobic	   polymers	  
suitable	  for	  drug	  loading	  and	  release)250.	  The	  same	  report	  also	  showed	  that	  hydrophobic	  initiators	  
such	  as	  benzoyl	  peroxide	   (BPO)	  did	  produce	   typical	  polyHIPE	  morphologies,	   consistent	  with	   the	  
findings	  from	  this	  study	  employing	  AIBN.	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5.5 Conclusions	  
The	  following	  conclusions	  can	  be	  made	  from	  the	  results	  of	  this	  Chapter:	  
	  
• Galactose	   can	   be	   incorporated	   onto	   the	   surface	   of	   an	   emulsion	   templated	   polystyrene	  
scaffold,	   potentially	   improving	   the	   biochemical	   relevance	   of	   these	  materials	   for	   in	   vitro	  
hepatocyte	  culture.	  	  
	  
• Functionalisation	  was	  achieved	  by	  adding	  26	  wt%	  PFPA	   into	   the	  HIPE	  external	  oil	  phase	  
and	   polymerising	   using	   AIBN	   as	   the	   initiator.	   The	   resulting	   scaffold	   displayed	   a	   typical	  
emulsion	   templated	   polystyrene	   scaffold	   morphology	   and	   porosity	   and	   also	   supported	  
the	  3D	  growth	  of	  hepatocyte	  cells.	  	  
	  
• XPS	   analysis	   revealed	   that	   the	   ester-­‐functionalised	   scaffold	   surface	   contained	   ca.	   9%	  
ester,	  which	  could	  be	  converted	  into	  pendent	  galactose	  functionality	  via	  a	  facile	  coupling	  
reaction	  with	  2ʹ′-­‐aminoethyl-­‐β-­‐D-­‐galactopyranoside.	  	  
	  
• The	  pendent	  galactose	  on	  the	  scaffold	  surface	  was	  found	  to	  be	  accessible	  and	  selective	  to	  
hepatocytes	  growing	  on	  the	  material	  and	  actually	  enhanced	  albumin	  synthesis	  during	  the	  
crucial	  adhesion	  period.	  
	  
• This	   study	   also	   showed	   that	  Aa	   could	   also	  be	   incorporated	   into	   an	  emulsion	   templated	  
polystyrene	  scaffold	  as	  an	  alternative	   route	   towards	   surface	  galactose	   functionalisation.	  
By	  adding	  13	  wt%	  Aa	  into	  the	  HIPE	  aqueous	  internal	  phase	  and	  using	  AIBN	  as	  the	  initiator,	  
a	  typical	  emulsion	  templated	  polystyrene	  scaffold	  morphology	  was	  produced.	  	  
	  
• XPS	   analysis	   revealed	   that	   this	   acid-­‐functionalised	   scaffold	   contained	   ca.	   7	  %	   carboxylic	  
acid	   functionality,	   which	   could	   potentially	   offer	   useful	   reactive	   sites	   for	   subsequent	  
reactions	   with	   galactose-­‐amines	   (similar	   to	   the	   strategy	   employed	   with	   the	   PFPA	  
scaffold).	   This	   acid	   functionality	   did	   not	   disrupt	   the	   initial	   adhesion	   of	   Upcyte®	  
hepatocytes	  onto	  the	  material.	  	  
	  
• Finally,	   the	   choice	   of	   initiator	   is	   crucial	   for	   functionalisations	   involving	   Aa.	   A	   more	  
hydrophobic	  initiator	  such	  as	  AIBN	  can	  deliver	  the	  required	  scaffold	  morphology,	  whereas	  
hydrophilic	  initiators	  such	  as	  KPS	  either	  lead	  to	  phase	  separation	  or	  deformed	  monoliths.	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6.1 Concluding	  Remarks	  
6.1.1 Recap	  of	  Research	  Field	  and	  Project	  Aim	  
Hepatocytes	  are	  the	  main	  functional	  cells	  of	  the	  liver	  and	  play	  a	  crucial	  role	  in	  drug	  detoxification	  
and	   metabolism32,	   33.	   In	   vivo,	   hepatocytes	   adopt	   specific	   3D	   cell	   geometries	   and	   tissue	  
architectures	   as	   part	   of	   the	   lobule	   unit.	   Moreover,	   within	   the	   3D	   hepatic	   plate	   hepatocytes	  
experience	   extensive	   cell-­‐cell	   contact	   with	   adjacent	   hepatocytes	   to	   form	   specialised	   sinusoidal	  
and	   bile	   canaliculi	   domains	   that	   are	   crucial	   for	   normal	   function.	   Hepatocytes	   also	   receive	  
anchorage	   and	   biochemical	   cues	   from	   a	   surrounding	   ECM	   that	   serves	   to	   regulate	   normal	  
behaviour.	  In	  short,	  hepatocyte	  function	  in	  vivo	  is	  highly	  dependent	  on	  a	  3D	  cell	  geometry,	  tissue	  
architecture	  and	  physical	  interaction.	  	  
	  
In	  vitro	  hepatocyte	  models	  are	  a	  key	  component	  of	  drug	  discovery	   in	  predicting	  toxicity	  profiles	  
prior	  to	  in	  vivo	  trials.	  However,	  in	  order	  for	  in	  vitro	  models	  to	  be	  predictive	  of	  in	  vivo	  they	  need	  to	  
be	  physiologically	  relevant	  and	  thus	  suitably	  mimic	  the	  native	  growth	  environment.	  Traditionally,	  
plastic	   Petri	   dishes	   and	  welled	   plates	   have	   been	   used	   as	   the	   artificial	   growth	   environment	   for	  
most	   in	   vitro	   hepatocyte	   models.	   Whilst	   this	   approach	   has	   proved	   an	   extremely	   practical	   and	  
accessible	  method	  of	  cell	  growth	  in	  the	  past,	  it	  is	  now	  regarded	  as	  highly	  unrealistic.	  Hepatocytes	  
in	  2D	  are	  forced	  into	  a	  flattened	  geometry.	  Crucially,	  cell	  geometry	  influences	  cell	  genotype	  and	  
function.	   Hence	   failing	   to	   mimic	   the	   native	   cuboidal	   shape	   can	   lead	   to	   deviations	   in	   normal	  
hepatic	   function	  and	  hence	  a	   loss	  of	  predictive	  accuracy	   in	   the	  model.	  Furthermore,	  2D	  models	  
severely	   limit	   cell-­‐cell	   contact	   between	   adjacent	   hepatocytes,	   which	   in	   turn	   can	   reduce	  
polarisation	   and	   the	   formation	   of	   important	   structural	   features	   such	   as	   sinusoidal	   and	   bile	  
canaliculi	   domains76.	  Unsurprisingly,	  most	  2D	  hepatocyte	  models	   cause	  a	   rapid	  deviation	   in	   cell	  
genotype	  and	  phenotype	  and	  thus	  deliver	  a	  poor	  prediction	  of	  a	  drug’s	  toxicity	  profile.	  	  	  
	  
Recognising	  the	   limitations	  of	  2D	  culture	  substrates	  there	   is	  now	  a	  strong	  demand	  for	  materials	  
that	   can	   offer	   hepatocytes	   a	   3D	   interface	   for	   growth57.	   By	   adding	   the	   third	   dimension	   to	   the	  
growth	   substrate,	   cells	   can	   more	   readily	   approximate	   their	   native	   3D	   geometry	   and	   tissue	  
architecture.	  This	  in	  turn	  encourages	  cell-­‐cell	  interactions	  to	  preserve	  key	  hepatic	  features	  such	  as	  
sinusoidal	   and	  bile	   canaliculi	   domains.	   	   It	   is	   therefore	  hypothesised	   that	   3D	  hepatocyte	  models	  
will	   promote	   a	   more	   realistic	   hepatocyte	   genotype	   and	   phenotype	   and	   thus	   produce	   more	  
accurate	  predictions	  of	  a	  drug’s	  toxicity	  profile.	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There	   are	   many	   technologies	   being	   developed	   for	   3D	   cell	   culture.	   Sandwiching	   cells	   between	  
layers	  of	  ECM	  proteins	  helps	  to	  preserve	  hepatocyte	  geometry	  and	  the	  formation	  of	  bile	  canaliculi	  
domains.	  However,	  this	  approach	  fails	  to	  mimic	  extensive	  3D	  organisation.	  Spheroid	  cultures	  and	  
hydrogels	  promote	  3D	  aggregates,	  although	  they	  pose	  issues	  with	  mass	  transfer	  of	  nutrients	  and	  
batch-­‐to-­‐batch	   consistency.	   Electrospun	   scaffolds	   are	   versatile	   and	   commercially	   available,	  
however	  they	  often	  have	  poor	  mechanical	  strength	  properties	  and	  only	  really	  encourage	  ‘pockets’	  
of	  3D	  cell	  growth	  where	  fibres	  overlap.	  Rapid	  prototyping	  is	  showing	  great	  promise	  for	  obtaining	  
reproducible	  and	  chemically	  inert	  in	  vitro	  scaffolds,	  although	  they	  are	  currently	  far	  too	  expensive	  
for	   broad	   application	   such	   as	   drug	   discovery.	   Porous	   polymers	   derived	   from	   conventional	  
techniques	   such	   as	   particle	   leaching,	   gas	   foaming	   or	   phase	   separation	   are	   also	   potential	  
candidates	   for	   3D	   scaffolds,	   although	   they	   carry	   issues	   with	   reproducibility	   and	   residual	  
contaminants	  that	  have	  severely	  limited	  their	  commercialisation	  for	  routine	  3D	  cell	  culture.	  
	  
Polystyrene	  scaffolds	  derived	  from	  emulsion	  templating	  are	  attractive	  materials	  as	  substrates	  for	  
3D	   hepatocyte	   growth	   for	   several	   reasons.	   They	   are	   essentially	   just	   an	   alternative	   geometric	  
version	  of	   the	  well-­‐known	  Petri	  dish.	  They	  are	  highly	  uniform	  and	   reproducible,	  enabled	  by	   the	  
strict	  control	  of	  processing	  parameters.	  They	  are	  highly	  porous,	  ensuring	  effective	  mass	  transfer	  
of	  nutrients	  throughout	  the	  3D	  cell	  mass.	  They	  are	  chemically	  inert,	  allowing	  them	  to	  be	  storable	  
products	  with	  sufficient	  robustness	  to	  typical	  laboratory	  processing	  chemicals.	  They	  have	  suitable	  
mechanical	  strength	  properties	  to	  support	  the	  weight	  of	  large	  cell	  numbers.	  They	  are	  also	  already	  
commercially	  available	  and	  can	  be	  supplied	  in	  typical	  welled-­‐plate	  formats.	  	  
However,	  prior	  to	  this	  thesis	  the	  suitability	  of	  polystyrene	  scaffolds	  for	  3D	  hepatocyte	  culture	  had	  
not	   been	   fully	   determined.	   Little	   was	   known	   about	   the	   optimum	   culture	   conditions	   for	  
approximating	   native	   hepatocyte	   growth	   in	   these	   materials.	   Hepatocyte	   geometry	   and	  
ultrastructure	   were	   not	   fully	   characterised.	   Hepatocyte	   function	   and	   gene	   expression	   in	  
polystyrene	  scaffolds	  was	  also	  poorly	  understood.	  There	  was	  also	  the	  question	  of	   improving	  the	  
biochemical	  relevance	  of	  the	  polystyrene	  surface,	  and	  if	  this	  could	  be	  modified	  with	  ligands	  such	  
as	  galactose	  to	   further	   improve	  hepatocyte	  adhesion	  and	  function.	  This	   thesis	   therefore	  set	  out	  
to:	  
	  
• Explore	  hepatocyte	  growth	  in	  polystyrene	  scaffolds	  under	  different	  culture	  conditions	  to	  
re-­‐create	  native	  liver	  tissue	  architecture	  in	  vitro.	  
• Compare	  structure,	  function	  and	  gene	  expression	  of	  hepatocytes	  cultured	  in	  polystyrene	  
scaffolds	   with	   to	   2D	   cultures	   and	   in	   vivo.	   The	   broad	   aim	   here	   was	   to	   determine	   if	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polystyrene	   scaffolds	   enable	   the	   preservation	   of	   key	   structure-­‐function-­‐genetic	  
relationships	  in	  vitro.	  
• Surface	   modify	   polystyrene	   scaffolds	   with	   galactose	   for	   further	   enhanced	   biochemical	  
relevance.	  
	  
6.1.2 Summary	  of	  Thesis	  Conclusions	  
The	  following	  conclusions	  that	  can	  be	  drawn	  from	  the	  study:	  	  
	  
• Emulsion	   templated	  polystyrene	   scaffolds	   can	   support	   the	  3D	  growth	  of	  hepatocytes	   in	  
vitro	   to	   approximate	   native	   liver	   tissue	   density	   and	   growth.	   Three	   different	   hepatocyte	  
sources	   were	   used	   to	   demonstrate	   this;	   HepG2	   cells,	   Upcyte®	   cells	   and	   primary	   rat	  
hepatocytes.	  All	  three	  hepatocyte	  sources	  adhered	  and	  remained	  viable	  on	  the	  scaffolds.	  
Scaffolds	   with	   larger	   voids	   (Alvetex®Scaffold)	   encouraged	   cell	   growth	   within	   the	  
membrane	  whereas	  scaffolds	  with	  smaller	  voids	  (Alvetex®Strata)	  encouraged	  cell	  growth	  
on	   top	   of	   the	   membrane.	   Manipulation	   of	   culture	   conditions	   was	   found	   to	   alter	   the	  
growth	   characteristics	   of	   the	   cells	   on	   the	   scaffolds,	   with	   contact	   cultures	   encouraging	  
growth	  profiles	  very	   similar	   in	   cell	  density	   to	   in	   vivo.	   Furthermore,	   conventional	   culture	  
optimisations	  such	  as	  ECM	  protein	  coatings	  and	  media	  perfusions	  were	  also	  found	  to	  be	  
suitable	   for	   polystyrene	   scaffolds	   to	   replicate	   native	   cell-­‐ECM	   interactions	   and	   steady-­‐
state	  nutrient	  conditions.	  	  
	  
• Hepatocytes	  cultured	  in	  polystyrene	  scaffolds	  are	  more	  physiologically	  relevant	  compared	  
to	   2D	  hepatocyte	  models.	  Hepatocytes	   in	   scaffolds	   displayed	   a	  more	   representative	   3D	  
morphology	   compared	   to	   those	   cultured	   in	   2D.	   This	   was	   demonstrated	   by	   several	  
techniques,	   including	  histological	   diameter	   analysis,	   confocal	   immunofluorescence,	   SEM	  
and	   TEM.	   	   Hepatocyte	   ultrastructure	   in	   scaffolds	  was	   also	  more	   comparable	   to	   in	   vivo,	  
unlike	  2D	  culture;	  hepatocytes	   in	  scaffolds	  showed	  signs	  of	  microvilli,	  bile	  canaliculi	  and	  
tight	  junction	  complexes	  that	  are	  present	  in	  vivo	  but	  almost	  absent	  in	  2D	  culture.	  Indeed,	  
when	   culturing	   hepatocytes	   on	   top	   of	   small-­‐void	   polystyrene	   scaffolds,	   extensive	   bile	  
canaliculi	   were	   observed.	   There	   were	   even	   signs	   of	   structural	   re-­‐organisation	   towards	  
lumen-­‐type	   features	   comparable	   to	   the	   sinusoidal	   lumens	   found	   in	   native	   liver.	  
Importantly,	   these	   structural	   differences	   between	   3D	   and	   2D	   hepatocyte	   cultures	  
translated	   into	   functional	   and	   genetic	   differences.	   Hepatocytes	   cultured	   in	   3D	   showed	  
enhanced	   albumin	   synthesis,	   urea	   synthesis	   and	   a	   different	   response	   to	   toxicological	  
challenge.	   They	   also	   showed	   a	   shift	   towards	   more	   representative	   gene	   expression	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profiles.	   Indications	   of	   even	   more	   enhanced	   function	   were	   observed	   for	   3D	   perfused	  
systems,	  evident	  by	  the	  increased	  in	  CY3A4	  activity	  over	  static	  3D	  cultures.	  
	  
• Emulsion	   templated	  polystyrene	   scaffolds	   can	  be	  made	  more	  biochemically	   relevant	   by	  
surface	  modification	  with	  galactose,	  a	  ligand	  that	  can	  selectively	  bind	  to	  hepatocytes	  via	  
the	   ASGP-­‐R.	   Two	   new	   functional	   polystyrene-­‐based	   scaffolds	   were	   developed	   in	   the	  
galactose-­‐attachment	   process;	   one	   carrying	   pendent	   ester	   functionality	   and	   the	   other	  
acid	   functionality.	   These	   scaffolds	   had	   physical	   properties	   typical	   to	   that	   of	   the	  
commercial	  Alvetex®Scaffold.	  The	  ester-­‐containing	   scaffold	  was	   then	  easily	  modified	  via	  
coupling	  with	  a	  galactose-­‐amine	  to	  attach	  pendent	  galactose.	  This	  pendent	  galactose	  on	  
the	   scaffold	   surface	   was	   found	   to	   enhance	   hepatocyte	   albumin	   synthesis	   during	   the	  
crucial	  adhesion	  period.	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6.2 Future	  work	  
A	  3D	  hepatocyte	  model	  using	  polystyrene	  scaffolds	  is	  now	  in	  place	  that	  approximates	  native	  liver	  
tissue	   density	   and	   architecture.	  Within	   this	   3D	  model	   hepatocyte	   structure	   function	   and	   gene	  
expression	  are	  more	  physiologically	   relevant	  compared	   to	  2D.	  Moreover,	   there	   is	  also	  potential	  
for	   these	   polystyrene	   scaffolds	   to	   be	  made	  more	   biochemically	   relevant	   via	   the	   attachment	   of	  
galactose	  onto	  the	  surface.	  	  
However,	  significant	  work	  still	  remains	  in	  this	  area.	  The	  following	  points	  are	  regarded	  as	  the	  key	  
next	  steps	  in	  the	  project:	  
	  
• Expanding	   and	   validating	   drug	   toxicity	   profiles	   in	   polystyrene	   scaffolds.	   This	   thesis	   has	  
shown	  that	  there	  is	  a	  different	  functional	  response	  to	  drug	  exposure	  in	  3D	  compare	  to	  2D.	  
The	  next	  step	  is	  now	  to	  use	  primary	  hepatocyte	  cultures	  to	  expand	  the	  range	  of	  drugs	  to	  
build	   a	   more	   comprehensive	   understanding	   of	   model	   predictive	   accuracy.	   A	   variety	   of	  
different	   drugs	   should	   be	   explored	   with	   different	   metabolism	   profiles.	   Hepatocytes	  
should	   then	   be	   assessed	   for	   viability,	   enzyme	   induction,	   metabolite	   formation	   and	  
necrosis/apoptosis	   during	   drug	   exposure.	   Crucially,	   the	   data	   should	   be	   compared	   with	  
known	   in	  vivo	  toxicity	  profiles	  (LD50	  values)	  for	  the	  appropriate	  species	  to	  understand	  if	  
3D	  models	  are	  indeed	  more	  predictive.	  	  
	  
• Microarray	   analysis	   of	   RNA	   expression	   in	   polystyrene	   scaffolds.	   This	   study	   showed	   that	  
RNA	  expression	   is	  different	   in	  2D	  and	  3D.	  This	  needs	  to	  be	  expanded	  further	  to	  explore	  
the	   broader	   genotype	   and	   then	   compared	   with	   in	   vivo.	   Microarray	   analysis	   (high-­‐
throughout	   genetic	   analysis)	   should	   be	   used	   for	   this	   and	   then	   subsequently	   validated	  
using	  real-­‐time	  quantitative	  PCR.	  
	  
• Proteomic	   studies.	   Whilst	   this	   study	   indicated	   differences	   in	   hepatic	   specific	   protein	  
synthesis	   (albumin),	   there	   is	   also	   a	   need	   to	   compare	   the	   wider	   proteome	   in	   scaffolds	  
versus	  in	  vivo.	  	  	  
	  
• Long-­‐term	  hepatocyte	  culture	  using	  the	  perfusion	  model.	  This	  study	   introduced	  a	  media	  
perfusion	  model	  for	  3D	  hepatocyte	  culture	  in	  polystyrene	  scaffolds.	  This	  perfusion	  system	  
now	   needs	   to	   be	   developed	   for	   optimum	   flow	   rate,	   cell	   seeding	   density	   and	   scaffold	  
presentation	   to	   enable	   long-­‐term	   hepatocyte	   viability	   (post	   3	   weeks).	   Furthermore,	   an	  
extensive	   characterisation	   of	   hepatocyte	   gene	   expression	   and	   function	   needs	   to	   be	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performed	   for	  perfusion	  cultures.	  Long-­‐term	  perfusion	  cultures	  should	   then	  be	  used	   for	  
prolonged	  drug	  exposure	  studies.	  	  
	  
• Development	   of	   a	   3D	   co-­‐culture	   model.	   This	   study	   only	   investigated	   hepatocytes.	  
However,	   the	   native	   liver	   has	   many	   other	   cells	   types	   that	   contribute	   to	   normal	  
hepatocyte	   function	   and	   drug	   metabolism.	   Co-­‐culture	   involving	   liver	   non-­‐parenchymal	  
cells	  and	  hepatocytes	  could	  therefore	  further	  enhance	  the	  physiological	  relevance	  of	  the	  
model	  and	  improve	  predictive	  accuracy.	  One	  method	  of	  co-­‐culture	  could	  be	  to	  simply	  mix	  
the	  different	  cell	   types	  and	  allow	  them	  to	  grow	  in	  the	  scaffold.	  Alternatively,	  some	  cells	  
could	  be	  seeded	  into	  the	  scaffold	  whilst	  other	  cell	  types	  could	  be	  grown	  as	  2D	  monolayers	  
below	  the	  scaffold	  inserts.	  
	  
• Culture	   of	   hepatic	   progenitor	   cells.	   	   Freshly	   isolated	   primary	   human	   hepatocytes	   are	  
limited	   in	   supply.	   Using	   hepatocyte	   progenitor	   cells	   as	   a	   potentially	   limitless	   supply	   of	  
mature	  hepatocytes	  could	  therefore	  have	  huge	  implications	  for	  drug	  toxicity	  studies	  as	  a	  
readily	  available	  and	  relevant	  hepatocyte	  source.	  Understanding	   if	  polystyrene	  scaffolds	  
can	  provide	  the	  appropriate	  stem-­‐cell	  niche	  to	  encourage	  hepatic	  progenitor	  cells	   into	  a	  
differentiated	   hepatocyte	   lineage	   could	   have	   important	   implications	   for	   managing	   the	  
supply	  of	  primary	  hepatocytes	  and	  thus	  reducing	  the	  need	  for	  animal	  sacrifice.	  	  
	  
• Further	  surface	  modifications	  with	  galactose.	  	  This	  study	  provided	  proof-­‐of-­‐principle	  that	  
emulsion	  templated	  polystyrene	  scaffolds	  could	  be	  surface	  functionalised	  with	  galactose	  
for	   enhanced	   hepatocyte	   function	   during	   adhesion.	   A	   key	   next	   step	   is	   to	   increase	   the	  
amount	   of	   galactose	   on	   the	   material	   by	   coupling	   the	   PFPA-­‐containing	   scaffold	   with	  
amines	   containing	  multiple	   galactose	   residues.	   There	   is	   also	   the	   potential	   to	   provide	   a	  
spacer/linker	   to	   separate	   the	   galactose	   from	   the	   scaffold	   and	   so	   potentially	   render	   the	  
carbohydrate	   more	   accessible	   to	   the	   cells.	   A	   better	   understanding	   of	   the	   impact	   of	  
galactose-­‐functionalised	  scaffolds	  on	  hepatocyte	  structure	  and	  function	  also	  needs	  to	  be	  
determined.	  
	  
• Towards	  an	  optimum	  3D	  hepatocyte	  model.	  The	  impact	  of	  using	  galactose-­‐functionalised	  
scaffolds	   combined	   with	   media	   perfusion	   and	   co-­‐culture	   with	   non-­‐parenchymal	   cells	  
should	   be	   explored.	   It	   is	   hypothesised	   that	   this	   model	   provides	   the	   relevant	   physical	  
environment	   (scaffold),	   surface	   chemistry	   (galactose),	   mass	   transfer	   (perfusion)	   and	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cellular	   interaction	   (co-­‐culture)	   for	   more	   appropriately	   mimicking	   the	   native	   liver	  
scenario.	  
	  
• Comparing	   polystyrene	   scaffold	   cultures	   with	   other	   3D	  models.	   Throughout	   this	   thesis	  
several	   other	   3D	   substrates	   have	   been	   discussed	   for	   3D	   hepatocyte	   growth,	   including	  
hydrogels,	   electrospun	   scaffolds,	   rapid	   prototyping	   scaffolds	   and	   sandwich	   cultures.	  
Consistent	   with	   results	   from	   this	   thesis,	   many	   of	   these	   other	   3D	   technologies	   have	  
demonstrated	   improvements	   in	   cell	   geometry,	   genotype	   and	   phenotype	   compared	   to	  
conventional	   2D	   cultures.	   However,	   a	   direct	   comparison	   between	   these	   different	   3D	  
technologies	   is	   yet	   to	   be	   made.	   Performing	   this	   comparison	   will	   give	   researchers	   an	  
informed	   choice	   on	   the	   suitability	   of	   each	   technology	   for	   their	   specific	   experimental	  
needs.	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